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Background: Emerging adulthood (EA) is a developmental period between the ages of 18-29 
that is characterized by numerous life transitions, as well as high rates of psychological distress 
and onset of several psychological disorders. Despite a high need for mental health services, EA 
are more likely to disengage from psychological treatment than other age groups, prompting a 
national policy review on mental health care systems and EA. Lack of comprehensive research 
on mental health needs and service use patterns among EA, as well as gaps in coordinated care 
across health systems, were two major issues identified in the report. To address these gaps, this 
thesis focuses on investigating clinical characteristics among EA receiving care in inpatient 
psychiatry, emergency departments (EDs), and community mental health agencies across 
Canada, with a particular focus on issues related to anxiety.    
Study one: While several research studies have explored mental health trends among EA in 
general and post-secondary settings, relatively little is known about individuals accessing formal 
mental health services. To determine clinical needs and service use patterns among EA in these 
settings, interRAI mental health assessment data for 18- to 35-year-olds were obtained from 
three sources: 1) Resident Assessment Instrument – Mental Health (RAI-MH) data from all 
inpatient psychiatric hospitals and units across Ontario between 2005-2019 (n=85,762); 2) 
Community Mental Health (CMH) data from participating agencies across Ontario between 
2005-2006 and 2017-2019, as well as Newfoundland between 2012-2014 (n=2,548) and; 3) 
Emergency Screener for Psychiatry (ESP) data from participating departments across Ontario 
between 2013-2014 and 2018-2019 (n=1,368). While clinical needs did not vary greatly across 
age groups within EA, a notable exception was observed for substance use, with more non-
primary substance use disorders and recent cannabis use among those aged 18-25. Across care 
settings, clinical characteristics often reflected aspects of system design, such as greater risk of 
harm to self and others in inpatient psychiatry and more severe symptoms of depression and 
social withdrawal in community mental health. Unlike the other two settings, the ED observed a 
greater proportion of primary to non-primary anxiety disorders, signaling potential gaps in 
continuity of care for anxiety. The depth of information provided in this study can be used to 
support research targeted at improving coordination of mental health care for EA across Canada.   
Study two: To adequately measure anxiety for clinical practice and research, a symptoms scale 
is needed in addition to diagnosis, but one has not yet been developed for the interRAI 
assessment instruments. This study fills this gap by creating an initial interRAI anxiety scale 
using data available through the RAI-MH. Admission and discharge assessments were obtained 
for adults aged 18+ from 2005-2019, representing all psychiatric inpatient hospitals and units 
across Ontario (n=237,862). Six items representing psychological symptoms of anxiety were 
tested, as well as five somatic health items. Factor analysis revealed that a unidimensional factor 
comprised of only the six psychological indicators was the best fit for the data (CFI=0.94, 
RMSEA=0.08), and so an additive, continuous scale was created. However, latent class analysis 
(LCA) and item response theory (IRT) revealed that the compulsive behaviour item did not 
perform well in the scale, and so an alternative version with five items was created, as well as a 
class-based structure representing frequency of symptom occurrence. Finally, decision tree 
algorithms were also developed, incorporating complex interactions between psychological and 
somatic symptoms. After testing each version through logistic regression analyses with anxiety 
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disorders, the five-item continuous scale was selected as the best candidate (c=0.70). Criterion 
validity measures of the anxiety scale were explored, as well as responsiveness to treatment, 
providing support for the creation of an anxiety scale using interRAI items. Although new items 
may be needed to complete the scale, such as social anxiety and generalized anxiety symptoms, 
the initial version can be used in research and clinical practice to address issues related to 
anxiety.  
Study three: Although anxiety disorders are prominent in the general population and are a major 
driver of emergency department visits among youth and EA, they have traditionally been rare in 
psychiatric hospitals. As rates of anxiety increase in health care settings, it is important to 
understand the current treatment patterns for individuals admitted to hospital with anxiety. Using 
RAI-MH admission data from 2005-2019 for EA aged 18-30 (n=65,528), as well as short-stay 
data (n=98,607), several treatment and social resource variables were examined using anxiety 
disorders and symptoms. Symptoms of anxiety shared a more consistent pattern with symptoms 
of depression than vice versa, indicating that anxiety is often treated as comorbid to depression in 
psychiatric hospitals. This is consistent with primary anxiety disorders demonstrating greater 
odds of short-stay hospitalizations (OR=1.78), with increasing severity of anxious symptoms 
decreasing the odds (OR=0.77-0.26). Opposite effects of anxiety disorders and symptoms were 
also observed for social resource variables, such as lower odds of staff reporting frustration when 
anxiety disorders were present (OR=0.66-0.56), but greater odds as symptoms of anxiety 
increased (OR=1.23-2.65). The results of this chapter indicate that anxiety is a major concern for 
EA seeking psychiatric help, and to properly address this need, both diagnoses and symptoms are 
required to gain a holistic understanding of care patterns and outcomes. 
Conclusions: Cross-sectoral mental health research that identifies gaps in continuity of care 
among EA is urgently needed to address high rates of disengagement from treatment in this 
population. To fulfill this need, this thesis provided information on clinical characteristics and 
service use of EA accessing inpatient psychiatry, ED, and community mental health settings. To 
better promote care for EA experiencing anxiety, an initial anxiety scale was created for the 
interRAI health assessment instruments, containing five psychological indicators of anxiety. The 
anxiety scale was then used to examine treatment patterns among EA receiving services in 
psychiatric hospitals and units, revealing that anxiety disorders and anxious symptom severity 
have opposite effects on care outcomes and social resources. Altogether, identifying the needs 
and service use patterns of EA is essential for building an evidence-based mental health system 
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1.1 Emerging adulthood and mental health  
Mental illness affects approximately one-fifth of Canadians each year, with elevated rates in 
younger age groups (Smetanin et al., 2011). While risk of developing mental illness has been 
well-researched in childhood and adolescence, less attention has been given to young adults, 
even though one-quarter of lifetime psychological disorders begin in the mid-20s (Kessler et al., 
2007). This age group is often referred to as emerging adulthood (EA), which is the 
developmental period marking the transition between adolescence and adulthood (Arnett, 2000; 
Arnett, 2007). Characterized by personal exploration, identity formation, newly acquired 
independence, and increased responsibility, EA occurs roughly between the ages of 18-29 in 
industrialized societies (Arnett, 2000; Arnett, 2007; Arnett, Žukauskienė, & Sugimura, 2014). 
Compared to other age groups in Ontario, EA have the highest rates of disengagement from 
mental health treatment despite higher rates of mental illness (Edlund et al., 2002), with 
especially low treatment rates for anxiety (O’Donnell et al., 2017; Roberge, Fournier, Duhoux, 
Nguyen, & Smolders, 2011). Disruptions in treatment among EA occur for a variety of reasons, 
such as poor transitions between youth and adult mental health systems, lack of coordination 
between care providers, and insufficient knowledge surrounding clinical needs. To create a better 
mental health system for EA, it is necessary to identify their clinical needs and pinpoint where 
gaps in treatment are occurring, particularly for those with anxiety. This dissertation will provide 
information on clinical characteristics and service use among EA in psychiatric hospital, 
emergency department (ED), and community mental health settings. By comparing patterns 
across these settings, disparities in the clinical symptoms that are treated across systems can be 
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identified, which can provide clues about risk factors for disengaging from treatment. The utility 
of this approach is extended by the creation of a new anxiety symptoms scale, which is then used 
to examine patterns of psychiatric hospital care and treatment resources associated with anxiety 
among EA. Policy decision-makers and service providers can make use of this information to 
adapt to unmet needs among EA and improve collaborative care structures. 
The length of time in which EA are exploring personal identity, social relationships, and 
occupational pathways has gradually increased since the 1950s (Arnett, 2000), which is reflected 
in recent sociodemographic trends among 18- to 29-year-olds. For example, more Canadian EA 
are enrolled in post-secondary education, living with parents or roommates, postponing 
marriage/common-law relationships and age at first birth, and delaying entry into the labour 
force (Galarneau et al., 2013). These sociodemographic shifts have unique implications for 
mental health of EA, both as an age group and a recent generational cohort. Longitudinal 
population health data obtained through Statistics Canada revealed that trends in education, 
occupation, and marital status were major protective and risk factors for psychological distress 
and accounted for the variance related to age and cohort (Drapeau, Marchand, & Forest, 2014). 
For example, the absence of post-secondary education was a risk factor for increased distress 
among men aged 18-39, while unemployment predicted distress in recent cohorts of women. 
Additionally, not having a spouse was a risk factor for psychological distress among all age 
groups except for women over the age of 60. Adverse effects on mental health resulting from 
reduced access to educational and occupational opportunities, as well as not having a spouse, can 
all be connected further to financial insecurity, which is a major predictor of psychological 
distress reported by EA (Newcomb-Anjo, Barker, & Howard, 2017; Power et al., 2015). Since 
instability in occupation, education, financial resources, and social relationships are heightened 
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during EA, especially in more recent cohorts, this may be one reason that lower mood (McNeil, 
Stones, Kozma, & Andres, 1994) and increased psychological distress are more prominent in this 
age group than others (Arnett et al., 2014; Drapeau et al., 2014; Smetanin et al., 2011). However, 
while sociodemographic factors during EA can increase psychological distress, they can also act 
as protective factors. For example, formation of new social networks has been associated with 
positive psychological well-being among EA, as well as stronger familial relationships 
(O’Connor et al., 2011). Further, EA report greater psychological well-being when they believe 
that many personal and occupational opportunities are available to them (Baggio, Studer, 
Iglesias, Daeppen, & Gmel, 2017). These factors may explain why participation in higher 
education was associated with lower risk of depression in a Canadian cohort (Colman et al., 
2014), since post-secondary institutions can provide opportunities for students to move away 
from home, build new relationships, and fulfill occupational aspirations (Taylor, Doane, & 
Eisenberg, 2014). Holistic mental health care for EA must account for the influence of these 
sociodemographic factors, which can contribute both negatively and positively towards mental 
health. 
In addition to several major life transitions, the age range for EA also coincides with the 
average age-of-onset for multiple psychological disorders (APA, 2013; Kessler et al., 2007; 
Pearson et al., 2013; Schulenberg & Zarrett, 2006; Smetanin et al., 2011). For example, while 
substance use often begins during adolescence, substance use disorders are most frequently 
diagnosed between the ages of 18-25 (APA, 2013; Kessler et al., 2007; Pearson et al., 2013). 
Similarly, most types of anxiety and depressive disorders are diagnosed in the mid-20s (APA, 
2013; Kessler et al., 2007; Pearson et al., 2013). Although they are rarer in the general 
population, the average developmental onset for schizophrenia, bipolar disorder, and sleep 
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disorders also falls within the period of EA (APA, 2013). It is possible that neurobiological 
changes, in combination with numerous stressful life events, are what lead some psychological 
disorders to develop at higher rates during EA (Schulenberg & Zarret, 2006). Despite elevated 
rates of mental illness, research has shown that few EA engage in mental health treatment 
(Substance Abuse and Mental Health Services Administration [SAMHSA], 2012; Statistics 
Canada, 2012), especially those who experience anxiety (O’Donnell et al., 2017; Roberge et al., 
2011). In Ontario, EA have the highest rates of disengagement from treatment of any age group 
(Edlund et al., 2002), indicating that the mental health system does not respond to their unique 
needs.  
1.2 Mental health care system in Ontario, Canada 
To determine why EA do not consistently engage in treatment for symptoms of mental illness, it 
is necessary to broadly understand how the mental health system is organized. The Canada 
Health Act is the national policy outlining the legal responsibilities for all publicly funded health 
care services and is based on five principles: universality, comprehensiveness, portability, 
accessibility, and public administration (Health Canada, 2021). To ensure that provinces and 
territories have sufficient funding to enact each of these principles, the Canada Health Transfer 
was written into the Act, which is a shared funding transfer agreement between the federal and 
provincial/territorial governments. In this agreement, the federal government transfers health 
care funds per capita to each province and territory to be used in subsidizing their unique health 
insurance plans. As part of the universal and comprehensive requirements of the Act, 
provincial/territorial health insurance plans must ensure that sufficient funds are allocated to 
fully compensate all residents for services that are deemed medically necessary, including 
diagnostic and treatment resources provided by EDs and psychiatric hospital units (Government 
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of Ontario, 2021b). Further, health insurance plans are also ‘portable,’ meaning that residents 
will be covered by their home province/territory for up to three months if they move to another 
province/territory, and if they have left Canada for a limited amount of time (Health Canada, 
2021).  
While each provincial/territorial government regulates the comprehensiveness, universality, 
and portability of their health insurance plans, the Act stipulates that as part of the public 
administration component, the management and provision of insured health care services be 
handled by not-for-profit health authorities. Until recently, the Ontario Ministry of Health was 
the provincial body overseeing health care, with regional health authorities separated into 14 
distinct Local Health Integration Networks (LHINs) (Office of the Auditor General of Ontario 
[OAGA], 2017). Each LHIN corresponded to a geographic region that oversaw financial 
compensation, operation, and monitoring of health care services, including public and private 
hospitals and certain community mental health organizations. Beginning in 2019, the 
Government of Ontario dissolved the LHIN system and created Ontario Health, which manages 
health care delivery across the province through five transitional geographic regions (Ontario 
Health, 2019). In 2020, Ontario Health created The Mental Health and Addictions Centre of 
Excellence to oversee mental health care delivery across the province (Ontario Health, 2020). 
However, while the Ontario Ministry of Health and Ontario Health are responsible for delivering 
mental health care to adults (aged 18+), mental health care for children and youth (0-18 years) is 
handled by the Ontario Ministry of Children, Community, and Social Services (MCCS) (2016) 
under the Child and Family Services Act (CFSA) (MCCS, 2016). As a result, the child/youth and 
adult mental health systems are handled by separate ministries according to chronological age, 
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meaning that youth accessing mental health treatment in Ontario will need to transition to the 
adult system once they turn 18 (Mental Health Commission of Canada [MHCC], 2015). 
In practice, the transition between the youth and adult mental health systems can be a 
difficult process for many individuals due to differences in funding allocation of services 
(MHCC, 2015), which is in opposition to the final principle of the Canada Health Act – 
accessibility. In addition to ensuring comprehensive and universal coverage of medically 
necessary services, health care services should be readily accessible to all citizens, regardless of 
their health status or financial resources. Despite the intention to provide accessible, universal 
health care, most types of mental health treatments are not covered under the Canada Health Act 
(Health Canada, 2021) or the provincial health insurance plans for adults. In Ontario, only the 
provision of emergency hospital services and primary care consultations are considered 
medically necessary (Government of Ontario, 2021b), creating financial barriers towards 
community-based services that are antithetical to the values of the Act. As a partial result of 
these financial impediments, even though the estimated prevalence of mental illness in the 
population is approximately 20% in any given year (Smetanin et al., 2011), self-reported mental 
health service use was 10.9% in 2012 (Statistics Canada, 2012). Financial obstacles are 
compounded further for EA who are transitioning from the youth to the adult mental health 
system, as the MCSS covers a variety of community mental health services up to the age of 18 
(Government of Ontario, 2021a), but the adult health insurance plan does not (Government of 
Ontario, 2021b). Although private health insurance plans may cover some community-based 
mental health care costs, many EA do not have jobs that offer these types of plans and are 
ineligible to benefit from parents’ plans at a certain age (Canadian Medical Association [CMA] 
& Canadian Psychiatric Association [CPA], 2016). Shifts in the financial requirements for 
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psychological treatment between the youth and adult mental health systems causes substantial 
disruptions to continuity of care among EA, who demonstrate the highest rates of mental health 
treatment attrition of any age group (Edlund et al., 2002). Due to these gaps in financial 
coverage, patterns of service use vary substantially between hospital and community-based 
mental health services, reducing the efficiency of emergency services as a result. 
1.2.1 Emergency and inpatient psychiatric services 
Emergency departments (EDs) assist in stabilizing acute psychiatric crises and are considered an 
essential medical service under the Ontario provincial health plan (Government of Ontario, 
2021b). Emergency psychiatry is typically provided in the ED of general hospitals (Canadian 
Institute for Health Information [CIHI], 2019b), but may also be delivered through crisis clinics 
or mobile intervention teams, particularly in rural areas where there are fewer ED resources 
(Lofchy, Boyles, & Delwo, 2015). To receive treatment in the ED, no health referrals are 
required, meaning that individuals can access them freely as needed (Health Canada, 2021). The 
types of mental health services offered in the ED involve assessment, diagnosis, and treatment of 
acute symptoms of mental illness, though medical treatment may also be necessary, such as in 
cases of self-harm and substance abuse (Allen et al., 2002). These services are delivered by an 
emergency psychiatry team typically consisting of psychiatrists, psychiatric nurses, medical 
doctors and nurses, and other types of clinicians (e.g., psychologists) (Lofchy et al., 2015). The 
most common psychological emergencies that service providers are trained to treat in the ED 
include emotional and behavioural agitation, suicide, substance use-related problems, and 
comorbidities between psychological and medical conditions. Following stabilization of 
psychological and medical symptoms, individuals may be discharged home with or without 
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referrals to community services, into a community residence, or into the hospital for ongoing 
psychiatric care (Lofchy et al., 2015). 
While the ED is designed to help treat acute and severe symptoms of mental illness, 
evidence suggests that many individuals visit the ED for non-acute mental health needs when 
they are unable to access care in the community (Canadian Mental Health Association [CMHA], 
2008). For instance, a qualitative study performed in an ED located in London, Ontario reported 
that several individuals seeking mental health care presented with concerns related to 
sociodemographic stressors such as housing, finances, and interpersonal conflict (Coristine, 
Hartford, Vingilis, & White, 2006). Among youth with or without acute mental health 
symptoms, the ED may also serve as an initial entry point into the mental health system (CMHA, 
2008). For instance, one-third of all Ontarians accessing the ED for psychiatric treatment have 
not previously been treated for a mental health issue (Brien, Grenler, Kapral, Kurdyak, & Vigod, 
2015), though this rate rises to 40-50% when looking at those aged 18-24 (Brien et al., 2015; Gill 
et al., 2017). Among youth, 15- to 19-year-olds had the highest rate of psychiatric ED visits per 
1,000 population (18.1%), followed closely by 20- to 24-year-olds (16.6%) (Brien et al., 2015). 
Further, ED visits for mental health treatment have grown rapidly over the last decade among 
youth and EA (CIHI, 2020). These results show that while the ED is an accessible and universal 
setting for mental health care delivery, gaps in the availability of other types of mental health 
services have caused overcrowding and long wait times in the ED (CMHA, 2008), especially 
among EA, who have the longest lengths of stay for psychiatric ED visits (CIHI, 2019b). 
Consequently, continuity of care between the ED and other mental health services has been 




The provincial health insurance plan also includes medically necessary services provided by 
psychiatric hospitals units (Health Canada, 2021), though unlike the ED, admission criteria are 
regulated. The Mental Health Act (MHA) (1990) is the Ontario legislation outlining the legal 
responsibilities for designated psychiatric inpatient facilities, including decisions surrounding 
admission to hospitals, as well as psychiatric assessment, examination, and treatment of patients. 
There are different admission pathways into psychiatric units in general hospitals, such as 
primary care doctors or through the justice system, but the most common is through the ED, 
accounting for 80% of inpatient admissions (CIHI, 2019b). To receive treatment in specialized 
psychiatric hospitals, referrals are generally needed from general hospitals, primary care doctors, 
psychiatrists, or another community mental health agency (OAGA, 2016). Admission into 
inpatient psychiatry is determined using the criteria contained in the MHA (1990), which 
emphasizes three areas: 1) person has attempted or stated that they will cause bodily harm to 
themselves, 2) person is behaving violently or has threatened to cause bodily harm to others, 
and/or 3) person is unable to care for themselves. While these regulations must be followed, 
admission standards for specialized psychiatric hospitals across the province can fluctuate by 
facility, creating inconsistencies in care pathways to these settings (OAGA, 2016). Once 
admitted, patients are required to be assessed within three days for their presenting clinical 
symptoms and needs (Gibbons et al., 2008). Following assessment and diagnosis, inpatients are 
expected to receive short-term psychological and/or pharmacological treatment to stabilize 
severe symptoms of mental illness (Government of Ontario, 1999), though hospital stays may be 
longer-term in some cases, particularly in specialized psychiatric hospitals (CIHI, 2019b). 
Additionally, at the time of admission, service providers must begin to formulate a discharge 
plan that incorporates input from the person being treated, as well as their social support 
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resources and functional needs. Further, discharge plans should involve follow-up contact with 
community health providers to ensure continuity of care and prevent short-term hospital 
readmissions (Government of Ontario, 1999). Following the guidelines for hospital discharges in 
the MHA (1990), as well as the information gathered in the discharge plan, patients are usually 
discharged when service providers believe that they no longer require acute observation and care.  
Psychiatric hospital units are a prominent form of mental health care for those experiencing 
severe symptoms of mental illness, though it is a less accessible and comprehensive service than 
the ED. Between 2009-2010, 14.7% of all hospitalizations in Canada involved a diagnosis of 
mental illness (CIHI, 2012). Psychiatric hospitalizations begin to increase around the age of 15, 
with approximately 16% of the inpatient psychiatric population between the ages of 15-24. 
Further, psychiatric hospitalizations among youth are increasing over time, especially for those 
diagnosed with a mood disorder (Brien et al., 2015). Although inpatient psychiatric treatment is 
universally available to all residents and is observing increased use over time, given the 
admission criteria in the MHA (1990), not all individuals with serious mental health needs may 
be admitted for care. For instance, mood disorders and schizophrenia are the most prevalent 
psychological diagnoses in both general and specialized psychiatric hospital units (CIHI, 2019b), 
and are also the most common disorders involved in first-time hospitalizations in Ontario (Brien 
et al., 2015). However, despite stronger prevalence in ED settings (Brien et al., 2015; CIHI, 
2019b), hospitalizations for individuals with anxiety and personality disorders are low (CIHI, 
2012), indicating that these settings are either not as comprehensive as they should be, or that 




Lack of accessible community care for mental health is a well-known issue in Canada, 
especially when it comes to youth (CMHA, 2008). For instance, even though it is included in 
operational policy documents for psychiatric hospital units as an important component to 
discharge planning (Government of Ontario, 1999), fewer youth receive follow-up contact with a 
health service provider within one week of discharge from a psychiatric hospital unit (Brien et 
al., 2015). Improved coordination between EDs, hospitals, and community mental health centres 
has consistently been identified as a target priority for the Canadian mental health system (CIHI, 
2019a; CMHA, 2008; Government of Ontario, 1999; Health Ontario, 2019; MHCC, 2015), but 
for various reasons, access to community mental health has remained an ongoing problem.  
1.2.2 Community mental health  
Beginning in the late 1950s, Canada’s mental health system began a period of 
deinstitutionalization, closing several psychiatric hospitals so that a greater proportion of mental 
health treatment could be provided in the community (Lin et al., 2016). By offering a 
comprehensive range of services covering a spectrum of resource intensity and severity of need, 
the shift towards community-based treatment was expected to promote greater quality of life, 
reduce the financial expenses associated with long-term hospital care, and lead to better health 
outcomes. However, because there is less government regulation and monitoring for community 
mental health services, it is challenging to summarize the types of treatments that are offered, 
how they are accessed, and what types of mental health needs are and are not being met. While 
no resource exists that comprehensively details the structure and function of community health 
agencies across Canada, a scan of services in each province and territory was performed by CIHI 
in 2017, providing a better understanding of the types of treatments provided in this setting. 
Examples across Ontario included outpatient services, addictions rehabilitation, residential 
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treatment, case management, early detection and intervention, vocational training and 
rehabilitation, and housing services. The scan did not include private practices, such as those 
offered by psychiatrists and psychologists, though they also serve an important role in provision 
of community-based mental health treatment.  
While the range of mental health treatments offered in the community is diverse, as of 2012, 
community-based psychological services remain the least accessible form of mental health 
treatment (Sunderland & Findlay, 2013). There are various obstacles that impede the 
accessibility and responsiveness of community mental health services. In general, community 
mental health is a fragmented system, with various services operating in an independent or 
‘siloed’ capacity (CMHA, 2008). Consequently, there is no integrated data collection and 
reporting strategy for community mental health (CIHI, 2017), meaning that evaluation of clinical 
needs, service use patterns, treatment efficacy, and evidence-based policy guidelines are not 
possible, reducing the overall effectiveness of the system. From the user perspective, a challenge 
arising from the lack of cohesion between community providers is difficulty in navigating the 
system, with many Canadians reporting that they do not know where to seek help when they 
need it (Moroz et al., 2020; Sunderland & Findlay, 2013). Pathways into community mental 
health care typically include referrals from family physicians and health teams, as well as EDs, 
hospitals, and the criminal justice system (CIHI, 2017). However, gaining these referrals may be 
difficult for certain individuals, especially those with severe symptoms of mental illness, who are 
less likely to have a regular family doctor (Ross et al., 2015). Even when a person has received a 
referral for community mental health care, they still may be unable to access treatment for 
various reasons, such as long wait times and financial costs (CIHI, 2019b). For instance, 
Canadians who received the most sessions from community-based psychiatrists had a higher 
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socioeconomic status and a less extensive history of psychiatric hospitalization, indicating 
disparities in service patterns related to personal income (Brien et al., 2015).  
Since community mental health programs are not considered medically necessary in the 
Canada Health Act (Health Ontario, 2021) or the provincial health insurance plan (Government 
of Ontario, 2021b), coverage for these services is provided through a mix of private and public 
funding sources. Private practitioners, such as psychologists and psychiatrists, are generally paid 
out-of-pocket or through private or occupational health insurance plans, though many Canadians 
do not have adequate access to these plans (CMA & CPA, 2016). However, some community 
mental health services are subsidized by funding from provincial and territorial governments, 
such as facility-based outpatient programs, case management, early detection and intervention, 
and vocational rehabilitation programs (CIHI, 2017). In these cases, funding is allocated through 
regional health authorities and non-government agencies, such as the Canadian Mental Health 
Association (CMHA). While this arrangement helps to reduce the financial barriers involved in 
accessing community care, Ontario spent less per capita than most other regions on community 
mental health care between 2016-17 (CIHI, 2019b). Overall, while community mental health 
agencies are provided with some government funding to help make their services more universal 
and accessible, evidence of low treatments rates show that current funding levels are insufficient 
to ameliorate barriers to care. 
While fragmented approaches to tracking, funding, and delivering community mental health 
services prevents individuals from engaging in community-based treatment (CMHA, 2008; 
Moroz et al., 2020; Sunderland & Findlay, 2013), this problem is even greater among EA. For 
instance, compared to other age groups, EA have the lowest rates of community mental health 
treatment (Edlund et al., 2002; SAMHSA, 2012), despite higher levels of psychological distress 
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(Drapeau et al., 2014; Smetanin et al., 2011) and ED visits involving mental illness (Brien et al., 
2015). This pattern is exacerbated further among individuals with primary anxiety disorders, 
which are relatively uncommon in community mental health settings (O’Donnell et al., 2017; 
Roberge et al., 2011), despite being the most common psychological diagnosis in the ED among 
youth (Gandhi et al., 2016). Given that early intervention and continuity of mental health care are 
predictors of improved health outcomes (Lin et al., 2016), it is essential that timely access to 
comprehensive and universal mental health treatment is made available to EA.  
1.3 Gaps in mental health care for EA 
In response to research demonstrating low uptake of mental health services among youth and 
EA, The Mental Health Commission of Canada (MHCC) published two policy reports focused 
on redesigning mental health systems to meet the needs of this population: “Taking the Next 
Step Forward: Building a Responsive Mental Health and Addictions System for Emerging 
Adults” (MHCC, 2015) and “The Mental Health Strategy for Canada: A Youth Perspective” 
(MHCC, 2016). As part of the development process for both reports, numerous stakeholders 
were consulted, including direct input from youth and EA stakeholders with lived experience 
accessing mental health care in Canada. In combination with environmental scans and literature 
reviews, the reports provide an extensive overview of the present context for mental health care 
of youth and EA in Canada, youth perspectives on best practices and existing gaps in service 
provision, as well as recommendations for policy, service provision, and research. One of the 
main contributors to low mental health treatment rates identified in the reports was the structure 
of the Canadian mental health system, which was designed to account for issues related to 
institutional planning and capacity, rather than research on clinical needs and service use. A 
prime example of this design is evident in the division of mental health care by chronological age 
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rather than developmental need, causing several EA to disengage from treatment once they turn 
18. Specific policy and service factors related to the transition process were described as causing 
disruptions to treatment, such as differences in funding allocation and out-of-pocket costs for 
treatment between youth and adult systems, poor coordination between youth and adult service 
providers, insufficient research for deriving evidence-based care practices specific to EA, and 
lack of services that specialize in treating EA (MHCC, 2015; Moroz et al., 2020). As part of a 
systematic approach for improving the transition process, the report calls for a cross-sectoral 
mental health research strategy focused on tracking the clinical needs, treatment outcomes, and 
service use trends of EA as they transition into the adult mental health system. 
Beyond the period of transition, research supporting mental health care of EA must also 
focus on the integration of different types of adult mental health service providers. EA frequently 
report that complications in service navigation poses a major barrier to accessing care (Moroz et 
al., 2020; Sunderland & Findlay, 2013), especially those without prior exposure to the system or 
assistance from a primary health care provider. Ensuring that service providers function within a 
connected network can help relieve the burden of service navigation by encouraging an ‘every 
door is the right door’ approach, wherein EA are redirected to the resources that most 
appropriately match their level of need. While service delivery models have been developed in 
various regions to promote coordinated mental health treatment for EA, there are no national or 
provincial policy guidelines in place to support implementation of these models, nor any national 
research mechanisms to enable knowledge exchange and provide data for outcome indicator 
reporting (MHCC, 2015; MHCC, 2016). Further, because EA are not considered as distinct 
subgroups in existing policy and service frameworks, their unique clinical and service needs are 
not well understood, making it difficult to create an evidence-based guideline for integrated 
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service delivery and resource pathways. Without comprehensive data on the clinical needs and 
service use of EA, the system is unable to adequately respond to the issues affecting this 
population. 
Following the 2015 policy report and consultation with the Canadian Advisory Group on the 
Mental Health of Emerging Adults, the MHCC (2019) adopted four priority recommendations 
aimed at improving systemic gaps in mental health care, two of which are relevant to this 
dissertation. One recommendation emphasizes the need to better integrate health sectors to 
promote a coordinated approach to mental health care for EA, while the other focuses on 
research, data reporting, and outcome evaluation. At the most resource-intensive end of the 
service delivery spectrum, hospital services and community mental health agencies are intended 
to work together to provide consistent treatment for individuals with more severe mental health 
needs, with the goal of providing most of the care in the community (Government of Ontario, 
1999; Health Ontario, 2020). However, as described earlier, individuals frequently access the ED 
for non-acute mental health treatment instead of community mental health services (Coristine et 
al., 2006; CMHA, 2008). To better determine where gaps in continuity of care are occurring, as 
well as which mental health needs are not well addressed by the current system, clinical 
assessment data from ED, hospital, and community mental health agencies needs to be analyzed 
simultaneously.   
Within this dissertation, an examination of trends in psychological diagnoses of EA seeking 
care within ED, hospital, and community mental health services, points to a potential gap in 
coordinated care for individuals with anxiety. Along with depression, anxiety is the most 
prevalent psychological disorder worldwide (Kessler et al., 2007), and within post-secondary 
populations, is the most common disorder present among EA (American College Health 
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Association [ACHA], 2016; Bayram & Bilgel, 2008; Beiter et al., 2015; Macaskill, 2013). Even 
though symptoms of anxiety are responsive to a combination of pharmacological and 
psychological treatment (Andrews et al., 2018; Bandelow et al., 2015), EA with primary 
diagnoses of anxiety have disproportionately low rates of treatment, especially when compared 
to those with primary depression (O’Donnell et al., 2017; Roberge et al., 2011). The only mental 
health care setting in which anxiety disorders are consistently reported to be present is in the ED 
(Aratani & Addy, 2014; Brien et al., 2015; Gandhi et al., 2016; Horenstein & Heimberg, 2020; 
Juhás & Agyapong, 2016), indicating that other types of services may be unresponsive to 
anxiety-related needs. If this is the case, one reason for the disparity in treatment rates for anxiety 
may be due to barriers in accessibility of treatment, such as the admission criteria for psychiatric 
hospitals (MHA, 1990) and financial costs for community care. Further, inconsistent mental 
health service use could also result from under-detection of anxiety by failing to measure 
symptoms alongside diagnosis. Without cross-sectoral data that accurately measures anxiety, it is 
not possible to determine service use patterns and treatment outcomes for EA with this concern, 
which are needed to identify solutions for improving engagement in treatment. 
1.4 Measurement-based care and interRAI 
Health care policies and services that effectively respond to the clinical and service use needs of 
the population require ongoing feedback from reliable and valid data sources, such as health 
assessment tools. The practice of using routine health assessment data to inform service 
provision is often referred to as measurement-based care (Aboraya et al., 2018; Connors et al., 
2021; Kilbourne et al., 2018; Scott & Lewis, 2015). Traditionally, the most common application 
of measurement-based care in psychiatric practice is the use of self-reported assessment tools to 
aid in diagnosis and treatment monitoring, though it is increasingly used for evaluation of system 
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performance as well. For instance, some health regions submit mental health assessment data to 
accreditation organizations, which use the information to generate performance reports and 
establish quality of care standards (Kilbourne et al., 2018; Scott & Lewis, 2015). Measurement-
based care has also been used by some regions to derive population-level benchmarks for mental 
health symptoms and service use patterns, determine health insurance reimbursement for 
services, and enable data sharing across different types of health care providers (Kilbourne et al., 
2018). Given the research evidence supporting the utility of measurement-based care, this 
approach has been proposed for adoption in the provincial mental health care system by the 
Mental Health and Addictions Centre of Excellence of Ontario Health (Kurdyak & Clark, 2021). 
One of the benefits arising from this recommendation is the ability of measurement-based care to 
fulfill the recommendations made by the MHCC (2019) for research, data gathering, and 
outcome reporting to support mental health care of EA. By incorporating mental health care 
assessment data for EA into system performance reviews, the clinical and service use needs of 
this population across multiple mental health settings can be used to improve quality and 
coordination of care, increasing rates of engagement in mental health treatment. 
While there are numerous advantages of measurement-based care for clinical practice and 
health system performance, there are some barriers that can prevent successful implementation 
of these practices, such as the time involved in collecting and disseminating high quality data, 
administrative burden on clinical staff, lack of organizational resources, and variations in 
assessment practices across facilities (Aboraya et al., 2018; Connors et al., 2021; Scott & Lewis, 
2015). Consequently, only a small proportion of mental health clinicians report using assessment 
tools over the course of treatment. Overcoming these limitations to increase clinician buy-in is a 
necessary endeavour for measurement-based care, prompting several recommendations for 
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psychiatric assessment design. For instance, assessment instruments should have excellent 
psychometric properties, be easy to use, contain clinically relevant information, and add value 
for treatment decision-making (Aboraya et al., 2018l Connors et al., 2021). Designed with these 
features in mind, interRAI (www.interrai.org) is an international, not-for-profit organization that 
develops comprehensive, person-centered assessment instruments for use in health care settings. 
Each instrument is designed to be compatible with the overall suite of assessments, offering a 
common language across multiple care settings that promotes continuity of care (Hirdes et al., 
1999). To accomplish this, assessments contain several core sections with items covering a 
person’s strengths, needs and preferences in terms of physical, mental, social, and functional 
health, including clinical symptoms of anxiety. To improve interpretations of the data, items may 
be combined into summary scales or clinical assessment protocols (CAPs), which provide an 
overview of a person’s status in a domain, (e.g., risk of harm to self). Data collected from the 
assessments have been used to inform care planning, decision-making, and outcome monitoring, 
with the goal of improving quality of care and system performance (Hirdes et al., 2020). 
interRAI has developed several assessment tools for mental health settings that would enable 
measurement-based care research for EA, including inpatient psychiatry, emergency psychiatry, 
and community mental health. Using these tools, clinical needs and service patterns of EA can be 
analyzed to inform cross-sectoral mental health system design, increasing accessibility and 
continuity of care. 
1.5 Dissertation overview 
The overarching goal of this dissertation is to inform accessible and comprehensive 
mental health care for EA through data-driven research, aligning with the requirements of the 
research and data gathering recommendation published by the MHCC (2019). To accomplish 
 
 20 
this objective, a measurement-based care approach - facilitated by the use of interRAI 
assessment instrument - was adopted to create three chapters covering the following research 
topics: 
1) What are the clinical needs and service use patterns of EA accessing care in psychiatric 
hospitals and units, emergency departments, and community mental health agencies? Further, 
what is the optimal cut-off for the age range of EA? 
2) Given the need to better address clinical anxiety in mental health settings, can a valid anxiety 
symptoms scale be created for the interRAI mental health assessment instruments?  






Many major life transitions occur during EA, such as moving out of family households, seeking 
long-term careers, enrolling in post-secondary education, and forming new relationships and 
communities (Arnett, 2000; Arnett, 2007; et al., 2014; Baggio et al., 2017; Galarneau et al., 
2013). At the same time, various forms of mental illness are at their peak severity and/or onset 
(APA, 2013; Kessler et al., 2007; Pearson et al., 2013; Schulenberg & Zarrett, 2006; Smetanin et 
al., 2011). In a longitudinal population study of Canadian adults, psychological distress was at its 
highest between the ages of 18-29, as well as in more recent cohorts (Drapeau, Marchand, & 
Forest, 2014). Further, comparisons of global mood scores between young, middle-aged, and 
older adult age groups found that young adults had lower average affect scores and felt less 
vigorous over the course of the day than older adults (McNeil et al., 1994). Despite a greater 
level of mental health needs in this population, EA are less likely to engage in treatment than 
other age groups (Edlund et al., 2002; Kessler et al., 2007; SAMHSA, 2012). To adequately 
address gaps in mental health care provision for EA, research on their clinical characteristics and 
service use patterns are needed to identify what their needs are. Currently, the types of 
psychiatric symptoms that develop and are at their most severe during this period have been 
identified through interviews and surveys of the general population and post-secondary students. 
However, less is known about EA who have accessed psychiatric services, as Canada does not 
have an evidence-based strategy in place to support mental health service provision for EA 
(MHCC, 2015). Following a measurement-based care approach (Aboraya et al., 2018; Kilbourne 
et al., 2018; Scott & Lewis, 2015), identifying clinical needs of EA receiving treatment from 
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psychiatric service settings can provide the data needed to construct national and provincial 
guidelines for care provision (Kurdyak & Clark, 2021). This chapter seeks first to fill this gap by 
examining EA in psychiatric settings such as hospitals, emergency departments (EDs), and 
community mental health agencies. Additionally, clinical and service use characteristics are 
compared across age groups to determine if there are differences in early versus late EA.  
2.1.1 Emerging adult mental health  
2.1.1.1 General population 
The most common diagnoses observed among EA in the general population are mood, anxiety, 
and substance use disorders. One method of ascertaining prevalence of disorders has been 
random population sampling with the WHO Composite International Diagnostic Interview 
(CIDI), a standardized interview for diagnosing psychiatric disorders contained in the 
International Classification of Diseases (ICD). For instance, adolescents in Mexico were 
interviewed using the CIDI 2.0 and re-assessed after eight years (Benjet et al., 2016). Between 
that time, 38% of those who responded had received a new psychiatric diagnosis. The most 
common disorder diagnosed was substance use followed by mood, anxiety, and eating disorders. 
Similarly, a Norwegian version of the Munich-CIDI was used to investigate the trajectory of 
psychiatric disorders among a cohort of twins, beginning when participants were in their twenties 
(Gustavson et al., 2018). Anxiety was the most prevalent disorder during the previous 12 months 
(20%), followed by mood (7%) and alcohol use (6%) disorders. By the time participants reached 
their late thirties, the prevalence of any mental disorder, phobia, and alcohol use diminished  
substantially. Major depression and other anxiety disorders saw an overall decrease but were still 
relatively stable, demonstrating the chronicity of these disorders. 
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A modified version of the CIDI was used to diagnose psychiatric disorders over the past 
12 months in the 2012 Canadian Community Health Survey – Mental Health (CCHS-MH), in 
which phone interviews were held with a random selection of nationally representative 
households (Statistics Canada, 2012). The report revealed that at 19%, those aged 15-24 had the 
greatest prevalence of a mood, anxiety, or substance use disorder of any age group. Substance 
use disorders were the most common (12%), with the next being mood disorders (8%). Since 
only generalized anxiety disorder (GAD) was reported for anxiety, the prevalence of anxiety 
disorders could not be determined beyond the 2% prevalence of GAD. Diagnostic trends for 
mental health disorders were somewhat different in the WHO - World Mental Health Surveys 
(WHO-WHMS), which used the CIDI 3.0 in 17 countries in Africa, Asia, the Americas, Europe, 
and the Middle East (Kessler et al., 2007). The inter-quartile range for overall lifetime 
prevalence of psychiatric disorders was 18-36%, with either mood or anxiety disorders ranking 
as the topmost diagnosis across countries. Substance use was one of the least prevalent disorders, 
though the authors noted that estimates may have been inaccurately low due to differences in 
assessments of illicit drug use and the exclusion of ‘dependence’ disorders in some countries. 
Like the CCHS-MH, the odds of having mood, anxiety and substance use disorders were all 
higher among adults aged 18-34 than older adult age groups in the WHO-WHMS dataset, as well 
as personality disorders (Huang et al., 2009), indicating that various psychological disorders are 
highly prominent in the EA population.  
In addition to the WHO – CIDI, an interview tool based on the Diagnostic and Statistical 
Manual (DSM) has also been used to estimate psychiatric disorders nationally. As part of the 
National Epidemiologic Study on Alcohol and Related Conditions (NESARC) between 2001-
2002, phone interviews were conducted using a random sample of nationally representative 
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households in the US (Blanco et al., 2008). Psychiatric disorders were measured using The 
Alcohol Use Disorder and Associated Disabilities Interview Schedule – DSM-IV version 
(AUDADIS-IV). The most prevalent mental health disorders diagnosed were substance use and 
personality disorders, and then anxiety and mood disorders. Among those aged 18-24, the 12-
month prevalence of any psychiatric disorder was 46%, which is a remarkably high estimate 
compared to the previous studies described. Even accounting for differences in study samples 
and assessment instruments, it is unclear why such a high prevalence estimate was reported in 
the NESARC study. Regardless, evidence demonstrates that various psychological disorders are 
heightened during EA, and while research on the general population does not replace the need 
for investigations of formal psychiatric settings, this information can provide insight into the 
potential drivers of mental health services among this subgroup.  
2.1.1.2 Post-secondary institutions 
The greatest source of information available on the mental health of EA is post-secondary 
students, who have been regularly studied for symptoms of mental illness and on-campus service 
use. Like the general population, mood and anxiety disorders are the most prevalent psychiatric 
diagnoses, with conflicting results on substance use disorders. Using the Structured Clinical 
Interview for DSM-IV Axis I Disorders – Clinician Version (SCID-CV), the prevalence of 
psychiatric diagnoses was assessed in sample of female university students in Spain. At the time 
of the interview, 37% met criteria for an existing disorder and 51% had a lifetime disorder 
(Vázquez, Torres, Otero, & Díaz, 2011). Nicotine dependence was the most common disorder, 
followed by depression and anxiety. Excluding nicotine dependence, the prevalence of current 
and lifetime diagnoses dropped to 24% and 38% respectively, which is closer to the estimates 
reported in the general population described earlier. 
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Although interviews are methodologically rigorous, they are resource intensive. As a 
result, a more popular method for investigating the prevalence of disorders among post-
secondary students is through surveys. A unique finding from surveys of post-secondary students 
is increased prevalence of ADHD. As part of the WHO-WMHS International College Student 
(ICS) project, an online survey screening for seven DSM-IV disorders was administered to first-
year students across eight countries (Auerbach et al., 2019). The 12-month prevalence of any 
psychiatric disorder was 38%, and 68% for lifetime disorders. Using latent class analysis, the 
researchers identified four classes of psychiatric comorbidities. The smallest class involved four 
or more diagnoses, typically including mania/hypomania, anxiety, depression, substance use, and 
ADHD. Among those with only one psychiatric disorder, ADHD was the most prominent 
diagnosis. The results of this study reveal that there is considerable psychiatric comorbidity 
among post-secondary students, and that except for ADHD, it is the same types of psychiatric 
diagnoses that are prevalent in the general population. However, a limitation is that only first -
year students were surveyed; data on students at various points in their studies would provide 
greater information on mental health of EA. 
Large-scale, ongoing surveys of post-secondary student mental health are conducted by 
some institutions. The American College Health Association (ACHA) - National College Health 
Assessment (NCHA) is an annual survey of physical and mental health of post-secondary 
students that covers the US and Canada. The survey contains questions about symptoms of 
depression and anxiety, as well as psychiatric diagnoses and service history. In 2019, a report 
was released for the Canadian population (ACHA, 2019). In the year preceding the survey, 24% 
were diagnosed or treated for anxiety, 19% for depression, 13% for panic attacks, 7% each for 
ADHD and insomnia, and 2% for substance use and addiction. Similar results were reported in 
 
 26 
the Healthy Minds (2018) study, an annual web-based survey of post-secondary students in the 
US. In 2018, 39% of students were struggling with at least one mental health problem and 36% 
had a lifetime diagnosis of a mental health disorder. The most frequent diagnosis was anxiety, 
followed by depression, attention and learning, and eating disorders. Once again, ADHD was a 
prominent psychological diagnosis reported in both surveys. Possible explanations may include 
that more EA with ADHD attend post-secondary school, or it may be identified and subsequently 
diagnosed more often in these settings. Only two studies have directly compared EA who are 
attending post-secondary school and those who are not, yielding inconsistent results (Blanco et 
al., 2008; Wiens et al., 2020). Regardless, variations in patterns of disorders observed in the 
general population and post-secondary schools demonstrate that there is a need for research that 
is setting-specific. 
While clinical disorders represent the moderate-to-severe spectrum of mental illness, it is 
also useful to examine the distribution of symptoms more broadly. By limiting research to 
diagnoses, information on sub-threshold clinical mental health needs is lost. Data on mild-to-
moderate symptoms is necessary for health promotion and prevention activities, which seek to 
prevent symptoms from escalating further, as well as care planning for those with comorbid 
psychological conditions and sub-threshold disorders. Assessing psychological symptoms can 
also provide an indication of psychiatric need among those who have not sought diagnosis and 
treatment. For disorders that are associated with especially low treatment rates, such as substance 
use (Blanco et al., 2008; Catchpole & Brownlie, 2016; SAMHSA, 2012) and anxiety disorders 
(Horenstein & Heimberg, 2020; Kessler et al., 2007; O’Donnell et al., 2017), analysis of 
symptoms may be the best method for detecting such problems.  
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In Turkey, the Depression, Anxiety and Stress Scale – 42 Item (DASS-42) was 
administered to university students through classroom recruitment and scores were split into 
several categories; normal, mild, moderate, severe, and extremely severe (Bayram & Bilgel, 
2008). The percentage of students scoring within moderate-to-extremely severe categories were 
as follows: anxiety (47%), depression (27%), and stress (27%). A shorter version of the same 
instrument - the DASS-21 – was also filled out by undergraduate students in the US (Beiter et 
al., 2015). The percentage of students scoring in the moderate-to-extremely severe category were 
stress (26%), anxiety (25%), and depression (23%). While depression and stress scores were 
comparable between the Turkish and US studies, anxiety was substantially higher among the 
sample of Turkish students, which could be due to variations in sampling, geography, and the 
version of the instrument used. At the least, a quarter of the students in both studies fell in the 
moderate-to-extreme range of depression, anxiety and stress. A similar value was reported 
among first-year students living in Belgium, with 24% meeting the threshold for internalizing 
mental health problems on the Global Appraisal of Individual Needs – Short Screener (GAIN-
SS) (Bruffaerts et al., 2018). The estimate was slightly lower in an English study that used the 
General Health Questionnaire (GHQ) – 28 to assess mental health among undergraduates 
(Macaskill, 2013). The threshold for potential mental illness was met by 17% of respondents; 
among that subsample, 97% met criteria for anxiety but only 46% for depression. Further, GHQ 
scores were higher among second- and third-year students compared to those in first year, 
indicating that psychological distress was greater among upper-year students. While the exact 
prevalence varies based on the study sample and the tools used, it is evident that symptoms of 
mental illness – especially anxiety – are pervasive in post-secondary student populations.  
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Institution-wide surveys also provide insight into the level of mental health among post-
secondary students. In the two weeks preceding the NCHA survey of Canadian post-secondary 
students, 26% stated that they felt things were hopeless, 52% were overwhelmed by all they had 
to do, 36% were very sad, 20% felt so depressed that it was difficult to function, 31% felt 
overwhelming anxiety, and 4% seriously considered suicide (ACHA, 2019). The results indicate 
that a substantial number of Canadian students experience symptoms of anxiety and depression, 
and that for one-fifth of students, it was severe enough to seek treatment. Across North America, 
the Center for Collegiate Mental Health (CCMH) releases an annual report on mental health of 
post-secondary students, using data collected from on-campus counselling centres. In 2018, 152 
post-secondary institutions participated in routine data gathering and reporting, covering 179,964 
students in total (CCMH, 2018). Anxiety and depression were the most common presenting 
concerns, followed by relationship problems and interpersonal functioning. Other issues that 
were frequently observed were suicidal ideation, unwanted sexual contact, harassment or abuse, 
traumatic events, and substance use. In the previous two weeks, 38% had engaged in binge 
drinking and 24% used marijuana over the last two weeks. Further, 27% agreed that they felt the 
need to reduce their substance use and 16% had someone express concern to them about their 
use. 
Substance use has been identified as a problem distinctly related to EA. Relative to older 
age groups, the annual National Survey on Drug Use and Health (NSDUH) report found that 
those aged 18-25 had the highest rates of alcohol, cannabis, and illicit substance use over the past 
year (SAMHSA, 2018). In Canada, two studies have replicated this finding when comparing EA 
to adolescents. A sample of 89 participating youth agency services located across the country 
were screened for substance use and mental health problems using the GAIN-SS (Henderson, 
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Chaim, & Hawke, 2017). The results demonstrated that substance use was lower among 
adolescents (12-18) than young EA (19-24). Likewise, research conducted in a concurrent mental 
health disorder program in British Columbia found that relative to adolescents (ages 14-18), EA 
(ages 19-25) had more lifetime diagnoses of substance use disorders and were more likely to 
report needing help with alcohol use (Catchpole & Brownlie, 2016).  
 In addition to comparisons against adults and adolescents, some studies have further 
narrowed down analysis of substance use within the EA age period . In a study of mental health 
symptoms and service use in the US, younger EA (18-25) were compared to older EA (26-34) 
(Adams, Knopf, & Park, 2014). Younger EA scored higher on the Kessler-6 (K6) for 
psychological distress and had more diagnoses of an alcohol or drug abuse/dependence disorder. 
In contrast, the 2012 Canadian Community Health Survey – Mental Health (CCHS-MH) 
reported that the prevalence of alcohol and drug abuse/dependence were similar between 
adolescents/early EA (15-22) and late EA (23-29), though both groups used more substances 
than young adults (30-39) (Qadeer, Georgiades, Boyle, & Ferro, 2019). It is possible that the 
incongruent results are due to overlap in the ages used to define EA, given that substance use 
tends to be heaviest between 18-24 (APA, 2013). In the Healthy Minds study, undergraduates 
demonstrated greater use than graduate students (Cranford, Eisenberg, & Serras, 2009). Among 
undergraduates, half of respondents had engaged in binge drinking during the last two weeks and 
17% had used marijuana in the past 30 days. In comparison, graduate students demonstrated 
lower substance use: 35% had binge drank in the last two weeks and 6% had used marijuana in 
the last 30 days. Overall, substance use tends to be highest during the ages of 18-25, coinciding 
with entry into post-secondary school for many EA.  
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While substance use is an issue among younger EA studying in post-secondary 
institutions, it is unclear whether this is a greater problem among EA who are not attending 
school.  EA enrolled in post-secondary schools in the US were more likely to report using any 
amount of alcohol in the last 12 months and equally as likely to use drugs as EA not attending 
school (Blanco et al., 2008). In contrast, a Canadian study revealed that students were less likely 
to engage in binge-drinking, cannabis use, and other illicit drug use in the last 12 months than 
those not attending post-secondary school (Wiens et al., 2020). Contradictory results highlight 
the importance of recognizing the context of study setting in research with EA.   
Prevalence estimates are used to describe the most common mental health issues among 
EA, but they do not indicate if they are unique to this developmental period. Isolating psychiatric 
disorders with an average age-of-onset during this timeframe can provide information about 
newly acquired mental health struggles, which may be concealed when looking solely at 
prevalence estimates. The most prevalent disorders among EA are also those that often develop 
during this period. Various anxiety disorders appear on average in the early- to mid-twenties 
(APA, 2013; de Lijster et al., 2017), while others can develop anywhere between young and 
middle-aged adulthood (de Lijster et al., 2017; Essau et al., 2018; Kessler et al., 2007). Similarly, 
major depressive disorder (MDD) is often first diagnosed in the early twenties to late thirties 
(APA, 2013; Rohde, Lewinsohn, Klein, Seeley, & Gau, 2013). Substance use disorders are also 
typically diagnosed between the ages of 18-24 (APA, 2013). However, several disorders that do 
not generally have high prevalence rates also share an average age-of-onset during EA. For 
instance, psychotic and schizophrenia disorders, bipolar II disorder, and sleep disorders all tend 
to develop in the early twenties (APA, 2013). For disorders that have an initial onset occurring 
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during EA, they should appear as stronger drivers of service use among this population 
specifically, reflecting an influx of initial treatment-seeking behaviour. 
Post-secondary settings offer a unique opportunity for research on service use among EA, 
as many institutions offer on-campus resources for mental health. In the Healthy Minds (2018) 
study, 34% of respondents were accessing some form of mental health treatment. For those with 
a possible psychiatric condition, treatments rates were higher at 52%. However, the opposite 
finding was reported when substance use was involved. Among students with co-occurring 
binge-drinking and psychiatric symptoms, 67% agreed that they needed mental health treatment; 
however, only 38% had received any form of mental health care in the previous year (Cranford 
et al., 2009). Similar results were reported in the 2018 CCMH report, wherein one-quarter of 
students reported that they wanted to reduce their substance intake, but only 3% had received 
treatment for it. Low uptake for substance use treatment is consistent with findings from other 
studies (Blanco et al., 2008; Catchpole & Brownlie, 2016; SAMHSA, 2012). The top concerns 
prompting treatment in the report were anxiety, depression, relationship problems, and stress. 
Finally, the College Mental Health Survey in the US randomly emailed students to ask about 
mental health service use (Soet & Sevig, 2006). Among respondents, 30% reported that they had 
received counseling at least once during their lifetime and 20% were currently in therapy. The 
top five diagnoses among those receiving counseling were for depression, eating disorders, 
anxiety, ADHD, and PTSD.  
While research conducted in post-secondary settings is fairly consistent with prevalence 
estimates for psychiatric disorders among EA in the general population, diagnoses with an age-
of-onset during this time - such as psychotic, bipolar, and personality disorders - are under-
represented (Healthy Minds Network, 2018; Soet & Sevig, 2006). Counselling centre patterns 
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suggest that there is a small group of students with complex mental health needs (CCMH, 2018). 
Altogether, roughly 2% of students were referred to a hospital for a mental health or substance 
use concern and of those, 1% were admitted. Overall, 10% of students had been previously 
hospitalized for a mental health concern. To learn more about the population of EA with more 
serious mental health needs, investigations of formal psychiatric settings are needed.   
2.1.2 Emerging adults in psychiatric care settings 
After reviewing mental health trends among EA in general and post-secondary populations, it is 
evident that depression, anxiety, and substance use are the most prevailing psychological 
concerns, and that they tend to be higher among this age group relative to others. Consequently, 
it is likely that depression, anxiety, and substance use are prominent drivers of service use among 
EA. However, as the MHCC (2015) report on mental health care for EA noted, there are 
numerous gaps and barriers to service access among this population, such as difficult transitions 
between the youth and adult policy systems. Since the pathways into mental health care are not 
straightforward, it cannot be assumed that clinical needs observed in these settings will be a 
direct match to those of the general population. Further, intensive mental health care settings 
such as hospitals and community agencies often have specific mandates surrounding admission 
criteria (MHA, 1990). As a result, psychological disorders that are less commonly observed in 
the general population, but which are associated with substantial functional impairment or risk of 
danger to self and others, should have a greater frequency in psychiatric settings. Investigating 
these clinical trends will reveal which subgroups receive more treatment from mental health 
services and what care gaps exist, providing necessary information for building a responsive 
mental health system for EA. To that end, the mental health services explored were emergency 
departments (ED), hospitals, and community mental health agencies. 
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2.1.2.1 Emergency departments 
The link between psychological distress and ED visits has been previously established 
(Stockbridge, Fernando, Wilson, & Pagán, 2014), with a stronger association among adolescents 
and EA (Brien et al., 2015; CIHI, 2017b). For instance, national data from the US demonstrated 
that EA aged 18-29 were twice as likely to visit an ED when experiencing severe psychological 
distress (Lin, Burgess, & Carey, 2012). Further, the ED can act as a first point of entry into the 
mental health care system for younger EA (Brien et al., 2015; Gill et al., 2017), meaning that 
EDs are a prime setting for early intervention strategies. The need for these types of strategies 
and research is even more pressing as ED usage continues to grow. The number of ED visits for 
psychiatric concerns has increased over time among EA aged 18-24 in the US (Kalb et al., 2019), 
as well as in Ontario among youth aged 10-24 (Gandhi et al., 2016). Across Canada, among 
youth aged 5-24, the number of individuals accessing the ED for mental health concerns between 
2008-2009 and 2018-2019 increased by 61% (CIHI, 2020). As of 2015, the annual rate of 
psychiatric ED visits per 1,000 people in the population of Ontario was 16.6 for those aged 20-24 
(Brien et al., 2015). Projection models from an academic hospital located in Toronto, Ontario 
estimated that psychiatric ED visits will continue to rise and rapidly outpace current resource 
capacity, leading to increased wait times and fewer patients treated (Baia Medeiros, Hahn-
Goldberg, Aleman, & O’Connor, 2019). The need to plan for the volume of EA accessing EDs 
for psychiatric treatment is evident, requiring that the clinical needs of EA accessing EDs for 
mental health treatment are well understood. To accomplish this, analysis of the clinical 
characteristics of EAs in ED settings must be performed. 
To represent clinical mental health needs, most studies make use of psychiatric 
diagnoses. During the index visit to an ED in California among 17- to 24-year-olds, substance 
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use was the most prevalent disorder followed by anxiety; depression was diagnosed in 8% of the 
sample and fewer than 5% had psychosis or bipolar disorders (Aratani & Addy, 2014). Substance 
use disorders were also the most prevalent among 18- to 24-year-olds in EDs across the US, 
though unlike the previous study, mood disorders were just as common (anxiety disorders were 
not reported) (Kalb et al., 2019). Given that both studies drew data from ambulatory databases, it 
is unclear why there is a disparity in the prominence of mood disorders, though it may be related 
to differences in the sampling procedures (i.e., state versus national). In Canada, various studies 
have examined psychiatric disorders in ED settings. While analyses were not stratified by age 
(though 20- to 29-year-olds comprised the largest age group), assessments made by a psychiatric 
team in the ED of a regional hospital in Alberta revealed that the most prevalent diagnoses were 
depressive disorders followed by anxiety, substance-related, and personality disorders (Juhás & 
Agyapong, 2016). Within Ontario, the most common psychological disorders observed in the ED 
between 2018-2019 among those aged 18-24 were anxiety disorders, followed by substance use, 
mood, and schizophrenia disorders (CIHI, 2020). Among youth aged 16+ who were accessing 
the ED for mental health treatment for the first time, the most common psychological diagnoses 
were substance-related and anxiety disorders, followed by mood/affective disorders, 
schizophrenia and other psychotic disorders, and personality disorders (Brien et al., 2015). 
Another study conducted within Ontario examined patterns of ED use among youth aged 0-24, 
finding that anxiety was the most common psychological disorder driving visits, and that anxiety 
disorders were increasing more rapidly than other disorders in these settings (Gandhi et al., 
2016). Like the general and post-secondary populations, the most common disorders in Canadian 
EDs appear to be related to anxiety, depression, and substance use.  
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Certain forms of substance use have been investigated more thoroughly among youth in 
ED settings, such as alcohol consumption. The Alcohol Use Disorders Identification Test 
(AUDIT) was used to detect problematic alcohol use in 18- to 29-year-olds visiting a university-
affiliated ED in the US (Horn et al., 2002). Half the sample screened positively for alcohol 
problems, with 9% scoring in the severe range. Notably, those who were intoxicated during their 
visit were ineligible to participate in the study and so the results may under-represent serious 
alcohol problems. Data on EDs obtained from the National Surveys on Drug Use and Health also 
demonstrated that 18- to 25-year-olds consumed more alcohol and drugs than other age groups 
and were more likely to have substance use disorders overall (Wu et al., 2012). Further, in 2018, 
Canada adopted the Cannabis Act, which legalizes possession of cannabis for adults aged 18 
years and over (Government of Canada, 2018). Following implementation of this policy, 
prevalence of cannabis use among EA in the general population has probably increased, which 
should also be reflected in ED settings. A hospital in Toronto sought to examine this hypothesis 
using a projection model. For the baseline data, the study used the hospital ED data from 2017, 
in which cannabis accounted for 2.5% of substance use-related visits, while alcohol-related 
problems comprised 73.6% of visits (Baia Medeiros et al., 2019). Incorporating time-series data 
available from the state of Colorado, which legalized cannabis in 2013, a projection model was 
created for the Toronto hospital data. The model demonstrated that overall, ED flow is unlikely 
to be affected by cannabis legalization. However, a caveat is that the model was predicting visits 
in which cannabis was the primary reason for care, and so it is possible that comorbid cannabis-
use will see an increase overall in ED settings, especially among youth.  
Overall, ED settings are likely to resemble the general population in terms of psychiatric 
disorders, though diagnoses related to psychotic, personality, and bipolar disorders should also 
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be elevated (Brien et al., 2015; CIHI, 2020). However, regardless of the type of mental illness or 
its severity, even mild levels of psychological distress have been shown to be predictive of future 
ED visits (Stockbridge et al., 2014), suggesting that any level of mental distress should be 
addressed seriously. Whether the individual is discharged into the community or admitted for 
inpatient care, youth need appropriate and adequate resources to maintain mental wellness after 
discharge. 
2.1.2.2 Psychiatric hospitals  
Psychiatric hospital units are designed to care for individuals who are experiencing acute and 
severe mental health crises (Government of Canada, 2019). Provincial health data obtained 
between 2008-2013 showed that 5/1,000 residents of Ontario were admitted to a psychiatric 
hospital or unit for treatment each year (Brien et al., 2015). Although this trend remained stable 
over the six-year period, there was an increase in admissions related to mood disorders among 
youth aged 0-24. Similar findings were reported in a national survey from the US (Watanabe-
Galloway & Zhang, 2007), where over a seven-year period, discharges from general hospitals 
containing serious mental illness rose by 10%, with the greatest increase observed among those 
aged 18-24. Like the ED, these results demonstrate that hospitals are a growing care setting for 
mental health treatment among EA. However, even though the ED is the most common pathway 
into inpatient psychiatry (CIHI, 2019b), only a small proportion of EA seeking emergency care 
for psychological distress are subsequently admitted into hospital. For instance, only 13% of 
referrals from a community response team were subsequently admitted to inpatient psychiatry in 
the UK (Brooker, Ricketts, Bennett, & Lemme, 2007). Similarly, only 20% of patients accessing 
the ED for psychiatric concerns were admitted for inpatient care in a hospital in Alberta (Juhás & 
Agyapong, 2016), with most ED patients in the young adult age group. Considering the volume 
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of EA who visit the ED for psychiatric reasons, a large disparity between ED use and hospital 
care signifies a mismatch between clinical needs and service design, leading to inefficient 
resource use and system capacity issues. 
Since the MHA (1990) outlines specific criteria for admission into psychiatric hospitals 
and units, certain types of mental health issues are observed more often. For instance, risk factors 
for psychiatric hospitalization related to self-harm, harm to others, and severity of psychiatric 
symptoms were investigated among EA aged 18-24 in Sweden (Beckman et al., 2016). 
Schizophrenia and other psychotic disorders shared the strongest association with self -harm and 
hospitalization, with a similar pattern reported for personality, substance use, and affective 
disorders, which is generally consistent with the diagnoses most frequently seen in psychiatric 
hospitals. For example, schizophrenia, bipolar disorder, and major depression were the most 
prevalent disorders in psychiatric hospitals across the US (Watanabe-Galloway & Zhang, 2007). 
In Ontario, the most responsible diagnoses for all inpatient hospital admissions between 2018-
2019 were listed among 18- to 64-year-olds (CIHI, 2020). Giving birth was the number one 
reason, followed by substance use disorders, mood disorders, and schizophrenia and other 
psychotic disorders, demonstrating a strong need for mental health care. Within psychiatric 
hospitals and units specifically, mood disorders are the most common among those aged 18 and 
over (Martin & Hirdes, 2009), as well as youth aged 0-24 (Brien et al., 2015). Notably, anxiety 
does not appear to be a common diagnosis in hospitals, despite its prevalence in the general 
population (Kessler et al., 2007; Statistics Canada, 2012) and in the ED (Aratani & Addy, 2014; 
Brien et al., 2015; CIHI, 2019; Juhás & Agyapong, 2016). While focusing exclusively on the EA 
population is unlikely to change this pattern, it may still be the case that anxiety disorders appear 
more frequently as comorbid disorders and symptoms across all ages. In contrast, some disorders 
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should be more strongly associated with EA. For example, substance use disorders are 
heightened among those aged 18-25 (APA, 2013; SAMHSA, 2018), and so there should be a 
strong association between young EA and substance use disorders in hospitals. Similarly, 
hospitals likely contain a higher proportion of EA diagnosed with eating disorders, which 
develop and peak during adolescence and young adulthood (APA, 2013).  
Outcomes following psychiatric hospitalization indicate the importance of early 
intervention and ongoing community care among EA. For instance, readmission to hospital 
within 30 days occurs for roughly 12% of psychiatric inpatients in Ontario aged 16 and over, 
with an elevated risk for those with psychotic disorders (Brien et al., 2015). Moreover, compared 
to the general population and those discharged from hospital with no psychiatric disorders, 
suicide rates following 90-day discharge are substantially higher among those with mental health 
disorders (Chung et al., 2017). While rates of suicide following 90-day discharge from hospital 
are lower among adolescents and those admitted for the first time, they remain higher than 
average for the general population for several years after discharge. These outcomes demonstrate 
that long-term care-planning is essential at the time of hospitalization. As part of the care 
planning process, clinical needs of EA need to be accounted for and treated as early as possible.  
2.1.2.3 Community mental health  
Clinical profiles and service patterns of community mental health agencies are difficult to 
summarize because unlike hospitals and EDs, admission criteria and the focus of treatment are 
unique to each individual program. Further, community agencies are widespread not only in 
terms of geographic location, but also the government ministry they are accountable to (e.g., 
health, social services, education, etc.,). Consequently, there are no integrated data sources 
covering community mental health in Canada (CIHI, 2019b), precluding a comprehensive 
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overview of these services and the characteristics of those who access them. An additional 
problem for data collection that is unique to EA is a particularly high rate of disengagement from 
mental health treatment (Edlund et al., 2002; MHCC, 2015; Roche, O'Sullivan, Gunawardena, 
Cannon, & Lyne, 2020), which is due in part to the accessibility barriers described earlier in the 
introduction, such as the transition between youth and adult mental health systems (MHCC, 
2015; Moroz et al., 2020). Despite numerous limitations to gathering data on community mental 
health care, there are a few community surveys that have either targeted youth specifically or 
provided age-stratified data, which can be used to identify age-related trends in care gaps. 
One trend revealed through surveys of EA with mood and anxiety disorders is a negative 
association between anxiety and community mental health treatment. Based on data obtained 
from the 2014 Survey on Living with Chronic Diseases in Canada—Mood and Anxiety 
Disorders Component, 18- to 34-year-olds were less likely than other age groups to receive any 
mental health treatment (medication or counselling), with the lowest rates for those with only an 
anxiety disorder (O’Donnell et al., 2017). Gaps in community care for individuals primarily 
experiencing anxiety may be one reason that anxiety disorders are prominent in Canadian EDs 
(CIHI, 2019a; Brien et al., 2015; Juhás & Agyapong, 2016). When EA do engage in community 
care for mental health, data from the 2012 CCHS-MH survey revealed that family doctors were 
the most common professional service used (Findlay & Sunderland, 2014). Social workers, 
counsellors, and psychotherapists were next, with a small proportion seeking help from 
psychologists and psychiatrists. Among those aged 15-24 with a mental health disorder, 35% 
reported accessing at least one of these types of professional services for treatment within the 
past 12 months. However, the prevalence of professional treatment rose to 60% when youth also 
had a comorbid chronic physical health condition. Overall, treatment was greatest for those with 
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multimorbidity, such as a combination of mental health and addictions disorders, chronic 
physical conditions, psychological distress, and traumatic childhood events. Altogether, the 
majority of EA who experience symptoms of mental illness do not receive specialized 
community mental health treatment. Further, even when EA do access these services, they 
disengage at a higher rate than other age groups (Satre, Mertens, Areán, & Weisner, 2004) and 
experience more frequent remissions (Smith, Godley, Godley, & Dennis, 2011). Given the small 
proportion of EA who receive community mental health services and remain in treatment, as 
well as the diffuse system of agencies and the lack of a unified data collection system across 
Canada, there is not enough information to provide a more extensive overview of this area. 
2.1.3 Limitations of Research 
In general, extensive information is available on the mental health characteristics of EA, 
providing a good starting point for a more in-depth examination of EA in psychiatric care 
settings across Canada. Regardless, there are still several gaps that need to be addressed. One 
such limitation is the inconsistency in the age range that is used to define EA. Initially, it was 
proposed that EA began at 18 and ended at the age of 25 (Arnett, 2000; Arnett, 2007), and 
several studies have generally followed this guideline (Baggio et al., 2017; Newcomb-Anjo et 
al., 2017; Smith et al., 2011). However, revisions to EA theory argue that it may extend up to 29 
years of age (Arnett, 2014). Studies that have stratified age groups within EA in an attempt to 
clarify an age cut-off have returned conflicting results: while one study found differences in 
substance use disorders between adults aged 18-25 versus 26-34 (Adams et al., 2014), another 
reported that there were no differences between those aged 15-22 and 23-29 (Qadeer et al., 
2019). The evidence surrounding the age period of EA in relation to mental health differences is 
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unclear, which has important implications for how youth and adult mental health services are 
currently structured in Canada (MHCC, 2015; MHCC, 2016).  
Similar to attempts to define the scope of EA, there are also issues surrounding how 
mental health needs are operationalized. In many studies, disorders classified under either the 
DSM or the ICD are used to define mental illness (Gustavson et al., 2018). While diagnoses are 
standard clinical representations of mental illness, they are reserved for those experiencing issues 
severe enough that functioning has been impacted and/or the person is in serious distress (APA, 
2013). While diagnoses capture severe categories of mental illness, persons with sub-threshold 
symptoms are not distinguished from those with mild or no symptoms. To better account for the 
spectrum of mental illness, individual symptoms can be assessed rather than diagnoses, allowing 
for different severity levels to be calculated. However, depending on the tool used, estimates of 
serious mental illness may be inflated when adding together symptoms. For instance, a meta-
regression compared the prevalence of MDD between diagnostic versus symptom-based 
instruments and found that estimates were considerably higher when using symptoms (Ferrari et 
al., 2013). Ideally, both diagnoses and symptoms should be used to assess the mental health 
characteristics of EA, providing a greater level of detail than either could alone. 
A related methodological concern of the existing literature is the lack of a comprehensive 
assessment to measure mental health symptoms, as well as related domains such as occupational 
and educational functioning, social relationships, and service use. The most exhaustive 
instruments that have been used to assess mental health among EA are the WHO-CIDI (WHO, 
2021) and the DSM-SCID (APA, 2021). Both assessments are administered via an in-person 
interview with a trained professional, and although the CIDI was initially designed for 
epidemiological purposes (Wittchen, 1994), both are used to aid in clinical decision-making and 
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determining diagnoses. The advantages of the CIDI and SCID are that they enable an in-depth 
assessment of clinical diagnoses and service use and rely on trained interviewers to gather data. 
Inter-rater reliability and diagnostic accuracy of the SCID–5 Clinician Version ranged from 
good-to-excellent among psychiatrists and psychologists conducting joint interviews and was 
also reported to have good clinical utility (Osório et al., 2019). A review of reliability studies of 
the CIDI found good-to-excellent inter-rater reliability for most sections, as well as external 
validity in various health care settings and countries (Wittchen, 1994). The drawback to these 
types of interviews is that they are resource-intensive and are not designed to capture a wide 
range of information related to mental health and well-being, diminishing their utility for 
informing general practices and policies related to psychological well-being.  
Other instruments that have been used to investigate psychological distress of EA include 
the K-6 (Adams et al., 2014; Drapeau et al., 2014; Lin et al., 2012), though it has demonstrated 
low sensitivity in some samples (Adams et al., 2014). Additionally, measuring distress through 
six items may be useful as a general screener for the broader population, but is not indicative of 
varying mental health needs. The Global Appraisal of Needs – Short Screener (GSS) has also 
been used in one study, though none of the sub-screeners produced acceptable fit indices in a 
structural equation model, indicating that it may not be valid for determining specific mental 
health domains (Henderson et al., 2017). Finally, institutional surveys such as the NCHA have 
the advantage of wide dissemination and breadth of information (ACHA, 2013), but  is 
susceptible to low response rates.
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Table 1. Summary of instruments used, sampling procedures, and response rates for surveys of student mental health 
conducted in post-secondary institutions. 
Research study Instrument(s) Sampling Procedure Response Rate 
American College Health 
Association: Canadian 
Reference Group (2019) 
National College Health Assessment 
(NCHA) 




Auerbach et al., (2018) World Health Organization – World 
Mental Health Surveys 
Convenience sample of 14,348 first-
year students in 19 post-secondary 
institutions across 8 countries. 
45% weighted response 
rate; range 7-79% 
Bayram & Bilgel (2008) Depression, Anxiety and Stress Scale 
(DASS) – 42 items 
Convenience sample of 1,617 
students during in-class time 
Unreported 
Beiter et al., (2015) Depression, Anxiety and Stress Scale 
(DASS) – 21 items 
Convenience sample of 407 
undergraduate students 
92%  
Blanco et al., (2008) National Institute on Alcohol Abuse and 
Alcoholism Disorder and Associated 
Disabilities Interview Schedule - DSM-
IV version 
Random sampling of adults aged 18+ 
living in households across the USA – 
5,092 aged 19-25 
81% (overall general 
population) 
Bruffaerts et al., (2018) Global Appraisal of Needs – Short 
Screener (GAIN-SS) 
4,921 first-year students randomly 
sampled as part of the Leuven 
College Surveys – WMH 
International College Student project 
73%  
Centre for Collegiate Mental 
Health (2019) 
Counseling Center Assessment of 
Psychological Needs (CCAPS) – 34. 
Standardized Data Set (SDS) and 
Clinician Index of Client Concerns 
(CLICC) 
179,964 students who accessed 
counselling services from 152 
participating institutions 
28% of institutions that 
hold CCMH membership 
provide routine data  
Cranford, Eisenberg & Serras 
(2009) 
Personal Health Questionnaire (PHQ) – 9 
items. Individual substance use items. 
Random sample of 5,021 
undergraduate and graduate students  
57% 
Healthy Minds Network 
(2018) 
Healthy Minds Survey – 2016/17 Random sample of ~4000 students 
from 54 participating institutions 
31% (institutional 
average) 
Macaskill (2013) General Health Questionnaire (GHQ) – 
28 items 
 
Convenience sample of 1,197 
undergraduate students 
90% (admission), 82% 
(first-year), 82% (second-
year), 77% (third-year) 
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Research study Instrument(s) Sampling Procedure Response Rate 
Soet & Sevig (2006) Counseling Center Assessment of 
Psychological Needs (CCAPS) – 70 
items 
Random sample of 5,000 students 19% 
Vázquez, Torres, Otero, & 
Díaz (2011) 
Structured Clinical Interview for DSM-
IV Axis 1 Disorders – Clinician Version 
(SCID-CV) 
Random sample of 1,054 female 
students 
98%  
Wiens et al., (2020) Canadian Community Health Survey 
(CCHS) 
14,500 students aged 18-25 who 
participated in annual, cross-sectional 




Response rates have proven to be a major limitation to many studies, as can be seen 
above in Table 1. Cross-sectional surveys of post-secondary students have been as low as 19% 
(ACHA, 2019; Soet & Sevig, 2006), and as high as 31% (Healthy Minds Network, 2018) and 
46% (Auerbach et al., 2019). Singular institutions relying on convenience samples of students 
have reported better response rates (between 70-90%) (Beiter et al., 2015; Bruffaerts et al., 2018; 
Macaskill, 2013), though they lack external validity and due to nonrandom sampling, also 
present some biases. For longitudinal studies conducted in the general population, sample 
attrition is also an issue. Some studies reported a loss of 20-35% of participants over time, with 
longer durations associated with greater attrition (Benjet et al., 2016; Gustavson et al., 2018). 
One method for diminishing the impact of attrition through statistical weighting for nonresponse 
bias (Benjet et al., 2016); however, caution should be used since these weights may not fully 
account for unmeasured confounding characteristics of non-respondents. Since convenience 
samples of students from individual institutions tend to have decent response rates, it is unlikely 
that general surveys with low response rates are biased in the wrong direction, since both types 
of studies consistently report a high prevalence of mental health issues. Regardless, low response 
rates and sample biases reduce the accuracy of the results, accounting for some of the variation 
observed in exact prevalence estimates across studies.  
While response rates and sample biases are a concern, when combined, the large number 
of studies that focus on mental health of EA in general and post-secondary settings create a fairly 
consistent account of common symptoms and trends. In contrast, a thorough description of EA 
receiving care in psychiatric settings could not be written since relatively few studies have 
examined EA in these contexts and of those, none examined hospital and community settings 
simultaneously. An issue that was encountered in the psychiatric studies that were found was 
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how age groups were categorized, such as combining young EA with children and adolescents 
(e.g., 0-24), or alongside adults up to the age of 64. Without creating distinct EA groups, it is not 
possible to determine whether or not they have unique clinical characteristics and service 
outcomes across settings. Another major challenge to identifying mental health needs of EA in 
community settings was low treatment uptake (Edlund et al., 2002; MHCC, 2015; Roche et al., 
2020). Further, among EA who did report receiving community mental health treatment, 
specialized professions such as psychologists and psychiatrists were rarely accessed (Findlay & 
Sunderland, 2014). In addition to problems with low engagement rates, the community mental 
health system in Canada is complicated and fractured, with no national data repositories 
currently available for this sector (CIHI, 2019b). Overall, there is little information available on 
the clinical characteristics and service use of EA accessing psychiatric services in Canada, 
highlighting the need to conduct more research in this area. 
2.1.4 Rationale and Objectives 
As part of the national report on designing mental health systems for EA, the MHCC 
(2015) noted the need for more data-driven Canadian research that can be used to inform clinical 
practice and policy guidelines. The purpose of this project is to contribute towards building an 
evidence-base to support the mental health care of EA, with a specific focus on the most 
intensive tiers of the service continuum proposed by the MHCC. These tiers include specialized 
hospital and community-based programs that are designed for individuals with severe and 
complex needs (MHCC, 2015), where little information on EA could be located in the literature 
review in comparison to general and post-secondary populations. To better design services that 
meet the needs of EA, identifying their clinical characteristics and service use patterns across 
both hospital and community settings is a necessary first step. Secondly, clarifying which 
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characteristics are associated with different stages of EA can provide context on how age groups 
might be separated for research, as well as detect potential differences in mental health trends.  
Having reviewed the studies available on EA located in psychiatric hospital and 
community settings, some hypotheses were generated about the patterns of clinical 
characteristics that were likely to be observed. For instance, substance use, mood, and anxiety 
disorders should be the most prevalent diagnoses in the ED (Aratani & Addy, 2014; Brien et al., 
2015; Juhás & Agyapong, 2016), with a higher proportion of primary anxiety disorders in the ED 
compared to inpatient and community settings. This pattern of mental health disorders is also the 
most similar to that seen in general and post-secondary populations, which is reasonable since 
the ED is the most accessible of the specialized care settings (CIHI, 2020). While mood 
disorders should also be highly prevalent among EA in inpatient psychiatry, given the admission 
criteria, uniquely high proportions of schizophrenia disorders are also likely to be seen in this 
setting (Beckman et al., 2016; CIHI, 2020; Watanabe-Galloway & Zhang, 2007). Finally, while 
no comprehensive data on community mental health of EA could be found, a national survey 
suggests there may be a greater degree of clinical complexity among those accessing specialized 
services (Findlay & Sunderland, 2014). As for potential differences between age groups within 
EA, it is possible that substance use will be greater among those aged 18-25, since this is 
typically when substance use disorders are at their peak (APA, 2013). However, while one study 
indicated that substance use was higher in the 18-24 age group (Adams et al., 2014), another 
demonstrated no differences between 15- to 22-year-olds and 23- to 29-year-olds (Qadeer et al., 
2019), so it is unclear to what extent substance use will vary by age group.  
Altogether, the primary objective of this study was to investigate the prevalence of 
clinical characteristics and service use of EA assessed in psychiatric hospitals, EDs, and 
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community mental health agencies located across Canada. The secondary objective was to 
examine whether there were age-related differences in the clinical characteristics of age groups 
within EA, which were defined as 18-25, 26-30, and 30-35.  
2.2 Methods 
2.2.1 Data Sources 
To evaluate the clinical needs and service use patterns of EA accessing mental health care 
services in Ontario, cross-sectional data was obtained from three interRAI assessment 
instruments. Corresponding to inpatient psychiatry, psychiatric EDs, and community mental 
health agencies, the three data sources used in this dissertation were the Resident Assessment 
Instrument – Mental Health (RAI-MH), interRAI Emergency Screener for Psychiatry (ESP), and 
interRAI Community Mental Health (CMH), respectively.  
2.2.1.1 Resident Assessment Instrument – Mental Health (RAI-MH) 
The RAI-MH is designed for inpatient psychiatric hospitals and units (Hirdes et al., 2000; Hirdes 
et al., 2002; Hirdes et al., 2020). Assessments are completed by mental health professionals, such 
as nurses, social workers, and clinicians, with some self-reported patient items and where 
possible, information from family and/or friends. Information is collected across a variety of 
domains, such as mental health symptoms and diagnoses, functional status, cognitive 
performance, occupational and educational status, socioeconomic indicators, social relationships, 
and treatment history. Observations of mood, behavior, functioning, and health status are 
conducted over a three-day period, while treatment use is examined over seven days. Depending 
on the domain, such as substance use, timeframes may extend up to a year or longer. 
Assessments are performed at admission, discharge - and for long-stay patients - every 90 days 
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or whenever a significant change in clinical status has occurred. The most current mental health 
instrument available for inpatient psychiatry is the interRAI Mental Health (MH). However, the 
province of Ontario continues to use the older version of RAI-MH, which does not contain all 
the variables present in the newest rendition, including enrollment in post-secondary education.  
RAI-MH assessments are contained in the Ontario Mental Health Reporting System (OMHRS), 
which collects and maintains data submitted from hospitals to CIHI (2021). OMHRS was 
implemented provincially in Ontario beginning in 2005, when the Ministry of Health and Long-
term Care mandated the use of the RAI-MH within inpatient psychiatry. Since its development, 
OMHRS has gathered RAI-MH assessments from 68 participating hospitals across Ontario. 
Further, RAI-MH data is also submitted to CIHI from two pilot facilities in Newfoundland and 
Labrador and one pilot facility in Manitoba. At the time of data analysis, RAI-MH assessments 
were available from October 2005 to March 2019. The reliability and validity of the RAI-MH 
have been previously established in several studies (Foebel et al., 2013; Gibbons et al., 2008; 
Hirdes et al., 2008; Hirdes et al., 2020; Martin et al., 2009). 
2.2.1.2 interRAI Community Mental Health (CMH) 
The interRAI Community Mental Health (CMH) assessment is intended for mental health care 
professionals providing treatment in the community, including assertive community teams and 
case managers (Hirdes et al., 2010; Hirdes et al., 2020; Mathias, Hirdes, & Pittman, 2010;). Like 
the RAI-MH, a three-day observation period is employed for items on mental health symptoms 
and diagnoses, behaviours, mood, functional status, and physical health. Social relationships, 
socioeconomic needs, housing environment, and occupational and educational functioning are 
also addressed. There are also historical items related to a person’s health and service use 
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history, including recent and lifetime psychiatric hospitalizations. Assessments are intended to be 
completed at intake, discharge, and for longer-term clients, every 6 months.  
The CMH was pilot tested in 12 participating sites across Ontario between 2005-2006, as well as 
by the Department of Community Services in Newfoundland and Labrador between 2012-2014 
(Mathias et al., 2010). The Chatham-Kent and Bluewater Health regions also implemented the 
mental health suite of instruments – including the CMH - as of 2017. 
2.2.1.3 interRAI Emergency Screener for Psychiatry (ESP) 
The ESP is designed to determine acute mental health needs for those accessing emergency 
departments, psychiatric emergency departments, and mobile crisis teams (Hirdes et al., 2020; 
Rabinowitz et al., 2013). Unlike the 3-day observation periods used in the RAI-MH and CMH, 
the ESP relies on a 24-hour look back period, with the expectation that those accessing further 
psychiatric care will receive either an inpatient or community assessment. There are fewer items 
than in the other instruments, since the focus is on immediate mental and physical health 
concerns. Based on the responses to these items, the ESP generates acute risk scales for self -
harm, harm to others, and self-care. The ESP was pilot tested across Ontario in 2005, as well as 
in psychiatric EDs located in the Niagara region of Ontario between 2013-2014. Finally, as of 
2018, the ESP has also been implemented in the Chatham-Kent and Bluewater health regions of 
Ontario.  
2.2.2 Study design and sample 
A cross-sectional study design was used to compare the clinical characteristics of adults aged 18-
25, 26-30, and 31-35 in community, ED and inpatient psychiatric settings. To avoid inflating the 
prevalence of sociodemographic and clinical characteristics, only the first episode of care was 
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retained for each individual. It is important to note that the first episode of care contained in the 
dataset does not mean that it was the individual’s first time in that care setting overall; it is 
possible that a person received care prior to implementation of the RAI assessments.  
RAI-MH data were obtained from OMHRS for the inpatient psychiatric population. In addition 
to the age restriction of 18-35 years, forensic patients and assessments with questionable data 
quality were also excluded. OMHRS monitors data quality control of incoming assessments and 
flags those that may contain inaccurate data. Forensic patients were excluded from the sample 
because their care needs, as well as their pathways into and out of psychiatric care, are different 
from those of other patient types. An additional difference that is unique to the RAI-MH data is 
the use of the discharge assessment from the first episode of care. Since psychiatric diagnoses are 
likely more reliable at the time of discharge than at intake, disorders were obtained from 
discharge assessments and added to the intake data. Figure 1, below, illustrates the process for 




Figure 1. Participant flow chart for the RAI-MH dataset. 
In the community sample, CMH intake data were obtained from all available Canadian 
sources (Newfoundland and Ontario). Other than restricting the age range to 18-35 years, no 
other exclusion criteria were applied. The total sample was N=2,548 unique individuals, with age 
groups broken down as follows: 18-25 (n=1,194); 26-30 (n=742); and 31-35 (n=612).  
In the ESP dataset, all sources of data were initially planned to be included. However, it was 
discovered that several assessments were missing data for variables essential to the calculation of 
some of the key patient risk scales. Considering the importance of these risk scales, it was 
decided that any assessment missing the information needed to calculate those scales would be 
excluded. The sites containing the majority of missing data were the Niagara region, as well as 
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the Chatham-Kent region between January 1, 2016 – March 28, 2017. Figure 2, displayed below, 
shows the process for creating the sample. 
 
Figure 2. Participant flow chart for the ESP dataset. 
2.2.2.1 RAI-MH variables 
Sociodemographic characteristics included sex (male, female, or other), marital status (never 
married, married/significant other, previously married), living arrangement (alone, with family, 
with others, or in group setting), education (less than high school, high school, more than high 
school), and employment status (employed, unemployed – seeking employment, unemployed – 
not seeking employment, or other). As a proxy for socioeconomic status (SES), an item was 
included on economic trade-offs: “during the last 30 days, because of limited funds, made trade-
offs on purchasing any of the following: prescribed medications, sufficient home heat, necessary 
health care, adequate food.”   
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Post-secondary student status is not an item that is included in the RAI-MH assessment; 
however, because it is a substantial sub-population of EA, an estimate of potential post-
secondary status was created based on existing variables. If all of the following conditions were 
met, post-secondary status was coded as a ‘1’: education (technical or trade school, some 
college/university, diploma/bachelor’s degree, or graduate degree), employment status 
(unemployed, NOT seeking employment), and three indicators of risk to 
unemployment/disrupted education that were scored as a ‘yes’ or ‘no’ (increase in lateness or 
absenteeism in last 6 months; poor productivity or disruptiveness at work/school; expresses 
intent to quit work/school). If the individual had any other type of educational attainment or 
employment status, and if the indicators were scored as ‘not applicable,’ then they were coded as 
a ‘0’ for post-secondary status.  
Items pertaining to social relationships and recent stressors were investigated. Regarding 
social relationships, two yes/no items were included: “reports having no confidant,” and “has a 
support person who is positive towards discharge/maintaining residence in the community.” 
Under the ‘stressors’ category, time since the stressor was experienced was collapsed into the 
following categories: ‘2’ if it occurred within the last seven days, ‘1’ if it occurred after more 
than seven days, and ‘0’ if it never occurred. The stressors examined were death of close family 
member or friend, conflict-laden or severed relationship, failed or dropped out of education 
program, major loss of income or serious economic hardship due to poverty, victim of sexual 
assault/abuse, and victim of emotional abuse. 
Mental health service history was measured as the number of psychiatric admissions 
(recent), number of psychiatric admissions (lifetime), contact with community mental health in 
past year, and age at first hospitalization. Since the first episode of care contained in the system 
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was selected for analysis, it was expected that recent and lifetime admissions to a psychiatric 
hospital would be minimal for most individuals.  
Regarding substance use, both alcohol and a selection of drugs were provided. For 
alcohol use, the number of drinks consumed in any single sitting over the last 14 days was coded 
using the highest number applicable (0, 1, 2-4, 5+). Time since last use of a substance was 
categorized as ‘2’ if it occurred within the past month, ‘1’ if it occurred between 30-365 days, 
and ‘0’ if it was never used or used more than a year ago. The following types of substances 
were examined: inhalants, hallucinogens, cocaine and crack, stimulants, opiates, and cannabis. 
Due to the rarity of inhalant consumption, it was removed from analysis. 
A variety of clinical needs were examined. DSM-IV diagnoses at admission were 
selected, as well as discharge diagnoses. While DSM-5 diagnoses replaced DSM-IV categories 
in 2016, the majority of data used for analysis occurred prior to this change. To ensure 
consistency among assessments, DSM-5 diagnoses were re-coded to match DSM-IV categories. 
To represent symptomatic distributions of clinical needs, several scales were analyzed: the 
Depressive Severity Index (DSI) (Perlman et al., 2013), Aggressive Behaviour Scale (ABS) 
(Martin et al., 2009; Perlman & Hirdes, 2008), CAGE scale, Cognitive Performance Scale (CPS) 
(Jones, Perlman, Hirdes, & Scott, 2010; Martin et al., 2009; Perlman et al., 2013), Positive 
Symptoms Scale – Short Version (PSS-S) (Martin et al., 2009), Social Withdrawal Scale (SWS) 
(Rios & Perlman, 2017), Severity of Self-Harm scale (SoS), Risk of Harm to Others (RHO) 
(Neufeld, Perlman & Hirdes, 2012), and Self-Care Index (SCI). Evidence related to the 
reliability and convergent validity of these scales is described further in a previous research 
paper (Hirdes et al., 2020). In addition, the following CAPs were investigated: substance use, 
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criminal activity, sleep, social relationships, interpersonal conflict, support systems for 
discharge, and trauma. Description and scoring of scales and CAPs are provided in Appendix A.   
2.2.2.2 CMH Variables 
Sociodemographic variables that were examined across age groups included the following: sex 
(male or female), marital status (never married, married/significant other, previously married), 
living arrangement (alone, with family, or with others), employment status (employed, 
unemployed – seeking employment, or unemployed – not seeking employment), and enrollment 
in a formal education program. Risk of unemployment or disrupted education was also 
investigated among students (increase in lateness or absenteeism over last 6 months, poor 
productivity or disruptiveness at work or school, and expresses intent to quit work or school). A 
proxy for socioeconomic status – financial trade-offs - was also added: “because of limited 
funds, during the last 30 days, made trade-offs on purchasing any of the following: adequate 
food, shelter, clothing; prescribed medications; sufficient home heating or cooling; necessary 
health care.”    
Individual items related to personal strengths, social relationships and recent stressors 
were examined. Personal strengths/social relationships encompass four “yes/no” items: reports 
having a confidant, consistent positive outlook, strong and supportive relationship with family, 
reports strong sense of involvement in community. The same list of stressors as in the RAI-MH 
were examined in the CMH (death of close family member or friend, conflict-laden or severed 
relationship, failed or dropped out of education program, major loss of income or serious 
economic hardship due to poverty, victim of sexual assault/abuse, and victim of emotional 
abuse). Time since stressor was last experienced was collapsed into the following categories: ‘2’ 
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if it occurred within the last 30 days prior to the assessment, ‘1’ if it occurred more than 30 days 
prior, and ‘0’ if it never occurred.  
History of mental health service use included the following variables: time since last 
contact with community mental health agency or professional within the past year, time since 
last psychiatric hospital discharge, number of psychiatric admissions in last 2 years, number of 
lifetime psychiatric admissions, and age in years at first overnight stay in a psychiatric hospital 
or unit.  
The same variables covering alcohol and substance use in the RAI-MH were examined in the 
CMH. Regarding clinical needs, DSM-IV diagnoses were obtained. Just as in the RAI-MH, 
diagnoses are ranked according to their importance. A primary diagnosis was one in which it was 
ranked as most important, while Non-primary diagnoses were those ranked as second, third or 
fourth most important, respectively. In addition, the same scales and CAPs that were used in the 
RAI-MH were included in the CMH analysis.   
2.2.2.3 ESP Variables 
Sex (male or female) is the only sociodemographic characteristic that is available in the ESP. In 
terms of social relationships and stressors, an item on time since conflict-laden or severed 
relationship was included. Two further “yes/no” items were used: “has a support person who is 
positive toward discharge or maintaining residence in community,” and “major life stressors in 
last 90 days” (episode of severe personal illness; death or severe illness of close family 
member/friend; loss of home; major loss of income/assets; victim of a crime such as robbery or 
assault; loss of driving license/car). History of mental health service use was measured using two 
items: “time since discharge from last psychiatric admission,” and “number of lifetime 
psychiatric admissions.”  
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The item representing alcohol use is different in the ESP than in the previous two 
instruments. The number of days in the last 30 days that the person consumed alcohol to the 
point of intoxication is measured using the following categories: none, 1-2 days, 2-8 days, 9 or 
more days (but not daily), and daily. The same substances and timeframes covering substance 
use descriptors in the RAI-MH and CMH were also investigated. DSM-IV disorders were 
obtained to represent clinical needs, as well as the same set of scales in the previous assessments. 
However, due to the limited number of items and observation timeframes used, the DSI and PSS-
S are modified specifically for the ESP. 
2.2.3 Statistical analysis 
The prevalence of independent variables in each dataset was explored using cross-tabulated 
distributions. Differences across age groups were tested using the chi-square procedure. Due to 
the large sample size of the RAI-MH and multiple comparisons in each dataset, the statistical 
significance of the p-value was not the only indicator considered. To avoid misinterpretations 
resulting from Type 1 errors, significance was determined by either the absolute difference in 
frequency across age groups (more than a 5% difference), or for variables with a low absolute 
frequency, the relative difference in proportion (more than 50% difference) were used to 
interpret clinical significance of the results. Two types of cross-setting comparisons were also 
tested. One type was a difference in the magnitude of frequencies and the other was a divergence 
in the pattern of characteristics across age groups. To select variables for cross-setting 
comparisons, the bivariate results described above were examined manually. The datasets were 
then merged into a composite dataset and chi-square tests were used to test the association 




The following sections provide descriptive results for the inpatient, community, and ED samples, 
as well as comparisons across age groups.  
2.3.1 Psychiatric hospital inpatients assessed with the RAI-MH  
Table 2. Sociodemographic characteristics of psychiatric inpatients aged 18-25 (N=44,438), 
26-30 (N=21,090), and 31-35 (N=20,234) receiving hospital care in Ontario, Manitoba, and 

















χ2 (2) = 63.5  
p<.0001 
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Yes 9.9 (4,423) 6.3 (1,321) 5.1 (1,037) 
χ2 (2) = 548.80 
p<.0001 
Economic trade-offs Yes 5.2 (2,308) 6.4 (1,356) 7.0 (1,423) 
χ2 (2) = 96.7  
p<.0001 
Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
Table 2, presented above, displays the sociodemographic characteristics of psychiatric 
patients aged 18-35. Across all age groups, just over half of patients were male. Compared to the 
26- 30 and 31-35 age groups, the following traits were less common among those aged 18-25: 
completed post-secondary school, married or had a significant other, employed, and lived alone. 
They were also identified more often as possible post-secondary school student.
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Table 3. Social relationships and presence of stressors among psychiatric inpatients aged 
18-25 (N=44,438), 26-30 (N=21,090), and 31-35 (N=20,234) receiving hospital care in 










Has a confidant Yes 
85.7 
(38,072) 
85.6 (18,052) 85.2 (17,233) 
χ2 (2) = 3.0 
p = 0.23 
Has a support person 
positive about discharge 
Yes 78.8 (35,027) 78.2 (16,495) 77.3 (15,643) 
χ2 (2) = 18.9 
p<.0001 
Death of a close family 
member or friend 
<7 days 0.8 (334) 0.8 (176) 0.9 (183) 
χ2 (4) = 508.7 
p<.0001 
>7 days 26.1 (11,611) 30.9 (6,516) 34.4 (6,963) 
Never 73.1 (32,493) 68.3 (14,398) 64.7 (13,088) 
Conflict-laden or 
severed relationship 
<7 days 11.9 (5,293) 12.6 (2,662) 13.7 (2,772) 
χ2 (4) = 962.2 
p<.0001 
>7 days 21.9 (9,734) 28.0 (5,897) 31.9 (6,450) 
Never 66.2 (29,411) 59.4 (12,531) 54.4 (11,012) 
Failed or dropped out of 
education program 
<7 days 1.5 (682) 0.5 (97) 0.3 (51) 
χ2 (4) = 977.8 
p<.0001 
>7 days 37.0 (16,428) 31.8 (6,712) 27.4 (5,552) 
Never 61.5 (27,328) 67.7 (14,281) 72.3 (14,631) 
Major loss of income or 
serious economic 
hardship due to poverty 
<7 days 3.9 (1,729) 5.2 (1,103) 5.7 (1,150) χ2 (4) = 
1263.1 
p<.0001 
>7 days 12.6 (5,619) 19.8 (4,178) 21.8 (4,413) 
Never 83.5 (37,090) 75.0 (15,809) 72.5 (14,671) 
Victim of sexual 
assault/abuse 
<7 days 0.5 (213) 0.4 (87) 0.3 (63) 
χ2 (4) = 38.1 
p<.0001 
>7 days 14.6 (6,488) 15.5 (3,272) 16.2 (3,277) 
Never 84.9 (37,737) 84.1 (17,731) 83.5 (16,894) 
Victim of emotional 
abuse 
<7 days 3.0 (1,335) 2.4 (515) 2.7 (541) 
χ2 (4) = 90.9 
p<.0001 
>7 days 23.8 (10,565) 25.9 (5,456) 26.8 (5,418) 
Never 73.2 (32,538) 71.7 (15,119) 70.6 (14,275) 
Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
As seen above in Table 3, within the week prior to assessment, those aged 18-25 had 
more frequently failed or dropped out of an education program. For stressors occurring more 
than seven days prior, the 18-25 age group experienced fewer instances of serious economic 
hardship, conflict-laden or severed relationships, and death of a family member or friend. Across 
all age groups, the most common stressor to transpire in the week prior to the assessment was a 
conflict-laden or severed relationship (12-14%). In terms of social resources, across all ages, 
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85% of people reported having a confidant. Further, 78% had a person in their lives who was 
supportive of discharge back into the community.  
Table 4. History of mental health service use among psychiatric inpatients aged 18-25 
(N=44,438), 26-30 (N=21,090), and 31-35 (N=20,234) receiving hospital care in Ontario, 
Manitoba, and Newfoundland and Labrador between 2005-2019. 









Number of psychiatric 
admissions (last 2 
years) 





χ2 (4) = 8.4  
p=0.08 
1-2 21.6 (9,586) 21.2 (4,468) 21.4 (4,326) 
3+ 4.5 (2,018) 5.0 (1,060) 4.8 (965) 
Number of psychiatric 
admissions (lifetime) 
None 63.8 (28,343) 57.6 (12,138) 
54.4 
(10,999) 
χ2 (6) = 
833.7 
p<.0001 
1-3 29.1 (12,914) 32.1 (6,775) 33.2 (6,704) 
4-5 4.4 (1,968) 5.8 (1,215) 6.7 (1358) 
6+ 2.7 (1,207) 4.5 (957) 5.7 (1,162) 
Time since contact 
with community 
mental health 
>365 days 57.3 (25,480) 55.2 (11,639) 
54.1 
(10,945) 




14.5 (6,419) 15.1 (3,193) 15.2 (3,066) 
<30 days 28.2 (12,533) 29.7 (6,253) 30.7 (6,212) 
Age at first 
hospitalization 
0-14 6.0 (2,666) 4.9 (1,022) 4.3 (873) 
χ2 (4) = 
41,703.7  
p<.0001 
15-24 87.6 (38,914) 25.0 (5,263) 18.6 (3,769) 
25-44 6.4 (2,852) 70.2 (14,800) 
77.1 
(15,581) 
Note. Data reflects the first episode of care captured in the dataset, so lifetime number of admissions are likely 
underestimated. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
 
As seen in Table 4, the number of recent admissions to a psychiatric hospital was similar 
across all age groups. Since the dataset for this study used the first episode of care contained in 
the dataset, most of the sample did not have a recent psychiatric admission. Among those who 
did, 5% or less had more than three admissions. Similarly, age at first hospitalization was often 
the same as the age at the time of assessment. However, a minority of individuals had been 
admitted to a psychiatric hospital before the age of 14, representing a more long-term and severe 
 
 62 
population. There were slight differences in the number of lifetime psychiatric admissions, which 
increased with age. Among those with a lifetime history of psychiatric admissions, most only had 
1-3 visits. Around 5% of those aged 26-35 had 6+ lifetime psychiatric admissions, likely 
corresponding with a younger age at first hospitalization. In terms of community mental health 
treatment, slightly more than half of the sample had been in contact with a mental health service 
at some point within the last 31-365 days, pointing to a divide in service use patterns. 
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Table 5. Substance use among psychiatric inpatients aged 18-25 (N=44,438), 26-30 
(N=21,090), and 31-35 (N=20,234) receiving hospital care in Ontario, Manitoba, and 









Number of drinks 
in any single sitting 
episode in the last 









χ2 (6) = 101.5 
p<.0001 
















Never or more 







χ2 (4) = 546.7 
p<.0001 
Within the last 
year 
4.8 (2,117) 3.4 (713) 2.3 (461) 
Within the last 
month 
3.9 (1,722) 2.4 (506) 1.6 (326) 
Cocaine 
Never or more 







χ2 (4) = 177.8 
p<.0001 
Within the last 
year 
7.0 (3,114) 7.1 (1,505) 6.0 (1,212) 









Never or more 







χ2 (4) = 55.1 
p<.0001 
Within the last 
year 
3.6 (707) 3.4 (707) 2.7 (546) 
Within the last 
month 
5.5 (2,445) 5.8 (1,213) 4.9 (985) 
Opiates 
Never or more 







χ2 (4) = 274.7 
p<.0001 
Within the last 
year 
2.9 (1,269) 3.8 (805) 3.3 (670) 
Within the last 
month 
5.5 (2,457) 8.1 (1,711) 8.1 (1,629) 
Cannabis 
Never or more 







χ2 (4) = 1887.7 
p<.0001 
Within the last 
year 
9.3 (4,110) 8.4 (1,779) 7.7 (1,555) 








Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
Overall, two-thirds of the sample had not consumed a drink in the 14 days prior to 
assessment. The 18-25 age group more frequently used hallucinogens within the past year and 
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month compared to the older age groups, and substantially more had used cannabis in the month 
preceding the assessment. Across all age groups, cannabis was the most common substance used.  
Table 6. DSM-IV admission diagnoses among psychiatric inpatients aged 18-25 (N=44,438), 
26-30 (N=21,090), and 31-35 (N=20,234) receiving hospital care in Ontario, Manitoba, and 












Primary 1.9 (836) 0.9 (183) 0.6 (127) χ2 (4) = 
361.2 
p<.0001 
Non-primary 2.6 (1,171) 1.6 (343) 1.3 (271) 
Substance use 
disorder 
Primary 14.2 (6,310) 19.8 (4,171) 20.9 (4,228) χ2 (4) = 
646.0 
p<.0001 




Primary 27.8 (12,364) 27.8 (5,863) 25.2 (5,103) 
χ2 (4) = 84.0 
p<.0001 Non-primary 3.5 (1,544) 2.9 (622) 2.8 (570) 
Mood disorder 
Primary 31.9 (14,200) 33.4 (7,038) 35.2 (7,129) χ2 (4) = 
169.3 
p<.0001 
Non-primary 8.0 (3,572) 9.1 (1,916) 9.9 (2,001) 
Anxiety disorder 
Primary 4.1 (1,843) 3.8 (800) 3.9 (789) 
χ2 (4) =  11.5 
p=0.02 Non-primary 10.6 (4,695) 10.6 (2,244) 11.2 (2,270) 
Eating disorder 
Primary 2.1 (929) 1.2 (246) 0.9 (180) χ2 (4) = 
191.6 
p<.0001 
Non-primary 1.4 (610) 1.1 (223) 0.9 (183) 
Personality disorder 
Primary 3.1 (1,367) 1.9 (399) 1.8 (360) χ2 (4) = 
189.5 
p<.0001 
Non-primary 8.1 (3,609) 7.4 (1,555) 6.6 (1,342) 
Psychiatric 
comorbidity 
0 disorders 0.04 (19) 0.06 (13) 0.04 (9) 
χ2 (4) = 80.7 
p<.0001 
1 disorder 54.6 (24,286) 56.6 (11,937) 58.3 (11,797) 
2-3 disorders 45.3 (20,133) 43.3 (9,140) 41.6 (8,428) 
Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
 
Table 6, shown above, displays the prevalence of select DSM-IV disorders and is 
separated by primary and secondary or tertiary ranking. Overall, disorders were similar across all 
age groups. 18- to 25-year-olds had a higher prevalence of neurodevelopmental and eating 
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disorders, as well as slightly more personality disorders. In contrast, they had the lowest 
proportion of primary substance use disorders. The most common disorder across all age groups 
were mood disorders, followed by schizophrenia or other psychotic disorders and substance use 
disorders. Except for anxiety and personality disorders, other disorders tended to be ranked as the 
primary diagnosis rather than secondary or tertiary.  
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Table 7. interRAI scale categories among psychiatric inpatients aged 18-25 (N=44,438), 26-30 (N=21,090), and 31-35 









Depressive severity index (DSI) 
0 24.8 (11,008)  24.5 (5,159) 23.0 (4,653) 
χ2 (6) = 80.6 
p<.0001 
1-3 32.8 (14,586) 32.2 (6,797) 31.1 (6,291) 
4-7 26.0 (11,577) 26.3 (5,553) 27.3 (5,531) 
8-15 16.4 (7,267) 17.0 (3,581) 18.6 (3,759) 
Cognitive performance scale 
(CPS) 
0 74.9 (33,273) 75.7 (15,959) 76.7 (15,511) 
χ2 (4) = 75.2 
p<.0001 
1-2 20.7 (9,193) 21.0 (4,426) 20.0 (4,040) 
3-6 4.4 (1,972) 3.3 (705) 3.4 (683) 
Aggressive behaviour scale 
(ABS) 
0 74.0 (32,882) 77.0 (16,248) 78.8 (15,949) 
χ2 (6) = 228.6 
p<.0001 
1-3 14.3 (6,343) 13.5 (2,851) 12.3 (2,485) 
4-6 7.9 (3,533) 6.6 (1,393) 6.2 (1,251) 
7-12 3.8 (1,680) 2.8 (598) 2.7 (549) 
Psychotic symptoms scale 
(PSS) 
0 55.1 (24,480) 57.0 (12,017) 59.1 (11,963) 
χ2 (6) = 127.1 
p<.0001 
1-2 10.7 (4,770) 10.8 (2,272) 10.3 (2,086) 
3-5 15.6 (6,922) 15.5 (3,272) 15.0 (3,028) 
6-12 18.6 (8,266) 16.7 (3,529) 15.6 (3,157) 
Social withdrawal scale (SWS) 
0 23.4 (10,392) 24.6 (5,187) 24.3 (4,926) 
χ2 (4) = 18.1 
p=0.001 
1-2 32.2 (14,306) 32.0 (6,754) 31.3 (6,335) 
3-6 44.4 (19,740) 43.4 (9,149) 44.4 (8,973) 
      











Severity of self-harm (SoS) 
0 18.9 (8,393) 24.0 (5,073) 26.2 (5,305) 
χ2 (4) = 685.0 
p<.0001 
1-3 32.1 (14,254) 33.6 (7,083) 33.1 (6,701) 
4-6 49.0 (21,791) 42.4 (8,934) 40.7 (8,228) 
Risk of harm to others (RHO) 
0 30.0 (13,320) 28.5 (6,008) 28.2 (5,698) 
χ2 (4) = 246.8 
p<.0001 
1-3 46.7 (20,766) 50.4 (10,629) 52.7 (10,661) 
4-6 23.3 (10,352) 21.1 (4,453) 19.1 (3,875) 
Self-care index (SCI) 
0 32.7 (14,543) 34.3 (7,238) 36.4 (7,367) 
χ2 (4) = 119.9 
p<.0001 
1-3 47.6 (21,149) 47.6 (10,039) 46.6 (9,438) 
4-6 19.7 (8,746) 18.1 (3,813) 17.0 (3,429) 
Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable).
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 In terms of age differences across the scales, the 18-25 age group exhibited a higher risk 
of self-harm than the older age groups. Otherwise, patterns of mental health symptoms were 
consistent across age groups. The most prevalent symptoms overall were those related to 
depression and social withdrawal; two-thirds of inpatients struggled with one or more symptoms 
in these areas. Around 40% of inpatients experienced positive symptoms of psychosis and 
approximately one-quarter demonstrated some difficulties with cognitive performance and 
aggressive behaviour. In terms of risk scales, risk of harm to self was the greatest, with almost 
half the sample scoring within the moderate-to-high range. For both risk of harm to others and 
self-care, around half the sample was within the mild-to-moderate range. 
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Table 8. interRAI CAP triggers among psychiatric inpatients aged 18-25 (N=44,438), 26-30 
(N=21,090), and 31-35 (N=20,234) receiving hospital care in Ontario, Manitoba, and 
Newfoundland and Labrador between 2005-2019. 









Substance use  






χ2 (4) = 409.2  
p<.0001 



















χ2 (4) = 130.8 
p<.0001 
Sleep disturbance and 








Sleep disturbance and 
severe cognitive 
impairment 
0.8 (336) 0.6 (127) 0.5 (102) 
Social 
relationships 






χ2 (4) = 9.8 
p=0.04 
Improve close 








Reduce social isolation 















χ2 (4) = 75.9 
p<.0001 
























(14,348) χ2 (2) = 20.7 













χ2 (2) = 15.4 
p=0.0004 

















χ2 (4) = 67.6 
p<.0001 
Reduce the impact of 
















Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
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 Relative to the 31-35 age group, more 18- to 25-year-olds triggered the ‘current substance 
use’ CAP, despite that fewer of them were diagnosed with a primary substance use disorder. The 
frequency distribution of other CAPs was similar across age groups. Issues pertaining to 
substance use, sleep, and social relationships were the most common needs experienced by 
inpatients. By the age of 18, one-in-five inpatients had already experienced a traumatic event.  
2.3.2 Community mental health clients assessed with the CMH  
Table 9. Sociodemographic characteristics of community mental health clients aged 18-25 
(N=1,194), 26-30 (N=742), and 31-35 (N=612) receiving care in Ontario (2005-2006), 











Gender Male 44.8 (535) 50.9 (378) 47.6 (291) 
χ2 (2) = 6.6  
p=0.04 
Marital status 
Married or significant 
other 
8.0 (96) 23.0 (171) 25.6 (157) 
χ2 (2) = 121.4 
p<.0001 
Employed* Yes 4.2 (34) 7.1 (37) 8.0 (34) 
χ2 (2) = 8.9 
p=0.01 
Lives alone Yes 12.1 (145) 21.7 (161) 22.4 (137) 




Yes 32.5 (387) 11.0 (80) 7.0 (42) 
χ2 (2) = 216.2  
p<.0001 
Economic trade-offs Yes 10.6 (126) 13.8 (101) 13.0 (78) 
χ2 (2) = 4.8 
p=0.09 
Note. *31% of the data is missing. Percentages are column percentages (e.g., % of those aged 18-25 with the 
independent variable). 
As can be seen in Table 9, there were slightly more women in the 18-25 age group than 
in the 26-30 group. Compared to both age groups, fewer 18- to 25-year-olds were married, 
employed, and living alone, but more were enrolled in a post-secondary education program. 
Among those aged 18-25, one-third were a post-secondary student. 
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Table 10. Social relationships and presence of stressors among community mental health 
clients aged 18-25 (N=1,194), 26-30 (N=742), and 31-35 (N=612) receiving care in Ontario 















χ2 (2) = 1.1  
p=0.59 
Consistent positive outlook Yes 
38.2 
(456) 
42.7 (314) 40.2 (245) 
χ2 (2) = 3.8 
p=.15 
Strong and supportive 
relationship with family 
Yes 59.1 (705) 64.2 (471) 58.8 (359) 
χ2 (2) = 5.8 
p=.05 
Reports strong sense of 
involvement in community 
Yes 20.2 (220) 19.2 (126) 21.1 (114) 
χ2 (2) = 0.7 
p=.71 
Death of a close family member 
or friend 
<30 days 2.0 (24) 2.6 (19) 2.7 (16) 
χ2 (4) = 6.0  
p=.20 
 >30 days 45.0 (531) 50.0 (366) 46.8 (280) 
Never 52.9 (624) 47.4 (347) 50.5 (302) 
Conflict-laden or severed 
relationship 
<30 days 8.8 (103) 6.9 (50) 9.7 (58) 
χ2 (4) = 30.9  
p<.0001 
>30 days 29.3 (345) 34.5 (251) 41.1 (246) 
Never 61.9 (728) 58.6 (427) 49.2 (295) 
Failed or dropped out of 
education program 
<30 days 1.5 (18) 0.8 (6) 0.2 (1) 
χ2 (4) = 9.3 
p=0.05 
>30 days 43.2 (511) 46.4 (338) 45.6 (273) 
Never 55.2 (653) 52.7 (384) 54.2 (324) 
Major loss of income or serious 
economic hardship due to 
poverty 
<30 days 4.1 (49) 7.7 (56) 5.8 (35) 
χ2 (4) = 47.7 
p<.0001 
>30 days 12.4 (147) 17.6 (128) 23.1 (139) 
Never 83.4 (985) 74.7 (543) 71.0 (427) 
Victim of sexual assault/abuse* 
<30 days 0.5 (6) 0.5 (4) 0.2 (1) 
χ2 (4) = 5.8 
p=.21 
 
>30 days 27.0 (320) 28.6 (208) 31.9 (191) 
Never 72.4 (857) 70.9 (516) 67.9 (406) 
Victim of emotional abuse 
<30 days 7.5 (88) 6.7 (49) 5.0 (30) 
χ2 (4) = 5.9 
p=.20 
>30 days 45.5 (538) 45.9 (333) 50.1 (299) 
Never 47.0 (555) 47.4 (344) 44.9 (268) 
Note. *some cells contain fewer than 5 cases. Percentages are column percentages (e.g., % of those aged 18-25 with 
the independent variable). 
 Across all age groups, roughly two-thirds of the sample reported having a confidant and a 
strong and supportive relationship with their family. However, only one-in-five individuals said 
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that they felt a strong sense of involvement in their community. Those aged 31-35 more 
frequently experienced a conflict-laden or severed relationship in the past 30 days, as well as 
major loss of income or economic hardship. Death of a family member or friend, failing or 
dropping out of an education program, and emotional abuse were all stressors that had occurred 
within the last 30 days for 40-50% of individuals across all age groups.  
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Table 11. History of mental health service use among community mental health clients aged 
18-25 (N=1,194), 26-30 (N=742), and 31-35 (N=612) receiving care in Ontario (2005-2006), 
Chatham-Kent and Bluewater Health (2017-2019), and Newfoundland and Labrador 
(2012-2014). 









Time since last contact with a 
community mental health 

























Time since last psychiatric 

























Number of psychiatric 


























































Age in years at first overnight 

































Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
 Across all age groups, over half the sample had previously been in contact with a mental 
health agency or professional, usually within the month prior to assessment. Compared to older 
age groups, more 18- to 25-year-olds had been discharged from a psychiatric hospital in the 
month preceding the assessment, though they had fewer lifetime admissions overall. Whereas 
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62% of the 18-25 age group had no lifetime psychiatric admissions, 55% of the 26-30 and 31-35 
age groups had none. Among those who had previously been admitted to a psychiatric hospital, 
most had between 1-3 visits. The most common age at first overnight stay in a psychiatric 
hospital was between the ages of 15-24, corresponding with the findings in the inpatient sample.  
Table 12. Substance use among community mental health clients aged 18-25 (N=1,194), 26-
30 (N=742), and 31-35 (N=612) receiving care in Ontario (2005-2006), Chatham-Kent and 










Number of drinks in 
any single sitting 
episode in the last 14 
days (code for highest 
number) 
None 58.1 (690) 63.1 (462) 
62.7 
(379) 
χ2 (6) = 
11.2  
p=.08 
1 8.4 (100) 8.9 (65) 9.9 (60) 
2-4 16.6 (197) 14.2 (104) 14.7 (89) 
5+ 16.9 (200) 13.8 (101) 12.6 (76) 
Hallucinogens 
Never or more than 1 
year ago 
75.8 (895) 72.6 (529) 
72.5 
(436) χ2 (4) = 
13.4  
p=.01 
Within the last year 21.9 (258) 26.6 (194) 
26.3 
(158) 
Within the last month 2.3 (27) 0.8 (6) 1.2 (7) 
Cocaine 
Never or more than 1 
year ago 
75.5 (893) 68.4 (499) 
68.3 
(409) χ2 (4) = 
30.0 
p<.0001 
Within the last year 18.3 (217) 27.6 (201) 
26.7 
(160) 
Within the last month 6.2 (73) 4.0 (29) 5.0 (30) 
Stimulants 
Never or more than 1 
year ago 
84.3 (995) 79.9 (583) 
79.5 
(478) 
χ2 (4) = 9.3 
p=.05 Within the last year 11.9 (140) 15.6 (114) 15.3 (92) 
Within the last month 3.8 (45) 4.5 (33) 5.2 (31) 
Opiates 






(494) χ2 (4) = 
20.0 
p=.0005 
Within the last year 10.2 (121) 14.6 (106) 13.9 (83) 
Within the last month 1.4 (17) 2.7 (20) 3.7 (22) 
Cannabis 
Never or more than 1 
year ago 
31.7 (374) 27.4 (201) 
31.5 
(189) 
χ2 (4) = 
33.6 
p<.0001 
Within the last year 24.2 (286) 34.4 (252) 
33.8 
(203) 
Within the last month 44.1 (520) 38.2 (280) 
34.7 
(208) 
Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
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 Compared to older age groups, the 18-25 group had less recently consumed cocaine and 
opiates but had more recently consumed cannabis. Cannabis was the most common substance 
used; over one-third of the sample had used it in the past month. Conversely, approximately 60% 
of the sample reported having no drinks in the last 14 days. 
Table 13. DSM-IV diagnoses among community mental health clients aged 18-25 
(N=1,194), 26-30 (N=742), and 31-35 (N=612) receiving care in Ontario (2005-2006), 













Primary 5.5 (66) 2.6 (19) 2.3 (14) 
χ2 (4) = 21.4  
p=.0003 Non-primary 5.3 (63) 3.4 (25) 3.9 (24) 
Substance use 
disorder 
Primary 2.4 (29) 2.4 (18) 2.4 (15) 
χ2 (4) = 7.0  




Primary 11.7 (140) 20.9 (155) 22.1 (135) 
χ2 (4) = 43.4 
p<.0001 Non-primary 1.7 (20) 1.6 (12) 2.0 (12) 
Mood disorder 
Primary 25.2 (301) 26.0 (193) 25.0 (153) 
χ2 (4) = 0.5  
p=.97 Non-primary 13.1 (157) 13.6 (101) 12.9 (79) 
Anxiety disorder 
Primary 9.7 (116) 9.0 (67) 9.6 (59) 
χ2 (4) = 1.2 
p=.87 Non-primary 22.3 (266) 20.7 (154) 20.9 (128) 
Personality disorder 
Primary 5.8 (69) 3.9 (29) 4.4 (27) 
χ2 (4) = 11.9 
p=.02 Non-primary 6.0 (72) 7.1 (53) 3.6 (22) 
Psychiatric 
comorbidity 
0 disorders 39.9 (458) 34.8 (248) 34.5 (203) 
χ2 (4) = 13.3 
p=.01 
1 disorder 21.5 (247) 27.3 (194) 27.7 (163) 
2-4 disorders 38.6 (444) 37.9 (270)  37.8 (222) 
Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
 Compared to the 18-25 age group, more of the older age groups presented with a primary 
diagnosis of schizophrenia or another psychotic disorder. In contrast, those aged 18-25 had more 
primary diagnoses of a neurodevelopmental disorder. The most common diagnosis was a mood 
disorder, followed by anxiety and psychotic disorders. However, most anxiety disorders were 
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ranked as secondary or tertiary in importance. Over one-third of the sample had no formal 
psychiatric diagnosis while 38% had 2-4 diagnoses. 
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Table 14. interRAI scale categories among community mental health clients aged 18-25 
(N=1,194), 26-30 (N=742), and 31-35 (N=612) receiving care in Ontario (2005-2006), 












index (DSI)  
0  12.1 (144) 18.0 (132) 19.3 (117) 
χ2 (6) = 26.0 
p=.0002 
1-3 17.4 (207) 17.0 (125) 15.0 (91) 
4-7 24.8 (294) 19.6 (144) 19.8 (120) 




0 72.2 (859) 71.4 (523) 70.8 (431) 
χ2 (4) = 1.5 
p=.82 
1-2 26.0 (309) 26.0 (190) 27.1 (165) 
3-6 1.8 (22) 2.6 (19) 2.13 (13) 
Aggressive behaviour 
scale (ABS) 
0 82.0 (967) 80.0 (583) 81.6 (496) 
χ2 (6) = 3.1 
p=.79 
1-3 15.1 (178) 17.0 (124) 16.4 (100) 
4-6 2.3 (27) 2.3 (17) 1.6 (10) 
7-12 0.6 (7) 0.7 (5) 0.3 (2) 
Psychotic symptoms 
scale (PSS)  
0 73.3 (859) 71.0 (518) 69.8 (418) 
χ2 (6) = 9.7 
p=.14 
1-2 13.1 (154) 13.7 (100) 12.5 (75) 
3-5 9.8 (115) 11.9 (87) 11.7 (70) 
6-12 3.7 (44) 3.4 (25) 6.0 (36) 
Social withdrawal 
scale (SWS) 
0 8.6 (99) 13.2 (95) 14.9 (88) 
χ2 (4) = 18.9 
p=.0008 
1-2 17.6 (203) 17.9 (129) 16.7 (99) 
3-6 73.8 (852) 68.9 (496) 68.4 (404) 
Severity of self-harm 
(SoS) 
0 37.6 (439) 43.2 (310) 45.3 (273) 
χ2 (4) = 11.8 
p=.02 
1-3 41.9 (489) 38.9 (279) 36.3 (219) 
4-6 20.4 (238) 17.8 (128) 18.4 (111) 
Risk of harm to 
others (RHO) 
0 50.8 (600) 47.2 (345) 49.4 (297) 
χ2 (4) = 2.8 
p=.59 
1-3 33.4 (394) 36.2 (265) 33.6 (202) 
4-6 15.8 (186) 16.5 (121) 17.0 (102) 
Self-care index (SCI) 
0 28.5 (324) 30.4 (218) 32.3 (191) 
χ2 (4) = 5.4 
p=.25 
1-3 62.1 (706) 61.7 (442) 60.9 (360) 
4-6 9.3 (106) 7.8 (56) 6.8 (40) 
Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
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 Overall, the three age groups displayed similar patterns of mental health symptoms. The 
most extensive symptoms of mental illness across all age groups were depression and social 
withdrawal. Severe depression was observed in 45% of the sample, while 68-74% of the sample 
had moderate-to-severe social withdrawal. Cognitive impairment and symptoms of psychosis 
were both present in roughly 30% of the overall sample, though most cognitive impairments 
were classified as mild while psychosis was mild-to-moderate in most cases. Aggressive 
behavior was the most infrequent issue; only one-fifth of the sample demonstrated any such 
behaviours and among those who did, most scored in the mild range. Despite low levels of 
aggressive behaviours, risk of harm to others was a concern for half the sample, with roughly 
16% at moderate-to-high risk, likely due to the presence of psychotic symptoms. Almost two-
thirds of the sample were also at mild-to-moderate risk of being unable to care for themselves.  
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Table 15. interRAI CAP triggers among community mental health clients aged 18-25 
(N=1,194), 26-30 (N=742), and 31-35 (N=612) receiving care in Ontario (2005-2006), 
Chatham-Kent and Bluewater Health (2017-2019), and Newfoundland and Labrador 
(2012-2014). 









Substance use  
Not triggered 26.2 (298) 22.6 (159) 26.4 (152) 
χ2 (4) = 
17.9 
p=.001 
Triggered for past 
use 
21.1 (240) 28.0 (197) 27.8 (160) 
Triggered for 
current use 
52.7 (600) 49.4 (348) 45.7 (263) 
Sleep disturbance 
Not triggered 37.2 (435) 41.7 (303) 43.8 (264) 
χ2 (2) = 
8.5 
p=.01 
Triggered due to 
current sleep 
disturbance 
62.8 (735) 58.3 (423) 56.2 (338) 
Social relationships 
Not triggered 49.1 (545) 50.6 (347) 47.2 (272) 






35.8 (398) 38.0 (261) 35.8 (206) 
Reduce social 
isolation and family 
dysfunction 
15.1 (168) 11.4 (78) 17.0 (98) 
Interpersonal conflict 
Not triggered 38.4 (454) 46.2 (338) 44.4 (268) 






38.5 (455) 34.6 (253) 36.3 (219) 
Reduce widespread 
conflict 
23.0 (272) 19.3 (141) 19.2 (116) 
Criminal activity 
Not triggered 76.5 (873) 74.3 (528) 72.3 (426) 
χ2 (2) = 
3.8 
p=.15 
Reduce risk of 
violent or nonviolent 
criminal behaviour 
23.5 (268) 25.7 (183) 27.7 (163) 
Traumatic events 
Not triggered 75.7 (859) 71.8 (501) 72.3 (417) 
χ2 (4) = 
7.5  
p=.11 
Reduce the impact of 
prior traumatic life 
events 
14.6 (166) 19.2 (134) 18.2 (105) 
Address immediate 
safety concerns 
9.6 (109) 9.0 (63) 9.5 (55) 
Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
 Substance use was the most frequently triggered CAP. Three-quarters of the sample 
required help with either past or current substance use, with a greater proportion of 26- to 35-
year-olds triggering the past use category. Sleep disturbance was another major concern, 
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especially among those aged 18-25, with over half the sample exhibiting problems with sleep. 
Improving social relationships with family and friends and reducing conflict with them was a 
consistent need across age groups, and to a lesser extent, assistance with widespread isolation 
and conflict. One-quarter of the sample had indications of criminal activity at some point in their 
lives. The same proportion experienced a traumatic event, 10% of whom had immediate safety 
concerns.  
2.3.3 Emergency department patients assessed with the ESP 
The proportion of males in each age group were as follows: 18-25 (n=371, 47.5%); 26-30 
(n=170, 52.0%), and 31-35 (n=129, 49.6%). There were no statistically significant differences in 
the gender distribution across age groups (χ2=1.91, p=.38). 
Table 16. Social relationships and presence of stressors among ED patients aged 18-25 
(N=781), 26-30 (N=327), and 31-35 (N=260) receiving care in Ontario (2005), Niagara 










Has a support person who is 








χ2 (2) = 1.1 
p=.57 






χ2 (2) = 5.7 
p=.06 
Conflict-laden or severed 
relationship 
<7 days 10.0 (61) 10.0 (25) 14.4 (27) 
χ2 (6) = 15.3 
p=.02 
<1 year 9.1 (56) 10.4 (26) 10.2 (19) 








Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
 Most patients had a support person who was positive towards their discharge, but around 
half were struggling with at least one major life stressor. Fewer of the 18-25 age group had 
experienced a conflict-laden or severed relationship than older age groups. 
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Table 17. History of mental health service use among ED patients aged 18-25 (N=781), 26-
30 (N=327), and 31-35 (N=260) receiving care in Ontario (2005), Niagara (2013-2014), and 
Chatham-Kent and Bluewater Health (2018-2019). 








Time since last psychiatric 
admission 
N/A 66.3 (407) 61.4 (154) 61.4 (116)  
χ2 (4) = 7.3 p=.12 <30 days 18.7 (115) 24.7 (62) 26.5 (50)  
>31 days 15.0 (92) 13.9 (35) 12.2 (23) 
Lifetime admissions to a 
psychiatric hospital* 
0 81.1 (498) 73.7 (185) 74.1 (140) 
χ2 (4) = 9.2 
p=0.06 
1-3 16.3 (100) 21.5 (54) 20.6 (39) 
4+ 2.6 (16) 4.8 (12) 5.3 (10) 
Note. *23% of data is missing. Percentages are column percentages (e.g., % of those aged 18 -25 with the 
independent variable). 
 Time since the last psychiatric admission was similar across age groups, and although the 
18-25 age group had fewer lifetime admissions to a psychiatric hospital, this difference was not 
statistically significant (p=.06). 
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Table 18. Substance use among ED patients aged 18-25 (N=781), 26-30 (N=327), and 31-35 
(N=260) receiving care in Ontario (2005), Niagara (2013-2014), and Chatham-Kent and 











Number of days in last 
30 days consumed 
alcohol to point of 
intoxication 
None 70.3 (548) 77.3 (252) 76.4 (198) 
χ2 (8) = 
23.9 
p=.0002 
1 8.5 (66) 6.1 (20) 4.2 (11) 
2-8  13.7 (107) 8.6 (28) 8.9 (23) 
9+ (not daily) 6.4 (50) 5.5 (18) 6.6 (17) 
Daily 1.0 (8) 2.4 (8) 3.9 (10) 
Hallucinogens 
Never or more than 1 
year ago 
87.1 (679) 86.5 (282) 86.4 (223) 
χ2 (4) = 
2.6 
p=.62 
Within the last year 10.0 (78) 11.3 (37) 12.0 (31) 
Within the last month 2.9 (23) 2.2 (7) 1.6 (4) 
Cocaine 
Never or more than 1 
year ago 
79.1 (617) 70.9 (231) 72.1 (186) 
χ2 (4) = 
13.0  
p=.01 
Within the last year 12.0 (94) 19.3 (63) 17.4 (45) 
Within the last month 8.9 (69) 9.8 (32) 10.5 (27) 
Stimulants 
Never or more than 1 
year ago 
84.7 (661) 77.3 (252) 80.2 (207) 
χ2 (4) = 
12.4 
p=.01 
Within the last year 9.2 (72) 11.0 (36) 11.2 (29) 
Within the last month 6.0 (47) 11.7 (38) 8.5 (22) 
Opiates 
Never or more than 1 
year ago 
91.0 (709) 81.3 (265) 87.2 (225) 
χ2 (4) = 
25.7 
p<.0001 
Within the last year 5.9 (46) 8.9 (29) 7.0 (18) 
Within the last month 3.1 (24) 9.8 (32) 5.8 (15) 
Cannabis 
Never or more than 1 
year ago 
39.2 (305) 38.6 (126) 46.5 (120) 
χ2 (4) = 
14.6  
p=.006 
Within the last year 15.1 (118) 22.4 (73) 16.3 (42) 
Within the last month 45.7 (356) 39.0 (127) 37.2 (96) 
Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
 Regarding drinking to the point of intoxication, fewer of the 18-25 age group had never 
done this, but fewer of them also drank to this extent daily than older age groups. Those aged 18-
30 consumed cannabis more recently than those aged 31-35, but fewer 18- to 25-year-olds had 
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recently taken stimulants, cocaine and opiates. Cannabis was the most common substance 
consumed across all ages, ranging from 39-46% of the sample.  
Table 19. DSM-IV diagnoses among ED patients aged 18-25 (N=781), 26-30 (N=327), and 
31-35 (N=260) receiving care in Ontario (2005), Niagara (2013-2014), and Chatham-Kent 












Primary 7.0 (55) 5.2 (17) 1.9 (5) χ2 (4) =  
10.6 
p=.03 
Non-primary 3.6 (28) 3.1 (10) 2.7 (7) 
Substance use disorder 
Primary 10.9 (85) 16.2 (53) 12.3 (32) 
χ2 (4) = 8.8 
p=.06 Non-primary 3.6 (28) 4.6 (15) 5.8 (15) 
Schizophrenia or other 
psychotic disorder 
Primary 7.7 (60) 9.8 (32) 11.1 (29) χ2 (4) = 
10.1 
p=.04 
Non-primary 0.3 (2) 1.5 (5) 0.4 (1) 
Mood disorder 
Primary 30.0 (234) 26.0 (84) 30.4 (79) 
χ2 (4) = 4.2 
p=.38 Non-primary 6.1 (48) 8.6 (28) 5.8 (15) 
Anxiety disorder 
Primary 11.6 (91) 14.1 (46) 13.1 (34) 
χ2 (4) = 4.0 
p=.40 Non-primary 9.9 (77) 11.6 (38) 7.7 (20) 
Personality disorder 
Primary 8.4 (66) 11.9 (39) 11.9 (31) 
χ2 (4) = 5.7 
p=.22 Non-primary 5.4 (42) 6.7 (22) 6.1 (16) 
Psychiatric 
comorbidity 
0 disorders 37.3 (288) 34.9 (111) 36.7 (95) 
χ2 (4) = 5.7 
p=.22 
1 disorder 28.1 (217) 23.3 (74) 26.6 (69) 
2-3 disorders 34.5 (266) 41.8 (133) 36.7 (95) 
Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
 Compared to other age groups, those aged 18-25 had more neurodevelopmental disorders 
but fewer psychotic disorders. Mood disorders were the most common diagnosis, followed by 
anxiety, substance use, and personality disorders. While most disorders were ranked more often 
as the most important presenting diagnosis, both anxiety and personality disorders were ranked 
as non-primary almost as often as primary.  
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Table 20. interRAI scale categories among ED patients aged 18-25 (N=781), 26-30 (N=327), 
and 31-35 (N=260) receiving care in Ontario (2005), Niagara (2013-2014), and Chatham-











index (DSI)  
0 19.9 (155) 21.4 (70) 22.3 (58) 
χ2 (6) = 6.9 
p=.33 
1 29.2 (228) 25.7 (84) 23.8 (62) 
2 26.5 (207) 25.4 (83) 23.5 (61) 




0 88.7 (693) 86.8 (284) 83.8 (218) 
χ2 (4) = 6.5 
p=.17 
1 9.7 (76) 10.1 (33) 13.8 (36) 
2 1.5 (12) 3.1 (10) 2.3 (6) 
Aggressive behaviour 
scale (ABS) 
0 84.1 (657) 86.2 (282) 78.1 (203) 
χ2 (4) = 19.3 
p=.0007 
1 8.2 (64) 7.3 (24) 16.5 (43) 
2 7.7 (60) 6.4 (21) 5.4 (14) 
Psychotic symptoms 
scale (PSS)  
0 79.0 (617) 74.3 (243) 69.6 (181) 
χ2 (6) = 13.1  
p=.04 
1 10.2 (80) 11.9 (39) 14.2 (37) 
2 5.9 (46) 9.5 (31) 10.4 (27) 
3 4.9 (38) 4.3 (14) 5.8 (15) 
Social withdrawal 
scale (SWS) 
0 23.3 (182) 24.2 (79) 26.1 (68) 
χ2 (4) = 1.0 
p=.91 
1-2 31.0 (242) 
 
30.0 (98) 30.4 (79) 
3-6 45.7 (357) 45.9 (150) 43.5 (113) 
Severity of self-harm 
(SoS) 
0 29.1 (226) 38.1 (124) 39.3 (101) 
χ2 (4) = 13.7 
p=.008 
1-3 46.6 (362) 40.9 (133) 39.7 (102) 
4-6 24.2 (188) 20.9 (68) 21.0 (54) 
Risk of harm to 
others (RHO) 
0 62.1 (485) 59.0 (193) 48.8 (127) 
χ2 (4) = 14.6 
p=.006 
1-3 25.6 (200) 26.9 (88) 33.1 (86) 
4-6 12.3 (96) 14.1 (46) 18.1 (47) 
Self-care index (SCI) 
0 48.1 (376) 43.1 (141) 38.1 (99) 
χ2 (4) = 11.5 
p=.02 
 
1-3 47.8 (373) 50.1 (164) 55.0 (143) 
4-6 4.1 (32) 6.7 (22) 6.9 (18) 
Note. Percentages are column percentages (e.g., % of those aged 18-25 with the independent variable). 
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 Positive symptoms of psychosis increased slightly with age. The 18-25 age group were at 
slightly higher risk of self-harm than older age groups, but lower in risk of self-care or harm to 
others. Depression and social withdrawal were the most common psychiatric needs. Regarding 
the DSI, only one-fifth of the sample had zero symptoms and around one-quarter scored in the 
most severe category. Likewise, 45% of the sample were in the moderate-to-severe range of 
social withdrawal symptoms. Risk of self-harm was notably high across all age groups; between 
40-46% were at mild-to-moderate risk, while 21-24% were at moderate-to-severe risk. 
2.3.4 Differences across settings 
The following section describes the differences in sample characteristics observed across care 
settings for all age groups combined. Table 21, below, displays the average frequencies for each 
characteristic, as well as the results of a chi-square test.  
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Table 21. Average frequencies of select variables among individuals aged 18-35 compared across the inpatient psychiatric 
(RAI-MH), community mental health (CMH), and ED (ESP) service setting datasets (N=89,678). 
Variable RAI-MH CMH ESP Chi-square test 
Has a confidant 
Yes 85.5 (73,357) 62.1 (1,573)  n/a χ2 (1) = 1,064.7  
p<.0001 
Victim of emotional abuse 
Never 72.2 (61,932) 45.8 (1,167)  n/a χ2 (1) = 846.3  
p<.0001 
Cocaine use  
Last month 11.5 (9,828) 5.2 (132)  9.4 (128)  χ2 (2) = 102.7  
p<.0001 
Cannabis use  
Last month 37.2 (31,917) 39.6 (1,008)  42.3 (579) χ2 (2) = 20.4  
p<.0001 
Neurodevelopmental disorder  
Primary 1.3 (1,146)  3.9 (99)  5.6 (77)  χ2 (4) = 351.1  
p<.0001 Non-primary 2.1 (1,785) 4.4 (112) 3.3 (45) 
Substance use disorder 
Primary 17.2 (14,709) 2.4 (62)  12.4 (170)  χ2 (4) = 773.4  
p<.0001 Non-primary 15.4 (13,188) 7.6 (193) 4.2 (58) 
Schizophrenia or other 
psychotic disorder  
Primary 27.2 (23,330)  16.9 (430)  8.8 (121)  χ2 (4) = 440.1  
p<.0001 Non-primary 3.2 (2,736) 1.7 (44) 0.6 (8) 
Anxiety disorder   
Primary 4.0 (3,432) 9.5 (242)  12.5 (171)  χ2 (4) = 740.2 
p<.0001 Non-primary 10.7 (9,209) 21.5 (548) 9.9 (135) 
Personality disorder  
Primary 2.5 (2,126) 4.9 (125)  9.9 (136)  χ2 (4) = 352.3  
p<.0001 Non-primary 7.6 (6,506) 5.8 (147) 5.8 (80) 
Number of psychiatric 
diagnoses  
0 0.0 (41) 37.1 (494)  36.6 (494) 
χ2 (4) = 31,367.9  
p<.0001 
1 56.0 (48,020) 24.7 (604) 26.7 (360) 
2+ 44.0 (37,701) 38.2 (936) 36.6 (494) 
Depressive Severity Index 
 
0 24.3 (20,820) 15.6 (393) 20.7 (283) 
χ2 (6) = 1,463.7  
p<.0001 
1-3 32.3 (27,674) 16.7 (423) 27.4 (374) 
4-7 26.4 (22,661) 22.1 (558) 25.7 (351) 
8-15 17.0 (14,607) 45.6 (1,152) 26.3 (359) 
Positive Symptoms Scale  0 56.5 (48,46) 71.8 (1,795) 76.1 (1,041) χ2 (6) = 656.1  
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Variable RAI-MH CMH ESP Chi-square test 
1-2 10.6 (9,128) 13.1 (329) 11.4 (156) p<.0001 
3-5 15.4 (13,222) 10.9 (272) 7.6 (104) 
6-12 17.4 (14,952) 4.2 (105) 4.9 (67) 
Social Withdrawal Scale  
0 23.9 (20,505)  11.4 (282)  24.0 (329) 
χ2 (4) = 704.4  
p<.0001 
1-2 31.9 (27,395) 17.5 (431) 30.6 (419) 
3-6 44.1 (37,862) 71.1 (1,752) 45.3 (620) 
Severity of Self-Harm  
0 21.9 (18,771) 41.1 (1,022)  33.2 (451) 
χ2 (4) = 1,068.3 
p<.0001 
1-3 32.7 (28,038) 39.7 (987) 44.0 (597) 
4-6 45.4 (38,953) 19.2 (477) 22.8 (310) 
Risk of Harm to Others  
0 29.2 (25,026) 49.4 (1,242)  58.8 (805)  
χ2 (4) = 1,018.1  
p<.0001 
1-3 49.0 (42,056) 34.3 (861) 27.3 (374) 
4-6 21.8 (18,680) 16.3 (409) 13.8 (189) 
Self-Care Index  
0 34.0 (29,148) 30.0 (733) 45.0 (616)  
χ2 (4) = 431.7  
p<.0001 
1-3 47.4 (40,626) 61.7 (1,508) 49.7 (680) 
4-6 18.6 (15,988) 8.3 (202) 5.3 (72) 




In Table 21, clinical characteristics with significantly different patterns across care 
settings are displayed. In the community mental health dataset, the following variables were less 
frequent than in the inpatient sample: having a confidant, never experiencing emotional abuse, 
cocaine use, substance use disorders, schizophrenia or other psychotic disorders, diagnosis of 
one or more psychiatric disorders, positive symptoms of psychosis, severe risk of self -harm, and 
severe risk of harm to others. Conversely, those in the community mental health dataset had 
more neurodevelopmental disorders, anxiety disorders, personality disorders, depressive 
symptoms, and symptoms of social withdrawal. The ED dataset had the greatest proportion of 
primary neurodevelopmental disorders, as well as primary anxiety and personality disorders, 
which were more often non-primary diagnoses in the inpatient and community settings. Cannabis 
use was more recently used among those in the ED as well, though fewer substance use disorders 
were seen than in inpatient settings. Finally, the lowest prevalence of schizophrenia and other 
psychotic disorders was observed in the ED.  
 There were few significant differences in mental health trends across settings that were 
related to age. Cannabis use in the last month was significantly different among only the 31-35 
age group, with fewer of those in inpatient psychiatry recently consuming cannabis than in 
community and ED settings (χ2 (2) = 25.56, p<.0001). Non-primary diagnoses of substance use 
were higher among 18- to 25-year-olds than older age groups in inpatient and ED settings, with 
no age differences in community mental health (χ2 (4) = 27.47, p<.0001). The same trend was 
found for primary diagnoses of schizophrenia and other psychotic disorders (χ2 (4) = 71.21, 




2.4.1 Summary and implications of results 
To fulfill gaps in knowledge surrounding clinical characteristics and service use patterns of EA 
receiving treatment in psychiatric settings (MHCC, 2015; MHCC, 2016), data from psychiatric 
hospitals and units, EDs, and community mental health agencies across Canada were collected 
and analyzed using descriptive statistical procedures. Additionally, age groups corresponding to 
different stages of EA and young adulthood were compared to determine if there were age-
related differences in mental health needs. The results of this study indicated that because 
inpatient psychiatric and community mental health care settings are structured to serve specific 
types of needs, this created distinctive samples with unique characteristics. While each setting 
differed from each other in terms of clinical characteristics, those distinctions did not vary much 
by age with some notable exceptions, such as substance use and risk of self-harm. When 
comparing the results of this study with research on general populations, it becomes apparent 
that individuals with primary anxiety disorders are not engaging in the mental health care system 
beyond the ED, pointing to gaps in continuity of care for this population. Using clinical interRAI 
assessment data, this chapter illustrates how the provincial mental health system can use a 
measurement-based care model (Aboraya et al., 2018; Connors et al., 2021; Kilbourne et al., 
2018; Scott & Lewis, 2015) to identify gaps in coordination of care between service settings and 
promote better mental health treatment for EA. 
Regarding age differences, clinical characteristics were generally similar across age 
groups, with some notable exceptions that need to be accounted for in research and service 
planning. For example, the types of substances that are used by different age groups, as well as 
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the resulting effects on diagnosis, require that age be considered as an important factor. Recent 
cannabis use was greatest among the 18-25 age group, with just over 40% consuming cannabis 
within the previous month across all care settings. As a result, more 18- to 25-year-olds triggered 
the ‘current substance use’ CAP, even though they consumed other types of substances less 
recently than older age groups, such as cocaine and opiates. These trends may explain why 18- to 
25-year-olds had fewer primary diagnoses of substance use disorders but more non-primary 
diagnoses in psychiatric hospital and ED settings, when it was expected that they would have 
more overall. It could be that primary substance use disorder diagnoses are more strongly 
associated with illicit substances such as cocaine and opiates, whereas cannabis is more related 
to a non-primary diagnosis. In addition to substance use, there were some other psychological 
diagnoses that varied across age groups. For example, a greater proportion of 
neurodevelopmental disorders was observed among the 18-25 age group in all settings, 
consistent with research conducted in post-secondary settings that reported ADHD as a 
prominent diagnosis among students (Auerbach et al., 2019; Healthy Minds Network, 2018). 
Similarly, consistent with research on the developmental onset for eating disorders (APA, 2013) 
and personality disorders (APA, 2013; Huang et al., 2009), a higher proportion of these disorders 
were present in the 18-25 age group. In contrast, there were fewer diagnoses of schizophrenia 
and other psychotic disorders among those aged 18-25 in community and ED settings. This result 
may be due to in part to later onset of psychotic disorders, which usually develop between the 
late teens and mid-30s (APA, 2013), but could also represent a delay between developing the 
disorder and accessing care in the community. In terms of the risk scale scores, 18- to 25-year-
olds had a higher risk of self-harm in inpatient and ED settings, even though mood disorders and 
depressive symptoms were invariant across age groups, though this is congruent with prior 
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research. For instance, a longitudinal study found that while the incidence of MDD was steady 
across adolescence, EA, and adulthood, actual suicide attempts declined with age (Rohde et al., 
2013). These patterns suggest that a greater emphasis on suicide prevention resources is needed 
for adolescents and young EA, as well as for substance use, neurodevelopmental, personality, 
and eating disorders. 
Altogether, because there were some differences in clinical characteristics observed 
across age groups, separating 18- to 25-year-olds from older age groups may be warranted when 
it comes to research and service planning for these specific conditions. However, clinical 
characteristics are not the only source of consideration for analysis and care planning – 
sociodemographic characteristics and service use patterns also demonstrated meaningful 
variations by age. In each care setting, EA were characterized by unique sociodemographic 
indicators that may still be relevant for treatment, such as living with others, ‘single’ marital 
status, post-secondary enrolment, and non-full-time employment. Beginning around 18, these 
sociodemographic characteristics often represent major changes in the person’s life that can act 
as sources of elevated psychological distress (Arnett, 2000; Arnett, 2007; et al., 2014; Baggio et 
al., 2017; Drapeau et al., 2014). At the same time, sociodemographic factors may also provide 
some benefits for maintaining psychological well-being outside of treatment, such as housing 
and financial resources, as well as social support from friends and family (O’Connor et al., 
2011). For EA who are attending post-secondary school, there may also be on-campus mental 
health resources that are available for providing follow-up care in the community (CCMH, 
2018). Another age-related distinction appeared when examining service use history among EA. 
In all three care settings examined, individuals first accessed these systems between the ages of 
15-24, with many individuals receiving care in more than one setting at some point in their lives, 
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reinforcing that EA is a critical developmental period for introducing consistent and coordinated 
care. This is especially relevant for EA engaging in mental health treatment before the age of 18 
in Ontario, as the transition between the youth and adult mental health systems has been 
described as a major cause of disruption to ongoing treatment (MHCC, 2015). Overall, 
sociodemographic factors and service use patterns are an important element of treatment 
planning, and so along with clinical needs, these variables must be included in measurement-
based care strategies for research supporting mental health care of EA. 
While clinical characteristics did not vary greatly by age, there were several differences 
observed across care settings. For example, the psychiatric inpatient sample demonstrated the 
highest prevalence of psychotic disorders and symptoms, substance use, psychiatric disorder 
comorbidity, risk of self-harm, and risk of harm to others, corresponding to greater acuity of 
illness and danger of harm. Given that psychiatric hospitals prioritize admissions involving risk 
of danger to self and others (MHA, 1990), and that higher hospital admission rates for substance 
use and schizophrenia disorders have previously been reported (Beckman et al., 2016; CIHI, 
2020; Watanabe-Galloway & Zhang, 2007), these results were expected. In contrast, community 
mental health programs are designed to help individuals who are not in immediate crisis, but who 
require help managing ongoing mental health needs (CIHI, 2017). Accordingly, risk of harm to 
self and others was lower in the community mental health sample, though more individuals had 
mild-to-moderate risk of being unable to care for themselves. There was also a higher proportion 
of non-primary anxiety disorders, as well as symptoms of severe depression and social 
withdrawal, indicating serious mental illness. Substance use disorders were less prominent than 
anticipated, which may be due to the types of community agencies included in the CMH dataset, 
as well as lower treatment-seeking for substance use in general (Blanco et al., 2008; Catchpole & 
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Brownlie, 2016; SAMHSA, 2012). Compared to the inpatient dataset, the community mental 
health sample was characterized by severity of illness and degree of functional impairment rather 
than by psychiatric diagnoses. While there were unique clinical distinctions between psychiatric 
hospitals and community mental health agencies, service use patterns revealed that several EA 
received care in both settings, meaning that they are not completely separate populations. 
Investigating predictors of service use in both types of settings among EA, as well as time 
intervals between community mental health treatment and psychiatric hospitalizations, would 
help to better establish pathways for coordinated care. 
Since the ED is the most accessible of the three care settings that were examined (CIHI, 
2019b; CMHA, 2008), the mental health needs present in the general population should be 
stronger drivers of service use in this setting. The results of this study were consistent with this 
expectation, as clinical needs more closely reflected the trends found in general and post-
secondary populations. For instance, compared to inpatient and community settings, the ED had 
the greatest proportion of primary anxiety disorders, as well as personality and 
neurodevelopmental disorders. Regarding the number of psychiatric disorders present for each 
person, an interesting result in the community and ED datasets was that roughly one-third of the 
sample had no diagnosis. It may be that at the time of the admission assessment, insufficient time 
had passed to be able to diagnose a disorder, that the resources needed to provide a diagnosis 
were not available, or that no disorder was truly applicable. Regardless, this result provides 
further evidence that psychiatric diagnoses alone are insufficient and that assessing symptoms of 
mental illness is needed to gain a better understanding of clinical needs. Assessing symptoms 
may also provide additional information when investigating gaps in continuity of care between 
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service settings, which is especially relevant for those disorders that are more common in the ED 
than other psychiatric service settings. 
Disparities between mental health trends observed in general populations versus those in 
health care settings is most evident when it comes to primary anxiety disorders. Worldwide, 
depressive and anxiety disorders are the two most prevalent psychiatric diagnoses in the general 
population (Kessler et al., 2007). Anxiety disorders and symptoms also tend to be the most 
prominent concern in post-secondary populations (ACHA, 2019; Bayram & Bilgel, 2008; 
Healthy Minds Network, 2018). While mood disorders were the most common psychiatric 
disorder in all three care settings examined, anxiety disorders were usually fourth or fifth. 
Further, anxiety disorders were typically considered to be of secondary or tertiary importance, 
likely in relation to depressive disorders, which typically involve comorbid anxious symptoms 
(Ferdinand, de Nijs, van Lier, & Verhulst, 2005). Primary diagnoses of anxiety only exceeded 
non-primary diagnoses in the ED, consistent with other Canadian research demonstrating 
disproportionate representation of anxiety in the ED compared to inpatient and community 
settings (Gandhi et al., 2016; O’Donnell et al., 2017). In hospital settings, a possible explanation 
is that unlike mood disorders, the evidence surrounding the association between anxiety and self -
harm is ambiguous (Cummings, Caporino, & Kendall, 2014; Kessler et al., 2005), which 
constitutes one of the primary admission criteria for inpatients (MHA, 1990). Within community 
settings, it is less clear why primary anxiety disorders are disproportionately lower than non-
primary disorders. One reason may be that individuals with primary anxiety disorders do not 
wish to engage in intensive community treatment or prefer to be treated with medication and/or 
private counselling, which are not services that would be represented in the CMH dataset. 
Another explanation could be that even when anxiety is normally the primary concern, comorbid 
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symptoms such as depression are targeted as the most important issue in health care settings. 
Finally, it may also be that there are inadequate resources available that target anxiety. To 
answer these questions, further exploration into anxiety and help-seeking among EA is required. 
In summary, there were few clinical characteristics were associated with the 18-25 age 
group. However, there is still merit in focusing on mental health trends in the EA population, 
especially as they transition between the youth and adult mental health systems. It is possible that 
unique sociodemographic factors play a role in service use, which may be connected to findings 
of higher rates of disengagement from treatment among EA (Edlund et al., 2002; MHCC, 2015). 
When performing research with EA in psychiatric settings, age cut-offs for defining EA could 
extend up to 30, though some characteristics are more strongly associated with younger age 
groups, such as substance use and self-harm. Most of the clinical variation observed was related 
to differences across care settings, which typically corresponded with their structural design. For 
example, the inpatient sample had more indicators of acute crisis, whereas the community 
sample demonstrated greater severity of mental health symptoms. While many individuals 
received care in both hospital and community settings, due to the siloed design of mental health 
care systems (CIHI, 2020; MHCC, 2015), gaps in care still appeared for some clinical conditions 
such as anxiety. Finally, it is also worth conducting more in-depth research on the relationship 
between anxiety and mental health service use, as anxiety was under-represented in clinical care 
settings compared to general and post-secondary populations. 
2.4.2 Strengths and limitations 
One of the major strengths of this study is its capacity to inform existing literature and policy 
decision-making for mental health care of EA. In terms of research, while several studies have 
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investigated mental health of EA in general and post-secondary settings, limited information 
could be located on those receiving care in psychiatric settings, especially in community mental 
health. By compiling information on clinical characteristics and service use of EA in psychiatric 
settings, this study contributes new and substantive knowledge to the field. This depth of 
information further serves to fill some of the gaps described in the MHCC’s reports on building 
mental health care systems for EA (2015) and the mental health strategy: youth perspective 
(2016). Both documents emphasized using research to build an integrated care system that spans 
the continuum of services. In this study, three types of mental health care settings were examined 
simultaneously using a common health assessment instrument, permitting rare cross-sectoral 
comparisons across a variety of health domains. Targeting multiple systems at once advances the 
goal of integrating care systems, as it provides a better opportunity to identify trends in service 
use and potential gaps in coordination. Further, the extensive information included in the 
interRAI instruments allows for a more holistic understanding of EA and the factors that can 
influence their mental health, such as life circumstances, functional and cognitive capacity, 
social resources, and physical health, which is essential for practicing measurement-based care 
(Aboraya et al., 2018; Connors et al., 2021; Kilbourne et al., 2018; Scott & Lewis, 2015). 
Through the knowledge generated by this study, mental health care stakeholders are better 
positioned to effectively structure services that meet the needs of EA. 
Evidence-based knowledge requires a foundation of reliable and valid data, which this 
study accomplished through rigorous study sampling and assessment tools. In particular, 
representative sampling of the inpatient psychiatric population, large sample sizes, and the use of 
standardized health care instruments all contributed to novel methodological advancements in 
mental health care research for EA. A unique advantage of this study is the inpatient sample, 
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which includes every adult who has been admitted to a psychiatric unit or hospital for at least 
three days in Ontario since 2005. The advantage of a fully representative sample is that it avoids 
the effects of sampling biases and increases the sample size. Large, representative samples are 
especially important for disorders that are rare or infrequently admitted for care, such as eating 
disorders and primary anxiety disorders. Without a fully representative sample, it would be 
difficult to analyze disorders with small case sizes and draw accurate conclusions. Since this 
information could be used to influence policies for mental health care of EA, it is essential that 
interpretations of data are not misled by poor data quality. Data quality is further enhanced using 
the interRAI mental health tools, which are designed to be compatible with one another. By 
using common language and scoring methods, indicators are measured consistently across 
hospital, ED, and community settings, allowing for direct comparisons to be made. Otherwise, 
the use of independent instruments for each setting could lead to situations in which clinical 
characteristics are interpreted differently, leading to poorer coordination between systems and 
moving further away from the goal of integrated care. Therefore, interRAI assessment tools - in 
combination with the representative samples that use these tools - allows this study to provide a 
strong foundation for cross-sector research of mental health care for EA.     
Whereas the inpatient sample was fully representative, a major disadvantage of the 
community mental health and ED datasets is that they relied on the use of convenience samples. 
Consequences of convenience samples include vulnerability to sampling biases and a reduced 
capacity to address research problems. For instance, data can be biased by the presence of 
confounding factors, which can be challenging to detect and control for. In the community 
mental health dataset, a confounding variable that could not be addressed was bias among 
services that elected to adopt the CMH. To protect client confidentiality, it is unknown which 
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agencies provide data and the types of treatments that they offer (e.g., first episode psychosis, 
addictions rehabilitation, etc.,). As a result, it could be that some clinical needs were over- or 
under-represented, based on the comprehensiveness of the services contained in the CMH 
dataset. Another limitation of a convenience sample is that it is difficult to analyze rare 
conditions, such as eating disorders. Based on the literature review, it was expected that eating 
disorders would be associated with the 18-25 age group. While this was true in inpatient settings, 
there were too few eating disorder diagnoses in the community and ED datasets to be able to 
compare prevalence across age groups. In light of this limitation, eating disorders were not 
emphasized as much as substance use, personality, and neurodevelopmental disorders, but policy 
reports on mental health of EA should also be mindful that eating disorders are also likely to be 
heightened during the earlier stages of EA. Altogether, since the patterns of clinical 
characteristics and service use in the community and ED samples were mostly consistent with a 
priori hypotheses generated through the literature review, it is unlikely that sampling biases led 
to inaccurate results. Future work will be able to diminish some sampling concerns of the ED 
and community mental health settings, since the Chatham-Kent health region of Ontario adopted 
all interRAI mental health instruments and are contributing towards a growing number of 
assessments. 
Finally, a disadvantage of the interRAI mental health assessments is the lack of a scale that 
measures symptoms of anxiety. Considering that symptoms of anxiety are the most prevalent 
issue among post-secondary students (ACHA, 2019; Bayram & Bilgel, 2008; Healthy Minds 
Network, 2018), and that anxiety is tied with mood disorders as the most common psychiatric 
diagnosis worldwide (Kessler et al., 2007), it is important that general mental health assessments 
are equipped with the capacity to assess this issue. Further, since there was a discrepancy in the 
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proportion of primary to non-primary anxiety disorders in hospital and community mental health 
settings in this study, there is evidently a need to further investigate service patterns related to 
anxiety. However, diagnoses do not provide enough granularity to be able to detect complex 
interactions between anxiety and other clinical characteristics and service use. To address this 
problem, as with other mental health conditions, the interRAI instruments would benefit from the 
inclusion of an anxiety symptoms scale. Overall, the limitations of this study can be resolved by 
accumulating a greater number of ESP and CMH assessments, which the Chatham-Kent and 
Bluewater Health regions of Ontario are currently establishing. Once more data is available, 
studies can be designed that connect interRAI assessments together, strengthening the statistical 
power and external validity of analyses. 
2.4.3 Future research 
This study examined clinical characteristics and service use of EA in three health mental care 
settings, building a foundation for ongoing research into coordinated care for EA. After 
reviewing the strengths and limitations, two directions for future research were identified: 1) 
connect interRAI datasets representing various health systems together and, 2) develop an 
anxiety scale for the interRAI health assessment instruments. Since service use patterns revealed 
that many individuals received mental health treatment in both hospital and community settings, 
a natural direction for future research would be to link together the interRAI assessment datasets, 
permitting longitudinal analyses that span multiple care systems (including home care, long-term 
care, etc.,). This will not only allow for long-term analysis of individuals as they move between 
care systems, but also potentially throughout their life course, as more interRAI Child and Youth 
- Mental Health (ChYMH) assessments are completed in Ontario. The ability to track individuals 
as they transition between the youth and adult mental health systems will prove incredibly 
 
 100 
valuable to mental health research for EA, as the disruptions that occur during this process have 
been identified as a major cause of disengagement in mental health treatment (MHCC, 2015; 
MHCC, 2016; Moroz et al., 2020). Identifying patterns of disengagement from treatment would 
be especially beneficial for subgroups that receive disproportionately less community mental 
health care, such as those with primary anxiety disorders. Whereas connecting interRAI datasets 
is an intensive project that requires ongoing data collection and integration beyond the scope of 
this dissertation, the anxiety scale can be developed using existing data. Given the urgency of 
addressing anxiety in mental health care settings, the next chapter constructs an initial anxiety 
scale for the interRAI assessment tools, which will then be used in the fourth chapter to examine 
service use outcomes and clinical treatment patterns among EA. 
2.4.4 Conclusions 
Building mental health systems that effectively care for EA requires continual adaptation to 
emerging trends in clinical needs and service use patterns (MHCC, 2015; MHCC, 2016). Using a 
measurement-based care model (Aboraya et al., 2018; Scott & Lewis, 2015) and interRAI health 
assessment data, the results of this chapter revealed that there are unique sociodemographic and 
clinical characteristics associated with early EA in psychiatric settings, corresponding with the 
age range in which many individuals first engage with the mental health care system. However, 
most of the variation in clinical needs appeared across care settings, highlighting the impact of 
service design on service use. An imbalance between the prevalence of primary anxiety disorders 
in the ED and inpatient and community-based care settings was observed, indicating the need to 
address anxiety more thoroughly in health care contexts. By using clinical assessment data to 
review clinical and service use patterns among EA, this chapter demonstrates how measurement-





Anxiety is highly complex and heterogeneous, making it difficult to generalize across the 
population even though it is one of two most prevalent psychiatric diagnoses in the world 
(Kessler et al., 2007). Broadly speaking, anxiety disorders are characterized by fear and 
apprehension that are disproportionate to one’s circumstances and which interfere with daily 
living (APA, 2013; WHO, 1992). While it may appear straightforward, relative to other 
diagnostic categories, there are numerous clinical presentations implicated in anxiety, involving 
a diverse range of symptoms and a variety of distinctive disorder subtypes (APA, 2013; WHO, 
1992). Symptoms of anxiety can manifest in several different forms, such as cognitive, mood, 
behavioural, and somatic indicators (APA, 2013; Beck, Epstein, Brown, & Steer, 1988; 
Hamilton, 1959; Spitzer et al., 2006), as well as those that are specific to the person’s culture 
(Reed et al., 2019). While each of these symptom expressions can be present in any given 
anxiety disorder, different diagnostic subtypes have their own set of defining features. In the 
DSM-5 and ICD-10, some of the diagnostic anxiety subtypes are phobias, social anxiety 
disorder, agoraphobia, generalized anxiety disorder (GAD), and panic disorder (APA, 2013; 
Kogan et al., 2016). Notably, although they were included in previous editions of both manuals, 
obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are no longer 
classified as anxiety disorders (APA, 2013; Kogan et al., 2016; Reed et al., 2019). Broadly 
speaking, phobias represent an intense fear of exposure towards a specific locus, such as fear of 
leaving one’s home in agoraphobia (APA, 2013; Kogan et al., 2016; WHO, 1992). Although 
social anxiety can be considered a form of phobia, it is categorized as a discrete subtype, with 
symptoms of fear and distress expressed for both social interactions and situations. Fear is also a 
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feature of panic disorder, acting as a trigger for episodic panic attacks involving acute and 
simultaneous onset of multiple physical health symptoms, with persistent worrying about 
recurrence between attacks (APA, 2013; Kogan et al., 2016; WHO, 1992). In contrast to fear-
based subtypes, GAD is marked primarily by symptoms of consistent, excessive, and non-
localized symptoms of apprehension and worrying, affecting various life domains (APA, 2013; 
Kogan et al., 2016; WHO, 1992). Altogether, it is challenging to concisely summarize the range 
of symptoms that are representative of anxiety, though contending with its complexities is 
necessary when it comes to identification and treatment. 
The range in which anxiety disorders can develop extends from childhood through to 
older adulthood, though average age-of-onset and prevalence varies by subtype. For instance, 
specific phobias tend to emerge during childhood but are a risk at any age, such as fear related to 
medical conditions/procedures in older adults (APA, 2013; WHO, 1992). Other disorders, such 
as panic disorder, agoraphobia, and GAD, have an age-of-onset that coincides with EA. A 
worldwide research project (Kessler et al., 2007) and a meta-analysis (de Lijster et al., 2017) also 
reported that most anxiety disorders develop between young- and mid-adulthood. In addition to 
affecting a wide variety of age groups, anxiety is also highly prevalent worldwide. Globally, the 
lifetime prevalence of anxiety disorders ranges between 5-31% (Kessler et al., 2007; Somers, 
Goldner, Waraich, & Hsu, 2006), while 12-month prevalence is estimated around 10% (Somers 
et al., 2006), making it the most common psychiatric diagnosis along with depressive disorders. 
Within anxiety disorders, phobias are the most common in the general population, affecting 6-
9% of those in the US and Europe, while the estimates for panic disorders and GAD are around 
2-3% (APA, 2013). One reason that point prevalence estimates for anxiety disorders are 
relatively high is because once diagnosed, the prognosis is often chronic and can persist for 
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decades (Essau et al., 2018; Kessler et al., 2009). Panic disorder, agoraphobia, and GAD all 
demonstrate low rates of full remission over the life course, while social anxiety may take 
several years to dissipate (APA, 2013). A long-term follow-up of patients admitted to a 
neuropsychiatric institute in Spain revealed that symptoms of anxiety persisted until the age of 
50 and for those diagnosed before the age of 25, the prognosis was especially poor (Rubio & 
López-Ibor, 2007). Further, anxiety disorders tend to be diagnosed more often in women than 
men (APA, 2013), suggesting the presence of gender- and sex-based effects on anxiety rates. 
Given that anxiety has a substantial impact on the population and does not typically subside 
naturally over time, mental health interventions are needed to reduce the figures.  
As well as being highly prevalent in the general population, anxiety disorders are a 
common psychiatric disorder in the ED (Aratani & Addy, 2014; Brien et al., 2015; CIHI, 2019b; 
Gandhi et al., 2016; Juhás & Agyapong, 2016), a finding that was replicated in chapter two of 
this dissertation. The demand for mental health care related to anxiety in the ED is increasing 
over time (CIHI, 2020; Gandhi et al., 2016; Kalb et al., 2019), and is already outpacing current 
psychiatric emergency resources (Baia Medeiros et al., 2019), so it is imperative that EDs in 
Canada are provided with immediate support to meet this growing need. To help reduce the 
number of psychiatric ED visits, a hospital in Toronto recommended that individuals presenting 
with heavy substance use be redirected to specialized community settings (Baia Medeiros et al., 
2019). A similar proposal could be made for individuals seeking care related to anxiety because, 
despite its prominence in the general population and ED, primary anxiety disorders are 
infrequently treated in inpatient and community care settings (O’Donnell et al., 2017; Roberge et 
al., 2011; Sunderland & Findlay, 2013). However, relying solely on a diagnosis when conducting 
clinical and policy research on anxiety is insufficient. A better alternative would be to use items 
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contained in an existing assessment to create an anxiety scale. Scales provide more granular 
information than disorders on levels of severity, changes over time, responses to different 
treatment modalities, and interactions with other clinical conditions. Greater information on 
symptoms of anxiety could benefit the treatment process for patients and service providers, as 
well as help researchers and policy decision-makers identify gaps in care coordination for those 
with severe anxiety, but a valid and reliable scale needs to be available to facilitate informed care 
planning. 
Currently, service providers working in psychiatric hospital units across Ontario must use 
the RAI-MH to inform clinical assessment, care planning, treatment, and accountability. 
Through this mandate, psychiatric hospitals are facilitated to practice measurement-based care, 
which emphasizes the use of valid and reliable health assessment tools to improve treatment 
process and outcomes in mental health systems (Aboraya et al., 2018; Connors et al., 2021; 
Kilbourne et al., 2018; Scott & Lewis, 2015). One example of how the RAI-MH promotes 
measurement-based care is through the availability of multiple quality indicators, representing 
various domains of mental health that can be tracked over time and compared across facilities 
(Perlman et al., 2013). Given that interRAI tools are frequently used in Canadian mental health 
care settings to enable measurement-based care, a built-in anxiety scale would address the needs 
of service providers treating a high volume of individuals with anxiety symptoms, without 
requiring the use of additional assessment tools. Presently, interRAI assessments contain a 
variety of psychiatric scales that are used as quality indicators, such as depression, positive 
symptoms of psychosis, and cognitive impairment (Hirdes et al., 2020; Perlman et al., 2013). 
However, a scale has yet to be designed for anxiety. The delay in creating an anxiety scale is due 
to the complexity inherent in anxiety disorders (APA, 2013; WHO, 1992), such as the 
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heterogeneity of symptoms and diverse range of diagnostic subtypes. Nevertheless, it is possible 
to create a scale that can detect anxiety in a reliable and valid manner, as other general anxiety 
scales have been developed for use in psychiatric populations. These existing anxiety tools can 
be used to guide the creation of an anxiety scale for the interRAI suite of assessment instruments, 
by mapping items that already exist within the instrument and by proposing new items, if 
needed. Two of the most popular scales used in clinical practice and research will be described in 
the following section to assess standards for reliability and validity and to identify 
methodological limitations. 
Where reliability covers the precision and stability of a tool, validity is a signal of how 
accurately an underlying construct is captured (Aday & Cornelius, 2006). In general, reliability is 
needed to ensure validity, as a large amount of random error means that it is unclear what the 
tool is measuring. However, even when a tool does reliably detect patterns, that does not 
necessarily mean it reflects the desired construct, so various validity tests are required to address 
this problem. These tests fall under two types of conditions: controlled study environments 
(internal) and real-world applications (external) (Aday & Cornelius, 2006). As it applies to 
anxiety scales, there are several sub-types of internal validity that have been commonly tested. 
One type is construct validity, which represents the degree to which the scale captures all 
elements of anxiety (Porter, 2017). Another is criterion validity, which can be separated into 
concurrent, predictive, and discriminant forms. An anxiety scale has concurrent validity when it 
is correlated with other measures of anxiety that are completed around the same time, such as 
other anxiety scales (Beck et al., 1988). Predictive validity operates in a similar manner, though 
the anxiety scale is used to predict other measures of anxiety that are completed in the future. In 
contrast, discriminant validity ensures that the anxiety scale is not capturing constructs other than 
 
 106 
anxiety, such as other psychiatric symptoms (Beck et al., 1988). Even when internal validity tests 
are promising, the tool may still fail to perform when it is used in actual practice, so it is also 
necessary to examine external validity. This can only be tested by comparing the tool across 
different populations, establishing its utility in multiple settings. If not, the tool requires 
adjustments that are appropriate to the context in which it is being used. For example, symptoms 
of anxiety can differ by culture and may require that a scale be re-structured (Reed et al., 2019). 
By reviewing each type of validity, the strengths and limitations of existing anxiety scales can be 
assessed and used to inform development of an interRAI scale. 
3.1.1 Anxiety scales 
3.1.1.1 Hamilton Anxiety Rating Scale (HARS) or (HAM-A) 
One of the first tools for measuring clinical anxiety that is still used today is the Hamilton 
Anxiety Rating Scale (HARS or HAM-A) (Hamilton, 1959). The HARS is a clinician-
administered scale containing 14 items and two subscales: ‘psychic anxiety’ and ‘somatic.’ Items 




Figure 3. Depiction of the two-factor model of psychic anxiety and somatic symptoms of 
anxiety, adapted from the Hamilton Anxiety Rating Scale (HARS) (Hamilton, 1959). 
3.1.1.1.1 Reliability 
Beginning with reliability, inter-rater tests are frequently performed because the HARS is 
administered using rater observations. During initial development, the weighted mean correlation 
between two independent raters assessing patients with primary anxiety disorders was r=0.89 
(Hamilton, 1959), concluding that inter-rater reliability was excellent. Significant inter-rater 
reliability for the global scale and the two subscales were achieved  in a subsequent study of two 
clinical samples (Maier, Buller, Philipp, & Heuser, 1988). However, certain items produced low 
intraclass correlation coefficients (ICC) across raters, such as tension (.37), respiratory symptoms 
(.28), autonomic symptoms (.23), and behaviour-at-interview (.24). The absence of standards for 
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administration, interviewing, and scoring may lead to inconsistencies in how items are 
interpreted, leading to lower reliability scores. For this reason, interview guides for the HARS 
have been developed to enhance reliability by clarifying interview procedures and scoring 
(Bruss, Gruenberg, Goldstein, & Barber, 1994; Shear et al., 2001).  
Two interview guides were reviewed for the HARS: the HARS-Interview Guide (HARS-
IG) (Bruss et al., 1994) and the Structured Interview Guide for the Hamilton Anxiety Scale 
(SIGH-A) (Shear et al., 2001). The first study included 30 psychiatric inpatients with various 
types of psychiatric disorders, assessed by two psychologists and three pre-doctoral 
psychologists (Bruss et al., 1994). Regarding inter-rater scores, the global mean ICC for the 
HARS-IG was .99, though behaviour-at-interview retained a low score (.32). The same metric 
was calculated for test-retest reliability of the HARS-IG, but because the original HARS was 
only used once at the beginning of the study, test-retest scores could not be computed for the 
regular version. Between day one and day two, the ICC was .79 for the global scale of the 
HARS-IG; behaviour-at-interview once again produced the lowest score (.31). Similar findings 
were reported for the SIGH-A, where paired raters assessed 32 videotaped interviews of 
psychiatric inpatients with anxiety disorders (Shear et al., 2001). The inter-rater ICC of the 
original HARS and the SIGH-A were .98 and .99, respectively, whereas behaviour-at-interview 
was once again the least reliable item in both versions (.76 and .81). ICCs for test-retest 
reliability, performed on day one and day two, was .86 for the original HARS and .89 for the 
SIGH-A (Shear et al., 2001). These results demonstrate that using interview guides, the HARS is 
a more reliable tool across raters and possibly across time, though the behaviour-at-interview 
item is consistently unstable.  
 
 109 
Where interview guides have been created to improve inter-rater and test-retest 
reliability, revised factor structures serve a similar purpose for internal consistency. Internal 
consistency represents the degree of variance between the relationships of observed items and is 
calculated using the Cronbach’s alpha statistic (Schmidt, 1996; Henson, 2019). Across three 
clinical studies, the Cronbach’s alpha was above .70 (Beck & Steer, 1991; Porter et al., 2017; 
Riskind, Beck, Brown, & Steer, 1987), which is considered acceptable by conventional standards 
(Henson, 2019). However, in two of the studies (Porter et al., 2017; Riskind et al., 1987), the two 
subscales were revised to produce the Reconstructed Hamilton Scale for Anxiety (HARS-R-II), 
which led to greater alpha coefficients in both cases. Further, while internal consistency tests 
were good in university-based clinics, Cronbach’s alpha scores were lower among those with a 
diagnosis of GAD (Shear et al., 2001). If the relationships between items are less reliable among 
samples with different types of anxiety disorders, it may be that the items are too specific to one 
subtype of anxiety, rather than general anxiety. Altogether, the reliability of the HARS is 
generally good when interview guides and revised scale structures are used, but there are still 
limitations in internal consistency that appear across different samples. 
3.1.1.1.2 Validity 
Given that the reliability of the HARS is generally acceptable, the next step is to verify its 
validity. Construct validity of the HARS is mixed due to possible model misspecification and 
items that are either inappropriate or potentially absent. To determine if the scale structure fits 
the observed data, structural equation modeling (SEM) techniques such as factor analysis, latent 
structure analysis, and principal components analysis (PCA) are commonly used. The original 
HARS was derived using PCA, which supported either a model with a general and two sub-
factors, or an orthogonal two-factor model (Hamilton, 1959). A general anxiety factor was 
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extracted that explained 27% of the variance, while 18% of the variance was attributed to the two 
sub-factors, consisting of somatic and psychic anxiety symptoms. Since both solutions resulted 
in orthogonal factors, Hamilton (1959) suggested either model could be used. To help clarify the 
structure, PCA was performed on the HARS among 367 outpatients with DSM-III primary 
disorders of anxiety (Beck & Steer, 1991). Two components were extracted from the scree test, 
corresponding with the somatic and psychic anxiety factors proposed in the two-factor 
orthogonal model. The only item that loaded onto a different component than in the original 
HARS model was insomnia, which belonged to the somatic factor instead of the psychic one. 
The somatic component explained a greater portion of variance than did  psychic anxiety, 
meaning that somatic symptoms shared more in common than psychic symptoms. Altogether, 
both components explained 43% of the total variance in the dataset, providing support for a two-
factor model of somatic and psychic symptoms. In contrast to the previous two studies, a latent 
structure analysis of the HARS among in- and out-patients diagnosed with panic disorders 
demonstrated insufficient model fit (p<0.01), though the two subscales were adequate when 
examined separately (p>0.01) (Maier et al., 1988). Varying statistical techniques, as well as 
samples, could be one reason that construct validity of the HARS is inconsistent across studies.  
In addition to testing the overall model, factor or principal component loadings of 
individual items can also be used to assess construct validity. Factor or principal component 
loadings describe how much of the item variance can be attributed to a common factor and are 
analogous to the correlation coefficient when standardized. Low factor loadings signal that an 
item is not well explained by the latent factor(s), which may mean that they should be removed 
from the scale. Items that produced the lowest principal component loadings among psychiatric 
outpatients with primary anxiety disorders were fears (.31), insomnia (.41), genitourinary (.42), 
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and behavior-at-interview (.45) (Beck & Steer, 1991). In another study, depressed mood, 
gastrointestinal symptoms, and behaviour-at-interview were the least homogenous items in a 
latent structure analysis (p <0.05) (Maier et al., 1988). In both studies, behaviour-at-interview 
had one of the lowest factor loadings and as such, is not a good candidate for inclusion in a new 
anxiety scale. Another problem that can arise when creating a scale is the absence of important 
items. Since there is no direct test for revealing which items need to be added in, addressing this 
issue relies on ongoing literature reviews and research. Regarding the HARS, it has been argued 
that it does not adequately capture cognitive processes believed to be essential to anxiety, such as 
worrying and apprehension (Porter et al., 2017; WHO, 1992), which are in turn related to overall 
psychological well-being (Stones & Kozma, 1985). While the construct validity of the two-factor 
model has generally received support, the item composition of the HARS has been debated, 
informing the variable selection process for the development of the interRAI anxiety scale.  
Even if a scale has construct validity, criterion validity still needs to be tested to ensure 
that the scale is both consistent with other measures of anxiety and distinct from measures of 
other psychological indicators.  If a scale accurately represents anxiety, it should have concurrent 
validity by sharing a relationship with other indicators of anxiety. However, an important 
consideration is that correlations between instruments are calculated using both of their unique 
data distributions. Since different shapes of data cannot be perfectly correlated, the interval for a 
possible correlation between instruments is less than -1 to 1 (Ratner, 2009). As a result, the range 
of correlation coefficients reported in psychological assessment studies is typically between .02 
to .78 (Hemphill, 2003). Concurrent validity of the HARS has been tested using different 
methods, one of which is through correlation analysis with other anxiety scales. For example, in 
a psychiatric outpatient sample of individuals diagnosed with panic disorders, as well as one with 
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depressive disorders, there was a significant relationship between the HARS and the Covi 
Anxiety Scale (rs = 0.63). Another example is a strong correlation between the HARS and the 
DSM-5 anxious distress specifier for mood disorders (r=0.60) (Zimmerman et al., 2017). While 
it is standard practice to investigate the correlation between two scales, examining relationships 
with different types of indicators can strengthen the case for concurrent validity even further. A 
relevant example with the HARS is its association with neurological structures, as demonstrated 
in a neuroimaging study using a general community sample (Donzuso, Cerasa, Gioia, 
Caracciolo, & Quattrone, 2014). Higher scores on the HARS were associated with greater 
cortical thickness of the anterior cingulate cortex, which is a brain region linked to emotional 
processing capabilities. By establishing that the HARS is related to neurological indicators of 
anxiety, there is greater evidence supporting its capacity to measure anxiety. 
While associations with other anxiety scales and brain regions have yielded positive 
findings, the HARS did not perform as well when diagnoses were used in a test of concurrent 
validity. In a study of patients with either pure panic disorder or MDD, the association between 
the HARS, HARS-R-II, and psychiatric diagnosis was explored (Porter et al., 2017). The HARS-
R-II showed a positive correlation with panic disorders, but the effect size of this association was 
modest (rpb=-.19, p<.001). Compared to the Reconstructed Hamilton Depression Rating Scale 
(HRSD-R-II), which was strongly correlated with MDD (rpb=.83, p<.001), the relationship 
between the HRSD-R-II and panic disorders is underwhelming. However, a larger problem was 
discovered for the original HARS. Unlike the HARS-R-II, outpatients with MDD had higher 
scores on the HARS than those with panic disorder, contrary to the study hypothesis and the 
intended function of an anxiety scale. Further, while the HARS-R-II was a significant predictor 
of panic disorder diagnoses (AUC=.61, p=.001), the original HARS performed worse than 
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chance (AUC=.39, p<.001), indicating a unique problem with the HARS regarding its diagnostic 
criterion validity.  
A possible explanation for the discrepancy in diagnostic criterion validity between the 
HARS and HRSD-R-II is that the HARS contains items directly relevant to depression, which 
weakens the power of the scale by reducing discriminant validity. In general, due to the high 
degree of comorbidity between anxiety and depression (APA, 2013; WHO, 1992), it  is expected 
that an anxiety scale will be positively correlated with measures of depression. However, when 
an anxiety scale contains items that explicitly describe depression, it becomes difficult to 
differentiate between the two psychiatric diagnoses. In this regard, the HARS has been criticized 
for insufficiently discriminating depression from anxiety (Maier et al., 1988; Porter et al., 2017; 
Riskind et al., 1987). This problem can be isolated to select items contained in the HARS: the 
"depressed mood" variable and certain somatic symptoms. Obviously, ‘depressed mood’ is an 
indicator of depression, rather than anxiety. In terms of somatic items, discriminant ambiguity 
may stem from the interpretation of broader physical health conditions. For example, while 
“muscular symptoms” can include backaches - which are more commonly associated with 
anxiety - heaviness in the body can also be interpreted as a muscular symptom and is related 
more to depression (Riskind et al., 1987). Therefore, these items do not belong in a scale 
intended for measuring anxiety. 
A similar problem with discriminant validity arises in the HRSD, which contains items 
that are specific to anxiety rather than depression, such as psychic anxiety, somatic anxiety, 
obsessive-compulsive, and agitation symptoms (Riskind et al., 1987). Using factor analysis, 
items from the HARS and the HRSD were restructured to produce scales that were specific to 
either anxiety or depression, respectively. These new structures are referred to as the 
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Reconstructed Hamilton Scale for anxiety (HARS-R-II) and depression (HRSD-II-R), both of 
which demonstrated improvements in reliability and validity estimates (Riskind et al., 1987). The 
HARS-R-II was replicated successfully in a study of 50 older adults with GAD and 93 
community controls (Beck, Stanley, & Zebb, 1999), as well as another study of 215 patients with 
MDD and 149 patients with panic disorder (Porter et al., 2017). However, as described earlier in 
the same study, while the HRSD and HRSD-R-II were associated with MDD, the HARS-R-II 
had only a small correlation with panic disorder (Porter et al., 2017). These results suggest once 
again that even when discriminant validity is addressed, construct validity remains an issue. 
Regardless, the reconstructed scales address discriminant validity by refining the items to more 
purely address either anxiety or depression.  
3.1.1.1.3 Summary 
Through an in-depth examination of the reliability and validity of the HARS, several limitations 
were revealed that are helpful for constructing a new anxiety scale in the interRAI assessments. 
One area of concern is related to content validity, which is one of the weaker aspects of the 
HARS (Beck & Steer, 1991; Maier et al., 1988; Shear et al., 2001). The primary issues noted 
were the absence of items representing cognitive symptoms of anxiety (Porter et al., 2017), as 
well as certain variables that achieved lower reliability and validity estimates, such as behaviour-
at-interview (Beck & Steer, 1991; Maier et al., 1988; Shear et al., 2001). While concurrent 
validity of the HARS has been supported through comparisons with other anxiety-related 
measures (Maier et al., 1988; Porter et al., 2017; Vaccarino et al., 2008; Zimmerman et al., 
2017), another area of concern is the insufficient discriminant validity between anxiety and 
depression (Beck & Steer, 1991; Maier et al., 1988; Porter et al., 2017; Riskind et al., 1987). The 
reason for poor discriminant validity is the inclusion of items pertaining to depression, so they 
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must be avoided in an anxiety scale to improve accuracy. Finally, while test-retest reliability 
scores were decent in studies using interview guides (Bruss et al., 1994; Shear et al., 2001), 
broader conclusions about this form of reliability cannot be made. Only two studies evaluated 
test-retest scores, and, in both cases, a two-day period was used. Despite these limitations, there 
are also benefits to using the HARS. For instance, it has demonstrated excellent inter-rater 
reliability (Bruss et al., 1994; Shear et al., 2001), decent internal consistency (Beck & Steer, 
1991; Porter et al., 2017; Riskind et al., 1987), and concurrent validity (Donzuso et al., 2014; 
Maier et al., 1988; Zimmerman et al., 2017). Therefore, the HARS is a valuable tool to consider 




3.1.1.2 Beck Anxiety Inventory (BAI) 
 
Figure 4. Depiction of the two-factor model of subjective and somatic symptoms of anxiety, 
adapted from the Beck Anxiety Inventory (Beck et al., 1988). 
3.1.1.2.1 Reliability 
The Beck Anxiety Inventory (BAI) is a self-report instrument containing 21 questions on 
symptoms of anxiety (Beck, Epstein, Brown, & Steer, 1988), and is the most used general 
anxiety scale in clinical practice (Rush Jr., First, & Blacker, 2009). Since items are self -reported, 
unlike the HARS, inter-rater reliability is not a property that requires testing. Instead, greater 
emphasis is placed on internal consistency and test-retest reliability. During development of the 
BAI, internal consistency of the two-factor model was evaluated using a sample of 160 
psychiatric outpatients (Beck et al., 1988). The final model yielded an excellent Cronbach’s 
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alpha (α=.92), while the range for item-total correlations of individual items was between .30 and 
.71. The item with the lowest correlation was numbness or tingling (r=.30), followed by 
indigestion or discomfort in abdomen (r=.42). The Cronbach’s alpha was also above .90 in two 
other studies involving outpatients with a primary anxiety diagnosis (Fydrich, Dowdall, & 
Chambless, 1992; Ulusoy; Sahin, & Erkmen, 1998). In one of the studies, psychometric 
properties of the Turkish version of the BAI were examined (Ulusoy et al., 1998). The range of 
item-total correlations was between .46 and .72, similar to those reported in the pilot study (Beck 
et al., 1988), supporting internal consistency of the BAI in different settings. Since the BAI is a 
widely used tool in research, a systematic review of its reliability estimates was able to be 
performed using data from 47 studies (de Ayala, Vonderharr-Carlson, & Kim, 2005). The 
average value for Cronbach’s alpha was .91, ranging from .83 to .95. Further, scores were 
consistent across outpatient, inpatient, and college populations, supporting the BAI as an 
internally consistent measure. However, while estimates of internal consistency are excellent, 
some caution is still warranted. Research has demonstrated that scales containing 18 items can 
produce acceptable alpha coefficients in one- and two-dimensional models, even when the 
average inter-item correlation is only r=.30 (Cortina, 1993). Since the BAI contains 21 items, 
there is a possibility the Cronbach’s alpha scores are inflated (Cortina, 1993; Henson, 2019). 
Further, Cronbach’s alpha is not an appropriate test of reliability when scales contain more than 
one factor (Cortina, 1993; Henson, 2019). Finally, certain items in the BAI share a strong 
descriptive similarity, such as ‘scared’ and ‘terrified,’ which can also cause the alpha coefficient 
to increase artificially. As a result, other reliability tests are needed to better establish the 
reliability of the BAI. 
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Test-retest is another form of reliability that can determine the accuracy of the BAI. In a 
subsample of 83 patients in the original study, the correlation between ratings at intake and after 
one week was r=.75 (Beck et al., 1988). The correlation coefficient was lower in a subsequent 
study of outpatients diagnosed with anxiety (r=.67), though the reassessment timeframe was 
longer at 11 days (Fydrich et al., 1992). Differences in the time intervals used across studies was 
posited as the reason for substantial variation in test-retest scores in the systematic review of the 
BAI, with correlation coefficients ranging from r=.35 to r=.83, and a mean of r=.66 (de Ayala et 
al., 2005). On average, the number of days between administration of the BAI across studies was 
32, though it extended anywhere from 7 to 112 days, making equitable comparisons difficult. 
Additionally, only four studies examined test-retest reliability using psychiatric populations, for 
which the BAI was originally intended (Beck et al., 1988). Restricting to the four psychiatric 
population studies, the average correlation for test-retest increased to .71 (de Ayala et al., 2005). 
Overall, compared to internal consistency, there was a greater degree of variation in test -retest 
reliability estimates, which can be attributed to the difference in reassessment timeframes. While 
this makes it difficult to generalize the test-retest reliability of the BAI across studies, estimates 
retrieved in psychiatric populations tend to fall within a “good” range (Cicchetti, 1994).  
3.1.1.2.2 Validity 
While reliability of the BAI is strong, evaluation of its construct validity is complicated, as SEM 
analyses have supported a different number of model factors across studies. Originally, a two-
factor model was proposed for the BAI (Beck et al., 1988), which is the model most often used 
in research (de Ayala et al., 2005), and the structure that has garnered the most research support 
(Bardhoshi, Duncan, & Erford, 2016). However, other studies have favoured models with three-, 
four-, and even five-factors (Osman, Kopper, Barrios, Osman, & Wade, 1997). In the BAI pilot 
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study, two factors emerged from PCA: 1) subjective anxiety/panic and 2) somatic (Beck et al., 
1988). Factor loadings for items in both factors ranged from .24 to .87, with the lowest scores 
belonging to numbness/tingling (.24), indigestion (.29), and feelings of choking (.32), making 
these the weakest items in the scale. The two subscales were distinct, with all cross-loadings 
below .30 and an inter-factor correlation of r=.56. Conversely, in a subsequent study by Beck 
and Steer (1991), PCA revealed four correlated subscales: neurophysiological, subjective 
anxiety, autonomic, and panic. The total proportion of variance explained was 58.7% and 
primary factor loadings ranged from .41 to .78. With four factors modeled instead of two, 
numbness/tingling, indigestion, and feelings of choking no longer had factor loadings less than 
.30, though each of them belonged to a different subscale, indicating that they d id not constitute 
a distinctive shared factor. Despite moderate-to-high primary factor loadings, several items had 
cross-loadings greater than .30 and the correlation between the subjective and neurophysiological 
subscales was r=.65, suggesting that four factors may be excessive. Nonetheless, a four-factor 
oblique model produced the best model fit statistics in factor analyses among adults residing in 
the community (Osman, Barrios, Aukes, Osman, & Markway, 1993), as well as undergraduate 
students (CFI=.93, RMSR=.04) (Osman et al., 1997). Since the number of factor structures 
fluctuates across studies (Beck et al., 1988; Beck & Steer,1991; Osman et al., 1993), the exact 
components of anxiety that are being measured by the BAI are not entirely clear. Specifically, 
subjective anxiety is consistently a distinct factor, but the somatic factors tend to diverge across 
models. The difference in somatic factors illustrates that evaluating physical health conditions as 
a primary component of anxiety is a complex process. Despite the instability in factor structures, 
the majority of individual items still demonstrate good primary factor loadings.  
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Although consistently high factor loadings are necessary for good construct validity, a 
problem with the BAI is its overrepresentation of physiological conditions. For example, in the 
two-factor model, the subjective anxiety scale contains two items that are arguably physical 
health conditions: “difficulty breathing” and “feelings of choking” (Beck et al., 1988). Due to 
this large emphasis on somatic symptoms, it has been argued that the BAI may be better 
described as a screener for panic disorder rather than a general anxiety scale (de Ayala et al., 
2005; Fydrich et al., 1992). Consistent with this assertion, studies have found that mean BAI 
scores were higher among individuals diagnosed with panic disorder relative to other types of 
anxiety disorders (Beck & Steer, 1991; Fydrich et al., 1992). Like the HARS, the BAI may 
benefit from incorporating items that reflect cognitive and behavioural aspects of anxiety, such 
as persistent worrying, avoidance behaviour, and social distress. For the purposes of an interRAI 
scale, selecting items that resemble those contained in the BAI is a good first step, though a 
greater array of items is needed to capture the range of diagnostic subtypes within anxiety.  
In contrast to construct validity, the evidence for criterion validity of the BAI is more 
apparent. Like the HARS, concurrent validity of the BAI has been assessed through its 
relationship to other measures of anxiety. During development, the association between the BAI 
and two instruments - the revised HARS and the Cognition Checklist – Anxiety (CCL-A) – was 
examined (Beck et al., 1988). For both instruments, the correlation with the BAI was r=.51. 
Another instrument that has been used to test concurrent validity of the BAI is the Weekly 
Record of Anxiety and Depression, which asks individuals to rate their level of anxiety and 
depression along a Likert scale every day over the course of a week (Fydrich et al., 1992). In this 
study, 71 outpatients with a primary diagnosis of anxiety submitted weekly records and 
completed both the BAI and Beck Depressive Inventory (BDI). Similar to the HARS-R and 
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CCL-A (Beck et al., 1988), the correlation coefficient between the Weekly Record Anxiety and 
the BAI was r=.54 (Fydrich et al., 1992). When interpreting the strength of correlation 
coefficients, it is necessary to consider the context of psychological research more broadly. As 
mentioned previously, the range of correlations between psychological assessments is commonly 
between .02 to .78 (Hemphill, 2003), and so moderate correlations are still positive indicators of 
concurrent validity for the BAI.  
Another consideration when testing associations between psychological instruments is 
the possibility that the comparison tool has poor reliability or validity. For example, in a sample 
of community-dwelling adults, the association between the BAI and the Brief Symptom 
Inventory (BSI) was explored (Osman et al., 1993). While the BAI was positively correlated 
with the anxiety subscale (r=.63), correlation coefficients were the same across all nine subscales 
of the BSI. Although this result appears to suggest that the BAI does not have strong criterion 
validity, the authors noted that the BSI may be the problem. Since the BSI subscales are all 
highly inter-related, anxiety cannot be isolated as a distinct construct, diminishing its utility as a 
comparison tool for anxiety. To address this problem, a subsequent study with undergraduate 
students examined the BAI in relation to other self-reported anxiety scales, such as the CCL-A 
and State Trait Anxiety Inventory (STAI) (Osman et al., 1997). The range of correlation values 
between the BAI and other anxiety measures was .35 to .69, which remained significant after 
accounting for depression. Altogether, mindful of the limitations to concurrent validity in 
psychological assessment research, the relationship between the BAI and other measures of 
anxiety tends to be positive and relatively strong.  
Finally, like the HARS, concurrent validity of the BAI has been tested using diagnoses of 
anxiety. For example, the pilot study (Beck et al., 1988) and the Turkish validation (Ulusoy et 
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al., 1998) contrasted the mean BAI scores of outpatients with various psychiatric diagnoses. 
Given that BAI scores were highest among those with an anxiety disorder, it was concluded that 
the BAI had appropriate concurrent validity. A subsequent study with psychiatric inpatients at a 
general hospital sought to replicate concurrent validity in this setting, but only eight patients (3% 
of the sample) had an anxiety diagnosis (Steer, Rissmiller, Ranieri, & Beck, 1993). Nonetheless, 
the distribution of BAI scores was similar to that found in the pilot study with outpatients (Beck 
et al., 1988), suggesting that the BAI should perform equivalently in an inpatient context. The 
relationship between the BAI and anxiety disorders can also be used to inform predictive 
validity, with the difference being that the diagnosis is made after the BAI is completed. In a 
Canadian study with 217 older adult outpatients diagnosed with a variety of psychiatric 
disorders, the BAI was administered at intake along with the Structured Clinical Interview for 
DSM-III-R (SCID) (Kabacoff, Segal, Hersen, & Van Hasselt, 1997). The total score on the BAI, 
as well as the subjective anxiety subscale, were significant predictors of anxiety disorders in a 
logistic regression (p<.0001), providing support for predictive validity. Evidence of concurrent 
and predictive validity using anxiety diagnoses, along with tests of concurrent validity with other 
anxiety scales, demonstrates that the BAI is a good representation of clinical anxiety.  
Given that the HARS demonstrated difficulty distinguishing between anxiety and 
depression, the BAI explicitly addressed this problem during its creation (Beck et al., 1988). 
Since the researchers had already developed the BDI - a similar self-reported tool measuring 
clinical depression - this instrument was used to inform construction of the BAI and ensure that 
symptoms of depression were not being captured (Beck et al., 1988). After inputting all items 
from both the BAI and BDI into a single PCA, the subjective anxiety, somatic, and depressive 
symptoms subscales all emerged as distinct factors, with each one retaining their original item 
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composition. Since symptoms of anxiety and depression were clearly delineated between the 
BAI and BDI, discriminant validity of both scales was deemed suitable. The Turkish version of 
the BAI replicated the results from the pilot study, though anxiety symptoms loaded onto one 
factor rather than separate subjective anxiety and somatic factors (Ulusoy et al., 1998). In both 
studies, discriminant validity of the BAI was further supported after demonstrating that 
individuals with primary anxiety disorders had higher mean scores on the BAI than those with 
primary depressive disorders (Beck et al., 1988; Ulusoy et al., 1998).  
Despite observable differences between anxiety and depression, the correlation between 
the BAI and BDI was r=.48 (Beck et al., 1988) and r=.46 (Ulusoy et al., 1998), representing a 
moderate correlation. Other than the possibility of poor discriminant validity, an explanation for 
the association between the two scales is its shared constructive test design. To determine if this 
hypothesis was correct, measures of depression other than the BDI were analyzed in relation to 
the BAI. In the pilot study, correlation analyses were computed between the BAI and  the HRSD-
R, Cognition Checklist – Depression (CCL-D) and the Hopelessness Scale (HS) (Beck et al., 
1988). In each case, the correlation with the BAI was weak (HRSD: r=.25; CCL-D: r=.22; HS: 
r=.15). The HS was also analyzed as a discriminant indicator for the Turkish version of the BAI, 
producing a weak correlation coefficient (r=.34) (Ulusoy et al., 1998). Finally, the correlation 
coefficient between the BAI and a daily depression diary was also weak among psychiatric 
outpatients (r=.38) (Fydrich et al., 1992). Altogether, though the BAI and BDI share a moderate 
correlation, evidence demonstrating weak associations with other depression measures, as well 
as comparisons with diagnostic groups and factor structure, all indicate that the BAI can 




Summarizing the reliability and validity of the BAI reveals that it is generally a well-constructed 
tool. Reliability estimates are excellent (Beck et al., 1988; de Ayala et al., 2005; Fydrich et al., 
1992; Ulusoy et al., 1998), though internal consistency may be elevated due to the number of 
items contained in the scale (Cortina, 1993). Concurrent validity and discriminant validity have 
both been established using various instruments, as well as diagnostic categories (Beck et al., 
1988; Fydrich et al., 1992; Ulusoy et al., 1998). However, construct validity has been criticized 
for two major reasons. One is that the factor structure of the BAI varies across studies, with the 
number of factors ranging from 2-5 (Osman et al., 1993; Osman et al., 1997). The other issue 
with construct validity is that the BAI contains a high proportion of somatic items, resulting in a 
greater sensitivity to panic disorders than other anxiety subtypes (de Ayala et al., 2005; Fydrich 
et al., 1992). By including a large number of somatic items, the consistency of the scale will 
increase, but will also negatively affect the ability to detect other anxiety domains (e.g., 
cognitive). Therefore, when constructing the interRAI scale, the number of somatic items needs 
to be balanced against other types of indicators, such as cognitive and behavioural symptoms. 
Not only will this allow the scale to better identify a range of anxiety disorders but will also 
potentially limit the number of factors related purely to somatic conditions. Taken together, the 
BAI is a useful tool for informing the development of an anxiety scale.  
3.1.1.3 Other Anxiety Scales 
3.1.1.3.1 Social anxiety disorder 
In addition to general anxiety scales, there are several assessment tools that target specific types 
of anxiety. Although they are not designed to assess broader clinical symptoms, specialized 
anxiety tools can still provide guidance on item selection for a general scale, as incorporating 
items that cover a range of diagnostic subtypes can improve overall detection of anxiety. A 
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notable diagnostic subtype is social anxiety disorder, which is distinct from general phobias due 
to its emphasis on fear and distress during social situations and interactions (APA, 2013; WHO, 
1992). While various social anxiety scales exist, three instruments were chosen for a brief review 
because of their established psychometric properties. First, the Liebowitz Social Anxiety Scale 
(LSAS) is a clinician-administered tool consisting of 24 social situations that are scored for both 
level of fear/anxiety and level of avoidance (Heimberg et al., 1999). Internal consistency of the 
scale is excellent (α=.96), though this may be inflated due to a large number of items and high 
inter-factor correlations (r=.68-.94). Concurrent validity was determined through associations 
with six other social anxiety instruments, with pre-treatment correlation coefficients ranging 
from r=.46-.68 for the total LSAS score. Further, pre-treatment discriminant validity from 
depression was examined using the HRSD (r=.39) and BDI (r=.52) (Heimberg et al., 1999), 
providing additional evidence for the criterion validity of the scale. 
The other two social anxiety scales reviewed are both self-reported tools, each containing 
20 Likert-scale items: The Social Phobia Scale (SPS) and Social Interaction Anxiety Scale 
(SIAS) (Heimberg, Mueller, Holt, Hope, & Liebowitz, 1992). The SPS and SIAS were created 
simultaneously to examine two major components of social anxiety: 1) situations in which an 
individual is having their performance observed (SPS) and 2) direct interactions with others 
(SIAS). Like the LSAS, internal consistency estimates for both instruments are good -to-
excellent, depending on the sample used. Cronbach’s alpha coefficients for the SPS and SIAS in 
a sample of individuals with social anxiety disorder were α=.86 and α=.90, respectively, 
compared to α=.90 and α=.93 in a community sample, and α=.85 and α=.87 in undergraduates 
(Heimberg et al., 1992). Concurrent validity estimates for the SPS and SIAS also tended to be 
higher in community samples than undergraduates and those with social anxiety disorder. For 
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example, the correlation between the SIAS and SPS with the Fear of Negative Evaluation Scale 
(FNE) was r=.82 and r=.79, respectively, in the community sample. In contrast, the same set of 
correlations among individuals with social anxiety disorder was r=.44 and r=.28, and r=.82 and 
r=.48 for undergraduates. Further, the SPS and SIAS shared a strong correlation in the 
community sample (r=.89), but a medium correlation among undergraduates (r=.52) and 
individuals with social anxiety disorder (r=.41) (Heimberg et al., 1992). It is possible that the 
reason for this difference is that community samples demonstrate consistently lower scores on 
social anxiety instruments than undergraduate and clinical samples, enhancing the correlation by 
reducing overall variation. Although internal consistency and concurrent validity of the SPS and 
SIAS varies by setting, based on results for all three social anxiety scales, there is a compelling 
case for including symptoms in the interRAI anxiety scale that represent social anxiety disorder.  
3.1.1.3.2 Generalized anxiety disorder (GAD) 
GAD is characterized by patterns of excessive and pervasive worrying (APA, 2013; WHO, 
1992), and while these symptoms are not included in the HARS or BAI, worrying has been 
shown to be an important component of overall psychological well-being (Stones & Kozma, 
1985). A relevant specialized anxiety scale designed to screen for GAD is the GAD-7, which is a 
brief tool consisting of seven items (Spitzer et al., 2006). Items are scored from 0-3 based on 
self-reported frequency of the symptom - encompassing cognitive, emotional, and physical 
indicators – with a maximum score of 21. Three of the seven items correspond with the DSM-IV 
core criteria for GAD, such as feeling nervous/anxious, persistent worrying, and indiscriminate 
worrying. In primary care settings across the US, internal consistency of the scale was excellent 
(α=.92), and test-retest reliability was good (intraclass coefficient=.83), though the exact retest 
timeframe was not specified. Convergent validity was supported through associations with 
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functional status scores, such as the mental health subscale of the Medical Outcomes Study 
Short-Form General Health Survey (SF-20) (r=.75), and other anxiety tools such as the BAI 
(r=.72) and the Symptom Checklist - Anxiety Subscale (r=.74). However, evidence is less 
encouraging for discriminant validity related to depression, as there was a strong correlation 
between the GAD-7 and the Patient Health Questionnaire depression scale (PHQ-8) (r=.75). 
Diagnostic concurrent validity of the GAD-7 was strongest when using a score cut-point of 10, 
with sensitivity and specificity values over 0.80. Overall, the GAD-7 is a useful tool for detecting 
possible GAD. Given that the HARS (Porter et al., 2017) and BAI (de Ayala et al., 2005; Fydrich 
et al., 1992) have each been criticized for a lack of indicators pertaining to cognitive elements of 
anxiety - particularly excessive worrying and generalized apprehension - drawing upon items 
from the GAD-7 can address this gap.  
3.1.1.3.3 interRAI scales 
While there is no scale currently available for anxiety in the interRAI suite of instruments, an 
internalizing subscale has been proposed for the Children and Youth Mental Health (ChYMH) 
assessment (Lau, Stewart, Saklofske, & Hirdes, 2019). Using a combination of factor analysis 
and multidimensional item response theory (IRT), several model structures were tested to 
explain the relationship between symptoms of depression, anhedonia, and anxiety. The anxiety 
subscale consisted of four items: repetitive anxious complaints/concerns, hypervigilance, 
unrealistic fears, and episodes of panic. Ultimately, a bifactor model produced the best fit to the 
data, with three distinct subscales and a general internalizing factor. Compared to the depression 
and anhedonia subscales, the anxiety scale had the lowest factor loadings on the internalizing 
factor. This suggests that while anxiety is part of a larger internalizing domain, it is separate from 
depression and anhedonia. Additionally, a factor analysis of various mental state indicators 
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contained in the RAI-MH was performed during the development of the interRAI Social 
Withdrawal Scale (SWS) (Rios & Perlman, 2018). In the CFA, items representing depressive and 
anxious symptoms loaded together onto one of four subscales. Since anxiety and depression are 
more strongly correlated with one another than other types of psychological domains (APA, 
2013; WHO, 1992), it is expected that they would load onto a common factor, similar to the 
internalizing subscale proposed for the ChYMH. However, consistent with the ChYMH study 
results, factor loadings for items in the anxious-depressive subscale were lower on average than 
items in other factors, demonstrating that some distinctions can be made between anxiety and 
depression. Based on the results of these studies, there is evidence supporting the creation of a 
scale measuring anxiety within interRAI instruments. 
3.1.1.4 Summary 
In summary, various scales have been created to measure clinical symptoms of anxiety, each 
with its own advantages and disadvantages. The benefit of the HARS is that it has good inter-
rater reliability, especially when accompanied by a structured interview guide (Bruss et al., 1994; 
Shear et al., 2001), as well as concurrent validity (Donzuso et al., 2014; Maier et al., 1988; 
Zimmerman et al., 2007). However, there is mixed evidence surrounding its internal consistency 
(Maier et al., 1988; Shear et al., 2001), content validity (Porter et al., 2017), and discriminant 
validity specific to depression (Beck & Steer, 1991; Maier et al., 1988; Porter et al., 2017; 
Riskind et al., 1987). Conversely, the BAI has demonstrated strong internal consistency (de 
Ayala et al., 2015; Fydrich et al., 1992; Ulusoy et al., 1998) and discrimination of anxiety from 
depression (Beck et al., 1988; Fydrich et al., 1992; Ulusoy et al., 1998). Despite promising 
results, content validity of the BAI is questionable due to over-representation of somatic 
symptoms (de Ayala et al., 2005; Fydrich et al., 1992). To enhance the coverage of the interRAI 
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anxiety scale, anxiety scales that are tailored to specific disorders were also briefly examined. 
The LSAS (Heimberg et al., 1999), as well as SPS and SIAS (Heimberg et al., 1992), are reliable 
and valid instruments that can be used as a reference for social anxiety items. Similarly, there are 
indicators in the GAD-7 that accurately reflect essential characteristics of GAD (Spitzer et al., 
2006), such as persistent worrying and apprehension. Finally, previous interRAI research was 
consulted to determine the feasibility of creating an interRAI anxiety scale. The interRAI 
ChYMH assessment was used to construct a bifactor model of internalizing symptoms with 
anhedonia, depression, and anxiety subscales (Lau et al., 2019), while anxiety items appeared to 
constitute half of an anxious-depressive subscale of broader mood indicators (Rios & Perlman, 
2018). With a variety of well-constructed anxiety scales to draw from, as well as preliminary 
anxiety scale research using the interRAI ChYMH, there is a compelling basis for creating an 
anxiety scale for the interRAI suite of assessment instruments.  
3.1.2 Methodological strengths and considerations 
Having reviewed research conducted with other anxiety scales, compiling the strengths and 
limitations to inform a pathway for scale construction is the next step in designing the interRAI 
anxiety scale. Beginning with internal consistency reliability, it is important to be mindful of the 
impact that the number of items and subscales can have on the Cronbach’s alpha. While the BAI 
demonstrates consistently excellent alpha coefficients (de Ayala et al., 2005), it also contains 21 
items and at least two factors (Beck & Steer, 1991), as well as some items that are synonyms for 
each other, which can artificially increase the alpha estimate (Cortina, 1993; Henson, 2019). In 
the event that the interRAI anxiety scale contains multiple items, an additional check for internal 
consistency is to ensure that items are at least moderately correlated with each other (Cortina, 
1993; Henson, 2019). Inter-rater reliability is another potential problem for scales that use 
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observer assessments. For instance, interview guides were constructed for the HARS to increase 
inter-rater scores (Bruss et al., 1994; Shear et al., 2001). In a reliability study of interRAI 
assessment tools across 12 countries, the mean Fleiss-Cohen weighted kappa coefficient for 
mental health variables was 0.64 (Hirdes et al., 2008), indicating that an anxiety scale based on 
interRAI items should have decent inter-rater reliability. Similarly, in a Chinese validation study 
of the interRAI Mental Health (MH), test-retest reliability of three mental health symptoms 
scales over a 3-week period yielded excellent ICCs (.76-.97) (Chan, Lai, & Chi, 2014), 
exceeding the mean correlation value of r=.66 for studies examining test-retest of the BAI (de 
Ayala et al., 2005). Altogether, while the capacity of this dissertation to test reliability is limited 
to internal consistency, prior interRAI reliability research suggests that the MH instrument can 
be used to create a scale that is consistent with existing general anxiety scales. 
Validity is another psychometric property that needs to be planned for prior to 
constructing the interRAI anxiety scale. Construct validity is typically assessed through two 
components: factor structure and factor loadings. Although the factor structure of the BAI is 
more variable across studies (Beck & Steer,1991; Osman et al., 1993), both the BAI and the 
HARS are typically represented in their original two-factor solutions consisting of psychological 
and somatic indicators of anxiety (Beck et al., 1988; Hamilton, 1959). Given that factor loadings 
for both psychological and somatic symptoms of anxiety are generally good, a similar two-factor 
structure should be tested for the interRAI anxiety scale. However, the scale should also 
incorporate other types of psychological symptoms not included in the HARS and BAI, as those 
pertaining to social anxiety (Heimberg et al., 1992; Heimberg et al., 1999) and GAD (Spitzer et 
al., 2006), to avoid over-emphasizing somatic health conditions (de Ayala et al., 2005; Fydrich et 
al., 1992; Porter, 2017). Concurrent validity with other anxiety scales and anxiety disorders is a 
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strong point for both the HARS (Donzuso et al., 2014; Maier et al., 1988; Zimmerman et al., 
2007) and the BAI (Beck et al., 1988; Fydrich et al., 1992; Kabacoff et al., 1997; Osman et al., 
1997; Ulusoy et al., 1998). Likewise, the BAI has shown great discriminant validity between 
anxiety and measures of depression, such as assessment scales and depressive disorders (Beck et 
al., 1988; Fydrich et al., 1992; Ulusoy et al., 1998). Since this project was limited to data 
obtained through interRAI instruments, criterion validity with other assessment tools was not 
able to be examined. Instead, diagnoses of anxiety and depression disorders were chosen as the 
main tests of concurrent and discriminant validity, respectively.  
A limitation of the inclusion of somatic health conditions in an anxiety scale is their lack 
of specificity. For example, many somatic symptoms listed in the BAI overlap with those 
observed in several medical conditions, such as ‘racing heart’ and ‘dizziness’ (Julian, 2011). For 
older adults especially, various medical comorbidities may be present that are unrelated to 
anxiety, but which share common health symptoms, reducing the effectiveness of somatic items 
at measuring anxiety in this population. Further, somatic indicators like sweating and restlessness 
can also be a side effect of substance and medication use, which are both associated with anxiety 
(APA, 2013). In settings that do not specialize in treating anxiety, such as general psychiatric 
hospitals and units, it is possible that somatic health conditions will be present for a variety of 
reasons that are not due to anxiety. As a result, there is the potential that somatic health 
conditions in the interRAI assessment instruments will not perform as well as psychological 
indicators in the anxiety scale and may reduce diagnostic validity. In this event, it may not be 
desirable to include somatic symptoms, despite their use in other clinical anxiety scales.  
Since the interRAI scale is intended to assess general anxiety levels in clinical 
populations, it should be able to detect the full range of anxiety disorders. A problem arises when 
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considering how to handle symptoms related to OCD and PTSD, which were considered anxiety 
disorders until they were separated into their own diagnostic categories in the ICD-10 (Kogan et 
al., 2016) and DSM 5 (APA, 2013). The reason for recategorizing OCD as its own ‘obsessive’ 
category was because of research findings that demonstrated biological and clinical divergence 
between it and anxiety disorders (Kogan et al., 2016). In contrast, stress-related disorders – 
including PTSD – were separated from anxiety disorders to denote the presence of a causal 
factor (Kogan et al., 2016). Since the interRAI mental health instruments were created prior to 
diagnostic changes to anxiety, half of the items listed under the ‘anxiety’ section of mood 
indicators include symptoms related to OCD and PTSD. Due to the reclassification of OCD and 
PTSD, there is ambiguity surrounding whether or not the associated symptoms belong in a 
general anxiety scale. The approach taken by this project was to retain the OCD and PTSD 
symptoms for analysis to provide an empirical argument for their role in the scale.  
In most studies that were reviewed, the sample sizes were relatively small. In the pilot 
studies for developing the HARS (Hamilton, 1959) and the BAI (Beck et al., 1988), there were 
35 and 1,086 participants, respectively. In the remaining original research studies described 
earlier, sample sizes ranged from 22 participants (Bruss et al., 1994) to 834 participants 
(Vaccarino et al., 2008), with most under 300. This finding is consistent with a systematic review 
of BAI reliability studies, which found a mean sample size of n=259 for coefficient alpha tests 
and n=121 for test-retest (de Ayala et al., 2005). Additionally, a meta-analysis was conducted on 
the English version of the BAI, encompassing 192 studies and 203 participant samples 
(Bardhoshi et al., 2016). To calculate internal consistency, 117 studies were combined to 
produce a total sample of n=43,932, which is smaller than annual number of interRAI mental 
health assessments in Ontario. Further, the authors reported that the sample sizes in exploratory 
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factor analyses did not provide sufficient statistical power in 4/18 studies, while for confirmatory 
analyses, 3/8 were underpowered. Consequences of small sample sizes include adverse effects on 
statistical accuracy and generalizability, which is likely one reason why the factor structure of 
the BAI is inconsistent across studies (Bardhoshi et al., 2016; de Ayala et al., 2005). A major 
advantage of using the interRAI sample for psychiatric inpatients in Ontario is that it has been 
mandated since 2005, resulting in a large sample, as observed in chapter two of this dissertation. 
While the Canadian interRAI community and ED samples are comparatively small, the number 
of participants in each setting is still larger than most of the studies reviewed.    
Another consideration related to sampling are the effects of sociodemographic 
characteristics such as age, ethnicity, sex, and gender on anxiety scores. Most of the studies 
reviewed did not compare anxiety scores across sociodemographic groups, despite that anxiety 
disorders are diagnosed differentially across gender and culture (APA, 2013). One potential 
explanation is that studies did not have sufficient sample sizes to stratify their analyses into 
distinct groups, as was often the case with ethnicity (de Ayala et al., 2005). However, reviews of 
the BAI did report some information relevant to gender and age. In the meta-analytic and 
systematic review studies of the BAI, women typically had higher raw scores than men 
(Bardhoshi et al., 2016; de Ayala et al., 2005). Further, scores on the BAI also tended to be 
higher among younger age groups (de Ayala et al., 2005). In both cases, neither age nor gender 
appeared to affect the reliability of the BAI (de Ayala et al., 2005), though differences in scores 
may have implications for severity thresholds and diagnostic evaluations of anxiety (Bardhoshi 
et al., 2016). Based on the information available, it was anticipated that younger age groups and 
women would score higher on the interRAI anxiety scale.  
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Given that the HARS and BAI were developed for clinical settings, it follows that many 
of the studies reviewed validated the scales using in- and out-patient psychiatric samples. Despite 
clinical intentions, both the BAI and HARS have been examined in college and general 
populations as well, though scale performance might be more variable. For example, in the 
systematic review of the reliability of the BAI, the lower ranges for internal consistency and test -
retest coefficients were more pronounced in nonclinical than in psychiatric populations (e.g., 
α=.83-.94 in noncollege community samples versus α=.91-.94 in inpatient psychiatry) (de Ayala 
et al., 2005). In contrast, the meta-analysis of the BAI did not find differences in internal 
consistency and test-retest scores between clinical and nonclinical samples (Bardhoshi et al., 
2016). One reason for the inconsistency in reliability across settings may be due to differences in 
the statistical techniques used in the systematic review versus the meta-analysis. Regardless, 
higher average scores and standard deviations on the BAI are typically observed in clinical 
settings, which has implications for factor structure and scale performance (Bardhoshi et al., 
2016; de Ayala et al., 2005). Since the interRAI instruments are primarily designed for health 
care settings, the anxiety scale should be tailored towards identifying clinical levels of severity, 
rather than a broader spectrum that would prove more useful in general populations.  
3.1.3 Rationale and hypotheses 
The purpose of this chapter is to develop an anxiety scale for the interRAI health assessment 
instruments. To guide item selection for initial testing, the BAI (Beck et al., 1988) and HARS 
(Hamilton, 1959) were the primary sources of influence. Where they could be matched to 
interRAI items, the LSAS (Heimberg et al., 1999), SPS and SIAS (Heimberg et al., 1992), and 
GAD-7 (Spitzer et al., 2006) were also consulted. The desired result is an anxiety scale covering 
cognitive, mood, behaviour, and somatic symptoms that are general to anxiety disorders overall, 
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as well as symptoms representing the range of diagnostic subtypes within anxiety. The anxiety 
scale should also demonstrate appropriate validity, as detailed in the review for the HARS and 
BAI. Finally, to improve clinical utility and account for the possibility of a non-normal 
distribution, categories representing severity levels are also a necessary property for the scale. 
Prior to beginning scale construction, two sets of hypotheses were generated corresponding to 
structure and construct validity, and criterion validity and responsiveness to change over time. 
3.1.3.1 Research question 1: Structure and construct validity.  
Based on the scale structure of the BAI and HARS, it was hypothesized that a two-factor model 
comprised of psychological and somatic subscales would be the best cand idate for the anxiety 
scale. Although it is expected that there will be two factors, it is also acknowledged that somatic 
symptoms might be less psychometrically rigorous than psychological symptoms, given 
concerns noted in the literature review (de Ayala et al., 2005; Julian, 2011). Other potential scale 
configurations include: 1) a bifactor model with a general anxiety factor alongside psychological 
and somatic factors, such as the interRAI ChYMH internalizing scale (Lau et al., 2019), 2) a 
class-based structure with distinctive subgroups of anxiety, and 3) decision tree algorithms 
incorporating psychological and somatic scales and individual items. To determine whether the 
two-factor scale is the best configuration, each scale candidate will be tested on their predictive 
power for primary and any anxiety disorder diagnoses, which are considered the gold standard 
criterion. Once chosen, severity levels for the anxiety scale will also be determined, with the 
expectation of the following categories: none, mild, moderate, and severe.  
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3.1.3.2 Research question 2: Criterion validity and responsiveness  
After the final anxiety scale is chosen, the next step is to establish its criterion validity and ability 
to detect changes over time. For concurrent validity, traumatic life events were identified as a 
convergent indicator, as responses to traumatic experiences frequently involve symptoms of 
anxiety (APA, 2013; Kogan et al., 2016). Additionally, based on previous research 
demonstrating greater anxiety among women and younger age groups (APA, 2013; Bardhoshi et 
al., 2016; WHO, 1992), it was also anticipated that these groups would show higher scores on the 
anxiety scale. In terms of discriminant validity, depression was the predominant criterion used 
for testing in other anxiety scales (Beck et al., 1988). Consistent with previous research, the 
anxiety scale should not be an equally significant predictor of mood disorders as anxiety 
disorders, nor should it be strongly correlated with a depressive symptoms scale. Finally, it  was 
hypothesized that the anxiety scale would demonstrate a moderate-to-strong ability to detect 
changes in anxiety over the course of treatment.  
3.2 Methods 
3.2.1 Resident Assessment Instrument – Mental Health 
3.2.1.1 Study sample and design  
The OMHRS dataset that was described in chapter two of this dissertation was also used for this 
chapter, except that age restrictions were lifted. The justification for expanding the study sample 
is that anxiety disorders are diagnosed across the life course (APA, 2013; de Lijster et  al., 2017; 
Kessler et al., 2007), and so an anxiety scale should be functional across all age groups. Further, 
the validity, reliability and clinical utility of the scale is enhanced if all adults are included in its 
development. After removing forensic patients and assessments that were flagged as potentially 
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inaccurate, the total number of assessments totaled N=1,266,847. From that subset, the first 
index episode recorded in the system was selected for each individual - with discharge DSM-IV-
TR diagnoses appended to the admission assessment - resulting in a final sample size of 
n=237,862.  
For the latent class analysis (LCA) only, a different sample of RAI-MH assessments was 
used as the source dataset because it was performed in a separate context from the rest of the 
analyses. As such, it was considered an alternative validation dataset for arriving at a class-based 
solution for anxiety symptoms. However, after reviewing the results of the LCA, the resulting 
class-based structure was developed and tested using the same dataset that was used for the rest 
of the analyses, permitting model comparisons. For the LCA sample, the last episode of care was 
selected for each individual between 2005-2019, rather than the first episode. The total sample 
size was n=190,034. 
Given that the RAI-MH has been mandated across the province of Ontario since 2005, 
OMHRS contains a larger and more representative sample than the datasets holding CMH and 
ESP assessments. For this reason, despite the lower proportion of anxiety disorders observed in 
psychiatric hospital units, OMHRS was selected as the primary dataset for creating and 
validating the anxiety scale. However, to aid in the process of choosing a final anxiety scale, 
each of the candidate scale structures were compared in a series of logistic regression models 
using both the RAI-MH and CMH datasets. Further, to establish diagnostic validity of the scale 
in multiple types of care settings, the final scale derived from the RAI-MH was also tested for its 
association with anxiety disorders in the CMH and ESP datasets. 
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3.2.1.2 Dependent variables 
To determine the concurrent validity of the anxiety scale, DSM-IV anxiety disorders were 
selected as the main criterion and grouped by diagnostic ranking. As in chapter two, DSM 5 
categories from 2016 onwards were re-coded to match DSM-IV disorders, affording a larger 
sample size. This means that OCD and PTSD were included as anxiety disorders, despite that 
they are no longer considered as such in the DSM 5 (APA, 2013) or ICD-10 (Kogan et al., 2016). 
“Primary anxiety disorders” were coded as a ‘1’ if they were ranked as the most important 
diagnostic disorder and ‘0’ if they were not. “Any anxiety disorders” were coded as a ‘1’ if an 
anxiety disorder was included in the list of top three most important diagnostic disorders and as a 
‘0’ if they were not.  
Concurrent validity was also tested through the use of the interRAI Traumatic Life 
Events CAP, since experiences of trauma should be positively related to anxiety (Kogan et al., 
2016). The Traumatic Life Events CAP is categorized into three levels: ‘0’ if the CAP was not 
triggered, ‘1’ if there is a need to reduce the impact of prior traumatic life events, and ‘2’ if there 
are immediate safety concerns. The following items from the interRAI assessments instruments 
are used to determine trigger levels for the Traumatic Life Events CAP: intense fear, serious 
accident, death of a family member, lived in war zone, witnessed severe accident, victim of 
crime, victim of sexual assault, victim of physical assault, victim of emotional abuse, fearful of 
family member, concerns for safety, and family history of abuse.  
Based on the literature review, it is common practice to investigate discriminant validity 
between anxiety and depression. To test whether the anxiety scale was distinct from measures of 
depression, DSM-IV mood disorders were selected as one dependent variable. As with anxiety 
disorders, the same process for establishing ‘primary mood disorder’ and ‘any mood disorder’ 
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groups were followed. In addition, the interRAI Depressive Severity Index (DSI) was also 
selected as another check for discriminant validity. The DSI is a scale that measures the severity 
of depressive symptoms based on their frequency of occurrence and ranges from 0-15, including 
the following items: sad/pained facial expression, negative statements, self-deprecation, 
guilt/shame, and hopelessness. 
3.2.1.3 Independent variables 
Based on the literature review of other anxiety scales, a series of variables from the RAI-MH 
were selected for inclusion in scale creation. Corresponding with the psychological factor of 
anxiety present in the HARS (Hamilton, 1959) and BAI (Beck et al., 1988), all items grouped 
under ‘mental state indicators: indicators of anxiety’ were included for testing, as well as items 
pertaining to health complaints and sleep disturbance. The response set for observations of all 
mental state indicators is based on a three-day look back period that is coded as follows: ‘0’ if 
the indicator was not exhibited in the last three days; ‘1’ if the indicator was not exhibited in the 
last three days but is reported to be present; ‘2’ if the indicator was exhibited on one or two of 
the last three days; and ‘3’ if the indicator was exhibited daily in the last three days. The list of 




Table 22. Description of selected mental state indicators listed in the RAI-MH assessment. 
Indicator (section of assessment) Indicator description 
Anxious complaints (mental state indicators - 
anxiety) 
Repetitive anxious complaints (non-health-related) 
(e.g. persistently seeks attention/reassurance). 
Fears/phobias (mental state indicators - anxiety) Expression (including non-verbal) of what appear 
to be unrealistic fears (e.g. fear of being 
abandoned, of being left alone, of being with 
others) or intense fear of specific objects or 
situations 
Obsessive thoughts (mental state indicators - 
anxiety) 
Unwanted ideas or thoughts that cannot be 
eliminated 
Compulsive behavior (mental state indicators – 
anxiety) 
Handwashing, repetitive checking of room, 
counting, etc.  
Intrusive thoughts/flashbacks (mental state 
indicators - anxiety) 
Disturbing memories, nightmares or images that 
intrude into patient’s thoughts; unwanted recall of 
adverse events. 
Episodes of panic (mental state indicators - 
anxiety) 
Patient unexpectedly overwhelmed by sense of 
panic  
Health complaints (mental state indicators - 
other) 
Repetitive health complaints (e.g. persistently 
seeks medical attention, excessive concern with 
bodily functions) 
Sleep problems (mental state indicators - other) Any sleep problems present: difficulty falling 
asleep, restless or non-restful sleep, interrupted 
sleep (including awakening earlier than desired), 
too much sleep 
In addition to the psychological factor, a somatic health factor was also included for 
testing, represented by several physical health conditions that were mapped to the HARS 
(Hamilton, 1959) and BAI (Beck et al., 1988). Similar to mental state indicators, the RAI-MH 
contains a section on health conditions with an observed frequency period that is recorded over 
three days: ‘0’ if the indicator was not exhibited in the last 3 days, ‘1’ if the indicator was 
exhibited on one to two days of the last three days, and ‘2’ if the indicator was exhibited on each 
of the last three days. The health conditions selected were headache, dizziness/vertigo or light -
headedness, shortness of breath, chest pain/pressure, nausea, constipation, and fatigue/weakness.   
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3.2.2 Community Mental Health  
The CMH dataset used to validate the anxiety scale was the same dataset that was used in 
chapter two, but with age restrictions lifted. The full number of assessments was N=9,566. After 
restricting to the first assessment for each individual, the final sample size was n=7,386.  
3.2.2.1 Dependent and independent variables 
While the RAI-MH allows up to three psychological disorder categories to be ranked for their 
importance, the CMH permits up to four. Further, because discharge assessments could not be 
appended to all of the initial assessments in the CMH dataset, the provisional DSM-IV anxiety 
disorder category was used. Despite these differences, the ‘primary’ and ‘any’ anxiety disorder 
dependent variables were coded in the same manner as in the RAI-MH dataset. The independent 
variables used to construct the anxiety scale were also the same, except that the 
‘fatigue/weakness’ variable was not available. Additionally, the observed look back period for 
health conditions is coded slightly differently in the CMH assessment than in the RAI-MH. For 
the CMH, health conditions are coded as follows: ‘0’ if the indicator was not present in the last 3 
days, ‘1’ if the indicator was present but not exhibited in the last three days, ‘2’ if exhibited on 1 
of last 3 days, ‘3’ if exhibited on 2 of last 3 days, or ‘4’ if exhibited daily in last 3 days. 
3.2.3 Emergency Screener for Psychiatry  
As with the RAI-MH and CMH datasets, the ESP dataset remained the same as in chapter two, 
except for age restrictions being removed. The initial sample was N=7,706. After selecting the 
first assessment for each individual, the final sample size was n=5,862. 
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3.2.3.1 Dependent and independent variables 
Like the CMH, the ‘primary’ and ‘any’ anxiety d isorder dependent variables were coded using 
the DSM-IV provisional anxiety disorder category, which could be ranked from first to fourth 
most important. There were fewer independent variables available to use in constructing the 
anxiety scale in the ESP dataset, as this assessment is intended to be shorter in length and assess 
urgent, acute psychological needs. Given the acuity of assessing and treating patient in 
emergency settings, the look back period is 24 hours with the following response codes: ‘0’ if 
not present, ‘1’ if present but not exhibited in last 24 hours, and ‘2’ if exhibited in last 24 hours. 
The anxiety mood indicators that were available were repetitive anxious complaints/concerns 
(non-health related); expressions, including non-verbal, of what appear to be unrealistic fears; 
intrusive thoughts or flashbacks; and episodes of panic. No health conditions are included in the 
ESP, so a somatic factor could not be replicated in this dataset. 
3.2.4 Statistical Analysis 
There are multiple statistical methods that can inform the development of a clinical scale. Five 
major statistical analyses were conducted: factor analysis, item response theory (IRT), latent 
class analysis, decision tree algorithms, and logistic regression. Each of these tests were 
conducted sequentially using data obtained through the RAI-MH dataset, resulting in a final 
proposed model. For the CMH and ESP datasets, only the final model was tested for validation 
purposes. Except for the decision tree algorithm analysis, all statistical tests were conducted 
using SAS 9.4 for Windows. SAS Enterprise Miner Workstation 15.1 was used to create the 
decision tree algorithm. 
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3.2.4.1 Bivariate analysis  
The first step in creating the anxiety scale was to examine the frequency distribution and 
significance of the independent variables in relation to primary and any anxiety disorders. By 
performing bivariate analysis first, the number of items to be entered into the subsequent factor 
analytic stage could be refined, enabling a more efficient model. The p-values of the chi-square 
tests were consulted but due to the large sample size and multiple comparisons, it was 
acknowledged that Type 1 errors were a risk. To account for the possibility of false positive 
significance values, greater emphasis was placed on the OR and 95% CI to guide variable 
selection. Specifically, an OR value of at least 1.50 was selected as the cut-off for variable 
inclusion in the anxiety scale.  
3.2.4.2 Factor analysis 
A popular method for scale creation is factor analysis. Exploratory factor analysis (EFA) is used 
to identify latent factors from a set of measured items by examining patterns of inter-item 
relationships (Osborne & Banjanovic, 2016). In a factor analytic model, the variances of 
measured items are predicted by two latent variables: the ‘true score’ – represented by the factors 
derived from the correlation matrix and referred to as ‘communalities’– and the error variance 
(Osborne & Banjanovic, 2016; Raykov, 2004). The true score is divided by the error variance to 
provide an estimate for the reliability of the model, with scores closer to ‘1’ indicating greater 
reliability (Raykov, 2004). This is referred to as the coefficient alpha and is a measure of internal 
consistency. However, the coefficient alpha is susceptible to inflation when many items are 
included and is not an appropriate test for scales containing multiple factors (Cortina, 1993). As 
part of the EFA procedure, numerous models with varying numbers of factors are extracted, 
allowing for identification of the factor structure that best explains inter-item relationships. There 
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are various extraction methods available, but one that is recommended for data that is not 
normally distributed is unweighted least squares (Osborne & Banjanovic, 2016). An additional 
step towards testing factor structures is rotation selection. When more than one factor is retained 
in a model, rotation methods position the factors so that their relationship to each other can be 
interpreted (O’Rourke & Hatcher, 2014; Osborne & Banjanovic, 2016). Orthogonal rotations are 
the most popular in social science research (O’Rourke & Hatcher, 2014), and assumes that 
factors are uncorrelated with one another. However, it is unrealistic in many research 
applications for factors to have no association with one another (Osborne & Banjanovic, 2016). 
To account for at least some degree of association, oblique rotations - which permit factors to be 
correlated - are commonly used in many disciplines as an alternative to orthogonal rotations 
(Osborne & Banjanovic, 2016).  
Various test statistics are available to aid in specification of factor structures. Eigenvalues 
indicate the amount of variance that a factor contributes towards the total variance score 
(O’Rourke & Hatcher, 2014; Osborne & Banjanovic, 2016). Generally, factors with an 
eigenvalue of 1 or greater are retained for analysis. However, the limitation of using a cut-off of 
1 or greater is that it can lead to over-factoring, particularly when several items are being 
analyzed or the communalities of items are small (O’Rourke & Hatcher, 2014). Alongside 
eigenvalues, the scree plot can provide additional guidance for selecting the number of factors to 
retain, though it is a more subjective measure and should not be used on its own (O’Rourke & 
Hatcher, 2014; Osborne & Banjanovic, 2016). By plotting the eigenvalues along a line, the scree 
plot can reveal where there is a ‘break’ in the number of factors, where more meaningful factors 
are located above the break. Using both the eigenvalues and the scree plot, a hypothesis about the 
number of factors present in the data can be reached and then tested in a series of models, using 
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rotation methods where more than one factor is specified. In each model, the communalities of 
the factor structure, as well as the factor loadings of measured items, guides model selection 
(Osborne & Banjanovic, 2016). Communality estimates indicate how much of the total variance 
is accounted for by each factor; if a factor has a relatively small communality, it may not be 
worth retaining. As for individual items, factor loadings represent the degree to which the item is 
correlated with the proposed factor. Generally, it is desirable for items to have factor loadings of 
at least 0.40 on one factor, and small cross-loadings onto other factors (O’Rourke & Hatcher, 
2014). Items that have either small primary factor loadings or high cross-loadings may require 
revision or deletion, as they otherwise diminish the construct validity of the scale. 
Once a hypothesis is reached about the number of factors that should be specified and 
how the measured items should be configured, confirmatory factor analysis (CFA) can be used to 
test the proposed structure against alternative models (Worthington & Whittaker, 2006). Using 
this method, one can evaluate how well a model fits the observed data using several different 
metrics. The chi-square statistic indicates how much the observed and expected covariance 
matrices differ. An insignificant p-value provides evidence in support of the proposed model, 
since it would suggest that it aligns with the observed data. However, a major limitation is that 
chi-square tests are unreliable in samples larger than 200, since even small deviations can result 
in a significant p-value (Kenny & McCoach, 2003). In addition to assessing the model with chi-
square, there are several other metrics used for evaluating model fit. The comparative fit index 
(CFI) ranges from 0-1, with higher values indicating a better model fit; values over .90 are 
considered acceptable (Hu & Bentler, 1999). Finally, the root mean square error of 
approximation (RMSEA) evaluates the residual error contained in the model. It also ranges from 
0-1 but in this case, a value close to 0 is better. Acceptable models should have a value equal to 
 
 146 
or less than .06 (Hu & Bentler, 1999). Another way that tests statistics are used is to inform the 
constraints that should be placed on a model, if any. In a congeneric model, all variable slopes 
and error variances are independent, while a tau-equivalent model fixes variable slopes but 
permits error variances to vary (SAS, 2013). Constraints affect the Cronbach’s alpha estimates 
for the model, so testing which constraints best fit the data is important for constructing a reliable 
scale. 
One of the advantages of CFA is that it allows competing models to be compared against 
one another. For example, EFA may have suggested that data can be explained by three factors. 
However, using CFA, one might discover that a model with one factor may fit the data just as 
well and have the advantage of being more parsimonious. This can be determined by using 
information criteria metrics, such as the Akaike information criterion (AIC) or the Bayesian 
information criterion (BIC). The AIC calculates the discrepancy between an estimated true 
model and the candidate models, though it has been criticized for endorsing too many factors 
(Kuha, 2004). The BIC assess the probability that each candidate model is the true model and in 
contrast to the AIC, accuracy improves with increasing sample sizes (Kuha, 2004). In both cases, 
a smaller value is preferable, suggesting that the candidate model is closer to the true model. 
The BAI (Beck & Steer, 1988) and HARS (Hamilton, 1959) were both derived using 
PCA, which is similar to factor analysis, except that measured items predict the latent factor 
rather than the other way around. However, attempts to replicate their structure in other studies, 
as described in the introduction, have been performed using factor analytic methods. In most 
cases, EFA is conducted first and is then followed by CFA, even when a hypothesis exists for an 
existing factor structure. Given that anxiety can be manifested as physiological, cognitive, 
behavioural, and emotional symptoms (APA, 2013; WHO, 1992), EFA is useful for deciding 
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how such an array of different indicators can be arranged to represent anxiety. However, since 
various competing models of anxiety were endorsed across different studies, CFA is necessary 
for determining which one best fits the observed data. Factor analysis has also been used to 
develop interRAI scales, such as the internalizing scale in the ChYMH (Lau et al., 2019). 
Through a combination of EFA and CFA techniques, items with low factor loadings were 
removed and multiple factor structures were examined, including one-, two-, three-, and bi-factor 
models. A similar factor analytic approach was used in this dissertation to create a scale for 
anxiety symptoms.  
To begin, variables for EFA were selected based on the results from the bivariate analysis 
and analyzed using the PROC FACTOR command in SAS. Each variable was entered in its un-
collapsed, ordinal format. Since the distribution of data was not normal across variables, an 
unweighted least squares method was used to extract factors. In the first model iteration, only 
one factor was specified. If the evidence suggested that more than one factor was present, 
another set of models with an unspecified number of factors would be explored. Rotation options 
can be selected for multi-factor models in which case, the orthogonal varimax option was tested 
along with promax and oblique varimax options. Based on the results of the EFA, subsequent 
CFA tests were run to confirm the model structures using the PROC CALIS command in SAS. 
To compare the fit statistics of the models while accounting for the non-normal distribution of 
the data, the estimation method chosen was maximum likelihood using least squares as the 
starting point (LSML) (SAS, 2013). Firstly, a unidimensional model was generated with the 
variables selected from the EFA. If there was evidence from the EFA of multiple factors, then 
variations on the constraints of the model structure were examined first. Starting with a 
correlated factors model, tau-equivalent and congeneric models were compared using the CFI 
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and RMSEA test statistics. Depending on which variation produced the superior fit, those 
constraints would be carried forward to subsequent models.  
In addition to unidimensional and two-factor models, two other structures were 
investigated based on factor analyses of anxiety scales in the literature review: a higher order 
model and a bifactor model. In both cases, the general factor being tested was purported to be 
anxiety. To successfully run the LINEQS language within PROC CALIS - a requirement for 
testing higher order and bifactor models - a correlation matrix needs to be input as the dataset 
(SAS, 2013). As well as inputting the default correlation matrix obtained from the EFA, a 
polychoric correlation matrix was tested as an alternative dataset, since asymptotic covariances 
provide better estimates of standard errors for ordinal variables (Yang-Wallentin, Jöreskog, & 
Luo, 2010). The results for the higher order and bifactor models are available upon request. 
3.2.4.3 Item response theory 
Initially developed to construct test questions in the field of education, IRT analyzes the extent to 
which individual test items differentiate between varying levels of a latent ability (Baker, 2001; 
Yang & Kao, 2014). The assumption underlying each question is that the probability of 
answering correctly – or endorsing a specific response - is a function of how much of the latent 
ability is possessed. Consequently, an ‘easy’ question has a higher probability of being endorsed 
given a lower level of ability, while a ‘difficult’ question poses the inverse. In terms of a clinical 
symptoms scale, the probability of having a symptom should be related to the latent health 
condition being assessed. Only one latent ability can be tested at a time in IRT and as a result, 
scales are assumed to be unidimensional (Yang & Kao, 2014). Individual items are also 
presumed to be independent of each other, meaning that only the level of the latent ability should 
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influence the score on an item. Prior to IRT, factor analysis is typically used to test assumptions 
related to unidimensionality and inter-item correlations. 
Item properties are analyzed via item characteristic curves (ICC). ICC graphically 
illustrates the probability of endorsing a ‘correct’ response at a given level of the latent ability. 
The graphs depict items in an ‘s’ shaped distribution involving two properties: difficulty/location 
and discrimination. Item discrimination, calculated as the slope estimate, is a measure of how 
well the item differentiates between ability levels (Baker, 2001; Yang & Kao, 2014). Like factor 
loadings, the slope represents the strength of the relationship between the item and latent factor 
(Toland, 2013). Steeper slopes indicate greater item discrimination and strength of relationship 
(Baker, 2001; Toland, 2013; Yang & Kao, 2014). While the range of slope parameters is 
theoretically infinite, after standardizing ability scores to have a mean of 0 and SD units of 1, a 
range of 0.5 to 3.0 is common in practice (Toland, 2013). Item difficulty indicates the level of 
ability needed for a 0.5 probability of endorsing a ‘correct’ response (Yang & Kao, 2014). For 
items that are easily endorsed, the curve will be located more to the left of the distribution, while 
difficult items will have curves located to the right (Baker, 2001). In terms of numerical 
estimates, a typical range for item difficulty is between -3.0 and 3.0 (Baker, 2001; Toland, 2013).  
While the ICC are used to examine individual items, the test information curve (TIC) 
describes the performance of the total scale. The TIC is plotted with the standardized ability 
score on the x-axis and test information on the y-axis, which is calculated as a summary score of 
both item discrimination and difficulty (Yang & Kao, 2014). Using the TIC as a guide, the range 
of ability scores that can be differentiated using the test can be evaluated. For instance, a scale 
with a wide TIC performs well at screening individuals in a setting where there is a broader 
range of ability (e.g., general population), whereas a narrow TIC provides greater discrimination 
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for a specific part of the population (e.g., clinical populations). The extent to which a scale 
should have a wide or narrow TIC depends on its intended purpose. An anxiety scale that is 
intended to measure symptoms in the general population will benefit from items with lower 
difficulty and discrimination, while higher values are more appropriate for scales that are meant 
to distinguish clinical anxiety. 
The purpose of using IRT in this project was simply to permit a descriptive examination 
of how each individual item functions as a test of anxiety, as well as how the scale performs 
overall at identifying clinical anxiety. Although IRT can be used to test factor structures for 
categorical variables, factor analysis was chosen instead because it was the most common 
method used to construct anxiety scales in previous studies, allowing other structures to be 
directly replicated. IRT was used for a similar purpose to create the interRAI Social Withdrawal 
Scale (SWS) (Rios & Perlman, 2018), in which discrimination and difficulty parameters for 
individual items were examined following CFA to refine item selection. For the IRT analysis, the 
PROC IRT command was used in SAS, with options specified for scree, ICC, and TIC plots. 
Since binary response categories are preferred in IRT (Baker, 2001; Yang & Kao, 2014), all 
variables were collapsed into binary response categories, with symptoms either present or absent. 
If a unidimensional model was selected as the best candidate in the factor analysis, the default  
options provided by the SAS program were enabled (two-parameter logistic model, logistic link 
function, marginal likelihood estimation method, and quasi-Newton optimization method).   
3.2.4.4 Latent class analysis 
As described in factor analysis, latent constructs are those phenomena that cannot be directly 
measured, and so they require that observable indicators be used to represent them. Whereas 
factor analysis is concerned with detecting underlying latent dimensions that explain 
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relationships in a dataset, latent class analysis (LCA) separates cases into discrete classes based 
on their shared patterns of the latent construct (Lanza, Bray, & Collins, 2013). To determine 
class membership status, LCA relies on the use of categorical indicators (Lanza, Collins, 
Lemmon, & Schafer, 2007). Since distributions and error variances of categorical variables are 
not estimated, it can be assumed that indicators within each class are independent of one another, 
except for their shared status on the latent construct. To arrange categorical variables into 
classes, two parameters are computed in LCA: 1) latent class probabilities and, 2) item-response 
probabilities for observed variables. Class probability is similar to a factor score in factor 
analysis (Lanza & Collins, 2008), though in this case it is calculated using the prevalence of 
cases assigned to each class (Lanza et al., 2013). Since each case can only be assigned to one 
class, class probabilities are summed together to equal one, with higher scores indicating a 
greater prevalence. Conversely, item-response probabilities are like factor loadings (Lanza & 
Collins, 2008), or item discrimination in IRT. This parameter represents the probability that 
cases in a latent class will have a certain response on a categorical variable. Probability scores 
range between 0 and 1, with a score of 0.5 signaling random chance (Lanza et al., 2013). Further, 
LCA assumes that all cases in a class have the same item-response probabilities, since variables 
are presumed to be independent except for the latent construct. 
To calculate the probability parameters and arrive at class solutions, a starting set of 
parameter values can be input with the dataset, otherwise a seed statement will be used to 
generate random starting values (Lanza et al., 2015). From the starting parameter values, a series 
of model iterations are run to calculate and estimate new parameter values across classes, until 
either an optimal solution is reached, or the maximum number of iterations has run. The most 
common estimation method for LCA is the EM algorithm, which is analogous to the maximum 
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likelihood function (Lanza et al., 2013). After the model iteration process has been completed for 
each number of latent classes being tested, various model fit statistics are provided to aid in 
model selection. Like factor analysis, the AIC and BIC test statistics are used to determine model 
fit and guide decisions on the number of latent classes to select. LCA also computes a deviance 
statistic – G2 – which compares the difference between the observed dataset and model 
predictions (Lanza et al., 2015). With all three fit statistics, smaller values indicate better model 
fit. Since parsimonious models are generally preferred over complicated ones, it is recommended 
that the least number of latent classes that still provide optimal fit statistics are selected. 
Like IRT, LCA was primarily used for the exploratory purpose of better understanding 
the nature of the relationship between items in the scale. In previous anxiety research, LCA has 
been used to examine the relationship between depressive/affective and anxiety symptoms 
among adolescent outpatients in The Netherlands (Ferdinand et al., 2005). Based on responses to 
the Youth Self-Report (YSR) instrument, three classes were discovered for anxiety and four for 
affective problems. The three anxiety classes were characterized primarily by the 
frequency/severity of symptoms rather than combinations of specific symptoms, though certain 
symptoms were more common than others across all classes (e.g., ‘nervous’ and ‘worries’). 
Through LCA, class structures of anxiety can reveal patterns of symptoms that are not readily 
detected in factor analysis. For instance, if symptom frequency is established as an important 
distinction for classes of anxiety, then a continuous, additive version of an anxiety scale would 
benefit from keeping variables in an ordinal format. The item-response probabilities provided by 
LCA were also expected to corroborate the findings from IRT. Depending on the results, a class-
based alternative to an additive, continuous anxiety scale would be also be tested. 
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3.2.4.5 Decision tree models 
The final statistical method used to derive a potential anxiety scale was an interactive decision 
tree algorithm. Decision trees can be used to classify and predict a dependent variable (root 
node) by splitting independent variables into a hierarchy of branching categories (internal nodes) 
– the result is a diagram that looks like an inverted tree (de Ville & Padraic, 2013; Song & Lu, 
2015). The goal of this process is to identify a series of rules that when followed, will be able to 
predict which class of the dependent variable that a person belongs to. This process enables 
complex interactions between predictor variables to be detected and modeled in a relatively 
straightforward manner, compared to regression models and factor analysis. There are two types 
of approaches that can be used to generate decision tree models: automatic and interactive. 
Automatic models are determined by the statistical software, while an interactive decision tree 
method permits variables to be selected manually by the researcher, which is preferable when 
theoretical relevance and clinical utility are desired considerations of the scale. Beginning with 
the root node, the entire sample is included and classified by their score on the dependent 
variable (e.g. ‘condition absent’ vs. ‘condition present’). From there, an internal node is selected 
that best distinguishes between the classes in the root node when split (e.g. a score of ‘1’ on the 
internal node is associated with being in class ‘1’ in the root node). Importance values may be 
used to guide the selection of internal nodes (de Ville & Padraic, 2013). The degree to which the 
internal node – and the splitting procedure selected – accurately predicts the classes in the root 
node is calculated using the training dataset. Relative importance values are determined by the 
reduction in the sum of squared errors of the prediction value. Each node is derived using a 
training dataset and then tested recursively with a separate validation dataset.  
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An internal node is split into branching pathways following ‘if/then’ rules. The sample is 
divided accordingly so that every branch emanating from an internal node has a mutually 
exclusive sample. There are several criteria that can be applied to splitting rules. For interval 
variables, node variance can be analyzed using an f-test and split on the size of the f-statistic and 
significance of the p-value (de Ville & Padraic, 2013). Alternatively, the means of the node can 
be used to find splits that decrease the sum of squared errors. For ordinal variables, a reduction in 
entropy or the Gini index can be specified, both of which represent the degree of random error 
associated with the prediction of a split (de Ville & Padraic, 2013). The splitting process 
continues until the model ends in ‘leaf’ nodes, where no further branches are drawn. This process 
is referred to as ‘stopping,’ which is necessary for building a model that is not over-fitted or too 
complex. In an interactive decision tree model, stopping procedures are at the discretion of the 
researcher. Otherwise, there are some guidelines for stopping, such as setting a minimum number 
of observations in each node and/or the maximum number of nodes permitted (de Ville & 
Padraic, 2013; Song & Lu, 2015).  
Decision tree modeling was used to construct an alternative anxiety scale to the one 
created through factor analysis. As such, in addition to the independent variables used in the 
preceding analyses, the anxiety scale resulting from the factor analysis was also input as a 
predictor variable in the decision tree dataset. By including the full anxiety scale as an 
independent variable, the decision tree algorithm can potentially refine it further by detecting 
unique associations between the scale and anxiety diagnoses. Two sets of decision tree models 
were created: one where the target variable was a primary diagnosis of anxiety, and one where 
the target was any diagnosis of anxiety. For each target, a tree was created manually using the 
interactive decision tree option, while a second tree was generated entirely by the SAS Enterprise 
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Miner program. An interactive decision tree allows for variables to be selected and split by the 
user, forming a decision tree that is guided by researcher judgment. The automatic tree is created 
entirely by statistical software, following the input criteria for splitting described above (de Ville 
& Padraic, 2013; Song & Lu, 2015). Regarding splitting, the maximum number of branches was 
set at four, while the maximum depth was set at 10. Further, the significance level for splitting 
criteria was set at p=0.05.  
3.2.4.6 Logistic regression 
Logistic regression is used to predict nominal or ordinal outcomes, including dichotomous and 
polytomous measures, based on a combination of independent variables at any level of 
measurement (Anderson, Jin, & Grunkemeier, 2003; Sperandei, 2014). Odds of the outcome 
occurring are calculated using the natural logarithm of an odds ratio (OR) and can be interpreted 
using regression coefficients and ORs (Anderson et al., 2003; Peng, Lee, & Ingersoll, 2002). 
Regression coefficients denote the change in the log-odds of an outcome occurring given a one-
unit increase in the independent variable and are calculated using the logit function of the OR. 
The OR represents the odds of the outcome given one level of an independent variable relative to 
another, which can be converted to the log odds using the exponential function (Anderson et al., 
2003; Peng et al., 2002; Sperandei, 2014).  
There are various means of evaluating the appropriateness of a regression model. In terms 
of the independent variables, the p-value may be used to determine if they have better odds of 
predicting the outcome than random chance (Peng et al., 2002; Sperandei, 2014). The confidence 
intervals (CI) surrounding the OR can also be used to make judgments about significance, ruling 
out those variables with CIs overlapping a value of 1.00 (indicating no difference in odds from 
the reference group). In cases where the sample size is large and type 1 errors resulting from 
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multiple comparisons are a higher risk, minimum thresholds for the OR values might be used to 
identify variables with an adequate strength of association for inclusion in the model. Regarding 
the adequacy of the entire model, one method is to compare the proposed model against a null 
model where only the intercept is included. Three tests are available for determining whether the 
proposed model is a significant improvement: the likelihood ratio test, score test, and Wald test 
(Peng et al., 2002). Goodness-of-fit statistics are also available, such as the Hosmer-Lemeshow 
(H-L) test, to evaluate whether the model fits the observed outcomes in the dataset. In this 
instance, an insignificant p-value is desirable (Anderson et al., 2003; Peng et al., 2002). Finally, 
the degree to which the predicted probabilities match with actual observed outcomes can be 
evaluated using different metrics. One is the c-statistic, which uses pairs of observations with 
differing outcomes and evaluates the degree to which each was correctly identified in the model 
(Anderson et al., 2003; Peng et al., 2002). Values range from 0.5-1.0, with higher values 
reflecting better probability measurements.  
Logistic regression can aid in the development of an anxiety scale by testing the 
performance of candidate scale relationships with concurrent and discriminant measures. For 
instance, if a scale is intended to measure clinical anxiety, it should be predictive of anxiety 
disorders. Similarly, the scale should not be highly predictive of mood disorders or other 
measures of depression. Logistic regression has previously been used to assess the power of the 
BAI and STAI in predicting anxiety disorders among older adult outpatients (Kabacoff et al., 
1997). There were two ways in which logistic regression models were used in this study. The 
first was to compare the ability of candidate scale structures in predicting anxiety disorder 
outcomes through the c-statistic. The scales were input separately as predictors of primary and 
any anxiety disorders, with an additional specification for an ROC plot and analysis. The second 
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way logistic regression was used was to determine the criterion validity of the scale. Based on 
the literature review, it was expected that anxiety would demonstrate concurrent validity for 
issues related to sleep disturbance and trauma, both of which have their own CAPs in the 
interRAI assessments. For discriminant validity, depression was examined as an outcome using 
the mood disorders diagnosis and the DSI.  
3.2.4.7 Change scores 
After constructing the final anxiety scale, differences in anxiety scores between admission and 
discharge were evaluated to determine if the scale is able to detect change over time. Various 
methods exist for assessing change over time using health-related tools, depending on the study 
design. Since this study did not involve randomized sampling, comparisons of treatment groups, 
or consistent assessment timeframes, simpler analytical methods were selected. The most 
straightforward approach is to analyze change between two points in time by calculating the 
effect size and standardized response mean (SRM) (Stratford, Binkley, & Riddle, 1996). To 
calculate the effect size, the mean change score is divided by the standard deviation of the initial 
score. Interpreting effect sizes for health assessment tools generally follow the recommendations 
posited by Cohen, where scores less than .20 are considered weak, .50 moderate, and .80 or 
greater are strong (Kazis, Anderson, & Meenan, 1989). The formula is similar for the 
standardized response mean (SRM), except that the denominator is the standard deviation of the 
change scores (Stratford et al., 1996). While the effect size and SRM can indicate the ability of a 
tool to detect an overall difference in scores, a limitation of these methods is that they are 
incapable of accounting for the degree of change over time. One method that can help to address 
this problem is to calculate the correlation between scores at admission and change scores 
(Stratford et al., 1996). Since individuals with higher anxiety scores at admission should 
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demonstrate greater improvement over time after receiving treatment, a strong, positive 
correlation would be expected. 
3.3 Results  
The percentage of inpatients with a primary diagnosis of anxiety was 4.0% (n=9,582), while the 
percentage of any diagnosis of anxiety was 14.5% (n=34,565). Among inpatients with primary 
and any mood disorder diagnoses, the percentage of comorbid anxiety disorders were 42.1% 
(n=100,246) and 52.7% (n=125,325), respectively. Conversely, the percentage of a comorbid 
mood disorder diagnosis among those with a primary disorder of anxiety was 35.8% (n=3,428), 
and 63.4% (n=21,919) for those with any anxiety disorder. These results suggest that  while 
anxiety and mood disorders share some association, they are distinct diagnoses that should be 
predicted differentially by the anxiety scale. Table 23, provided below, breaks down the 
proportion of various diagnostic subtypes within the primary and any anxiety disorder samples. 
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Table 23. Distribution of anxiety disorder subtypes among inpatients with primary and any 
anxiety disorders receiving care in psychiatric hospitals and units across Ontario, 
Newfoundland and Labrador, and Manitoba between 2005-2019 (n=237,862). 
Anxiety disorder subtype Primary diagnosis 
(n=9,582) 
Any diagnosis (n=34,565) 
Panic disorder 26.7 (2,561) 21.9 (7,557) 
GAD 22.2 (2,123) 19.5 (6,750) 
PTSD 22.7 (2,174) 15.4 (5,322) 
Unspecified or other anxious state 14.3 (1,369) 14.3 (4,930) 
OCD 8.4 (804) 5.9 (2,030) 
Social anxiety 3.0 (284) 4.1 (1,431) 
Agoraphobia 2.5 (237) 2.0 (700) 
Other anxiety subtypes 0.2 (30) 16.9 (5,845) 
Note. ‘Other anxiety subtypes’ include diagnoses that were not categorized separately due to small sample sizes. 
Examples include specified and unspecified phobias, alcohol- and drug-induced anxiety disorders, acute stress 
disorder, and so on. 
As observed in Table 23, the most common subtype of anxiety disorder in the inpatient 
sample was panic disorder, followed by GAD and PTSD. OCD was less commonly diagnosed, 
though it still constituted a higher proportion of primary than any anxiety disorders. Social 
anxiety disorder and agoraphobia were relatively rare, though social anxiety more commonly 
appeared as non-primary disorders. Another important finding is that 14% of both groups were 
given an unspecified or other anxious state diagnosis, suggesting that their symptoms could not 
be differentiated into clear categories. 
3.3.1 Bivariate analysis 
The bivariate analysis was used to address two questions: 1) what is the prevalence of each 
indicator within the dependent variable groups and, 2) is the indicator prevalence different 
between those with and without a diagnosis of anxiety? To answer the first question, the 
percentage of mental state and somatic indicators present among those with a primary anxiety 
diagnosis, other primary diagnosis, any anxiety diagnosis, and no anxiety diagnosis were charted. 
After a cursory examination of the indicators in their original format, it was decided that they 
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would be collapsed into ‘absent’ or ‘present’ binary categories for bivariate analyses. The results 
are illustrated below in Figures 5-6. 
 
Figure 5. Prevalence of psychological indicators among inpatients with a primary diagnosis 
of anxiety, any diagnosis of anxiety, and no diagnosis of anxiety, receiving care in 
psychiatric hospitals and units across Ontario, Newfoundland and Labrador, and 
Manitoba between 2005-2019 (n=237,862). 
As observed in Figure 5, the most common mental state indicator across all groups was 
anxious complaints, which occurred in over 60% of those with an anxiety disorder and half of all 
other inpatients. Sleep disturbance – the second most frequent symptom - was also present in half 
the overall sample. Unrealistic fears, obsessive thoughts, intrusive thoughts/flashbacks, and 
episodes of panic were present in roughly one-third of those with a primary anxiety disorder, and 
over 20% in those with any anxiety disorder. Conversely, for those with no anxiety disorder, 
unrealistic fears and obsessive thoughts occurred in one-fifth of the sample, while intrusive 
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specified indicator – was the least common symptom across all groups. The prevalence among 
those with a primary diagnosis of anxiety and any anxiety disorder was 13% and 10%, 
respectively. For those with no anxiety disorder, the prevalence was 6%.  
 
Figure 6. Prevalence of somatic indicators among inpatients with a primary diagnosis of 
anxiety, any diagnosis of anxiety, and no diagnosis of anxiety, receiving care in psychiatric 
hospitals and units across Ontario, Newfoundland and Labrador, and Manitoba between 
2005-2019 (n=237,862). 
Compared to the psychological indicators, the prevalence of somatic indicators in Figure 
6 is substantially lower. Fatigue/weakness and headaches were the most frequent health 
problems across all diagnostic groups. For individuals with anxiety disorders, approximately 
20% experienced fatigue/weakness and 19% had headaches. The corresponding prevalence for 
those without an anxiety disorder was 15% and 13%, respectively. Dizziness and nausea were 
present in one-tenth of the anxiety disorder sample, and 7% and 6% of those with no anxiety 
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The second question involved comparing the proportion of indicators between groups 
with and without anxiety disorders. For each indicator, chi-square tests were performed to 
determine whether a significant difference existed between groups, along with the unadjusted 
OR value. Both primary anxiety disorders and any anxiety disorders were examined separately. 
The results are displayed below in Table 24.
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Table 24. Odds ratio and chi-square tests for psychological and somatic indicators in predicting primary anxiety disorders 
among inpatients receiving care in psychiatric hospitals and units across Ontario, Newfoundland and Labrador, and 
Manitoba between 2005-2019 (n=237,862). 
Variable % (n) Unadjusted OR (95% CI) Chi-square test 
Anxious complaints 
Primary Anxiety Disorder 





2.19 (2.10-2.29) χ2 (1) = 1,281.62 
p<.0001 
Unrealistic fears 
Primary Anxiety Disorder 





1.76 (1.68-1.84) χ2 (1) = 643.07  
p<.0001 
Obsessive thoughts 
Primary Anxiety Disorder 





1.72 (1.65-1.81) χ2 (1) = 575.89 
p<.0001 
Compulsive behavior 
Primary Anxiety Disorder 





2.04 (1.92-2.18) χ2 (1) = 530.40  
p<.0001 
Intrusive thoughts 
Primary Anxiety Disorder 





2.63 (2.51-2.75) χ2 (1) = 1,786.29 
p<.0001 
Episodes of panic  
Primary Anxiety Disorder 





2.75 (2.63-2.89) χ2 (1) = 1,925.51  
p<.0001 
Health complaints 
Primary Anxiety Disorder 





1.21 (1.15-1.27) χ2 (1) = 64.32  
p<.0001 
Sleep disturbance 
Primary Anxiety Disorder 





1.20 (1.15-1.25) χ2 (1) = 74.10  
p<.0001 
Headaches 
Primary Anxiety Disorder 





1.37 (1.29-1.44) χ2 (1) = 130.22  
p<.0001 
Dizziness 
Primary Anxiety Disorder 









Variable % (n) Unadjusted OR (95% CI) Chi-square test 
Shortness of breath 
Primary Anxiety Disorder 





1.62 (1.48-1.77) χ2 (1) = 106.65   
p<.0001 
Chest pain 
Primary Anxiety Disorder 





1.76 (1.57-1.96) χ2 (1) = 103.58  
p<.0001 
Nausea  
Primary Anxiety Disorder 





1.45 (1.35-1.56) χ2 (1) = 100.35  
p<.0001 
Vomiting  
Primary Anxiety Disorder 





1.15 (1.01-1.30) χ2 (1) = 4.8  
p=0.03 
Fatigue/weakness 
Primary Anxiety Disorder 





1.21 (1.14-1.27) χ2 (1) = 48.1  
p<.0001 
Impaired balance 
Primary Anxiety Disorder 





0.70 (0.64-0.78) χ2 (1) = 49.53  
p<.0001 
Akathisia 
Primary Anxiety Disorder 





0.85 (0.73-0.99) χ2 (1) = 4.17  
p=.04 
Note. Percentages are row percentages for disorder by independent variable (e.g., % of those with a primary anxiety disorder who had the independent variable). 
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Nearly all the indicators in Table 24 were higher among those with anxiety, with the 
exception of impaired balance (OR=0.70) and akathisia (OR=0.85). The following variables did 
not meet the significance criteria of OR=1.50 or higher: health complaints (OR=1.21), sleep 
disturbance (OR=1.20), headaches (OR=1.37), dizziness (OR=1.35), nausea (OR=1.45), 
vomiting (OR=1.15), and fatigue/weakness (OR=1.21). The anxiety-specified psychological 
indicators had greater OR values than health complaints or sleep disturbance. In terms of the 
somatic indicators, shortness of breath and chest pain had the highest OR values.
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Table 25. Odds ratio and chi-square tests for psychological and somatic indicators in predicting any anxiety disorders among 
inpatients receiving care in psychiatric hospitals and units across Ontario, Newfoundland and Labrador, and Manitoba 
between 2005-2019 (n=237,862). 
Variable % (n) Unadjusted OR (95% CI) Chi-square test 
Anxious complaints 
Any Anxiety Disorder 





2.01 (1.97-2.06) χ2 (1) = 3,418.20  
p<.0001 
Unrealistic fears 
Any Anxiety Disorder 





1.47 (1.43-1.50) χ2 (1) = 834.42 
p<.0001 
Obsessive thoughts 
Any Anxiety Disorder 





1.36 (1.32-1.39) χ2 (1) = 491.87 
p<.0001 
Compulsive behavior 
Any Anxiety Disorder 





1.59 (1.53-1.66) χ2 (1) = 545.15 
p<.0001 
Intrusive thoughts 
Any Anxiety Disorder 





2.01 (1.95-2.07) χ2 (1) = 2,290.54 
p<.0001 
Episodes of panic  
Any Anxiety Disorder 





2.34 (2.27-2.41) χ2 (1) = 3,426.29 
p<.0001 
Health complaints 
Any Anxiety Disorder 





1.19 (1.16-1.22) χ2 (1) = 165.49 
p<.0001 
Sleep disturbance 
Any Anxiety Disorder 





1.30 (1.27-1.33) χ2 (1) = 497.45 
p<.0001 
Headaches 
Any Anxiety Disorder 





1.61 (1.57-1.67) χ2 (1) = 1,016.28 
p<.0001 
Dizziness 
Any Anxiety Disorder 









Variable % (n) Unadjusted OR (95% CI) Chi-square test 
Shortness of breath 
Any Anxiety Disorder 





1.55 (1.47-1.64) χ2 (1) = 249.90  
p<.0001 
Chest pain 
Any Anxiety Disorder 





1.74 (1.63-1.86) χ2 (1) = 280.02  
p<.0001 
Vomiting 
Any Anxiety Disorder 





1.45 (1.36-1.55) χ2 (1) = 130.31 
p<.0001 
Nausea  
Any Anxiety Disorder 





1.75 (1.68-1.82) χ2 (1) = 750.26 
p<.0001 
Fatigue/weakness 
Any Anxiety Disorder 





1.41 (1.37-1.45) χ2 (1) = 545.04 
p<.0001 
Impaired balance 
Any Anxiety Disorder 





0.84 (0.80-0.88) χ2 (1) = 45.73 
p<.0001 
Akathisia 
Any Anxiety Disorder 





1.03 (0.95-1.11) χ2 (1) = 0.41 
p=0.52 
Note. Percentages are row percentages for disorder by independent variable (e.g., % of those with any anxiety disorder who had the independent variable). 
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In Table 25, the only variable that was not higher among those with anxiety was impaired 
balance (OR=0.84). In terms of the clinical significance criterion of OR=1.50, the following 
variables were deemed inadequate: unrealistic fears (OR=1.47), obsessive thoughts (OR=1.36), 
health complaints (OR=1.19), sleep disturbance (OR=1.30), vomiting (OR=1.45), 
fatigue/weakness (OR=1.41), and akathisia (OR=1.03). In contrast to the bivariate analysis of 
primary anxiety disorders, two of the anxiety-specified indicators were considered insignificant 
in the any anxiety disorder group (unrealistic fears and obsessive thoughts).  
Variables were selected for the factor analytic stage if they met the significance criteria of 
OR=1.50 in either the primary anxiety or any anxiety groups. Based on that, the following 
variables were dropped from further analysis: health complaints, sleep disturbance, vomiting, 
fatigue/weakness, impaired balance, and akathisia. 
3.3.2 Exploratory factor analysis 
Prior to running factor analytic models, sample size requirements were addressed first. 
Guidelines for sample size in EFA are at least 300 participants, or a participant-to-item ratio of at 
least 3:1 (Worthington & Whittaker, 2006). The sample size for the psychiatric hospital dataset is 
N=237,862 individuals and 11 items were included for testing, which is a ratio of roughly 
21,623:1 participants-to-items. The Kaiser-Meyer-Olkin measure of sampling adequacy was also 
tested for the full 11-item model. A good value for sampling adequacy is above 0.80, but the 
0.75 estimate achieved in this sample is still considered sufficient (SAS, 2013). Since the sample 
size far exceeded the recommended guidelines, returned an appropriate Kaiser-Meyer-Olkin 
sampling adequacy estimate, and is representative of all adults admitted to psychiatric hospitals 
in Ontario, the sample was deemed appropriate for factor analysis.  
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The first exploratory model examined was a unidimensional test of the variables selected from the bivariate analyses. The 
correlation matrix is provided below in Table 26. A polychoric correlation matrix was also created for hierarchical and second-order 
factor models to account for the ordinal structure of variables, and those results are available by request. 
Table 26. Pearson’s correlation matrix of items entered in a unidimensional EFA for inpatients receiving care in psychiatric 
hospitals and units across Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 (n=237,862). 





Complaints 1.00 0.31 0.23 0.12 0.16 0.23 0.08 0.06 0.04 0.05 0.07 
Fears 0.31 1.00 0.42 0.20 0.28 0.32 0.04 0.07 0.04 0.05 0.03 
Obsessive 0.23 0.42 1.00 0.34 0.32 0.27 0.03 0.06 0.03 0.04 0.02 
Compulsive 0.12 0.20 0.34 1.00 0.20 0.19 0.01 0.02 0.02 0.02 0.01 
Intrusive 0.16 0.28 0.32 0.20 1.00 0.31 0.08 0.08 0.04 0.05 0.05 
Panic 0.23 0.32 0.27 0.19 0.31 1.00 0.08 0.10 0.08 0.08 0.07 
Headaches 0.08 0.04 0.03 0.01 0.08 0.08 1.00 0.29 0.14 0.15 0.26 
Dizziness 0.06 0.07 0.06 0.02 0.08 0.10 0.29 1.00 0.22 0.22 0.27 
Short breath 0.04 0.04 0.03 0.02 0.04 0.08 0.14 0.22 1.00 0.33 0.13 
Chest pain 0.05 0.05 0.04 0.02 0.05 0.08 0.15 0.22 0.33 1.00 0.15 
Nausea 0.07 0.03 0.02 0.01 0.05 0.07 0.26 0.27 0.13 0.15 1.00 
Note. Since response codes varies between mental state indicators (0-3) and health conditions (0-2), the correlation matrix is preferred to the covariance matrix.  
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The Cronbach’s alpha for the full 11-item correlation matrix in Table 26 was α=0.63. 
Given the minimum convention of α=0.70 (Schmitt, 1996), the 11-item scale does not have 
appropriate internal consistency reliability. The greatest inter-item correlation in Table 26 was 
observed between fears/phobias and obsessive thoughts (r=0.42). In general, items that were 
categorized as psychological symptoms of anxiety tended to be more highly correlated with one 
another, while the same was true for the somatic health items. The range of correlation values for 
psychological symptoms was r=0.12-0.42, while for somatic symptoms, it was r=0.13-0.33. 
Overall, the range of correlation values are small-to-medium in size (Cohen, 1988), though small 
correlations are not unusual in psychological assessment research (Hemphill, 2003).  
 
Figure 7. Scree plot of the number of factors in a unidimensional EFA of anxious symptoms 
for inpatients receiving care in psychiatric hospitals and units across Ontario, 




To determine how many factors to retain, the eigenvalues were consulted. The eigenvalue 
for the first factor was 1.66 and for the second, 0.91. Given that only one factor had an 
eigenvalue above 1.00, this supports a unidimensional model structure. However, the scree plot, 
illustrated in Figure 7, demonstrates potential for a second factor. Although the second factor 
does not have an eigenvalue above 1.00, the curve of the scree plot does not begin to break off 
until the third factor, suggesting that a second factor may account for a substantial amount of 
remaining measurement variance. 
Table 27. Factor loadings and final communality estimates for a unidimensional EFA of 
psychological and somatic symptoms for inpatients receiving care in psychiatric hospitals 
and units across Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 
(n=237,862). 
Psychological/Somatic Indicator Factor Loading Final Communality Estimate 
Anxious complaints 0.41 0.17 
Fears/phobias 0.59 0.35 
Obsessive thoughts 0.60 0.35 
Compulsive behaviours 0.37 0.14 
Intrusive thoughts/flashbacks 0.49 0.24 
Episodes of panic 0.52 0.27 
Headaches 0.19 0.04 
Dizziness 0.23 0.05 
Shortness of breath 0.17 0.03 
Chest pain/pressure 0.18 0.03 
Nausea 0.17 0.03 
Note. Unweighted least squares estimation method was used to derive factor loadings. 
The factor loadings and final communality estimates for the 11-item, unidimensional 
model are provided above in Table 27. The final total communality estimate was 1.70, with 
higher estimates among the psychological versus the somatic items. Since the somatic items had 
low factor loadings (<0.23), a unidimensional scale containing only the psychological items may 
be a better representation of the data. Regardless, since the scree plot suggested that there may be 
two factors, a set of two-factor EFA models were tested in addition to a unidimensional factor. 
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Three two-factor EFA models were run with different types of rotations: orthogonal 
varimax, oblique varimax, and oblique promax. The results of the orthogonal and oblique 
varimax solutions are presented below. Since the results of the oblique promax did not differ 
substantially from the oblique varimax they are not reported here; however, those results are 
available upon request.  
Table 28. Factor structure of a rotated orthogonal varimax with two factors representing 
psychological and somatic symptoms for inpatients receiving care in psychiatric hospitals 




Factor 1 (Psychological 
symptoms) 




Anxious complaints 0.40 0.09 0.16 
Fears/phobias 0.62 0.04 0.39 
Obsessive thoughts 0.66 0.00 0.43 
Compulsive behaviours 0.40 -0.01 0.16 
Intrusive 
thoughts/flashbacks 0.48 0.08 0.24 
Episodes of panic 0.50 0.13 0.26 
Headaches 0.05 0.46 0.21 
Dizziness 0.07 0.56 0.32 
Shortness of breath 0.04 0.42 0.18 
Chest pain/pressure 0.05 0.43 0.19 
Nausea 0.03 0.44 0.19 
Note. Unweighted least squares (ULS) estimation method with an orthogonal rotation. 
The orthogonal factor structure shows that psychological symptoms loaded highly onto 
the first factor, whereas somatic symptoms loaded highly onto the second factor. The Cronbach’s 
alpha for the psychological symptom subscale was α=0.68, while the coefficient for the somatic 
symptom subscale was α=0.58. Since the psychological symptom subscale approaches the 
Cronbach’s alpha minimum standard of 0.70 (Schmitt, 1996), this further supports a 
unidimensional model of psychological symptoms alone. The factor loadings for all items were 
above 0.40 on their respective factors and had cross-loadings < 0.13, indicating good construct 
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validity (O’Rourke & Hatcher, 2014). The final communality estimate was 2.76. The first factor 
explained 1.64 of the total variance (59%), whereas the second factor explained 1.12 (41%).  
Table 29. Factor structure of the rotated oblique varimax with two factors representing 
psychological and somatic symptoms for inpatients receiving care in psychiatric hospitals 




Factor 1 (Psychological 
symptoms) 




Anxious complaints 0.40 0.12 0.16 
Fears/phobias 0.62 0.09 0.39 
Obsessive thoughts 0.66 0.05 0.43 
Compulsive behaviours 0.40 0.02 0.16 
Intrusive 
thoughts/flashbacks 0.49 0.12 0.24 
Episodes of panic 0.51 0.17 0.26 
Headaches 0.08 0.46 0.21 
Dizziness 0.10 0.57 0.32 
Shortness of breath 0.06 0.42 0.18 
Chest pain/pressure 0.08 0.44 0.19 
Nausea 0.06 0.44 0.19 
Note. Priors estimated using SMC. Factor loadings based on the rotated correlation matrix. 
Like the orthogonal varimax factor structure, the oblique varimax clearly separated 
psychological symptoms (Factor 1) from somatic symptoms (Factor 2). Primary factor loadings 
were above 0.40 for all items and cross-loadings were < 0.17, indicating good construct validity. 
The final total communality estimate was 2.76. The first factor explained 1.67 of that variance 
(60%) and the second factor explained 1.17 (40%). The inter-factor correlation between the 
psychological and somatic factors was 0.14, which is a small correlation (Cohen, 1988).  
After reviewing the EFA models, it was hypothesized that a unidimensional factor 
comprised only of psychological items would provide the best model fit for the data. Given that 
the factor loadings for all psychological items were at least 0.40 across all models, except for 
compulsive behaviour in the unidimensional EFA with all items (0.37), all items were retained 
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for the CFA phase. Similarly, for alternative CFA models containing somatic items, all items 
were retained from the EFA.  
3.3.3 Confirmatory factor analysis 
To test the theory that a unidimensional factor of psychological items would provide the best 
model fit, the following CFA models were conducted: unidimensional (psychological items 
only), unidimensional (all items), uncorrelated factors, and correlated factors. To be consistent 
with CFA models tested on other anxiety scales in the literature review, higher order and bifactor 
models were also examined. Since the results of these models did not provide substantial 
contributions to the anxiety scale in this study, the data for them are available on request. 
Beginning with the unidimensional model containing only psychological symptoms, the 




Figure 8. Unidimensional CFA with least-squares maximum likelihood estimation of 
psychological symptoms for inpatients receiving care in psychiatric hospitals and units 
across Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 
(n=237,862). 
The unstandardized factor loadings are provided on the pathways leading from the latent 
anxiety factor to the measured items, while the error variance is written below the measured 
items. By standardizing the estimates - accomplished by subtracting each individual score on a 
variable from the mean score and then dividing by the standard deviation - the scaling of each 
item becomes comparable, and the covariance matrix is transformed into the correlation matrix. 
As a result, the factor loadings represent the degree of correlation between the measured item 
and the latent factor. The standardized factor loadings and the corresponding proportion of 
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variance accounted for by the latent factor for each variable are as follows: anxious complaints 
(0.41, 17%), fears/phobias (0.63, 39%), obsessive thoughts (0.65, 42%), compulsive behaviour 
(0.41, 17%), intrusive thoughts/flashbacks (0.49, 24%), and episodes of panic (0.50, 25%).  
Model fit statistics are also displayed in Figure 8. The chi-square value is statistically 
significant (χ2=12,073.60, p<.0001), indicating that the expected covariance matrix deviates from 
the observed matrix. However, because the sample size is large (n=237,862), it is possible that 
statistical significance is the result of a Type 1 error and that all models tested will return a p-
value less than 0.0001. The CFI value exceeds the convention of 0.90 (CFI=0.94), though the 




Figure 9. Unstandardized unidimensional factor model containing psychological and 
somatic symptoms for inpatients receiving care in psychiatric hospitals and units across 
Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 (n=237,862). 
The unidimensional model containing psychological and somatic items is presented 
above in Figure 9. The standardized factor loadings and proportion of variance explained for 
each variable are: anxious complaints (0.41, 17%), fears/phobias (0.62, 38%), obsessive thoughts 
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(0.63, 39%), compulsive behaviours (0.39, 15%), intrusive thoughts/flashbacks (0.49, 24%), 
episodes of panic (0.51, 26%), headaches (0.14, 2%), dizziness (0.18, 3%), shortness of breath  
(0.12, 2%), chest pain/pressure (0.14, 2%), and nausea (0.12, 2%). The model fit statistics are 
inadequate for this model. The chi-square test is once again significant (χ2=107,434.00, 
p<.0001). The CFI is 0.64 and the RMSEA is 0.10, both of which fail to meet conventional 




Figure 10. Unstandardized correlated factors model with psychological and somatic factors 
for inpatients receiving care in psychiatric hospitals and units across Ontario, 
Newfoundland and Labrador, and Manitoba between 2005-2019 (n=237,862). 
As shown above in Figure 10, the correlated factors model separates psychological from 
somatic items while allowing the two latent factors to share a correlation (r=.19). The 
standardized factor loadings and proportion of variance explained for the psychological items 
were as follows: anxious complaints (0.41, 17%), fears/phobias (0.63, 39%), obsessive thoughts 
(0.65, 42%), compulsive behaviours (0.40, 16%), intrusive thoughts/flashbacks (0.49, 24%), 
episodes of panic (0.50, 26%). For somatic items, the same metrics were as follows: headaches 
(0.47, 22%), dizziness (0.58, 33%), shortness of breath (0.42, 17%), chest pain/pressure (0.43, 
18%), and nausea (0.44, 19%). Like previous models, the chi-square test of the correlated models 
is significant (χ2=28,111.05, p<.0001). The CFI=0.90 and the RMSEA=0.05, which are the 
conventional standards for acceptability.  
An uncorrelated factors model was also tested, which yielded similar factor loadings to 
those obtained in the correlated factors model. In terms of fit statistics, the CFI=0.89 and the 
RMSEA=0.06, which is slightly less optimal than the correlated factors model. 
Table 30. Model fit statistics for competing CFA models containing psychological and/or 
somatic symptoms for inpatients receiving care in psychiatric hospitals and units across 
Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 (n=237,862). 








0.64 0.10 107,480.0 107,718.72 
Uncorrelated factors 0.89 0.06 31,911.53 32,139.88 
Correlated factors  0.90 0.05 28,157.05 28,395.78 
Note. For the CFI, values > 0.90 are better. For the RMSEA, values < 0.06 are better. For the AIC and BIC, lower 
values are better. Values that are in bold are the best compared to other models. 
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Comparing the model fit statistics in Table 30, the unidimensional model containing only 
psychological items provided the best overall fit for the data. Given that the results from the EFA 
initially supported a unidimensional model of psychological items, this was selected as the best 
model candidate for further testing. 
3.3.4 Item response theory  
After reviewing the results from the EFA and CFA, a unidimensional model of psychological 
items was the best candidate. To further investigate how each item functioned as part of the 
overall scale, descriptive IRT analysis was performed. Since a one-factor model was being 




Figure 11. Item characteristic curves for psychological symptoms of anxiety for inpatients 
receiving care in psychiatric hospitals and units across Ontario, Newfoundland and 
Labrador, and Manitoba between 2005-2019 (n=237,862).  
The ICCs for psychological symptoms of anxiety are illustrated above in Figure 11, with 
‘x’ denoting the item difficulty parameter. Difficulty parameters are given at the top of the chart 
for each item and range from x=-0.04 to x=2.15, which falls within the conventional range of -
3.0 to 3.0 (Toland, 2013). Anxious complaints were the easiest item to endorse, with a 50% 
probability of having the symptom at the mean level of the anxiety trait. This finding 
corresponds to the relatively high frequency of anxious complaints found in the bivariate 
analysis, which were common even among those without an anxiety disorder. Conversely, the 
most difficult item was compulsive behaviour, which had a 50% chance of occurring at 2 SDs 
above the mean level of anxiety. Compulsive behaviour was also the rarest symptom observed in 
the bivariate analysis. Fears/phobias and obsessive thoughts had a difficulty level of around 1 SD 
above the mean, while intrusive thoughts and episodes of panic were around 1.5 SDs, 
representing intermediate difficulty. These results are similar to those obtained from the CFA, 
where the lowest factor loadings belonged to compulsive behaviour and anxious complaints. 
In addition to difficulty estimates, the slope parameters for each item are as follows: 
anxious complaints (1.09), fears/phobias (2.23), obsessive thoughts (2.30), compulsive behaviour 
(1.68), intrusive thoughts (1.67), and episodes of panic (1.78). The values of all items are within 
the common range of 0.5 to 3.0 (Baker, 2001; Toland, 2013), indicating that none of the items 
are problematic or should be deleted to enhance discrimination (SAS, 2019). The items with the 
steepest slopes were fears/phobias and obsessive thoughts, meaning that they are better at 
differentiating between different levels of the underlying anxiety trait. The item with the lowest 
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slope parameter was anxious complaints, suggesting it shares the weakest association with latent 
anxiety.  
 
Figure 12. Test information curve for psychological symptoms of anxiety for inpatients 
receiving care in psychiatric hospitals and units across Ontario, Newfoundland and 
Labrador, and Manitoba between 2005-2019 (n=237,862). 
The test information curve for the scale as a whole is presented in Figure 12. The results 
of this curve indicate that the anxiety scale is skewed towards discriminating those with a higher 
level of the anxiety trait and does not function as well at identifying those with average or lower 
levels of anxiety. For use in a clinical population, a narrow TIC on the right-hand side of the 
distribution is an appropriate reflection of its intended purpose. 

















3.3.5 Latent class analysis  
Since the IRT analysis revealed that discrimination and difficulty parameters varied across the 
six psychological indicators of anxiety, they were entered into an LCA analysis to investigate 
how they might be organized to form distinct classes of anxiety subgroups. As explained in the 
methods section, a different derivation sample was used only to arrive at class solutions for 
anxiety symptoms, not to test the resulting scale. The number of latent classes to be tested was 
set at 1-8, and for each model, 100 iterations were run to obtain the best likelihood ratio estimate. 
Model fit statistics for the number of classes are plotted below in Figure 13.  
 
Figure 13. AIC, BIC, and a-BIC values for each of 1-7 latent classes containing 
psychological symptoms of anxiety for inpatients receiving care in psychiatric hospitals and 
units across Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 
(n=190,034). 
 A visual inspection of Figure 13, which operates similarly to a scree plot in factor 
analysis, revealed that fit statistics were noticeably smaller for 4 classes compared to 3, without 
substantial improvement afterwards. Therefore, the optimal number of latent classes for the 
dataset was 4 and so this number was selected for the remaining LCA tests. The latent class and 

























Figure 14. Latent class and item-response probabilities for the observed frequency of psychological symptoms of anxiety 
across four latent classes for inpatients receiving care in psychiatric hospitals and units across Ontario, Newfoundland and 
Labrador, and Manitoba between 2005-2019 (n=190,034).
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Overall, the pattern of symptom probabilities – irrespective of their frequency – was the 
same across all classes. For instance, anxious complaints always had the highest probability of 
being present while compulsive behaviour had the lowest, which is consistent with the results 
from the bivariate and IRT analyses. Since classes were not formulated based on combinations of 
different symptoms, this suggests that an anxiety scale is applicable across diagnostic subtypes. 
Instead, the primary difference detected by the item-response probabilities across classes was 
related to symptom frequency. Beginning with class 4 (none) – the most prevalent latent class – 
this group appeared to be characterized by an absence of most anxiety symptoms. The exception 
was repetitive anxious complaints, which still occurred 38% of the time, suggesting an 
alternative class where no anxiety symptoms are present aside from complaints. The class with 
the second highest prevalence was class 1 (moderate). The characterizing pattern for this class 
was a symptom frequency of 1-2 days during the 3-day observation period. The third most 
prevalent was class 2 (severe), with a higher probability of symptoms occurring daily relative to 
other groups. Lastly, class 3 (mild) had the lowest prevalence, with symptoms present but not 
exhibited during the period of observation. Altogether, these results suggest that an alternative 
anxiety scale is a class-based structure corresponding to severity levels. 
3.3.6 Decision tree models 
Based on the results of the factor analysis, it was decided that three types of additive scales 
would be input into the decision tree dataset as predictor variables, each with two versions: one 
where variables in the scale were kept in their original ordinal format and one where variables 
were collapsed into binary ‘present/absent’ categories. One type of scale was a combination of 
the six psychological indicators of anxiety, which was the best candidate model in the factor 
analysis. Another scale containing only the five somatic indicators was also entered, to determine 
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if certain combinations of psychological and somatic indicators were related to anxiety 
diagnoses. The final type of scale was a combination of both psychological and somatic 
indicators. The remaining predictor variables in the decision tree dataset were the individual 





Figure 15. Interactive decision tree model predicting primary diagnoses of anxiety for inpatients receiving care in psychiatric 
hospitals and units across Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 (n=237,862). 
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The first target variable that was tested was a primary diagnosis of anxiety. The 
interactive-designed algorithm is depicted in Figure 15, and the automatic decision tree 
generated by the SAS program is available upon request. The most important variable in 
predicting primary anxiety disorders was the continuous anxiety scale consisting of 
psychological indicators. A four-way split on the scale was chosen, corresponding with scores of 
0, 1-2, 3-6, and 7-18. Since the ‘0’ score category contained a small percentage of those with a 
primary anxiety disorder (1.9% of the validation sample), no further splits were chosen. For the 
remaining nodes, the next most important variable was intrusive thoughts/flashbacks. Beyond 
that, three more variables appeared as important branching points: obsessive thoughts, episodes 
of panic, and - in one instance - headaches. Where intrusive thoughts/flashbacks occurred less 
often, greater frequency of episodes of panic led to an increase in primary anxiety disorders, 
probably reflecting panic disorder. Similarly, the proportion of primary anxiety disorders were 
greater when intrusive thoughts/flashbacks were present without any obsessive thoughts, likely 
differentiating PTSD.  
In most cases, the training and validation percentages were similar to each other, 
indicating a stable algorithm. A notable exception is node 29, where the training percentage was 
20.3% and the validation was 9.1%. The range of validation percentages for predicting primary 
anxiety disorders was between 1.9% to 14.8%. This means that in the lowest scoring branch, as 
few as 1.9% of the subsample still had a primary anxiety diagnosis, whereas in the higher scoring 
branches, as many as 14.8% of the subsample had the diagnosis. Considering the primary anxiety 
disorder prevalence was 4.0%, the scale demonstrates a good ability to differentiate between 




Figure 16. Interactive decision tree algorithm predicting any diagnosis of anxiety for inpatients receiving care in psychiatric 
hospitals and units across Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 (n=237,862).
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The second target variable was any diagnosis of anxiety. The interactive-designed model 
is presented above in Figure 16. The automatic decision tree generated by the SAS program is 
available upon request. Once again, the most important variable was the continuous anxiety scale 
of psychological indicators, which was split into four categories: 0, 1-3, 4-8, and 9+. Intrusive 
thoughts/flashbacks and episodes of panic once again appeared as important branching points, 
but unlike the algorithm for primary anxiety disorders, the following variables were also 
included: anxious complaints, a continuous scale of binary somatic symptoms, and the combined 
continuous scale of binary somatic and psychological symptoms. The binary somatic scale was 
selected as a branching point for those who scored at the extreme ends of the psychological scale 
(0 or 9+). In both cases, the presence of somatic symptoms was associated with more diagnoses 
of anxiety. For those who scored between 1-3 on the psychological scale, the next branching 
point was intrusive thoughts/flashbacks, with each increase in frequency associated with more 
anxiety disorders. If there were no intrusive/thoughts flashbacks present, the next branch was the 
combined total binary scale, with higher scores demonstrating more diagnoses of anxiety. In this 
case, the presence of somatic symptoms - in addition to some psychological symptoms (not 
intrusive thoughts/flashbacks) - contributed to greater numbers of anxiety disorders.  
Finally, among those with a score of 4-8 on the psychological scale, episodes of panic 
constituted the next branching point. If those were not present, then increasing frequency of 
intrusive thoughts/flashbacks demonstrated an increase in anxiety disorders, potentially pointing 
to PTSD. If episodes of panic were present, greater frequency of anxious complaints led to 
greater numbers of anxiety disorders. Altogether, this algorithm demonstrates that somatic 
symptoms are positively associated with anxiety disorders and reiterates the relative importance 
of intrusive thoughts/flashbacks and episodes of panic.   
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The training and validation percentages were generally similar to one another across 
nodes. The two nodes with a disparity between training and validation percentages greater than 
2% were 40 and 41. Node 41 had the biggest difference of approximately 7%, demonstrating that 
the algorithm is stable overall. The range of validation percentages across nodes was between 
8.3% and 31.5%, with 14.5% of the total sample having any anxiety disorder. Unlike the tree for 
primary anxiety disorders, the subsample with the lowest percentage of anxiety disorders was not 
close to 0. This demonstrates that even after ruling out a variety of psychological and somatic 
symptoms, there were still several individuals who had been diagnosed with an anxiety disorder, 
suggesting that some important indicators of anxiety may be missing. On the other end of the 
spectrum, the highest validation percentage was double that of the total sample prevalence, 
indicating that the algorithm can predict the presence of anxiety disorders fairly well. 
3.3.7 Final anxiety scale derivation 
After performing factor analysis, IRT, LCA, and decision tree modeling, various types of anxiety 
scales were constructed. Based on the results of the factor analysis, the first option was a 
continuous, additive scale containing psychological indicators. Since previous analyses revealed 
that compulsive behaviour was a rare and specific symptom – and OCD is no longer considered 
an anxiety disorder - two versions of the continuous scale were tested: one with all six 
psychological indicators, and one with five indicators where compulsive behaviour was 
removed. The Cronbach’s alpha of the 5-item scale was α=0.67, similar to α=0.68 for the 6-item 
scale. The second option was created using results from the IRT and LCA, which pointed to a 
class-based scale in which the six psychological symptoms were grouped together based on their 
frequency of occurrence. The final four anxiety scale options represented the various decision 
tree algorithms that were generated. 
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The continuous, additive scale of psychological symptoms was a straightforward sum of 
each indicator. Since each indicator could be scored from 0-3, the range on the 6-item scale was 
0-18, and 0-15 for the 5-item scale. The class-based scale was more complicated to construct and 
is depicted below in Figure 17. 
  
Figure 17. Flowchart representing the coding process of the class-based anxiety scale for 
inpatients receiving care in psychiatric hospitals and units across Ontario, Newfoundland 
and Labrador, and Manitoba between 2005-2019 (n=237,862). 
As can be seen in Figure 17, a true 0 class was created, wherein an individual had no 
psychological symptoms of anxiety present. In addition, class 1 was created as a near-0 option, 
where the only psychological symptom present was anxious complaints. Since the bivariate, IRT, 
and LCA tests all demonstrated that anxious complaints were a pervasive symptom across the 
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whole sample, it was reasonable to differentiate this group from a ‘true 0’ group. The next step 
was to determine whether or not at least two psychological symptoms occurred on a daily basis. 
If ‘yes,’ they were grouped into class 4, representing the most severe anxious class. If ‘no,’ the 
next decision point was whether at least one symptom occurred on a daily basis, or if at least two 
occurred on 1-2 of the last 3 days. If ‘yes’, they were placed into class 3, the moderate anxiety 
group. If ‘no,’ they were automatically grouped into class 2, which is a mild anxiety group. An 
alternative version of the scale was tested, wherein the symptom frequency cutpoints for 
determining class membership were increased by one (e.g., at least three daily symptoms instead 
of two for class 4). Since few differences were observed in logistic models between the two 
versions, the more lenient class structure was retained.  
To create a scale from the decision tree models, nodes were grouped into categories 
based on the percentage of anxiety disorders in the training sample. The variable width bar chart 
was used as a visual guide to aid in the grouping process, which is a bar chart that organizes 
nodes by the training sample percentage of anxiety disorders. Nodes with similar percentages 
were grouped together, generally remaining within a range of 5%. For both interactive decision 
tree models, as well as the automatic model predicting primary disorders, there were four 
categories. The automatic model predicting any anxiety disorder contained six categories. Table 




Table 31. Categorical classes created for the interactive decision tree models predicting 
primary and any anxiety disorders among inpatients receiving care in psychiatric hospitals 
and units across Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 
(n=237,862).  
Primary anxiety disorders 
Node IDs (training sample % range) 
Any anxiety disorders 
Node IDs (training sample % range) 
14, 55, 57, 60 (2-4) 35, 36, 52 (8-13) 
31, 56, 58, 59, 64, 84 (6-10) 37, 39, 53, 54, 57, 60 (15-20) 
27, 65, 75, 85 (11-15) 40, 58, 59, 61, 63 (21-27) 
28, 29 (20-29)* 41, 62, 64 (31-34) 
Note. * indicates that the nodes in this group shared a large discrepancy between training and validation sample 
percentages as well as small sample sizes, indicating an unstable group.  
The exact categorization of nodes for the automatic decision tree models are available 
upon request. For nodes that had a difference greater than 5% between the training and validation 
samples, additional versions of the scale were tested that excluded them. No statistical 
differences in the c-statistics for the logistic models were found between scales with and without 
the unstable nodes, so the versions where they are included are reported below.  
Table 32. Binary logistic regression models for five anxiety scales predicting primary and 
any anxiety disorders for inpatients receiving care in psychiatric hospitals and units across 
Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 (n=237,862). 
Scale Version 
Primary anxiety disorder 
(n=9,582) 
Any anxiety disorder (n=34,565) 
OR (95% CI) C stat OR (95% CI) C stat 
Additive, continuous 
scale of six 
psychological indicators 
(0-18) 




scale of five 
psychological indicators 
(0-15) 
1.16 (1.15-1.16) 0.66 1.12 (1.12-1.12) 0.61 
Class-based scale of six 
psychological indicators 
(5 classes) 
1.45 (1.43-1.47) 0.65 1.29 (1.28-1.30) 0.61 
Interactive decision tree 
model (4 classes) 
2.20 (2.14-2.26) 0.63 1.69 (1.67-1.71) 0.62 
Automatic decision tree 
model (4 classes) 
2.61 (2.53-2.69) 0.63 1.47 (1.46-1.49) 0.63 




Table 33. Binary logistic regression models for five anxiety scales predicting primary and 
any anxiety disorders for individuals receiving community mental health care in Ontario 
(2005-2006), Chatham-Kent and Bluewater Health (2017-2019), and Newfoundland and 
Labrador (2012-2014) (n=7,386). 
Scale Version 
Primary anxiety disorder 
(n=535) 
Any anxiety disorder (n=1,888) 
OR (95% CI) C stat OR (95% CI) C stat 
Additive, continuous 
scale of six 
psychological indicators 
(0-18) 




scale of five 
psychological indicators 
(0-5) 
1.17 (1.14-1.19) 0.70 1.18 (1.16-1.19) 0.70 
Class-based scale of six 
psychological indicators 
(5 classes) 
1.70 (1.59-1.83) 0.69 1.63 (1.57-1.70) 0.69 
Interactive decision tree 
model (4 classes) 
2.45 (2.19-2.74) 0.70 1.78 (1.69-1.87) 0.68 
Note. 157 cases were missing data for one of the psychological indicators needed to construct the anxiety scale. 
Missing data was evenly distributed across indicators, location, and time of assessment, so they were deleted from 
the analysis. Regression coefficients for all anxiety scale versions are statistically significant  at p<.0001. 
As observed in Tables 32 and 33, the c-statistics were similar across scale variations. 
Both of the additive, continuous scales with psychological indicators produced the best c-
statistics for predicting primary anxiety disorders in the inpatient sample and were tied with the 
interactive decision tree model in the community sample. The continuous scales also had the 
highest c-statistics for predicting any anxiety disorder in the community sample. Since none of 
the alternate anxiety scale models had considerably better fit statistics than the five-item additive, 
continuous scale, this version was chosen as the best candidate due to its simplicity. As an 
additional check, even though the ESP assessment only contains four anxiety indicators, they 
were added together to create a shorter version of the continuous anxiety scale (0-12). The ESP 
anxiety scale was significantly predictive of both primary anxiety disorders (OR=1.25, 95% 
CI=1.20-1.30, c=0.63) and any anxiety disorder (OR=1.27, 95% CI=1.23-1.32, c=0.63), 
suggesting the scale still functions in the expected direction.  
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The ROC curve and area under the curve (AUC) statistic for predicting primary anxiety 
disorders using the final anxiety scale in the inpatient sample is displayed below in Figure 18. 
 
Figure 18. ROC curve of the anxiety scale in predicting primary anxiety disorders for 
inpatients receiving care in psychiatric hospitals and units across Ontario, Newfoundland 
and Labrador, and Manitoba between 2005-2019 (n=237,862). 
The area under the curve (AUC) is 0.66, indicating that there is a 66% chance that the 
anxiety scale can identify who has an anxiety disorder and who does not. The ROC curve also 
shows that the false positive rate (1-specificity) increases gradually with the true positive rate 
(sensitivity). Considering that in the bivariate analyses, some anxious symptoms still occurred 
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The distribution of anxiety scale scores across the inpatient sample are displayed below 
in Figure 19. 
 
Figure 19. Distribution of anxiety scale scores across various quantiles for inpatients 
receiving care in psychiatric hospitals and units across Ontario, Newfoundland and 
Labrador, and Manitoba between 2005-2019 (n=237,862). 
The median score (50% quantile) on the anxiety scale was 2.0, indicating low levels of 
anxiety on average across the sample. There was a gradual increase in anxiety symptoms until 
the 90th quantile, where steeper increases were seen for the most severe 10% of the sample. At 
the most extreme end, the maximum score of 15 on the scale was rare, considering that the 99% 
quantile contained a score of 12. Overall, Figure 19 illustrates that the distribution of scores on 























Figure 20. Mean and the 95% confidence limit for means (CLM) of anxiety scale scores 
across various anxiety disorder subtypes for inpatients receiving care in psychiatric 
hospitals and units across Ontario, Newfoundland and Labrador, and Manitoba between 
2005-2019 (n=237,862). 
In addition to investigating the distribution across the whole sample, mean anxiety scale 
scores were also calculated for anxiety disorder subtypes, as illustrated above in Figure 20. It is 
important to note that across disorders, only one indicator at most corresponded directly with 
diagnostic criteria, meaning that scores above three involve symptoms that are not specific to the 
disorder. The highest average score was observed for panic disorders, followed by OCD. Among 
all the anxiety disorders, mean scores were >3.0, indicating that scores were not influenced 
solely by diagnostic relevancy of indicators. Lastly, in all cases, anxiety scale scores were higher 
























3.3.8 Criterion validity  
The first set of tests with the new anxiety scale were comparisons of mean scores across two 
types of demographic characteristics. Sex (male and female) and age (18-25, 26-30, 31-64, and 
65+) were initially compared using a t-test and ANOVA, respectively. However, while the 
results were statistically significant (p<.0001), due to the non-normal distribution of the anxiety 
scale, these tests were deemed inappropriate. Instead, to permit a more effective comparison of 
anxiety levels, the scale was collapsed into four classes based on a combination of the splits 
chosen in the interactive decision tree for primary anxiety disorders and the distribution of 
anxiety scale scores. The cut-points selected for the anxiety scale were: 0 (none), 1-3 (mild), 4-6 
(mild-moderate), and 7-18 (moderate-severe). The results of the comparisons across age and sex 
are displayed below. 
 
Figure 21. Percentage of individuals in the 18-25, 26-30, 31-64, and 65+ age groups for each 
severity category of the anxiety scale in psychiatric hospitals and units across Ontario, 





























Figure 21 illustrates a significant difference in anxiety scores across age groups 
(χ2=270.3, p<.0001), with a slight decline in severity with older age. After reviewing the degree 
to which each cell contributed to the chi-square value, it was evident that the 65+ age group was 
the most irregular group, especially at the level of 0 anxiety symptoms. 
 
Figure 22. Percentage of men and women represented in each severity category of the 
anxiety scale in psychiatric hospitals and units across Ontario, Newfoundland and 





























Figure 23. Percentage of men and women with any anxiety disorder represented in each 
severity category in psychiatric hospitals and units across Ontario, Newfoundland and 
Labrador, and Manitoba between 2005-2019 (n=237,862). 
Beginning with Figure 22, there was a significant difference in the distribution of anxiety 
scores between men and women (χ2=2,918.7, p<.0001), with more women represented in the 
higher severity groups. To determine if anxiety scale severity scores shared a similar pattern with 
anxiety disorder diagnoses between men and women, a three-way chi-square test was conducted, 
as seen in Figure 23. At each severity level of the anxiety scale, there were significantly more 
women with an anxiety disorder diagnosis than men (p<.0001), indicating that men who are 
diagnosed with anxiety disorders exhibit fewer symptoms.  
The next set of tests focused on investigating concurrent validity indicators other than 
anxiety diagnoses, which were already examined as part of the scale derivation process. In 
addition to the Traumatic Life Events CAP, sleep disturbance - a binary-coded variable that was 
























indicator given its presence in other anxiety scales. In a binary logistic regression model, the 
anxiety scale significantly predicted problems with sleep disturbance (OR=1.16, 95% CI=1.16-
1.16, c=0.62). A proportional-odds ordinal logistic regression model also showed that the anxiety 
scale was a significant predictor of triggering the traumatic life events CAP (OR=1.12, 95% 
CI=1.12-1.13, c=0.60), supporting the concurrent validity of the scale. 
Discriminant validity from depression was also tested to determine criterion validity of 
the anxiety scale. Similar to the logistic regression models for primary and any anxiety disorders, 
the anxiety scale was entered as the sole predictor of primary and any mood disorders. While the 
anxiety scale was a significant predictor of both primary mood disorders (OR=1.01, 95% 
CI=1.00-1.01, c=0.52) and any mood disorder (OR=1.02, 95% CI=1.02-1.02, c=0.53), c-
statistics of 0.50 indicate that the scale is not substantially better at identifying mood disorders 
than random chance (Peng et al., 2002; Sperandei, 2014). Further, the ORs and c-statistics were 
greater for anxiety disorders than mood disorders, providing evidence of discriminant validity. 
Similarly, the correlation between the anxiety scale and the Depressive Severity Index (DSI) was 
significant (r=0.37, p<.0001), but the size of the correlation was moderate. In contrast, there was 
a strong correlation between the interRAI Depression Rating Scale (DRS) and the anxiety scale 
(r=0.66, p<.0001). However, the DRS contains two of the same indicators included in the 
anxiety scale (anxious complaints and fears/phobias), and so the correlation is artificially 
inflated. Overall, the results of the discriminant validity tests demonstrate that the anxiety scale 
can adequately distinguish between anxiety and depression.  
3.3.9 Responsiveness 
The last test that was performed with the anxiety scale was assessing its responsiveness through 
change scores between admission and discharge. To calculate a change score, an anxiety scale at 
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the time of discharge was first created using the variables from the discharge assessment, then 
subtracted from the anxiety scale at admission. During this step, it was discovered that n=8,444 
cases were missing anxiety indicators in the discharge assessment, all of which occurred during 
the early implementation years between 2005-2009. Since the missing cases were not 
systematically related to other factors (e.g., age, geographic location, etc.,) missing data was 
deleted from the change score analyses. The quantile distribution of change scores is presented 
below in Figure 24, with positive scores indicating improvement in anxiety over time, and 
negative scores indicating worsening of symptoms over time. 
 
Figure 24. Quantile distribution of change scores in the anxiety scale between admission 
and discharge among those with a score >0 at admission, in psychiatric hospitals and units 
across Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 
(n=229,418). 
For those who had an anxiety scale score greater than zero at admission, the mean change 
was 2.4 points, indicating that anxiety symptoms generally improve over time. As illustrated in 




















symptoms between admission and discharge, with fewer than 10% experiencing worsening 
symptoms. To establish the power of the anxiety scale to detect change, the SMR and effect sizes 
were calculated. The SMR=0.78 and ES=0.79, indicating a strong power to detect change (Kazis 
et al., 1989). Since the scale is continuous, the correlation was also calculated between the 
admission anxiety scale and the change scores. The scatterplot is presented below in Figure 25. 
 
Figure 25. Scatterplot of the anxiety scale score at admission on the x-axis and change in 
anxiety scale scores between admission and discharge on the y-axis for inpatients receiving 
care in psychiatric hospitals and units across Ontario, Newfoundland and Labrador, and 
Manitoba between 2005-2019 (n=229,418). 
There was a strong, positive correlation (r=0.73) between the admission and change 
scores, further illustrating that the anxiety scale is able to detect changes of varying magnitudes 
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categories between admission and discharge was also assessed. The results are shown below in 
Figures 26 and 27. 
 
Figure 26. Movement between anxiety scale severity categories at admission and discharge 
for inpatients receiving care in psychiatric hospitals and units across Ontario, 

















































Figure 27. Alternate version of movement between anxiety scale severity categories 
between admission and discharge, where the ‘severe’ category has been divided into two 
groups, for inpatients receiving care in psychiatric hospitals and units across Ontario, 
Newfoundland and Labrador, and Manitoba between 2005-2019 (n=229,418). 
As seen in Figure 26, over 80% of those who had no anxiety symptoms at admission still 
had no symptoms at discharge. This means that 13% of individuals admitted with no anxious 
symptoms developed mild anxiety over the course of their stay. For those with mild anxiety at 
the time of admission, approximately half moved into the ‘none’ category at discharge. Over 
70% of those with moderate anxiety at admission had either mild or no anxiety by discharge, 
while almost 80% of those with severe anxiety moved into one of the lower severity categories at 
discharge. The remaining 20% still had severe anxiety by the time they were discharged, 
representing a concerning outcome. To determine whether lack of improvement among the 20% 
subgroup in the severe category was being masked by a wide range of scores, an alternate 
















































(7-11) and severe (12-15). In the moderate-severe group, 17% of individuals were still in the 
same category by discharge, indicating minimal difference from the previous categorization. 
This finding was replicated in the most severe category, where even though 12% dropped down 
to the moderate-severe category, 14% were still considered severe at the end of their stay. 
Altogether, Figures 26-27 illustrate that increasing levels of anxiety severity at admission 
demonstrate greater improvement by discharge, though poor outcomes occurred as well.  
3.4 Discussion 
3.4.1 Summary and implications of results 
After identifying gaps in mental health care for individuals with anxiety disorders in chapter two 
of this dissertation, as well as the absence of an anxiety scale in the interRAI health assessment 
instruments, the goal of this chapter was to construct an anxiety scale that could be used to 
inform measurement-based care planning and policy research. As a starting point, two of the 
most popular general anxiety scales – the HARS (Hamilton, 1959) and BAI (Beck et al., 1988) – 
were examined to establish conventional psychometric properties and guide item selection. 
Based on this review, it was hypothesized that a two-factor scale containing psychological and 
somatic indicators of anxiety would be the optimal structure for the anxiety scale. However, this 
hypothesis turned out to be incorrect after multiple statistical analyses supported a continuous 
scale with five psychological indicators as the best candidate. This initial version offers insight 
into individual symptoms form together to represent anxiety, showing that an anxiety scale 
within the interRAI instruments is possible. 
To arrive at the final anxiety scale, multiple statistical procedures were conducted, 
providing substantial insight into item performance. First, bivariate analyses were performed on 
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the initial set of variables selected, revealing their prevalence across the inpatient sample and 
association with anxiety disorders. After narrowing down to the final item pool, relationships 
among selected items were tested using EFA and CFA, which suggested that the optimal model 
structure for the data was a single scale consisting of only psychological anxiety indicators. 
While somatic items did constitute a separate second factor, factor loadings were small and the 
somatic factor did not result in better model fit, and so a unidimensional scale of psychological 
indicators was preferred. Following the factor analyses, IRT and LCA were used to investigate 
individual performance of the psychological indicators and determine whether a class-based 
scale structure was viable. The results indicated that frequency of symptoms was the 
distinguishing feature of anxiety subclasses, leading to a five-class scale based on anxious 
symptom severity. During this process, it was discovered that compulsive behaviour did not 
perform well as a general indicator of anxiety, and so a five-item version of the continuous scale 
from the factor analyses was created that excluded this item. Finally, decision tree models were 
created in the event that complex interactions needed to be represented in the scale, including 
somatic items once again. The continuous scale of psychological indicators was consistently 
identified as the most important variable for predicting anxiety disorders, though pathways 
emerged that reflected the unique influence of panic disorders and PTSD. By the end of all these 
analyses, five scale candidates were created: two continuous and three categorical. To decide 
which scale would be the chosen one, each was entered into separate logistic regression models 
predicting primary and any anxiety disorders. Model fit statistics were comparable across the 
various scale structures, and so the 5-item continuous scale was selected as the final model since 
it best represented the underlying data and was also the most parsimonious.  
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After deciding on the final structure for the anxiety scale, a series of criterion validity and 
responsiveness tests were performed to better establish its psychometric properties. The first 
criterion test was technically performed during the scale derivation process, where predictive 
validity of the scale was examined in relation to anxiety diagnoses. The scale generally produced 
adequate fit statistics in all three health care settings examined, except for predicting any anxiety 
disorder in the inpatient and ED datasets, both of which had c-statistics in the lower .60 range. 
Predictive validity for any anxiety disorder diagnosis could potentially be enhanced by adding 
new variables to the scale, which can be addressed in future research. Further evidence for 
criterion validity of the scale was obtained using concurrent indicators associated with anxiety, 
including traumatic life events and sleep disturbance, both of which were positively predicted by 
the scale. Anxiety scale scores were also greater among women and younger age groups, 
consistent with previous research with the BAI (Bardhoshi et al., 2016; de Ayala et al., 2005). In 
terms of discriminant validity, the anxiety scale was examined in relation to measures of 
depression, including mood disorders and depressive symptoms. The anxiety scale did not 
produce adequate fit indices for predicting mood disorders, and the correlation between the 
interRAI DSI and anxiety scale was weak-to-moderate, consistent with estimates achieved 
between the BAI and BDI (Beck et al., 1988; Ulusoy et al., 1998). In addition to criterion 
validity, responsiveness of the scale to change over time was investigated between admission and 
discharge. The effect size and SMR of change scores, as well as the correlation between 
admission and change scores, all demonstrated that the scale has a strong responsiveness to 
changes in anxiety. Overall, the psychometric properties of the first version of the interRAI 
anxiety scale are encouraging, with several implications for discourse on general anxiety scales, 
research, and clinical practice. 
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3.4.1.1 Construct validity  
Throughout the process of creating an anxiety scale for the interRAI assessment instruments, 
three major implications for construct validity of general anxiety scales were discovered: 
1) exclusion of somatic health items, 2) balancing common versus disorder-specific variables to 
ensure that general anxiety is measured and, 3) inclusion and exclusion of symptoms belonging 
to OCD and PTSD. Although somatic indicators feature prominently in both the HARS and 
BAI, concerns were revealed during the literature review that they may not function well as 
measures of general anxiety. One problem is that over-emphasis of health conditions can cause 
the scale to be overly biased towards identifying panic disorder, as this diagnostic subtype has a 
greater focus on physical health symptoms than others (de Ayala et al., 2005; Fydrich et al., 
1992; Porter, 2017). Since individuals with panic disorders demonstrated the highest mean score 
on the interRAI anxiety scale, and somatic health items were not correlated with the episodes of 
panic variable, there is no concern that excluding somatic items adversely affects the ability of 
the scale to detect panic, and so there is little value in retaining them. While the review indicated 
that somatic indicators were too specific to panic disorder, it also noted that health conditions are 
not specific enough to general anxiety (Julian, 2011). Given that several psychiatric and physical 
health conditions present in inpatient psychiatric settings involve similar somatic symptoms (i.e., 
difficulty breathing) - especially older adults - this is likely a major reason that somatic items 
performed poorly in the anxiety scale. By excluding a somatic component, the interRAI anxiety 
scale diverges from the structure of other general anxiety scales. However, because the 
continuous scale performed better when somatic items were excluded, there is no empirical 
justification for keeping it. Further, by excluding somatic indicators altogether, there is less 
ambiguity in the factor structure of the model, which has been identified as a problem of the BAI 
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(Beck & Steer, 1991; Osman et al., 1993; Osman et al., 1997). Consequently, this study suggests 
that physical health items are not necessary for measuring general anxiety in clinical 
populations.  
In addition to uncertainty about somatic items, another concern prior to constructing the 
anxiety scale was that each of the psychological indicators would strongly correspond with one 
diagnostic subtype, resulting in a scale that does not measure general anxiety. While there are 
numerous anxiety disorders that each contain unique features (APA, 2013; WHO, 1992), and 
representing various anxiety disorders is a desirable property, it is essential that the anxiety scale 
also contains common elements of anxiety that are applicable to the broader clinical population. 
The correlation matrix used in the factor analyses displayed weak-to-moderate correlations 
among the psychological indicators, indicating that scale is less cohesive than ideal, which may 
explain why the scores on the anxiety scale were relatively low across the sample. Nonetheless, 
factor loadings for psychological items - as well the difficulty and discriminatory estimates from 
the IRT analysis - pointed in a positive starting direction. Unrealistic fears/phobias and obsessive 
thoughts were indicative of anxiety without being restrictive to diagnosis, and while intrusive 
thoughts/flashbacks and episodes of panic were slightly more specific to anxiety disorders, they 
were still within reasonable parameters. Repetitive anxious complaints were pervasive across the 
sample, including those with no anxiety disorder, making it a less discriminate variable. 
However, the scale is intended to contain some items that are observable across the broader 
clinical population, especially since anxiety is so prominent in general populations (ACHA, 
2019; Gustavson et al., 2018; Kessler et al., 2007) and can be elevated during stressful 
circumstances such as hospitalization. Further, as shown in the bivariate analysis, anxious 
complaints were still substantially higher among those with anxiety disorders, increasing its 
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capability as a diagnostic predictor. For these reasons, even though repetitive anxious complaints 
had low difficulty and slope parameters, it was considered a useful item. In contrast, compulsive 
behaviour demonstrated the highest difficulty estimate and a low slope parameter and factor 
loading, implying that it is highly specific to OCD. Since OCD is no longer considered an 
anxiety disorder (APA, 2013; Kogan et al., 2016), it was concluded that compulsive behaviour 
did not belong in a general anxiety scale. After removing the compulsive behaviour item, a better 
balance between general and disorder-specific symptoms in the scale was achieved. However, 
the correlations between items in the scale are still weaker than what is considered optimal 
(Osborne & Banjanovic, 2016), and so any future revisions incorporating disorder-specific 
variables will need to be mindful of any potential negative impact on the correlation matrix. 
Since compulsive behaviour was removed from the anxiety scale because OCD is no 
longer an anxiety disorder, a similar argument could be made for obsessive thoughts, since it is 
the other main component of OCD. However, unlike compulsive behaviour, obsessive thoughts 
were generalizable to the broader inpatient sample. A possible explanation for this discrepancy 
can be found in the correlation matrix between psychological indicators, which showed that 
obsessive thoughts were most strongly related to unrealistic fears/phobias. This finding suggests 
that obsessive thoughts are coded not only as a criterion of OCD, but as a cognitive element 
associated with fear. Given the ambiguity surrounding obsessive thoughts as a symptom of 
anxiety, there are three options for handling it: a) remove it from the scale along with compulsive 
behaviour, b) retain it as is or, c) edit it to represent a more general cognitive symptom. 
Regarding the first option, the anxiety scale constructed for the ESP dataset did not contain 
obsessive thoughts or compulsive behaviour and it produced similar fit statistics as those 
obtained in the inpatient sample. As such, it is possible that obsessive thoughts could be removed 
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along with compulsive behaviour without affecting the predictive strength of the scale. However, 
the value of obsessive thoughts was not its association with an anxiety disorder, but as a more 
general symptom of anxiety. Since the ideal version of the anxiety scale contains both disorder-
specific and broader symptoms of anxiety, option two is preferred over option one. By retaining 
obsessive thoughts in the anxiety scale, the third option of editing the variable description to 
reflect a more general cognitive symptom becomes a possibility. The disadvantage of this option 
is that it would require further research and extensive consultation with clinical staff to determine 
how obsessive thoughts are evaluated, as well as alterations to numerous interRAI instruments. 
As a result, the second option is recommended, though consulting clinical stakeholders on the 
anxiety scale is still advisable as a direction for future research.   
If compulsive behaviour is excluded from the interRAI anxiety scale because OCD is no 
longer categorized as an anxiety disorder, then symptoms related to PTSD must also be 
considered for the same reason (APA, 2013; Kogan et al., 2016). In the interRAI anxiety scale, 
intrusive thoughts/flashbacks are associated with trauma, which is a criterion of PTSD. This 
relationship is reflected in the bivariate analysis and IRT, which illustrated that intrusive 
thoughts/flashbacks have a greater difficulty estimate and a stronger association with disorders. 
Intrusive thoughts/flashbacks also consistently appeared as an important variable for predicting 
anxiety disorders in the decision tree models, likely due to the high prevalence of PTSD 
diagnoses. While OCD was removed from anxiety disorders following evidence from 
psychological, neurological, and genetic studies suggesting that it is structurally and clinically 
distinctive (Kogan et al., 2016), PTSD was removed to create a section for stress-related 
disorders with identifiable causes (APA, 2013; Kogan et al., 2016), representing a more 
conceptual reorganization. In the ICD-11, it is acknowledged that stress-related disorders such as 
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PTSD do commonly involve symptoms of fear and anxiety, and so they are referred to as 
‘adjacent’ to anxiety disorders (Kogan et al., 2016). Thus, unlike compulsive behaviour, 
intrusive thoughts/flashbacks are still strongly linked to anxious emotional responses, and so 
there is an empirical justification to retain it as a symptom in the anxiety scale. 
As well as removing variables from the anxiety scale, it is also worth contemplating 
whether new variables should be added, particularly those related to social anxiety and GAD. 
The decision tree predicting any anxiety disorder revealed that 8% of those with a score of ‘0’ on 
the anxiety scale still had a diagnosis, suggesting that some important items may be missing from 
the scale. One possibility is a variable related to social anxiety disorder, which is distinctive and 
prevalent enough in the general population to be considered its own separate disorder (APA, 
2013; Kogan et al., 2016). Although social anxiety disorder was uncommon in the inpatient 
sample, including a social symptom in the scale may still reduce the percentage of anxiety 
disorders that were represented in the ‘0’ score group. Further, social anxiety disorder could be 
more relevant in the community mental health and ED populations, which observed more cases 
of anxiety disorders than inpatient settings, as well as among youth, as social anxiety disorder 
typically emerges during adolescence and early EA (Cummings et al., 2014; de Graaf et al., 
2003; Kessler et al., 2009). Another potential benefit of a social anxiety item could be a 
moderate relationship with other cognitive- and fear-based items in the scale (APA, 2013; 
Kessler et al., 2009; Kogan et al., 2016), which would enhance the correlation matrix and the 
performance of the scale at measuring general anxiety levels across the clinical population. 
Likewise, another anxiety disorder that lacks coverage in the HARS and BAI is GAD (de Ayala 
et al., 2005; Fydrich et al., 1992; Porter, 2017), represented by symptoms of persistent, non-
specific, and excessive worrying (APA, 2013). The lack of an indicator for GAD in the interRAI 
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anxiety scale is evident when examining average scores across diagnostic subtypes, as it was 
lower for GAD than others. Given that GAD is tied with PTSD as the second most prevalent 
disorder in the inpatient sample, it is possible that boosting detection of GAD would improve the 
c-statistic in the regression models, enhancing its predictive power. Additionally, early detection 
of GAD among EA could be highly beneficial for improving long-term mental health outcomes, 
as clinical prognosis is often worse among those who are diagnosed before the age of 25 (Rubio 
& López-Ibor, 2007). Finally, because worrying has been shown to be an element of 
psychological well-being (Stones & Kozma, 1985), including this variable in the anxiety scale 
may enhance its overall clinical utility. Altogether, it is recommended that symptoms of social 
anxiety and GAD are explored with the intent of improving construct validity, as well as address 
existing gaps of other general anxiety scales. 
3.4.1.2 Scale structure: continuous versus categorical 
An additional consideration related to scale construction is how the data is structured to 
configure the anxiety scale. Although the scale was created to be continuous, with scores ranging 
from 0-15, five categories representing different severity levels were also developed. Depending 
on the context in which the anxiety scale is being used, there are different statistical and practical 
implications for continuous and categorical organizations. Statistically, it is usually more 
advantageous to use continuous rather than categorical data to represent psychological 
constructs, as it confers more statistical power and improves the reliability and validity of the 
scale (Markon, Chmielewski, & Miller, 2011). Unlike categorical structures, continuous scales 
provide a greater depth of information, which increases the capability to accurately detect 
significant variations in data. Enhanced precision also helps to better establish patterns of 
relationships between variables, which are used in the calculations for several statistical 
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procedures that are common in psychological research (Markon et al., 2011), including the factor 
analysis performed in this study (O’Rourke & Hatcher, 2014; Osborne & Banjanovic, 2016). In 
terms of tracking individual progress throughout the course of treatment, it is also beneficial for 
clients and care providers to have access to more granular information. For these reasons, it is 
important to preserve the continuous structure of the anxiety scale.  
While continuous data offers several advantages, there are times where categorical data 
can provide more insight into a problem. One example is when the distribution of data is not 
normal, which is a common assumption for many statistical procedures that use continuous data 
(O’Rourke & Hatcher, 2014). In clinical populations, non-normal data distributions often 
correspond with differences in severity levels (Markon et al., 2011), which was the case in this 
study. Through the use of statistical tests designed for categorical data, group comparisons of 
anxiety levels with nonnormal distributions can be facilitated in a more straightforward manner. 
Whenever continuous data is transformed into discrete categories, it is imperative that an 
empirical approach is taken towards establishing appropriate thresholds, otherwise the reliability 
and validity of the scale may become compromised (Markon et al., 2011). In this study, a 
combination of the univariate distribution and decision tree algorithms were used to set cut-
points for the anxiety severity categories, which is an effective method for deriving statistically 
significant splits in data (Song & Lu, 2015). Overall, whether the continuous or categorical 
structure of the anxiety scale is used depends on the research question or clinical purpose in 
question, and so both continuous and categorical configurations for the interRAI anxiety scale 
should be available. 
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3.4.1.3 Change over time and measurement-based care 
One of the main clinical uses for the interRAI anxiety scale is to track changes in anxiety 
symptoms over the course of treatment, aligning with the principles of measurement-based care 
to improve health outcomes (Aboraya et al., 2018). Since the anxiety scale demonstrated a good 
ability to detect change over time, the results from the analysis can be used to interpret care 
trends for anxious symptoms in psychiatric hospital units across Ontario. Among those who had 
at score of at least one on the anxiety scale at admission, most individuals demonstrated 
improvement by the time of discharge. However, 25% of the sample displayed either no change 
in anxiety or worse symptoms by discharge, pointing to a substantial group with poor health 
outcomes. To investigate this group further, movement between severity categories of anxiety 
were also examined. The most static group were those with mild anxiety symptoms at admission, 
as 44% of the sample still had mild symptoms by discharge. While retaining mild symptoms of 
anxiety by the end of the hospital stay is not ideal, it is likely that these individuals were 
admitted for other psychiatric concerns, and that comorbid anxious symptoms were too mild to 
warrant staying in hospital. In contrast, a concerning trend was that 20% of individuals admitted 
with severe symptoms of anxiety were still in the severe category by the time of discharge. To 
ensure that the range of scores constituting the ‘severe’ category was not too wide to detect 
clinically meaningful improvement, alternate cut-points were tested (7-11 and 12-15). Even after 
breaking down the severe category further, it was evident that clinical recovery was still an issue 
for more than 10% of those with moderate-severe anxiety. It is unclear why individuals with 
serious anxiety would be discharged from hospital, especially since community treatment for 
primary anxiety disorders is low (O’Donnell et al., 2017). To ensure that individuals with anxiety 
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are receiving appropriate quality of care for their symptoms, it is recommended that the anxiety 
scale be explored as a potential quality indicator for psychiatric hospitals.  
3.4.2 Strengths and limitations 
The primary advantage of this study was the comprehensiveness of the inpatient psychiatric 
sample that was used to derive the interRAI anxiety scale, enabling extensive testing for internal 
validity. As described earlier in this chapter, beginning in 2005 in Ontario, all adults admitted to 
a psychiatric hospital or unit for at least three days must be assessed with the RAI-MH at 
admission, discharge, and – if applicable - every three months. This provincial mandate ensures 
the availability of a fully representative adult psychiatric inpatient population, averting the 
effects of sampling bias and increasing the sample size substantially. In contrast to the anxiety 
scale studies reviewed in the introduction, which typically included fewer than 300 individuals 
and a limited number of treatment sites, the RAI-MH dataset contained 237,862 unique 
individuals across 64 participating hospitals. As a result, the statistical power to detect 
relationships between variables in the anxiety scale far exceeded that of any other study 
identified. The capacity to accurately draw conclusions about which variables belong in the 
anxiety scale was vital, since it allowed this study to empirically address contentions surrounding 
the role of somatic items and symptoms related to OCD and PTSD. Likewise, the 
comprehensiveness of the inpatient sample provided a unique opportunity to compare scores on 
the anxiety scale across various diagnostic subtypes of anxiety, including disorders that are 
infrequently admitted for hospital care such as social anxiety disorder. The benefit of disorder-
specific analyses is that it allows for a more thorough investigation of construct validity, such as 
revealing which types of anxiety symptoms may be missing. Further, since there is heterogeneity 
in the onset, symptom profiles, and treatment of anxiety disorders (APA, 2013; WHO, 1992), 
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research on anxiety needs to account for both diagnostic subtype as well as general anxiety 
severity. Due to the exceptional strength of the inpatient sample, this study was capable of 
analyzing the internal validity of the anxiety scale through increased statistical power and 
diagnostic comparisons, beyond what is typically found in other anxiety scale research. 
Given the national priority on building a coordinated mental health care system with 
access to shared data sources and research mechanisms (MHCC, 2015; MHCC, 2016), it is 
essential that the interRAI anxiety scale not only has good internal validity, but also external 
validity in multiple settings. To promote cross-sector utility, the diagnostic validity of the 
interRAI anxiety scale was tested in hospital, ED, and community mental health samples, 
comprising a unique advantage compared to other anxiety scale derivation studies. Both the BAI 
(Beck et al., 1988) and the HARS (Hamilton, 1959) were initially developed using outpatient 
samples of individuals being treated primarily for anxiety disorders, and while samples with a 
high proportion of anxiety disorders by design can help with enhancing the internal validity of 
the scale, they also reduce external validity and introduce sampling bias into the analyses. 
Although a subsequent study attempted to validate the BAI in inpatient psychiatry, there were 
too few cases of anxiety disorders to analyze (Steer et al.,1993), highlighting the strength of the 
RAI-MH dataset yet again. By including three different types of health care settings, this study 
was able to determine that the anxiety scale functioned best in the community setting, 
demonstrating the viability of the tool for outpatient contexts. Model fit statistics for predicting 
anxiety disorders in the ED sample were similar to those in the inpatient dataset, despite a higher 
proportion of disorders being present in the ED. The probable reason for this is that the scale 
contained four items instead of five (obsessive thoughts is not included in the ESP instrument), 
and several cases were missing data for the mood indicators section. Given these setbacks, it is 
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possible that the performance of the anxiety scale in ED settings was under-estimated in this 
study, though future research will be required to determine whether this theory is correct. 
Regardless, predictive validity tests of the anxiety scale were positive in all three health care 
settings, increasing its value as a tool to support integrated mental health care. 
Despite the benefits of including multiple mental health care settings, analyses in the ED 
and community datasets were limited to tests of diagnostic validity because both consisted of 
convenience samples. As a result, the inpatient sample had to be used as the primary data source 
for creating the anxiety scale instead, despite being the setting with the lowest proportion of 
anxiety disorders. Of all three health care settings, the ED has the greatest proportion of primary 
anxiety disorders and the most urgent need for an anxiety scale (CIHI, 2019b; CIHI, 2020; 
Gandhi et al., 2016). However, only four of the five items in the interRAI anxiety scale were 
available in the ESP assessment, and several cases were missing data for variables needed to 
construct the scale. Further, DSM codes are not collected in the CMH and ESP datasets, and so 
subtypes of anxiety disorders cannot be identified. Finally, although the sample sizes for the 
CMH and ESP datasets are still larger than the average of 300 participants in other anxiety scale 
studies, the inpatient sample was substantially larger and more representative of its population. 
For these reasons, although anxiety has a stronger presence in the community and ED samples, 
neither could be used as the derivation sample for the scale. Although more extensive analyses 
were not performed, the predictive validity of the anxiety scale was encouraging in the ED and 
community samples, suggesting that it can be viably used in clinical practice and research 
focused on anxiety disorders. Further, as the number of CMH and ESP assessments grow in the 




Similarly, another limitation that should be addressed in future studies is a comparison 
between the interRAI anxiety scale and other anxiety tools. When testing concurrent validity, it 
is common practice for anxiety scales to be evaluated against ‘gold standard’ tools that have 
demonstrated good reliability and validity (Julian, 2011), such as the HARS (Hamilton, 1959) 
and BAI (Beck et al., 1988). However, this study was restricted to choosing concurrent indicators 
available in the interRAI assessment instruments. While trauma and sleep disturbance are 
associated with anxiety (APA, 2013; WHO, 1992) and thus valid concurrent indicators, the 
validity of the anxiety scale would benefit further from testing its association with other 
measures of general anxiety. However, due to the exclusion of somatic items from the interRAI 
anxiety scale, it is possible that it will have a weaker relationship with the HARS and BAI than 
they do with each other. As a result, while a positive association is still be expected, it is not 
necessarily a failure of the interRAI anxiety scale if it is weakly related to the HARS and BAI. 
Overall, there were many methodological strengths of this study that allowed a promising first 
version of an anxiety scale to be created, while future studies can be planned that account for the 
limitations that do exist. 
3.4.3 Future research 
One avenue for future research involves addressing the limitations that arose from unavailability 
of certain types of data, such as concurrent tests with other anxiety scales and adding in new 
anxiety variables to the interRAI tools. General anxiety scales that could be used to further test 
concurrent validity of the anxiety scale are the HARS (Hamilton, 1959) and BAI (Beck et al., 
1988), though treatment sites would have to be recruited that either already use these tools, or 
that would be willing to adopt them to participate in research. Another consequence of being 
restricted to available data was the inability to include certain types of anxiety variables. In 
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particular, gaps in coverage were noted for social anxiety disorder and GAD, reducing the 
construct validity of the scale. Three scales were reviewed in the introduction that measure social 
anxiety: the LSAS (Heimberg et al., 1999), SPS (Heimberg et al., 1992), and SIAS (Heimberg et 
al., 1992). Since all three tools demonstrated good reliability and validity, they can be used as a 
guide for evaluating items that depict social anxiety, much like the HARS and BAI were used to 
inform the anxiety scale in this study. A good starting point for creating social anxiety variables 
would be to adapt items from the interRAI Long-term Care Facilities (LTCF) assessment, which 
contains a section on ‘sense of involvement’ with the following variables: a) at ease interacting 
with others, b) at ease doing planned or structured activities, c) accepts invitations into most 
group activities. The advantage of using the LTCF as a basis for introducing a social anxiety 
variable into the mental health instruments is that it would be cross-compatible within the suite 
of interRAI instruments, permitting cross-sectoral comparisons of anxiety, and it also follows the 
same 3-day look back period as the mental health indicators.  
Unfortunately, a comparable item representing GAD could not be located in the interRAI 
instruments. To cover the core criteria involved in GAD, a variable is needed that emphasizes 
pervasive and excessive worrying/apprehension, representing a persistent problem that is not 
merely a response to stressful circumstances (APA, 2013; WHO, 1992). If a new variable is 
created to reflect GAD, the GAD-7 could be used as one source of assistance (Spitzer et al., 
2016). With these resources available, future studies should make use of them to explore adding 
social anxiety and GAD variables to the mental health suite of interRAI assessment tools. 
However, as previously mentioned, future research will need to ensure that when adding 
disorder-specific items to the anxiety scale, the correlation matrix for items is not weakened as a 
result. If adding symptoms of social anxiety and GAD do diminish the ability of the scale to 
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measure general anxiety, one solution would be to include another variable that is common to 
anxiety disorders broadly, some examples of which are available in the GAD-7 (Spitzer et al., 
2016). Additionally, consultation with clinical experts could be conducted to determine whether 
there are shared features of anxiety that are missing from the current interRAI instruments. 
However, the disadvantage of this approach is that the interRAI MH and CMH assessment 
instruments already contain over 300 items, and so there may be some reluctance towards adding 
in several new items. In any case, the current study was unable to address these concerns, but it 
is recommended that future studies investigate additional anxiety items. 
Another research opportunity that arises from the creation of an anxiety scale is its 
potential to be used as a quality indicator for mental health care settings. A previous research 
study examined how the interRAI depressive severity index (DSI) and cognitive performance 
scale (CPS) functioned as quality indicators for psychiatric hospitals in Ontario (Perlman et al., 
2013). Both scales were examined in relation to provisional DSM diagnosis and change scores 
across facilities, with the latter analysis including adjustments for the RAI-MH System for 
Classification of Inpatient Psychiatry (SCIPP), which is an algorithm used to describe resource 
intensity within inpatient psychiatry units across Ontario. This study has already established the 
ability of the anxiety scale to predict anxiety disorders and detect changes in symptoms over 
time, providing a solid foundation for further research into its use as a quality indicator. Other 
examples of quality-related research questions that can be addressed using the anxiety scale 
include treatment processes and outcomes that are specific to subgroups of individuals with 
anxiety who are receiving mental health care, which will be the focus of the fourth chapter in this 
dissertation. In addition to examining individual care settings, the anxiety scale can also be used 
to examine outcomes following transitions between health sectors, which is another quality-
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related concern that has been identified as a priority for mental health systems across Canada 
(MHCC, 2015; MHCC, 2016). Altogether, there are multiple potential uses for the interRAI 
anxiety scale, providing a rich foundation for ongoing research initiatives. 
3.4.4 Conclusions 
There is a growing demand for mental health care of anxiety in Canada (Aratani & Addy, 2014; 
Brien et al., 2015; CIHI, 2019b; CIHI, 2020; Gandhi et al., 2016; Juhás & Agyapong, 2016), 
though systems are already struggling to meet this need (Baia Medeiros et al., 2019). To 
facilitate evidence-based strategies that effectively target anxiety in mental health care systems, 
evaluation tools are needed that assess symptoms of anxiety. While the interRAI mental health 
assessment instruments are widely used in Canada, an anxiety symptoms scale was not available, 
due to the complexity involved in cohesively capturing various anxiety disorder subtypes (APA, 
2013; WHO, 1992). Using other general anxiety scales as a guide, including the HARS 
(Hamilton, 1959) and BAI (Beck et al., 1988), this study sought to create an anxiety scale for the 
interRAI assessment tools. Factor analysis was the primary method used to identify the structure 
of the anxiety scale, though LCA, IRT, and decision trees were also utilized to create alternative 
scale structures. The final model chosen for the anxiety scale was a 5-item continuous scale, 
excluding somatic items and compulsive behaviour. The scale demonstrated good criterion 
validity and responsiveness to change over time, providing strong support for the official 
creation of an interRAI anxiety scale. Ongoing research is needed to explore the potential 
addition of new variables representing features belonging to social anxiety and GAD, as well as 
to determine its viability as a quality indicator for multiple mental health care systems. As the 
scale undergoes further refinement, it can start being used as a tool to support research on 





Recent trends in mental health care among EA illustrate a growing demand for services (Brien et 
al., 2015; CIHI, 2020), but several systemic barriers exist that hinder coordinated care, leading to 
high rates of disengagement from treatment (Edlund et al., 2002; MHCC, 2015; Roche et al., 
2020) and inappropriate utilization of emergency services (CMHA, 2008). Acknowledging 
barriers to accessibility of mental health care among EA, the Mental Health Commission of 
Canada (MHCC) has identified integration of health care systems as a key priority. While 
holistic care systems are needed to improve treatment for all types of mental health concerns, 
there are certain psychological conditions for which gaps in care are especially prominent. For 
example, the rising prevalence of anxiety disorders in emergency department (ED) settings 
across Canada are becoming an urgent concern (Aratani & Addy, 2014; Brien et al., 2015; Juhás 
& Agyapong, 2016), especially among youth and EA (CIHI, 2020; Gandhi et al., 2016). With 
more EA accessing the ED for treatment related to anxiety, it is possible that the prevalence will 
also increase in inpatient psychiatry, in which rates of primary anxiety have historically been 
very low. In the second chapter of this dissertation, primary anxiety disorders were present in 
only 4% of the inpatient population between 2005-2019, while 10% had a non-primary anxiety 
disorder. Further, while the average score on the anxiety scale was relatively low (M=2), mild 
anxiety was still present in a large portion of the population. The wider prevalence of  non-
primary anxiety disorders and mild symptoms may be due to comorbidity with depression, which 
shares a strong relationship with anxiety (APA, 2013; WHO, 1992), and is the leading 
psychological disorder implicated in psychiatric hospitalizations among youth (Brien et al., 
2015). If rates of anxiety also begin to increase in inpatient psychiatry, it is important to 
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understand the treatment patterns associated with diagnostic status and severity of symptoms to 
identify best practices, as well as any potential gaps in care. 
To improve quality of care for specific mental health needs, regular data reporting on 
performance and outcome measurements for these conditions is needed (Aboraya et al., 2018; 
MHCC, 2015). To streamline this process, interRAI has developed several measurement scales, 
which summarize variables contained in the assessment to provide an overview of a specific 
domain, such as depression and positive symptoms of psychosis (Hirdes, et al., 2020; Perlman et 
al., 2013). The scales are then used to evaluate factors related to quality of mental health care, 
such as resource utilization, responsiveness to treatment over time, and variations in outcomes 
across facilities. Scales are also useful for predicting trends and outcomes at a more granular 
level than diagnoses, providing a deeper depth of information for service and policy planning. In 
some cases, disorders and symptoms may even produce conflicting results, which must be 
incorporated into research focused on advising mental health system design. For example, 
research with older adults living in long-term care facilities found that symptoms and diagnoses 
of depression were differentially related to rates of anti-depressant medication prescriptions 
(Hirdes et al., 2000), indicating that service providers may overlook symptoms in the absence of 
a diagnosis when administering treatment. Now that an initial anxiety scale is available, not only 
can this study investigate treatment patterns and social resources related to primary anxiety 
diagnoses among EA in psychiatric hospital units, but also determine how severity of anxious 
symptoms further influences these outcomes.  
4.1.1 Mental health care service use 
To establish what is presently known about health care use for anxiety, research studies derived 
from community populations were reviewed, which demonstrated that although collaborative 
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mental health care results in better outcomes, treatment rates were low. In general, individuals 
with anxiety disorders typically access medical care agencies for treatment of symptoms, rather 
than mental health services (Horenstein & Heimberg, 2020; Kessler et al., 2007; O’Donnell et 
al., 2017; Somers et al., 2006). For example, using data obtained from the Canadian Community 
Health Survey – Mental Health (Roberge et al., 2011), treatment adequacy for anxiety disorders 
was examined over the past 12 months in both general medical and specialized mental health 
settings. Sufficient access to pharmacological treatment was defined as receiving at least four 
outpatient visits with the same provider in either setting, as well as the use of a prescribed 
anxiolytic or antidepressant medication. For psychotherapy, the criteria for treatment adequacy 
involved seven outpatient visits with the same provider in a specialized mental health setting. 
Overall, only 36.9% of respondents with a diagnosed anxiety disorder reported accessing any 
mental health treatment over the past year. Among those who did, fewer received specialized 
mental health services than general medical care (20.2% versus 29.9%, respectively), though the 
proportion who received adequate treatment in the former setting was greater (51.5% versus 
36.8%). However, treatment adequacy was highest among individuals who received care from 
both general medical and specialized mental health centres (79.5%), indicating that collaborative 
care promotes better engagement in treatment among individuals with anxiety disorders.  
Despite the positive effects of continuity of care on long-term engagement in treatment 
for individuals with anxiety disorders, mental health care utilization remains low (O’Donnell et 
al., 2017; Roberge et al., 2011; Somers et al., 2006), especially among EA, who experience more 
disruptions to mental health treatment than other age groups (Edlund et al., 2002; MHCC, 2015). 
A major reason for low uptake of community mental health treatment across Canada is due to 
systemic barriers in accessibility of these services, including financial costs, long wait lists, 
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limited availability by location, and complications in navigating the system (Moroz et al., 2020). 
Considering the numerous obstacles involved in accessing community mental health treatment, 
individuals may be more inclined to seek care from emergency health settings instead, which are 
covered under the Canada Health Act (Health Canada, 2021). Consistent with this theory, 
psychiatric emergency departments (EDs) observe relatively high proportions of anxiety 
disorders compared to other health care settings (Aratani & Addy, 2014; Brien et al., 2015; CIHI, 
2020; Gandhi et al., 2016; Horenstein & Heimberg, 2020; Juhás & Agyapong, 2016). Not only is 
anxiety comparatively higher in the ED than other settings, but a study of mental health service 
use among youth in Ontario found that anxiety disorders were the most common diagnosis 
implicated in psychiatric ED visits (CIHI, 2020; Gandhi et al., 2016), highlighting a strong need 
for treatment of anxiety. Further, as reported in the second chapter of this dissertation, the ratio 
of primary to non-primary anxiety disorders was greater only in the ED dataset, meaning that 
treatment specifically for anxiety is disproportionately low in community and psychiatric 
hospital settings. A repercussion resulting from this lack of accessibility is over-crowding and 
long wait times in the ED (CMHA, 2008), which is heightened among youth presenting with 
mental health concerns (CIHI, 2019b). Further, because most individuals receiving care in 
general psychiatric hospital units are admitted through the ED (CIHI, 2019b), it is likely that the 
prevalence of anxiety will begin to rise in psychiatric hospitals as well, requiring evidence-based 
care guidelines for treating individuals with these symptoms and diagnoses. 
Although EA frequently seek mental health care for anxiety in the ED, relatively few 
individuals with anxiety disorders are subsequently admitted for inpatient psychiatric care 
(Horenstein & Heimberg, 2020), due in part to the admission criteria outlined in the Mental 
Health Act (MHA, 1990). As described in the Act, admissions into inpatient psychiatry are 
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determined based on urgency of risk of harm to self and others. Unlike depression, which is a 
known risk factor for self-harm and suicidality, the evidence for risk of danger resulting from 
symptoms of anxiety is unclear (Bandelow & Michaelis, 2015; Cummings et al., 2014). As a 
result, even when youth with primary depression or anxiety disorders sought the same level of 
care from school psychologists, only those with primary depression received inpatient 
psychiatric care (Essau, 2005). While anxiety disorders are rarely observed in psychiatric 
hospitals and units, it is possible that symptoms of anxiety predict hospitalization more strongly, 
but these are often omitted in studies of health care use among individuals with anxiety 
disorders. For instance, it may be that individuals who present with severe symptoms of anxiety 
are more frequently admitted into psychiatric hospitals, regardless of their diagnosis. Assessing 
symptoms of anxiety may be especially informative among EA who recently developed anxiety 
and are only accessing mental health services for the first time, as they may not have had the 
opportunity to receive a diagnosis yet. Ensuring that anxiety is thoroughly assessed at intake and 
incorporated into treatment is necessary for efficient service planning in psychiatric hospitals, as 
rates of anxiety may begin to increase as more youth and EA present to the ED for anxiety-
related care (Aratani & Addy, 2014; Brien et al., 2015; Juhás & Agyapong, 2016). To prepare for 
growth in anxiety symptoms and disorders, it is necessary to establish current care practices for 
EA presenting with anxiety and identify potential gaps in treatment resources.   
4.1.2 Psychiatric hospital care for anxiety  
Evidence-based care practices for anxiety within inpatient psychiatry are unknown, since 
admittance into these settings are rare for individuals with primary anxiety disorders, meaning 
that there have not been any large-scale opportunities to conduct research with this population 
(Bandelow & Michaelis, 2015). To ensure that optimal quality of care is provided, it necessary 
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for studies to comprehensively investigate and report on treatment patterns and outcomes for 
individuals with anxiety. In the meantime, recommendations for treating anxiety disorders in 
inpatient settings have been made using evidence-based research derived from outpatient 
sources. For example, the Royal Australia and New Zealand College of Psychiatrists developed a 
clinical practice guideline for treating panic disorder, social anxiety disorder, and generalized 
anxiety disorder (GAD), detailing best practices for outpatient and inpatient care (Andrews et al., 
2018). While treatment options should ultimately be selected with input from the patient, the 
recommended interventions for anxiety were cognitive-behavioural therapy (CBT), 
pharmacology, or ideally, a combination of both. While group-therapy formats for CBT 
interventions have shown some efficacy in improving clinical outcomes, because individual-
therapies have produced greater effect sizes, individual sessions are the preferred mode of 
delivery (Andrews et al., 2018; Bandelow et al., 2015). Although individual CBT has been 
shown to be beneficial in treating anxiety, pharmacology treatments are associated with greater 
short-term improvement in anxiety symptoms and are more easily accessible to most patients 
(Bandelow et al., 2015), suggesting that medication options should  also be explored with the 
patient, depending on their personal preferences and underlying health conditions.  
Given the opportunity, it is better to offer both psychotherapy and pharmacotherapy than 
either alone, as research has shown that a combination of medication and CBT have the strongest 
impact on improving symptoms of anxiety (Andrews et al., 2018; Bandelow et al., 2015). 
Further, as described earlier, treatment adequacy for anxiety disorders was greatest when 
individuals received resources from both specialized mental health and general medical services 
(Roberge et al., 2011), reiterating the benefits of a combined medical and psychological 
approach. Consequently, both psychotherapy and pharmacotherapy should be offered to 
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individuals who are admitted to hospital with anxiety, with input from a medical doctor or nurse 
practitioner when medical conditions may be a concern. Currently, it is unknown what the 
treatment patterns are for EA with anxiety in psychiatric hospital care (Bandelow & Michaelis, 
2015), or how those trends may differ based on diagnostic status (primary versus non-primary) 
and severity of symptoms. 
While the type of intervention provided and the way it is delivered are essential 
components to inpatient care, another important element of treatment in hospital settings 
involves interpersonal interactions with staff members, which can enhance clinical outcomes by 
establishing a therapeutic alliance with the individual (Andrews et al., 2018). In two inpatient 
psychiatric units in Australia, psychiatric nurses participated in interviews about their 
experiences with treating patients who had symptoms of anxiety (Webster et al., 2012). Nurses 
emphasized the importance of being able to properly assess and monitor symptoms of anxiety, as 
well maintaining positive communication with their patients. Fostering communication and 
social relationship-building skills among patients was also identified as a crucial aspect of 
treatment, such as encouraging the patient to share their thoughts and feelings with a support 
person and teaching them therapeutic interpersonal skills. In the guideline for treating anxiety 
disorders in Australia and New Zealand, the clinical value of cultivating a strong therapeutic 
alliance with patients was also referenced, as well as incorporating the patient’s social life into 
their care plan (Andrews et al., 2018). Finally, in the “Mental Health Strategy for Canada: A 
Youth Perspective” (2016) report, youth contributors highlighted positive interpersonal 
interactions with service providers and inclusion of social relationship-building skills as 
necessary components of excellent care, affirming the need to examine interpersonal factors 
involved in mental health treatment.  
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Altogether, little is known about patterns of care for individuals experiencing anxiety in 
psychiatric hospitals, particularly when it is their primary concern. Further, no studies could be 
located that used both diagnosis and symptoms of anxiety to examine treatment processes and 
outcomes in inpatient settings, which is needed to account for degree of symptom severity and 
disorder status (primary versus non-primary). Understanding how diagnosis and symptoms of 
anxiety are currently treated in psychiatric hospitals is necessary for adopting a measurement-
based care approach, which is of immediate concern given that anxiety disorders are on the rise 
in ED settings (Baia Medeiros et a., 2019; Gandhi et al., 2016). This chapter will address gaps in 
knowledge surrounding the types of treatments that individuals with anxiety receive in inpatient 
settings, as well as interpersonal experiences of care. 
4.1.3 Comorbidity between anxiety and depression 
Prior to investigating patterns of care for anxiety in hospital, a factor that needs to be accounted 
for is comorbidity with depression. In general, depression and anxiety are highly comorbid 
psychological disorders (APA, 2013; WHO, 1992), though evidence suggests that depression 
involves comorbid anxiety more often than vice versa (Cummings et al., 2014; Garber & 
Weersing, 2010). For example, a study in The Netherlands examined latent classes of anxiety 
and depression among adolescents referred to outpatient mental health services between 1988-
2003 (Ferdinand et al., 2005). While most adolescents with symptoms of anxiety or depression 
had an equal combination of both, there was a small class (5%) consisting of individuals with 
severe anxiety and moderate depressive symptoms. However, there was no class where 
adolescents had severe depression and non-severe anxiety. A potential explanation for the 
imbalance in comorbidity between anxiety and depression is the difference in developmental 
trajectories of symptom onset between the two conditions. Two other studies based in The 
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Netherlands examined comorbidity between diagnoses of anxiety and depression using data 
obtained from the Netherlands Mental Health Survey and Incidence Study (NEMESIS) (de 
Graaf, Bijl, Spijker, Beekman, & Vollebergh, 2003) and the Netherlands Study of Depression 
and Anxiety (NESDA) (Lamers et al., 2011). Among respondents with comorbid anxiety and 
depression in the NEMESIS survey, most reported anxiety as the primary diagnosis, which 
emerged prior to the secondary depression diagnosis (de Graaf et al., 2003). Similarly, in the 
NESDA dataset, 57% of individuals with comorbid diagnoses developed anxiety before 
depression, whereas depression appeared first in 18% of cases (the remaining 25% had 
simultaneous onset) (Lamers et al., 2011). As a result, symptoms of anxiety may appear more 
prevalent than depression among youth, though there is still a risk of developing subsequent 
depression as time goes on.   
Although most anxiety disorders have an average age-of-onset in the mid-20s (de Lijster 
et al., 2017; Kessler et al., 2007), and anxiety frequently appears prior to depression (de Graaf et 
al., 2003; Lamers et al., 2011), it is unlikely that EA receiving care in psychiatric hospitals have 
symptoms of anxiety without a similar degree of depressive symptoms. Research has shown that 
most individuals receiving treatment for anxiety also have comorbid depression by the time they 
seek care (Bandelow & Michaelis, 2015; Essau, 2005; Mackenzie, Reynolds, Cairney, Streiner, 
& Sareen, 2012; Preisig, Merikangas, & Angst, 2001), and that individuals with singular anxiety 
disorders receive less treatment than those with singular or comorbid depressive disorders 
(Mackenzie et al., 2012; Preisig et al., 2001). As a result, while comorbid depressive symptoms 
predict health care utilization among individuals with anxiety disorders, the same is not 
necessarily true when anxiety symptoms are comorbid to depression (Essau, 2005; Roberge et 
al., 2011). This pattern is likely exaggerated in psychiatric hospitals, since depressive disorders 
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are the most prevalent diagnosis treated, while anxiety disorders are relatively uncommon (Brien 
et al., 2015; Gandhi et al., 2016). In this case, anxiety should frequently accompany depression 
among EA in psychiatric hospital settings, despite opposite findings in the general population 
(Cummings et al., 2014; Ferdinand et al., 2005; Garber & Weersing, 2010). Consequently, while 
non-primary anxiety disorders should positively predict full admissions into psychiatric 
hospitals, primary anxiety disorders should not.  
4.1.4 Rationale and hypotheses 
To better support EA who access mental health care services, it is essential that research is used 
to identify gaps in care corresponding to specific clinical needs (Aboraya et al., 2018; MHCC, 
2015). Considering that anxiety disorders are a growing cause of psychiatric ED visits among 
EA in Canada (Baia Medeiros et al., 2019; CIHI, 2020; Gandhi et al., 2016), but are infrequently 
observed in community mental health and inpatient psychiatry, it is crucial to investigate how 
anxiety is currently being treated in these settings to establish possibilities for improving 
continuity of care. Based on the results from chapters two and three, it is known that there are 
few cases of primary anxiety disorders in psychiatric hospitals across Ontario. However, while it 
is probable that diagnosis is a negative predictor of admission into inpatient psychiatry, it is 
unclear what role different severity levels of anxious symptoms plays. It is possible that severe 
symptoms of anxiety are positively associated with admissions into hospital and may be the 
reason that some primary anxiety disorders are observed in these settings.  
Since cases of primary anxiety disorders in psychiatric hospitals are rare, it is unknown 
how diagnoses and symptoms of anxiety are related to treatment patterns in these settings. Based 
on a national guideline (Andrews et al., 2018) and a meta-analysis (Bandelow et al., 2015) of 
effective interventions for clinical anxiety, individual CBT therapy sessions and 
 
 235 
pharmacotherapy are recommended, and so they should be resources that are offered to 
individuals with anxious symptoms and disorders. Further, positive interactions with staff 
members and other social relations in the person’s life are influential components of effective 
care (Andrews et al., 2018; MHCC, 2016; Webster et al., 2012), and so it is crucial to examine 
these factors as part of inpatient treatment for EA experiencing anxiety. Finally, it is well known 
that anxiety and depression frequently co-occur (APA, 2013; WHO, 1992). Given developmental 
trajectories for developing comorbid anxiety and depression (Cummings et al., 2014), there may 
be a unique subgroup of EA with severe anxiety and mild depression in psychiatric hospitals. At 
the same time, unlike general population research, it is probable that anxiety symptoms overall 
are more frequently connected to depression in psychiatric hospitals (Bandelow & Michaelis, 
2015; Essau, 2005; Mackenzie et al., 2012; Preisig et al., 2001). This chapter seeks to address 
each of these gaps in knowledge by answering three research questions:  
1) What is the nature of comorbidity between anxiety and depression among EA in psychiatric 
hospitals? 
2) How do diagnoses of anxiety disorders and the interRAI anxiety scale predict admissions into 
psychiatric hospitals, as well as depressive disorders and symptoms? Is there a difference 
between primary and non-primary diagnoses of anxiety? 
3) How do the types of treatment interventions and informal social supports differ across anxiety 




4.2.1 Study sample and design 
As previously described in chapters two and three in this dissertation, the interRAI Resident 
Assessment Instrument – Mental Health (RAI-MH) dataset from 2005-2019, available through 
the Ontario Mental Health Reporting System (OMHRS), was used as the data source for this 
study. The study sample was restricted to EA, who were defined as those between the ages of 18-
30, based on the results from chapter two demonstrating similarities in the prevalence of anxiety 
and depression within this age range. The first episode of care contained in the system was 
selected as the unit of analysis, with only one episode retained per individual. Exclusion criteria 
included cases flagged as containing possible data quality issues (CIHI, 2021), forensic patients, 
and short-stay patients. The final sample size was n=65,528. 
 To examine outcomes related to admissions into inpatient psychiatry, a separate dataset 
was created that included short-stay assessments, which are defined as visits that are 72 hours or 
less in length. Unlike full admission assessments, not all information contained in the RAI-MH is 
required to be filled in for short-stay assessments, meaning that some admission data may be 
missing. For this reason, the dataset including short-stay assessments was only used for analyses 
predicting this outcome. Using the same coding process for the full admission dataset, the final 
sample size for the short-stay admission dataset was n=98,607. 
4.2.2 Dependent variables 
To analyze short-stay versus full admissions into inpatient psychiatry, a dataset retaining ‘short-
stay’ assessments was created. In the OMHRS dataset, CIHI added a variable that identifies the 
‘assessment type’ for each record in the system (CIHI, 2021). A full admission assessment is 
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defined as a net length of stay greater than 72 hours and contains the full RAI-MH admission 
assessment. In contrast, a short-stay assessment is a net length of stay less than or equal to 72 
hours, with some information pertaining to both admission and discharge. For the purposes of 
analysis, a binary category was created called ‘short stays,’ where short-stay assessments were 
coded as ‘1,’ and as ‘0’ if it was a full admission assessment.  
Various indicators on service utilization/treatment are included in the RAI-MH, which 
were used to examine care patterns among EA. The ‘formal care’ section lists various types of 
professional roles and asks the assessor to record the number of days in which the individual 
received at least 15 minutes of contact with someone of that profession, either within the past 
seven days or since admission. The roles examined in this study included psychiatrist, nurse 
practitioner or MD (non-psychiatrist), and psychologist or psychometrist, as these are the 
professions that would primarily be responsible for administering pharmacology (psychiatrist or 
MD) and CBT (psychologist) interventions. Since full admission assessments are set at three 
days, the number of days in which the individual received at least 15 minutes of contact with 
each profession was collapsed into the following categories: ‘0’ if there were 0 days of contact, 
‘1’ if there was 1-2 days, and ‘3’ if there were 3 or more days. Although the exact type of 
intervention is not recorded (e.g., CBT), treatment modalities for delivering psychotherapy are 
included in the RAI-MH, including individual therapy, group therapy, family/couple therapy, 
and self-help group. Each of these treatment modalities were selected for examination, though it 
was expected that individual therapy would be the most relevant, given the recommendations for 
providing individual CBT among those with anxiety disorders (Andrews et al., 2018; Bandelow 
et al., 2015). Treatment modalities are coded as follows: ‘0’ if not offered and not received, ‘1’ if 
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offered but refused, ‘2’ if received in the last 7 days, and ‘3’ if not received but scheduled to start 
within the next 7 days.  
The final set of dependent variables focused on social relations and interpersonal conflict, 
all of which are coded as either “no” or “yes.” The following variables were included for 
analysis: reports having no confidant, family/close friends report feeling overwhelmed by 
person’s illness, family/friends are persistently hostile towards or critical of person, and staff 
reports persistent frustration in dealing with person.  
4.2.3 Independent variables 
The independent variables used in this study were anxiety disorders, depressive disorders, the 
anxiety scale, and the Depressive Severity Index (DSI). The anxiety disorder category from the 
list of DSM-IV psychological disorders was used to create a variable for anxiety diagnosis, 
including OCD and PTSD from the updated DSM 5 list. Since assessors can choose up to three 
psychological diagnoses and rank them in order of their importance, an ordinal variable with 
three levels was created for anxiety disorders. If an anxiety disorder was ranked as the most 
important, it was considered a primary anxiety diagnosis and was coded as ‘2.’ If an anxiety 
disorder was ranked as second or third most important, it was a non-primary anxiety diagnosis 
and was coded as ‘1.’ Otherwise, if no anxiety disorder was recorded, it was coded as ‘0.’ The 
same procedure was used to define depressive disorders, except that rather than using the list of 
DSM psychological disorder categories, the individual DSM codes were compiled instead. The 
reason for using the DSM codes is because prior to the DSM 5, depression was grouped together 
with bipolar disorders to form a general mood disorder category, which would have confounded 
the results. Since the codes are also entered in order of their importance, distinctions between 
primary and non-primary depressive disorders were still able to be made. 
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 To represent symptoms of anxiety and depression, the anxiety scale created in chapter 
three of this dissertation was used, as well as the DSI (Perlman et al., 2013). Both scales are 
derived from items contained in the ‘mental state indicators’ section of the RAI -MH. Each of the 
items is observed over a three-day lookback period and is coded as follows: ‘0’ if the indicator 
was not exhibited in the last three days, ‘1’ if the indicator was not exhibited in the last three 
days but is reported to be present, ‘2’ if the indicator was exhibited on one to two of the last three 
days, and ‘3’ if the indicator was exhibited daily in the last three days. The anxiety scale, which 
ranges from 0-15, is a sum of repetitive anxious complaints, unrealistic fears/phobias, obsessive 
thoughts, intrusive thoughts/flashbacks, and episodes of panic. However, since the distribution of 
the scale is non-normal, the severity categories created in chapter three were used for the 
analyses in this chapter. The severity categories for the anxiety scale were coded as follows: 0 
(none), 1-3 (mild), 4-6 (moderate), and 7-15 (severe). The DSI, which also ranges from 0-15, 
adds the scores from the following items: sad/pained facial expression, negative statements, self-
deprecation, guilt/shame, and hopelessness. The corresponding severity categories for the DSI 
were: 0 (none), 1-3 (mild), 4-7 (moderate), and 8-15 (severe).  
4.2.4 Statistical analysis 
4.2.4.1 Distribution comparisons 
Patterns of comorbidity between severity levels of anxiety and depression were examined 
through a cross-tabulated frequency distribution and tested using the weighted kappa coefficient. 
The weighted kappa coefficient can be used to analyze inter-rater agreement for scales with 
ordinal data structures, as the equation assigns greater penalties the further that scores are apart 
(Cichetti & Allison, 1971; Fleiss & Cohen, 1973). The default procedure used by SAS 9.4 for 
calculating the weighted kappa statistic is the Cicchetti-Allison method of linear weighting, 
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though quadratic Fleiss-Cohen weights were specified instead (Fleiss & Cohen, 1973). Like the 
intraclass correlation coefficient (ICC) for continuous measures, the Fleiss-Cohen weighted 
kappa statistic is based on inverse-square spacing of the data table, which assigns weights to each 
cell by calculating the squared distance between ordinal categories. So, in a data table 
representing two scales that each contain four severity categories (none, mild, moderate, and 
severe), categories that are only one space away from each other (e.g., mild - moderate) will have 
a greater weight assigned to them than those that are two spaces away (e.g., mild - severe). 
Unlike linear weights, quadratic weights are more lenient when categories are close together and 
harsher when they are further apart. For psychological diagnoses, weighted kappa values 
typically range between 0.40-0.60 (Fleiss & Cohen, 1973). By analyzing the weighted kappa 
coefficient, the consistency in severity scores between the anxiety scale and the DSI can be 
determined, accounting for the distance between ordinal levels.  
 To determine how treatment patterns varied by the level of anxious severity and primary 
anxiety disorder status, three-way chi-square tests were performed using the psychiatrist, 
psychologist, and nurse/MD dependent variables, as well as the individual and group therapy 
variables. The same procedure was also used to examine patterns of social resource dependent 
variables. Chi-square tests of independence are used to determine whether significant differences 
exist between observed and expected data patterns for nominal or ordinal categories, and because 
it is a non-parametric test, it does not require that data be normally distributed (McHugh, 2013). 
Significance of the chi-square test is determined using probability values (p-values), which 
represent the degree to which the observed data differs from expected values due to random 
chance. For the three-way chi-square tests between anxiety disorders, the anxiety scale, and the 
dependent variables, chi-square tests were used to determine whether patterns on the dependent 
 
 241 
variable differed across anxious symptom severity categories at each level of anxiety disorder 
status. To establish whether there was also a main effect of anxiety disorders on dependent 
variables, separate two-way chi-square tests were performed omitting the anxiety scale.  
4.2.4.2 Logistic regression 
An advantage of logistic regression is that it can estimate the probability of an outcome while 
accounting for several independent variables at once. However, in small samples, the inclusion 
of too many variables may produce a saturated model that has insufficient statistical power to 
explain the relationship between independent variables and the outcome of interest (Bursac, 
Gauss, Williams, & Hosmer, 2008; Sperandei, 2014). The process of entering independent 
variables into a regression model also has consequences for standard error estimates, reliability, 
confounding effects, and interactions between sets of variables (Bursac et al., 2008). Variable 
selection is generally done in one of three ways: forward selection, backward elimination, or 
stepwise selection. Forward selection methods begin with an intercept-only model and adds in 
variables sequentially based on their chi-square statistic, stopping when there are no further 
variables that meet the statistical requirements (Bursac et al., 2008). Conversely, backward 
elimination starts with all variables in the model and removes the one with the least significant 
Wald test statistic, repeating the process until only significant variables remain. Stepwise 
selection is a combination of forward selection and backward elimination processes, adding in 
variables and removing them in stages until the optimal model is reached (Bursac et al., 2008). 
Notably, backward elimination and stepwise selection processes are more accurate methods than 
forward selection when the sample size is larger (Bursac et al., 2008). While these methods can 
be handled automatically by statistical software programs, the researcher can also manually 
control the process using empirical evidence, which was the approach taken in this study.  
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Short-stay hospitalizations were predicted using logistic regression models, which 
calculate the odds of an outcome occurring for each independent variable through odds ratios 
(ORs) and regression coefficients (Sperandei, 2014). Additionally, if it appeared that anxiety 
disorders and severity of anxious symptoms had different patterns of association with the 
treatment and social resource dependent variables in the distribution analyses, logistic regression 
was also used to better establish the direction of effects. To determine whether anxiety disorders 
and symptoms had a significant effect on dependent variables, the ORs and 95% confidence 
intervals (CIs) were consulted, as well as the p-values associated with the regression coefficients. 
Since the intention was to investigate how the anxiety variables are related to outcomes, rather 
than trying to fully identify all covariates that explain variation in the dependent variables, the c-
statistic is reported but is not the primary metric of interest.   
 For all logistic regression models, a stepwise selection process was followed. The first set 
of variables that were entered into the model were anxiety disorders, the categorical version of 
the anxiety scale, gender, and age (continuous from 18-30). Following this step, a second model 
was conducted that included depressive disorders and the categorical version of the DSI. If 
anxiety disorders and anxiety symptoms were both statistically significant in the second model, a 
third model was performed that included an interaction term between the two variables to 
determine whether there were significant interaction effects. However, none of these interaction 





4.3.1 Descriptive statistics 
In the short-stay dataset, 39% of the sample had a short-stay assessment, meaning that several 
EA aged 18-30 were not admitted into inpatient psychiatric care for more than 72 hours during 
their first index episode in the OMHRS dataset. Further, if the full admission dataset is 
subtracted from the short-stay dataset, the result is a reduction of the sample size to n=33,079. 
However, the actual number of short-stay assessments was n=38,890, meaning that 5,811 
individuals with a full admission assessment had a prior short stay episode recorded in the 
system. Sociodemographic characteristics and DSM diagnoses of anxiety and depression for 
individuals with either a full admission or short-stay assessment are shown in Table 34.  
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Table 34. Sociodemographic characteristics and DSM psychological diagnoses of inpatients 
aged 18-30 with either a full admission (n=59,717) or short-stay assessment (n=38,890) in 
psychiatric hospitals and units across Ontario, Newfoundland and Labrador, and 
Manitoba between 2005-2019. 
















Less than high school 23.2 (13,867) 23.2 (4,142) 
45.63 (3) 
p<.0001 
High school 29.5 (17,640) 31.7 (5,531) 
Some post-secondary 41.1 (24,508) 38.7 (6,736) 
Marital status 
Married or significant 
other 
10.2 (6,106) 7.3 (2,836) 
245.62 (1)  
p<.0001 
Employment 
Employed 31.1 (18,602) 27.2 (10,572) 
8,143.12 (2) 
p<.0001 
Unemployed 52.6 (31,422) 31.5 (12,267) 
Other/Unknown 16.2 (9,693) 41.3 (16,051) 
Lives alone* 




Primary  4.3 (2,574) 5.6 (2,184) 498.26 (2) 
p<.0001 Non-primary 10.8 (6,478) 6.9 (2,682) 
Depressive 
disorder 
Primary  14.9 (8,894) 8.5 (3,302) 1,171.05 (2) 
p<.0001 Non-primary 3.00 (1,786) 1.5 (583) 
Note. *The education variable was missing for n=21,467 (22%) cases in the short-stay dataset, and n=18,021 (18%) 
cases were missing for lives alone. 
Across both samples, several markers of EA were present across the sample, such as: 
~40% of individuals had some degree of post-secondary education, ~10% were married or had a 
significant other, ~19% lived alone, and ~30% were employed. Sociodemographic characteristics 
between EA with a full admission assessment and a short-stay assessment were significantly 
different, though the greatest difference was observed for the employment variable. Consistent 
with the amount of missing information for the education (22%) and living arrangement (18%) 
variables, those with a short-stay had a greater proportion of ‘other/unknown’ response codes for 
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employment (41.3%). In terms of psychological disorders, 4.3% of EA with a full admission had 
a primary anxiety disorder diagnosis and 10.8% had a non-primary anxiety diagnosis. In contrast, 
5.6% of EA with a short-stay assessment had a primary anxiety diagnosis and 6.9% had a non-
primary disorder, indicating that anxiety disorders are associated with short-stay admissions into 
inpatient psychiatry. Conversely, primary depressive disorders were consistently higher than 
non-primary depressive disorders among EA with full- and short-stay assessments, signalling 
that primary anxiety disorders are uniquely related to short hospital stays. 
 
Figure 28. Percentage of inpatients with primary and any anxiety disorders who have a 
comorbid depressive disorder, and vice versa, among individuals aged 18-30 receiving care 
in psychiatric hospitals and units across Ontario, Newfoundland and Labrador, and 
Manitoba between 2005-2019 (n=65,528). 
Figure 28 illustrates the comorbidity between anxiety and depressive disorders among 
EA. Among individuals with a primary anxiety disorder, 22.9% had a comorbid depressive 
disorder, though this was not statistically significant (χ2[1]=0.10, p=0.75). Although a similar 
percentage of EA with primary depressive disorders had a comorbid anxiety disorder (21%), this 
difference was significant within that group (χ2[1]=375.37, p<.0001). Regarding non-primary 
diagnoses, while 24.2% of individuals with any depressive disorder also had a comorbid anxiety 
disorder, 35.8% of individuals with any anxiety disorder had a comorbid depressive disorder 
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(χ2[1]=1,164.03, p<.0001). This result indicates that anxiety disorders more frequently 
accompany depressive disorders than vice versa. To determine whether the same pattern was true 
for symptoms of anxiety and depression, the quantile scores on both the anxiety scale and DSI 
for individuals diagnosed with any depressive disorder diagnosis and any anxiety disorder are 
displayed below in Figure 29. 
 
Figure 29. Quantile distribution of anxiety scale and DSI scores among inpatients aged 18-
30, with any depressive or anxiety disorder, receiving care in psychiatric hospitals and 
units across Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 
(n=65,528). 
Scores on the DSI were higher than they were on the anxiety scale for EA with either 
depressive or anxiety disorders, suggesting a slightly higher prevalence of depressive symptoms 
in general. However, the anxiety scale still demonstrated higher scores among individuals with 
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4.3.2 Distribution comparisons 
4.3.2.1 Comorbid anxiety and depression  
The weighted Fleiss-Cohen kappa statistic for agreement between severity categories of anxiety 
scale and DSI was k=0.33. Though the kappa statistic was significantly different from zero 
(p<.0001), it was evident that severity of depression and anxiety did not follow the same pattern. 
To determine where deviations in comorbid severity of anxious and depressive symptoms 
occurred, the cross-tabulated distribution of severity categories for each scale was graphically 
illustrated – one with the DSI on the x-axis and another with the anxiety scale on the x-axis. 
These graphs are displayed below in Figures 30 and 31. 
 
Figure 30. Distribution of anxiety scale severity categories across severity categories for the 
DSI among inpatients aged 18-30 receiving care in psychiatric hospitals and units across 







































Figure 31. Distribution of DSI severity categories across severity categories for the anxiety 
scale among inpatients aged 18-30 receiving care in psychiatric hospitals and units across 
Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 (n=65,528). 
Through a visual comparison of Figures 30 and 31, it is evident that EA with symptoms 
of anxiety generally have a similar level of depressive symptoms as well. However, individuals 
with depressive symptoms do not always have a corresponding degree of anxious symptoms, 
reiterating that depression is a more pervasive condition within inpatient psychiatry. Combined 
with the descriptive results demonstrating that depressive disorders are more prevalent in 
psychiatric hospitals, and that symptoms of depression were greater than symptoms of anxiety 
even among those with an anxiety disorder, it appears that anxiety is often treated as a comorbid 






































4.3.2.2 Short-stay hospitalizations 
The relationship between short-stay hospitalizations and symptoms of anxiety were investigated 
among individuals with and without primary anxiety disorders, which are illustrated below in 
Figure 32.  
 
Figure 32. Short-stay hospitalizations among inpatients aged 18-30, by anxious symptom 
severity and anxiety disorder, in psychiatric hospitals and units across Ontario, 
Newfoundland and Labrador, and Manitoba between 2005-2019 (n=98,607). 
There was a significant relationship between severity of anxiety symptoms and short-stay 
hospitalizations in the primary anxiety disorder group (χ2[3]=260.55, p<.0001), non-primary 
anxiety disorder group (χ2[3]=196.11, p<.0001), and no anxiety disorder group (χ2[3]=2,155.78, 
p<.0001). Increasing severity of anxious symptoms was associated with fewer short-stay 
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4.3.2.3 Treatment patterns 
The number of days over the past week in which an individual received at least 15 minutes of 
contact with a psychiatrist, psychologist, and nurse or MD is plotted below in Figures 33-35.  
 
Figure 33. Number of days over the past week in which inpatients aged 18-30 received at 
least 15 minutes of contact with a psychiatrist, by anxious symptom severity and anxiety 
disorder, in psychiatric hospitals and units across Ontario, Newfoundland and Labrador, 
and Manitoba between 2005-2019 (n=65,528). 
There was a significant difference in the number of days with contact from a psychiatrist 
by anxious symptom severity among individuals with no anxiety disorder (χ2[6]=525.03, 
p<.0001), non-primary anxiety disorders (χ2[6]=59.73, p<.0001), and primary anxiety disorders 
(χ2[6]=25.87, p=.0002). If no symptoms of anxiety were present, there were fewer days of 

























































































There was a significant main effect of anxiety disorder diagnosis (χ2[4]=164.04, p<.0001). 
Individuals with a primary diagnosis of anxiety more frequently received care from a 
psychiatrist, while those with a non-primary anxiety disorder had the least amount of contact. 
Overall, contact with a psychiatrist was common for most individuals. 
 
Figure 34. Number of days over the past week in which inpatients aged 18-30 received at 
least 15 minutes of contact with a psychologist, by anxious symptom severity and anxiety 
disorder, in psychiatric hospitals and units across Ontario, Newfoundland and Labrador, 
and Manitoba between 2005-2019 (n=65,528). 
 Anxious symptom severity was significantly related to the number of days with contact 
from a psychologist among individuals with no anxiety disorder (χ2[6]=135.60, p<.0001), non-
primary anxiety disorders (χ2[6]=66.33, p<.0001), and primary anxiety disorders (χ2[6]=16.81, 
p=.01). There was also a significant main effect of anxiety disorder diagnosis (χ2[4]=765.48, 




















































































disorder, with only 7% of those with severe symptoms receiving at least 15 minutes of care. In 
comparison, individuals with anxiety disorders received more frequent contact with a 
psychologist, typically over 1-2 days prior to the admission assessment. Unlike psychiatrists, 
most of the sample did not receive any contact with a psychologist by the time their admission 
assessment had been completed. 
 
Figure 35. Number of days over the past week in which inpatients aged 18-30 received at 
least 15 minutes of contact with a nurse practitioner or MD, by anxious symptom severity 
and anxiety disorder, in psychiatric hospitals and units across Ontario, Newfoundland and 
Labrador, and Manitoba between 2005-2019 (n=65,528). 
The number of days with contact from a nurse practitioner or MD was significantly 
different across categories of symptom severity among individuals with no anxiety disorders 



















































































primary anxiety disorders (χ2[6]=15.38, p=.02). While there was not a linear pattern between 
days of contact and symptom severity in any diagnostic group, individuals with severe symptoms 
of anxiety consistently received more days of formal care from a nurse or MD, though the 
absolute difference was less than 5% in the ‘no anxiety’ and ‘non-primary anxiety’ disorder 
groups. Compared to the other two diagnostic groups, individuals with primary anxiety disorders 
received significantly fewer days of contact with a nurse or MD (χ2[4]=111.50, p<.0001). In 
general, around half of the sample received formal care from a nurse or MD during the week 
prior to their assessment.  
In addition to looking at contact with different types of health professionals, patterns of 
therapy modalities were also examined and are plotted below in Figures 36-39. 
 
Figure 36. Prevalence of individual therapy among inpatients aged 18-30, by anxious 
symptom severity and anxiety disorder, in psychiatric hospitals and units across Ontario, 
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Beginning with individual therapy, there was a significant difference across anxious 
symptom severity categories among individuals with no anxiety disorder (χ2[9]=261.94, 
p<.0001), non-primary anxiety disorders (χ2[9]=45.81, p<.0001), and primary anxiety disorders 
(χ2[9]=35.29, p<.0001). Across all diagnostic groups, individuals presenting with any symptoms 
of anxiety were offered individual therapy more often. Further, there was a significant main 
effect of anxiety disorder diagnosis on individual therapy patterns (χ2[6]=58.08, p<.0001), 
though the absolute difference across groups was small (<3%). Overall, individual therapy was 
commonly received by most individuals in the sample. 
 
Figure 37. Prevalence of group therapy among inpatients aged 18-30, by anxious symptom 
severity and anxiety disorder, in psychiatric hospitals and units across Ontario, 
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The prevalence of group therapy was significantly different across anxious symptom 
severity categories among individuals with no anxiety disorders (χ2[9]=140.57, p<.0001), non-
primary anxiety disorders (χ2[9]=27.95, p=.001), and primary anxiety disorders (χ2[9]=28.22, 
p=.0009). Within the primary anxiety disorder group, individuals with no symptoms of anxiety 
were less frequently offered group therapy, otherwise the pattern was the same when any 
symptoms of anxiety were present. There was also a significant main effect of anxiety disorder 
diagnosis (χ2[6]=624.97, p<.0001), wherein individuals without an anxiety disorder were offered 
group therapy the least often. Compared to individual therapy, group therapy was less frequently 
offered to the whole sample. 
 
Figure 38. Prevalence of family/couple therapy among inpatients aged 18-30, by anxious 
symptom severity and anxiety disorder, in psychiatric hospitals and units across Ontario, 
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For the primary anxiety disorder group (χ2[9]=17.55, p=.04), non-primary anxiety 
disorder group (χ2[9]=62.04, p<.0001), and no anxiety disorder group (χ2[9]=250.50, p<.0001), 
there was a significant difference in family/couple therapy patterns across anxious symptom 
severity categories. For all diagnostic groups, individuals with severe symptoms of anxiety most  
often received family/couple therapy within the week prior to assessment. There was a 
significant main effect of anxiety disorder diagnosis (χ2[6]=70.84, p<.0001), but like individual 
therapy, the absolute difference in family/couple therapy patterns was small (<3%). In most 
cases, family/couple therapy was not offered.  
 
Figure 39. Prevalence of self-help therapy among inpatients aged 18-30, by anxious 
symptom severity and anxiety disorder, in psychiatric hospitals and units across Ontario, 
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There was a significant difference in the prevalence of self-help therapy across anxious 
symptom severity categories among those with no anxiety disorder (χ2[9]=148.62, p<.0001) and 
non-primary anxiety disorders (χ2[9]=25.16, p=.003), but not those with primary anxiety 
disorders (χ2[9]=15.01, p=.09). Despite statistical significance, the absolute difference in self-
help therapy across severity categories was less than 5% in both the non-primary and no anxiety 
groups. Overall, individuals with non-primary anxiety disorders received significantly more self-
help therapy over the previous week than the other two groups (χ2[6]=241.81, p<.0001). 
4.3.2.4 Social resources 
The differences in social resource variables between anxiety disorders and severity of anxious 
symptoms are plotted below in Figures 40-43. 
 
Figure 40. Prevalence of inpatients aged 18-30 who report having no confidant, by anxious 
symptom severity and anxiety disorder, in psychiatric hospitals and units across Ontario, 






























































Anxiety scale severity category
 
 258 
 Reports of not having a confidant were significantly different across categories of 
anxious symptom severity among individuals with no anxiety disorder (χ2[3]=226.62, p<.0001) 
and non-primary anxiety disorders (χ2[3]=49.39, p=.003), but not primary anxiety disorders 
(χ2[3]=6.03, p=.11). In the non-primary and no anxiety disorder groups, not having a confidant 
increased with severity of anxious symptoms.  
 
Figure 41. Prevalence of family/friends who report feeling overwhelmed by the person’s 
illness, by anxious symptom severity and anxiety disorder, among inpatients aged 18-30 
receiving care in psychiatric hospitals and units across Ontario, Newfoundland and 
Labrador, and Manitoba between 2005-2019 (n=65,528). 
Severity of anxious symptoms was significantly associated with family and friends 
feeling overwhelmed in the group with no anxiety disorders (χ2[3]=391.68, p<.0001), non-
primary anxiety disorders (χ2[3]=95.15, p<.0001), and primary anxiety disorders (χ2[3]=39.76, 
p<.0001). Across all diagnostic groups, family and friends reported feeling overwhelmed more 
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effect of anxiety disorder diagnosis (χ2[2]=46.88, p<.0001), wherein fewer family and friends 
reported feeling overwhelmed when the person had a diagnosis of anxiety.  
 
Figure 42. Prevalence of family/friends who are persistently hostile or critical towards the 
person, by anxious symptom severity and anxiety disorder, among inpatients aged 18-30 
receiving care in psychiatric hospitals and units across Ontario, Newfoundland and 
Labrador, and Manitoba between 2005-2019 (n=65,528). 
Although it rarely occurred in the sample, there was a significant difference in persistent 
hostility or criticism towards the person by categories of anxious symptom severity among those 
with no anxiety disorder (χ2[3]=90.74, p<.0001), non-primary anxiety disorders (χ2[3]=47.30, 
p<.0001), and primary anxiety disorders (χ2[3]=14.18, p=.003). In general, hostility or criticism 
















































































Figure 43. Prevalence of staff reporting persistent frustration in dealing with the person, by 
anxious symptom severity and anxiety disorder, among inpatients aged 18-30 receiving 
care in psychiatric hospitals and units across Ontario, Newfoundland and Labrador, and 
Manitoba between 2005-2019 (n=65,528). 
Except for individuals with primary anxiety disorders (χ2[3]=6.93, p=.07), there was a 
significant difference in the prevalence of staff reporting frustration by anxious symptom 
severity among individuals with no anxiety disorder (χ2[3]=299.41, p<.0001) and individuals 
with non-primary anxiety disorders (χ2[3]=25.82, p<.0001). With each increase in severity of 
anxious symptoms, more staff reported feeling frustrated with the person, though like persistent 
hostility or criticism from family and friends, this outcome rarely occurred overall. Further, there 
was a significant difference associated with diagnosis (χ2[2]=29.01, p<.0001), with fewer staff 
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4.3.3 Logistic regression models 
4.3.3.1 Short-stay hospitalizations 
Using the short-stay dataset, the odds of having a short stay of hospitalization were predicted 
using two logistic regression models, which are displayed below in Table 35. 
Table 35. Binary logistic regression models predicting short-stay hospitalizations among 
inpatients aged 18-30 receiving care in psychiatric hospitals and units across Ontario, 
Newfoundland and Labrador, and Manitoba between 2005-2019 (n=98,607). 
Model Variables Variable level 
Parameter 
estimate (SE) 
OR (95% CI) χ2 p value 
1 
Anxiety disorder 
None (ref) n/a n/a n/a 
Non-primary -0.21 (0.02) 0.81 (0.78-0.85) <.0001 
Primary 0.58 (0.03) 1.78 (1.67-1.90) <.0001 
Anxiety scale score 
0 (ref) n/a n/a n/a 
1-3 -0.31 (0.02) 0.73 (0.71-0.76) <.0001 
4-6 -0.72 (0.02) 0.49 (0.47-0.51) <.0001 
7-15 -1.41 (0.03) 0.24 (0.23-0.26) <.0001 
Age Continuous -0.04 (0.00) 0.96 (0.96-0.97) <.0001 
Gender Female 0.21 (0.01) 1.23 (1.20-1.27) <.0001 
2 
Anxiety disorder 
None (ref) n/a n/a n/a 
Non-primary -0.13 (0.02) 0.88 (0.84-0.92) <.0001 
Primary 0.58 (0.03) 1.78 (1.67-1.89) <.0001 
Anxiety scale score 
0 (ref) n/a n/a n/a 
1-3 -0.27 (0.02) 0.77 (0.74-0.79) <.0001 
4-6 -0.66 (0.03) 0.51 (0.49-0.54) <.0001 
7-15 -1.34 (0.03) 0.26 (0.24-0.28) <.0001 
Depressive disorder 
None (ref) n/a n/a n/a 
Non-primary -0.64 (0.05) 0.53 (0.48-0.58) <.0001 
Primary -0.50 (0.02) 0.61 (0.58-0.64) <.0001 
DSI score 
0 (ref) n/a n/a n/a 
1-3 -0.17 (0.02) 0.84 (0.81-0.88) <.0001 
4-7 -0.12 (0.02) 0.89 (0.86-0.93) <.0001 
8-15 -0.24 (0.02) 0.79 (0.75-0.83) <.0001 
Age Continuous -0.04 (0.00) 0.96 (0.96-0.97) <.0001 
Gender Female 0.26 (0.01) 1.30 (1.26-1.33) <.0001 
Note. The c-statistics for model one and model two were c=0.62 and c=0.63, respectively. 
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In the first model, the odds of experiencing a short stay hospitalization were significantly 
higher for individuals with primary anxiety disorders than no anxiety disorder, but lower for 
individuals with non-primary anxiety disorders. This result indicates that hospital stays are 
especially short when anxiety disorders are the primary psychological concern, rather than a 
comorbid one. In terms of the anxiety scale, the odds of short stays were lower for each increase 
in symptom severity. Increasing age was also associated with lower odds of a short stay, while 
women had higher odds. In the second model, the same patterns were observed for variables in 
the first model, but now depressive disorders and increasing severity of depressive symptoms 
were both significantly associated with lower odds of a short stay, indicating that primary 
anxiety disorders are uniquely related to higher odds of short-stay hospitalizations. Compared to 
depressive symptoms, anxious symptom severity had a stronger association with short stay 
outcomes. For example, compared to the group with no symptoms of anxiety, the odds of short-
stay hospitalizations were 74% lower in the group with severe symptoms. In contrast, the same 
ratio for severe symptoms of depression was 21%. Altogether, the odds of short-stay 
hospitalizations are greater when anxiety is ranked as the primary diagnosis, but lower when 
symptoms of anxiety are more severe. 
4.3.3.2 Social resources 
Since anxiety disorders and severity of symptoms appeared to have different relationships with 
social resources, a series of logistic regression models were performed to test this hypothesis. For 
social resource variables that demonstrated significant main effects for both anxiety disorders 
and anxiety symptoms, a third model was tested that included an interaction term between the 
two variables but is not included because interactions were insignificant in all models. Table 36, 
below, shows the logistic regression models predicting reports of not having a confidant.  
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Table 36. Binary logistic regression models predicting ‘reports having no confidant’ among 
inpatients aged 18-30 receiving care in psychiatric hospitals and units across Ontario, 
Newfoundland and Labrador, and Manitoba between 2005-2019 (n=65,528). 
Model Variables Variable level 
Parameter 
estimate (SE) 
OR (95% CI) χ2 p value 
1 
Anxiety disorder 
None (ref) n/a n/a n/a 
Non-primary 0.09 (0.03) 1.09 (1.02-1.17) 0.01 
Primary 0.02 (0.05) 1.02 (0.91-1.13) 0.77 
Anxiety scale score 
0 (ref) n/a n/a n/a 
1-3 0.18 (0.03) 1.19 (1.13-1.26) <.0001 
4-6 0.30 (0.03) 1.36 (1.27-1.44) <.0001 
7-15 0.56 (0.04) 1.76 (1.64-1.89) <.0001 
Age Continuous -0.00 (0.00) 1.00 (0.99-1.00) 0.62 
Gender Female 0.05 (0.02) 1.05 (1.01-1.10) 0.02 
2 
Anxiety disorder 
None (ref) n/a n/a n/a 
Non-primary -0.01 (0.04) 1.00 (0.93-1.07) 0.89 
Primary 0.00 (0.05) 1.00 (0.90-1.12) 0.96 
Anxiety scale 
symptom severity 
0 (ref) n/a n/a n/a 
1-3 0.05 (0.03) 1.05 (1.00-1.11) 0.07 
4-6 0.11 (0.03) 1.11 (1.04-1.19) 0.001 
7-15 0.28 (0.04) 1.33 (1.23-1.43) <.0001 
Depressive disorder 
None (ref) n/a n/a n/a 
Non-primary 0.07 (0.06) 1.08 (0.96-1.20) 0.19 
Primary 0.22 (0.03) 1.24 (1.18-1.32) <.0001 
DSI score 
0 (ref) n/a n/a n/a 
1-3 0.33 (0.03) 1.39 (1.30-1.48) <.0001 
4-7 0.56 (0.03) 1.75 (1.63-1.87) <.0001 
8-15 0.88 (0.04) 2.41 (2.24-2.60) <.0001 
Age Continuous -0.00 (0.00) 1.00 (0.99-1.00) 0.75 
Gender Female -0.04 (0.02) 0.96 (0.92-1.00) 0.04 
Note. The c-statistics for model one and model two were c=0.55 and c=0.60, respectively. 
Whereas non-primary anxiety disorders were significant in the first model (p=.01), they 
were insignificant in the second (p=.96). Further, primary anxiety disorders were insignificant in 
both models. In model one, each increase in anxious symptom severity led to greater odds of not 
having a confidant (p<.0001). In model two, mild anxiety (1-3) scores were no longer significant 
(p=.07), though moderate and severe anxiety were still positively predictive of not having a 
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confidant (p=.001 and p<.0001, respectively). In contrast, having a primary depressive disorder 
(p<.0001), as well as increasing severity of depressive symptoms (p<.0001), significantly 
increased the odds of not having a confidant, demonstrating that depression has a stronger effect 
than anxiety. Age was insignificant in both models, and though gender was significant in model 
one (p=.02), it was no longer significant in model two (p=.04).  
Table 37. Binary logistic regression models predicting ‘family/close friends report feeling 
overwhelmed by person’s illness’ among inpatients aged 18-30 receiving care in psychiatric 
hospitals and units across Ontario, Newfoundland and Labrador, and Manitoba between 
2005-2019 (n=65,528). 
Model Variables Variable level 
Parameter 
estimate (SE) 
OR (95% CI) χ2 p value 
1 
Anxiety disorder 
None (ref) n/a n/a n/a 
Non-primary -0.10 (0.03) 0.90 (0.86-0.95) <.0001 
Primary -0.33 (0.04) 0.72 (0.66-0.78) <.0001 
Anxiety scale score 
0 (ref) n/a n/a n/a 
1-3 0.19 (0.02) 1.22 (1.17-1.26) <.0001 
4-6 0.33 (0.02) 1.39 (1.33-1.46) <.0001 
7-15 0.62 (0.03) 1.87 (1.77-1.97) <.0001 
Age Continuous -0.01 (0.00) 0.99 (0.98-0.99) <.0001 
Gender Female -0.29 (0.02) 0.75 (0.73-0.77) <.0001 
2 
Anxiety disorder 
None (ref) n/a n/a n/a 
Non-primary -0.08 (0.03) 0.93 (0.88-0.97) 0.004 
Primary -0.37 (0.04) 0.69 (0.63-0.75) <.0001 
Anxiety scale score 
0 (ref) n/a n/a n/a 
1-3 0.17 (0.02) 1.18 (1.14-1.22) <.0001 
4-6 0.27 (0.02) 1.31 (1.25-1.37) <.0001 
7-15 0.54 (0.03) 1.71 (1.62-1.81) <.0001 
Depressive disorder 
None (ref) n/a n/a n/a 
Non-primary 0.12 (0.04) 1.13 (1.04-1.22) 0.004 
Primary -0.44 (0.02) 0.64 (0.62-0.67) <.0001 
DSI score 
0 (ref) n/a n/a n/a 
1-3 0.15 (0.02) 1.18 (1.13-1.23) <.0001 
4-7 0.19 (0.02) 1.23 (1.17-1.28) <.0001 
8-15 0.24 (0.03) 1.31 (1.24-1.38) <.0001 
Age Continuous -0.01 (0.00) 0.99 (0.98-0.99) <.0001 
Gender Female -0.27 (0.02) 0.76 (0.74-0.79) <.0001 
Note. The c-statistics for model one and model two were c=0.57 and c=0.58, respectively. 
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In model one, both anxiety disorders (p<.0001) and anxious symptom severity scores 
(p<.0001) were significant predictors of family and friends feeling overwhelmed. However, 
while anxiety disorders were associated with lower odds of feeling overwhelmed, each increase 
in anxious severity resulted in higher odds, indicating that having a diagnosis of anxiety might be 
a protective factor. Increasing age and female gender were also significantly associated with 
lower odds of family and friends feeling overwhelmed (p<.0001). In model two, all variables 
from model one remained significant. Like anxious symptoms, increasing severity of depressive 
symptoms resulted in greater odds of family and friends feeling overwhelmed (p<.0001). 
However, unlike non-primary anxiety disorders, non-primary depressive disorders increased the 
odds of family and friends feeling overwhelmed (p=.004), illustrating that diagnosis is not 
always a protective factor.  
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Table 38. Binary logistic regression models predicting ‘family/friends are persistently 
hostile towards or critical of person’ among inpatients aged 18-30 receiving care in 
psychiatric hospitals and units across Ontario, Newfoundland and Labrador, and 
Manitoba between 2005-2019 (n=65,528). 
Model Variables Variable level 
Parameter 
estimate (SE) 
OR (95% CI) χ2 p value 
1 
Anxiety disorder 
None (ref) n/a n/a n/a 
Non-primary 0.11 (0.06) 1.12 (1.00-1.26) 0.05 
Primary -0.15 (0.10) 0.86 (0.71-1.05) 0.13 
Anxiety scale score 
0 (ref) n/a n/a n/a 
1-3 0.09 (0.05) 1.10 (1.00-1.21) 0.06 
4-6 0.29 (0.06) 1.33 (1.19-1.49) <.0001 
7-15 0.64 (0.06) 1.90 (1.69-2.14) <.0001 
Age Continuous -0.00 (0.00) 1.00 (0.98-1.01) 0.39 
Gender Female 0.28 (0.04) 1.32 (1.22-1.43) <.0001 
2 
Anxiety disorder 
None (ref) n/a n/a n/a 
Non-primary 0.07 (0.06) 1.07 (0.95-1.20) 0.27 
Primary -0.17 (0.10) 0.85 (0.69-1.03) 0.10 
Anxiety scale score 
0 (ref) n/a n/a n/a 
1-3 0.01 (0.05) 1.01 (0.92-1.12) 0.78 
4-6 0.15 (0.06) 1.16 (1.04-1.31) 0.01 
7-15 0.43 (0.06) 1.54 (1.36-1.75) <.0001 
Depressive disorder 
None (ref) n/a n/a n/a 
Non-primary 0.05 (0.10) 1.05 (0.87-1.27) 0.59 
Primary -0.01 (0.05) 0.99 (0.90-1.09) 0.84 
DSI score 
0 (ref) n/a n/a n/a 
1-3 0.11 (0.06) 1.12 (1.00-1.26) 0.06 
4-7 0.31 (0.06) 1.36 (1.21-1.54) <.0001 
8-15 0.61 (0.07) 1.85 (1.62-2.10) <.0001 
Age Continuous -0.00 (0.00) 1.00 (0.98-1.01) 0.41 
Gender Female 0.22 (0.04) 1.25 (1.15-1.35) <.0001 
Note. The c-statistics for model one and model two were c=0.57 and c=0.59, respectively. 
In model one, anxiety disorders did not significantly predict reports of hostility or 
criticism of the person from family or friends (p>.05). Mild symptoms of anxiety were also 
insignificant (p=.06), though moderate and severe symptoms of anxiety resulted in greater odds 
of hostility or criticism (p<.0001). Additionally, whereas age was not a significant predictor 
(p=.39), women had greater odds of reporting hostility or criticism from their family and friends 
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(p<.0001). In model two, moderate-severe symptoms of anxiety and gender remained significant. 
Like anxiety, depressive disorders and mild symptoms of depression were not a significant  
predictor of hostility or criticism from family and friends (p>.05), though moderate and severe 
symptoms of depression were (p<.0001).  
Table 39. Binary logistic regression models predicting ‘staff reports persistent frustration 
in dealing with person’ among inpatients aged 18-30 receiving care in psychiatric hospitals 
and units across Ontario, Newfoundland and Labrador, and Manitoba between 2005-2019 
(n=65,528). 




OR (95% CI) χ2 p value 
1 
Anxiety disorder 
None (ref) n/a n/a n/a 
Non-primary -0.42 (0.07) 0.66 (0.57-0.75) <.0001 
Primary -0.58 (0.11) 0.56 (0.45-0.70) <.0001 
Anxiety scale 
score 
0 (ref) n/a n/a n/a 
1-3 0.18 (0.05) 1.20 (1.09-1.33) 0.0003 
4-6 0.51 (0.06) 1.67 (1.50-1.86) <.0001 
7-15 0.94 (0.06) 2.56 (2.29-2.87) <.0001 
Age Continuous -0.01 (0.00) 0.99 (0.98-1.00) 0.07 
Gender Female 0.08 (0.04) 1.09 (1.01-1.17)  0.03 
2 
Anxiety disorder 
None (ref) n/a n/a n/a 
Non-primary -0.32 (0.07) 0.73 (0.63-0.83) <.0001 
Primary -0.59 (0.11) 0.56 (0.45-0.69) <.0001 
Anxiety scale 
score 
0 (ref) n/a n/a n/a 
1-3 0.21 (0.05) 1.23 (1.11-1.36) <.0001 
4-6 0.53 (0.06) 1.69 (1.51-1.90) <.0001 
7-15 0.96 (0.06) 2.60 (2.31-2.94) <.0001 
Depressive 
disorder 
None (ref) n/a n/a n/a 
Non-primary -0.32 (0.11) 0.73 (0.58-0.90) 0.004 
Primary -0.76 (0.06) 0.47 (0.41-0.53) <.0001 
DSI score 
0 (ref) n/a n/a n/a 
1-3 0.01 (0.05) 1.01 (0.91-1.12) 0.90 
4-7 -0.00 (0.06) 1.00 (0.89-1.12) 0.95 
8-15 -0.05 (0.07) 0.95 (0.83-1.08) 0.45 
Age Continuous -0.01 (0.00) 0.99 (0.98-1.00) 0.05 
Gender Female 0.16 (0.04) 1.17 (1.08-1.26) <.0001 
Note. The c-statistics for model one and model two were c=0.59 and c=0.62, respectively. 
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In model one, anxiety disorders were associated with lower odds of staff reporting 
frustration with the person (p<.0001). However, increasing severity of anxious symptoms 
resulted in greater odds of staff frustration (p<.0003), indicating once again that anxiety 
diagnoses can potentially confer protective effects. Although age was insignificant (p=.07), the 
odds of staff reporting frustration were higher for women than men (p=.03). In model two, all 
variables retained their significance level. Both non-primary (p=.004) and primary depressive 
disorders demonstrated significantly lower odds of staff frustration (p<.0001). However, 
depressive symptoms were not significant predictors of staff frustration at any level (p>.05), 
demonstrating that anxiety is uniquely associated with poor therapeutic alliance.  
4.4 Discussion 
4.4.1 Summary and implications 
To date, because primary anxiety disorders have been relatively rare in inpatient psychiatry, 
there has been limited capacity to gain the information necessary for establishing best care 
practices (Bandelow & Michaelis, 2015). Additional considerations need to be made when 
treating EA, since the first onset for many anxiety disorders occurs during this time (de Lijster et 
al., 2017; Kessler et al., 2007), but typically go untreated until symptoms of comorbid depression 
appear (Bandelow & Michaelis, 2015; Essau, 2005; Mackenzie et al., 2012; Preisig et al., 2001). 
To ensure that psychiatric hospitals are better equipped to provide coordinated care for EA 
presenting with anxiety, this chapter investigated three research questions covering the 
comorbidity between anxiety and depression, short-stay hospitalization outcomes, treatment 
patterns, and social resources. EA with primary anxiety disorders had lower odds of full 
admission into inpatient psychiatry, as anxiety is typically treated in these settings as a comorbid 
condition. However, while a primary anxiety diagnosis may lead to shorter hospital stays, it is 
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associated with positive treatment patterns and informal social resources once in hospital, 
highlighting the need to assess symptoms to better identify anxiety among those without a 
diagnosis. As more Canadian youth present to EDs for treatment related to anxiety (Aratani & 
Addy, 2014; Brien et al., 2015; CIHI, 2020; Gandhi et al., 2016; Juhás & Agyapong, 2016), it is 
important that anxiety is recognized and care pathways from the ED are well-established, 
improving coordination of care and preventing over-utilization of emergency resources. 
 A higher proportion of primary anxiety disorders in the ED demonstrates that EA are 
seeking treatment for this condition, yet they are not receiving consistent care in other mental 
health settings. To understand existing pathways into inpatient psychiatric care among EA with 
anxiety, examination of depression was required as well, given that depression has been shown 
to influence health service use among those with anxiety (Bandelow & Michaelis, 2015; Essau, 
2005; Mackenzie et al., 2012; Preisig et al., 2001). Consistent with previous health research, the 
results of this study found that anxiety disorders were more frequently comorbid with depressive 
disorders than the other way around, and that while individuals with symptoms of anxiety had 
comparable levels of depressive symptoms, EA with depression had varying levels of anxiety. 
Since primary anxiety disorders were present in only 4% across the sample, it is evident that 
anxiety is typically treated in hospital only when it is a comorbid condition. Given this 
association, it was expected that anxiety diagnoses would predict short-stay hospitalization 
outcomes differently depending on the order in which they were ranked. This hypothesis was 
correct, as the odds of short-stay hospitalizations were greater for primary anxiety disorders but 
lower for non-primary anxiety disorders. Further, both primary and non-primary depressive 
disorders demonstrated lower odds of short-stay hospitalizations, confirming that primary 
anxiety disorders are uniquely associated with short admissions into hospital. However, greater 
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severity of anxious symptoms increased the odds of full admissions into inpatient psychiatry, 
regardless of diagnostic status. This means that even though fewer EA receive inpatient 
psychiatric care when anxiety is identified as their primary concern, they may still be admitted 
when they present with anxious symptoms, especially the more severe that they are. 
Additionally, the results demonstrate the importance of including the anxiety scale in addition to 
diagnosis when analyzing health service utilization, as meaningful variations in access will 
otherwise be overlooked.  
 Once EA with anxiety did receive inpatient care, they were not allocated fewer 
psychiatric resources than others. However, in some cases, diagnostic status was associated with 
slightly more professional consultative services, regardless of symptom severity. For instance, 
those with primary anxiety disorders had more contact with psychiatrists and psychologists, even 
when their scores on the anxiety scale were low. Additionally, individuals with primary anxiety 
disorders received individual, group, and family/couple therapy either more or just as recently as 
those with non-primary and no anxiety disorders. In contrast, less contact with nurse 
practitioners and MDs was observed when anxiety disorders were the primary diagnosis, which 
was unexpected given that medical resource utilization tends to be higher than other types of 
health care for individuals with anxiety disorders (Horenstein & Heimberg, 2020). It is possible 
that contact with psychiatrists was sufficient in meeting the pharmacological needs associated 
with anxiety, and that somatic health symptoms were recognized as indicators of anxiety rather 
than underlying medical conditions, and so less consultation with a nurse or MD was required. 
As well as diagnosis, increasing severity of anxious symptoms were also associated with a 
greater level of treatment, though this pattern was not as consistent as diagnosis. For example, 
individuals with no anxiety disorder - but a severe score on the anxiety scale - received less 
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contact with a psychologist than those with a primary anxiety disorder and no symptoms of 
anxiety. Similarly, those with non-primary anxiety disorders and severe symptoms of anxiety 
received a similar degree of consultation with a psychiatrist as individuals with a primary anxiety 
disorder but no symptoms of anxiety. These patterns indicate that diagnosis may be an influential 
factor in receiving psychological treatment among EA, representing an important barrier to 
accessibility of care. Altogether, because most EA with anxiety received consultative services 
from a psychiatrist, as well as individual psychotherapy, it appears that psychiatric hospitals are 
generally following best care practice recommendations for treatment of anxiety disorders 
(Andrews et al., 2018; Bandelow et al., 2015). 
 While diagnosis and symptoms of anxiety generally shared a similar pattern for treatment 
interventions, there are still benefits of receiving a diagnosis when it comes to social resources. 
For instance, primary anxiety disorders demonstrated a protective effect against family and 
friends feeling overwhelmed by the person’s illness, as well as staff reporting frustration in their 
interactions with the person. In contrast, increasing severity of anxious symptoms led to greater 
odds of not having a confidant, family and friends feeling overwhelmed, persistent hostility or 
criticism from family and friends, and staff reporting frustration. These results indicate that the 
presence of a diagnosis can positively affect social resources in a person’s life, even when 
symptoms of anxiety are more severe. There are various possible reasons that diagnoses could be 
helpful for social relations, such as contributing towards better understanding of what the person 
is experiencing and helping to establish treatment plans, which may reduce conflict and the sense 
of feeling overwhelmed. While this could be true to some extent for psychological disorders 
generally, differential effects between diagnosis and symptoms on social resources were unique 
to anxiety in two instances: staff reporting frustration and family and friends feeling 
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overwhelmed. Whereas symptoms of anxiety increased the odds of staff reporting frustration, 
depressive symptoms were insignificant. Since staff rarely reported frustration overall, it is 
difficult to determine the reason for this relationship. One potential explanation could be that 
because anxiety is not typically treated in psychiatric hospitals (Bandelow & Michaelis, 2015), 
this leads to some uncertainty in how to identify and approach treatment for these symptoms. 
The second unique effect of anxiety was that non-primary diagnoses did not contribute towards 
family and friends feeling overwhelmed, unlike non-primary diagnoses of depression. It is 
unclear why non-primary diagnoses of depression demonstrated a different pattern than anxiety, 
though it may involve differences in the level of functional impairment, which is typically more 
severe among those with depression (Cummings et al., 2014). Additionally, differences in social 
resources were also observed across gender, with more interpersonal conflict reported among 
women than men, suggesting that interpersonal responses to anxiety must also account for 
gender-based differences. Overall, incorporating social resource variables into mental health care 
is an essential component of treatment (Andrews et al., 2018; MHCC, 2016; Webster et al., 
2012), especially for women and EA who are experiencing recent onset of anxious symptoms but 
are not yet diagnosed, as the results of this study suggest that they may be especially vulnerable 
to sources of interpersonal conflict. 
Beyond contributing new knowledge on service use and treatment patterns for anxiety in 
psychiatric hospitals and units, the results of this study illustrate how measurement-based care 
can be used to advance the research and data-gathering recommendation proposed by the MHCC 
(2019) for improving mental health care of EA. Using interRAI assessment data, differences in 
health care accessibility among EA with anxiety disorders and symptoms were able to be 
identified, enabling mental health systems to recognize and respond to these trends. For EA with 
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primary anxiety disorders, it is evident that continuity of care is a major challenge, as they have 
lower odds of receiving inpatient psychiatric care after visiting the ED. At the same time, they 
are also less likely to receive mental health care in the community (Horenstein & Heimberg, 
2020; O’Donnell et al., 2017; Somers et al., 2006), meaning that primary care and ED settings 
may be the only settings where they can readily receive treatment. Consequently, ED visits 
involving anxiety are growing among EA (Brien et al., 2015; CIHI, 2020; Gandhi et al., 2016), 
which are struggling to maintain capacity for psychiatric visits as is (Baia Medeiros et al., 2019; 
CIHI, 2019b). To resolve this issue, mental health systems must develop ongoing community 
care interventions for EA with primary anxiety disorders following ED visits, which can be 
supported through the interRAI ESP and CMH assessments. At the same time, since anxiety is 
rising in the ED, psychiatric hospitals are also likely to observe greater frequencies of anxious 
symptoms. Therefore, in addition to developing strategies to improve accessibility of community 
mental health, mental health systems should also focus on establishing care guidelines for 
anxiety in psychiatric hospitals using data from the RAI-MH. 
Within the interRAI suite of assessment instruments, a major implication arising from 
this study is that both diagnosis and symptoms are needed to effectively address anxiety in health 
research and care planning. For each set of analyses in this chapter, measuring anxious 
symptoms contributed important information that either enriched the knowledge obtained from 
diagnosis, or revealed an entirely different pattern. For instance, the anxiety scale demonstrated 
that increasing severity of anxious symptoms was associated with full admission into psychiatric 
hospitals, as well as greater susceptibility to lack of social resources, where anxiety diagnoses 
suggested the opposite. Since many anxiety disorders have an average age-of-onset beginning in 
the mid-20s (de Lijster et al., 2017; Kessler et al., 2007), it is crucial that symptoms of anxiety 
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are incorporated into assessments and care planning for EA, as they may not yet have an anxiety 
diagnosis, or could be treated for other primary concerns such as depression. Anxious symptom 
severity also provided greater detail on treatment patterns than diagnosis alone, which is 
important when examining quality of care and resource allocation. This is especially relevant for 
individuals who do not have a diagnosed anxiety disorder but still experience symptoms of 
anxiety, as they received less treatment in some cases than individuals with a diagnosis but fewer 
symptoms of anxiety. Considering the differences observed between diagnosis and symptoms in 
predicting service use outcomes and informal social supports, this study highlights the benefits of 
including an anxiety scale in the interRAI assessment instruments. 
4.4.2 Strengths and limitations 
This study offers novel insight into psychiatric inpatient treatment for EA with anxiety, 
providing a more thorough understanding of how care is accessed, as well as treatment patterns 
and social resources related to anxious symptom severity. Since primary anxiety disorders are 
rare in psychiatric hospitals, there is little research available that examines this population 
(Bandelow & Michaelis, 2015), which is compounded further when focusing on EA due to high 
rates of disengagement from treatment (Edlund et al., 2002; MHCC, 2015). In this study, the 
relationship between anxiety and depression in accessing psychiatric hospital treatment among 
EA was illuminated, revealing that anxiety is more frequently treated as a comorbid condition to 
depression, despite having an earlier age-of-onset (Cummings et al., 2014; de Graaf et al., 2003; 
Ferdinand et al., 2005). As well as describing pathways into care, the results from this study can 
be used to improve care outcomes and social relationships. Given that diagnoses increased access 
to some treatment interventions and improved social relationships, this study articulates the value 
of recognizing anxiety among EA receiving care in psychiatric hospitals. Identifying anxiety, in 
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the absence of an existing diagnosis, can be facilitated using the anxiety scale developed in the 
third chapter of this dissertation, marking another major strength of this study. Using the anxiety 
scale, it was possible to understand how severity of anxious symptoms influenced care patterns, 
such as increasing full admissions into psychiatric hospitals and treatment resources, as well as 
adverse effects on social relationships. The unique effects of anxious symptom severity on 
numerous dependent variables further served to showcase the utility of the initial anxiety scale. 
Finally, the use of RAI-MH data provided by OMHRS ensured comprehensive analysis of 
anxiety in inpatient psychiatric units and hospitals across Ontario, which is especially important 
given the rarity of anxiety disorders in these settings. Overall, this study offered new information 
on treatment of anxiety in psychiatric care settings, contributing towards measurement-based 
care for EA with anxiety. 
 While this study was able to determine how recently EA received contact from a 
psychiatrist, psychologist, and nurse practitioner or MD, as well as engagement in individual and 
group therapy, it was unknown what the nature of the treatment was. For individuals diagnosed 
with anxiety, recommended interventions include individual CBT and pharmacotherapy 
(Andrews et al., 2018; Bandelow et al., 2015). Since most of the sample was offered individual 
therapy and contact with a psychiatrist, it is possible that CBT and pharmacotherapy were 
regularly delivered, but this cannot be fully determined. Similarly, while short-stay 
hospitalizations were able to be analyzed, they do not represent those individuals who accessed 
the ED but were not admitted for any inpatient care. Considering the disparity between primary 
anxiety disorders in the ED and psychiatric hospitals in chapter two of this dissertation, it is 
likely that many EA with primary anxiety are discharged back into the community following ED 
visits. Comparing EA with primary anxiety who were admitted for short-stay inpatient care to 
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those discharged back into the community following an ED visit could illuminate the risk and 
protective factors for admission, but this outcome could not be examined. Another limitation that 
this study was not able to address was engagement in mental health treatment following 
discharge from psychiatric hospitals, which would be useful for determining coordination of 
care. The previous two limitations can be addressed in further research by linking interRAI 
assessment datasets together. 
4.4.3 Future research 
Given that this study found that treatment patterns varied by anxiety disorder and anxious 
symptom severity, the next step would be to examine whether these differences affect change in 
symptoms over time. In particular, individuals with severe symptoms of anxiety received fewer 
resources when they had no anxiety disorder diagnosis, and so it would be useful to determine 
whether they also demonstrate less improvement in anxious symptoms over time due to lower 
resource allocation. As alluded to in the limitations section, a promising direction for ongoing 
research involves linking interRAI datasets to examine continuity of care across settings. By 
including data from ESP assessments, EA who are not admitted for any inpatient psychiatric care 
can be compared to those who are admitted for short-stay hospitalizations, providing greater 
depth of information on pathways into care. Similarly, longitudinal trends could be examined 
among EA who receive community mental health care before or after psychiatric hospitalization, 
enabling identification of factors that promote ongoing engagement in treatment, as well as 
longer-term effects of treatment interventions on mental health symptoms. If psychiatric 
hospitals are not an appropriate setting for treating anxiety, then collaboration between ED and 
community mental health agencies is essential for responding to the needs of EA accessing 
emergency care for anxiety, which could be researched by linking ESP and CMH assessments. 
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Finally, examining care pathways for anxiety among EA transitioning from the child and youth 
to the adult mental health system will be possible as more interRAI ChYMH assessments are 
completed in the future, which is needed to explore patterns of disengagement from treatment 
that result from policy disruptions.  
4.4.4 Conclusions 
Mental health care systems that effectively serve the needs of EA require integration between 
service providers, ensuring that individuals have access to ongoing care that matches their level 
of need and promotes their long-term well-being, as prolonged delays between development of 
anxious symptoms and consistent mental health treatment have been associated with worse 
clinical prognosis (Horenstein & Heimberg, 2020). Coordinated care is also necessary for 
preventing over-utilization of emergency resources (CMHA, 2008; MHCC, 2015; MHCC, 
2016), which is a growing issue as more Canadian youth present to EDs for treatment related to 
anxiety (Aratani & Addy, 2014; Brien et al., 2015; CIHI, 2020; Gandhi et al., 2016; Juhás & 
Agyapong, 2016). Given increases in anxiety among youth presenting to the ED, psychiatric 
hospitals across Canada need to prepare for potential increases in anxiety as well. Traditionally, 
anxiety is treated in psychiatric hospital units as a comorbid psychological condition, frequently 
alongside depression. As a result, while non-primary anxiety disorders and severity of anxious 
symptoms are related to full admissions into inpatient care, individuals with primary anxiety 
disorders experience short stays. Despite lower odds of being admitted for inpatient psychiatric 
care, EA with primary anxiety disorders did not receive fewer treatment resources while in 
hospital. However, in some cases, treatment was lower for individuals with no anxiety disorder 
diagnosis but severe symptoms of anxiety, demonstrating the importance of diagnosis in resource 
allocation. Further, primary anxiety diagnoses were protective against adverse effects on social 
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resources in one’s life, even as increasing severity of anxious symptoms were associated with 
interpersonal challenges. Differences in treatment and social resource outcomes between 
individuals with and without anxiety disorder diagnoses highlight the need to measure symptoms 
as part of care planning. By improving recognition of anxious symptoms, mental health systems 






5.1 Summary of dissertation 
Between the ages of 18-29, EA undergo several major life transitions (Arnett, 2000; Arnett, 
2007; Arnett et al., 2014), while also demonstrating high rates of psychological distress (Drapeau 
et al., 2014), lower mood and daily vigour (McNeil et al., 1994), and new onset of various 
psychological disorders (APA, 2013; Kessler et al., 2007; Pearson et al., 2013; Schulenberg & 
Zarrett, 2006; Smetanin et al., 2011). Despite greater need for mental health care, EA 
consistently report low rates of mental health treatment (SAMHSA, 2012; Statistics Canada, 
2012), as well as higher rates of treatment attrition than other age groups (Edlund et al., 2002). 
To determine which systemic factors may be responsible for reducing mental health treatment 
among EA, the MHCC released two policy reports focused on this issue. Several factors were 
identified as obstacles for attaining ongoing care, such as the transition between the youth and 
adult mental health systems, poor integration between service providers, and lack of mental 
health research initiatives focused on EA. To resolve these problems, the MHCC published four 
priority policy recommendations for improving mental health care of EA, two of which are 
coordination of care across service settings and enhancing national infrastructure for research 
and data gathering. This dissertation contributed to both these recommendations using a 
measurement-based care approach (Aboraya et al., 2018; Connors et al., 2021; Kilbourne et al., 
2018; Scott & Lewis, 2015) and assessment data obtained from interRAI mental health 
instruments, identifying gaps in coordination of care between psychiatric EDs, hospital, and 
community mental health settings among EA.  
 
 280 
To better understand the clinical needs of EA receiving mental health care in psychiatric 
hospitals and units, EDs, and community mental health agencies, the second chapter of this 
dissertation used interRAI assessment data to examine the characteristics of EA receiving 
treatment in these settings. While some differences were observed across age groups within EA, 
most of the clinical variation was related to care setting. For instance, psychiatric hospitals 
demonstrated stronger patterns of acute illness and risk of danger, while EA receiving treatment 
in community settings had higher frequencies of functional impairment and symptoms of 
depression and social withdrawal. Those accessing the ED had characteristics that corresponded 
more closely with needs observed in the general population, such as higher frequencies of 
primary anxiety, neurodevelopmental, and personality disorders. Considering the widespread 
prevalence of anxiety disorders in the general population (Kessler et al., 2007) and post-
secondary institutions (ACHA, 2016; Bayram & Bilgel, 2008; Beiter et al., 2015; Macaskill, 
2013), the service pattern results of this study suggests that continuity of care among EA with 
anxiety is especially problematic.  
Although there is an urgent need to investigate anxiety in mental health care settings, it is 
challenging to adequately research this construct, as anxiety disorders are one of the most 
heterogeneous psychological diagnostic categories (APA, 2015; WHO, 1992). Nonetheless, 
because there are limitations to using diagnosis as the sole indicator of anxiety in research and 
clinical practice, the third chapter of this dissertation constructed a general anxiety symptoms 
scale. Using the HARS (Hamilton, 1959) and BAI (Beck & Steer, 1988) as a guide, six 
psychological and five somatic health variables from the RAI-MH were selected for the initial 
item pool in deriving an interRAI anxiety scale. Results from factor analyses suggested that a 
unidimensional scale consisting of only psychological indicators was the best fit for the data, 
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with weak factor loadings observed for all somatic health items. Among the six psychological 
indicators, both IRT and LCA analyses indicated that compulsive behaviour was not a strong 
contributor to anxiety, and so a five-item version of the continuous psychological indicators scale 
was created that excluded this item. After testing several alternate versions of the anxiety scale 
using logistic regression models, the five-item continuous scale was chosen as the final 
candidate, as it produced the best balance between model fit and parsimony. Criterion validity of 
this initial scale was supported by its relationship with concurrent indicators and discriminant 
measures of depression. Further evidence of validity for the anxiety scale was demonstrated by 
responsiveness to change over time. While future work may lead to some refinements to the 
anxiety scale, the initial version can be used to support research initiatives and clinical practice.  
An immediate research opportunity involving the interRAI anxiety scale in chapter four 
was to examine continuity of care for EA with primary anxiety disorders in psychiatric hospitals, 
which has historically been challenging to investigate due to small sample sizes (Bandelow & 
Michaelis, 2015). Overall, anxiety disorders and symptoms were frequently comorbid with 
depression, indicating that anxiety is typically treated alongside this condition. Consequently, 
primary anxiety disorders reduced the odds of hospital stays lasting at least three days, while 
increasing severity of anxious symptoms increased those odds. Once in hospital, EA with anxiety 
disorders and symptoms generally received comparable treatment resources as those without 
anxiety. However, individuals with more severe anxiety symptoms received slightly less contact 
with mental health professionals when they did not have an anxiety disorder, indicating the 
importance of diagnosis. Disparities between diagnoses and symptoms of anxiety were especially 
evident for social resources, with diagnoses conferring some protective effects. Altogether, it is 
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essential that inpatient service providers assess symptoms of anxiety when they are formulating 
care plans, as anxious symptoms may be overlooked.  
Altogether, each chapter of this dissertation contributes towards a broader understanding 
of clinical needs and service use patterns among EA receiving mental health care in Canada, as 
well as demonstrating how policy decision-makers and researchers can use clinical assessment 
data to identify gaps in service provision across care settings. In particular, the results revealed 
an urgent need to address mental health care for EA with primary anxiety concerns, as they are 
especially susceptible to disruptions in ongoing care and informal social support resources. The 
implications of these findings for mental health care systems and research, as well as 
recommendations for ongoing work, are described in the following sections. 
5.2 Implications and recommendations for mental health care of EA  
5.2.1 Policy and system design 
As per the Canada Health Act, all citizens must be provided with health care that is publicly 
administered, comprehensive, universal, portable, and accessible (Health Canada, 2021). 
However, because community mental health services are not covered under Ontario’s provincial 
health insurance plan for those over the age of 18 (Government of Ontario, 2021b), mental health 
care is neither fully universal nor accessible. Further, the transition into the adult mental health 
system is particularly disruptive to EA, leading to disengagement from mental health treatment 
(MHCC, 2015; MHCC, 2016). The results from this dissertation provide suggestions for policy 
revision covering mental health care of EA in two areas: 1) establishing service pathways for EA 
with primary anxiety concerns and, 2) adopting a measurement-based care model for system 
performance evaluation and the interRAI suite of mental health assessment instruments.  
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The results of this dissertation suggest that accessibility of mental health services are 
influenced by the administrative structure of care settings, creating gaps in continuity of care that 
can be solved through service restructuring and funding for community mental health. These 
gaps were exacerbated among individuals with specific types of mental health needs, such as EA 
with primary anxiety and personality disorders, who were disproportionately represented in the 
ED. This pattern indicates that psychiatric hospital units and community mental health agencies 
are not structured to meet the needs of all EA seeking mental health care, leading to overuse of 
the ED (CMHA, 2008). Examination of care pathways into inpatient psychiatry among EA 
revealed that while primary diagnoses of anxiety led to shorter hospital stays, non-primary 
diagnoses had the opposite effect, demonstrating that anxiety is not usually the main focus of 
psychiatric intervention. It is possible that psychiatric hospitals are not the optimal setting for 
treating primary anxiety, in which case, short stays may not necessarily be an inappropriate 
outcome. Instead, a combination of counselling and pharmacological treatment in the community 
is likely the most suitable care plan following discharge from the ED (Roberge et al., 2011). 
However, community mental health is often inaccessible to EA with primary anxiety disorders, 
due in part to financial barriers and system-related factors (CMA & CPA, 2016; O’Donnell et al., 
2017; Roberge et al., 2011; Sunderland & Findlay, 2013). Without access to community mental 
health treatment or a primary care doctor, youth and EA struggling with anxiety may have no 
recourse but to visit the ED when they need help managing their symptoms. As EDs across 
Canada are currently struggling to meet the capacity for psychiatric treatment (Baia Medeiros et 
al., 2019), especially among youth and EA (Brien et al., 2015; CIHI, 2017b; CIHI, 2020), 
resourcing problems are likely to worsen as more youth seek mental health treatment over time 
(CIHI, 2020; Gandhi et al., 2016; Wiens et al., 2020). Although funding for community mental 
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health programs is limited in Ontario (CIHI, 2019b), it is recommended that Ontario Health 
invest in community-based services that specialize in treating anxiety among EA, as well as 
ensuring that these services are integrated with partner EDs to support the referral process. 
In addition to increasing accessibility of mental health services, policy makers can use the 
methods established in this dissertation to ensure that data-driven decision-making is integrated 
into national and provincial research strategies. To promote an evidence-based approach to 
mental health system planning in Ontario, the Mental Health and Addictions Centre of 
Excellence of Ontario Health (Kurdyak & Clark, 2021) recommended the adoption of a 
measurement-based care approach. Measurement-based care proposes that the clinical 
assessment data gathered during treatment serve as the basis for evaluating service provision and 
system performance (Aboraya et al., 2018; Connors et al., 2021; Kilbourne et al., 2018; Scott & 
Lewis, 2015). Using interRAI assessment data, this dissertation applied the principles of 
measurement-based care to reveal clinical needs and gaps in service use among EA receiving 
psychiatric treatment in different settings, showcasing the utility of this approach for informing 
responsive system design. In addition to benefiting regional health systems that have mandated 
health assessment tools, measurement-based care can provide globally valuable health service 
research. For instance, because the RAI-MH is used in all inpatient psychiatric hospitals and 
units across Ontario, sufficient data was available to investigate service use outcomes and 
treatment patterns among a rare subgroup of EA with primary anxiety disorders, which no 
previous studies have been able to do (Bandelow & Michaelis, 2015). Combined with the cost-
effectiveness of using routine clinical assessment data gathered by service providers, there are 
several benefits of adopting a measurement-based care framework for mental health research and 
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policy, supporting The Mental Health and Addictions Centre of Excellence’s proposal for 
adopting measurement-based care (Kurdyak & Clark, 2021).  
For measurement-based care models to be effective, it is necessary that service providers 
use valid and reliable health assessment tools that are cross-compatible across care settings, such 
as the interRAI tools and the anxiety scale introduced in this dissertation. Not only does interRAI 
offer a suite of mental health assessment instruments that have demonstrated strong 
psychometric properties (Chan et al., 2014; Foebel et al., 2013; Hirdes et al., 1999; Hirdes et al., 
2008; Hirdes et al., 2020), but several of these tools are already being used to support service 
provision and system planning in various regions across Canada. For example, data from the 
RAI-MH assessment is used in regular quality indicator reporting for psychiatric hospitals across 
Ontario (CIHI, 2021; Hirdes et al., 2020; Perlman et al., 2013). This dissertation can further 
support interRAI’s utility in quality reporting by introducing the anxiety scale as a potential new 
indicator. Initial evidence for the anxiety scale as a quality indicator was demonstrated through 
its responsiveness to change over time, as well as its ability to detect variations in care outcomes, 
revealing that approximately 20% of individuals with severe symptoms of anxiety did not 
improve substantially by the time of discharge. Combined with the finding that EA with severe 
symptoms of anxiety received less consultation from psychologists and psychiatrists when they 
did not have a primary anxiety diagnosis, it is possible that lack of improvement in anxiety 
symptoms is partially due to differences in service provision. If future research determines that 
this is the case, then it is especially important that the anxiety scale be considered as a quality 
indicator, ensuring that anxiety symptoms are recognized and treated accordingly.  
Overall, to improve the inconsistent mental health treatment rates observed  among EA 
(Edlund et al., 2002; MHCC, 2015 Statistics Canada, 2012), it is necessary to implement 
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systemic policy changes that better align with their psychiatric service use patterns and clinical 
needs. Based on the results of this dissertation, policy decision-makers and service planners must 
prioritize improving care pathways and treatment outcomes for EA with primary anxiety 
disorders - especially within the community - ensuring that the ED is not the only resource for 
those seeking affordable and available treatment. With the addition of a new anxiety scale - 
pending future research - quality indicator reporting for treatment of anxiety can be facilitated 
using the interRAI assessment instruments. Further, given that interRAI data are already being 
used to support system evaluation and accountability in psychiatric hospitals and units across 
Ontario, it is recommended that policy decision-makers adopt these instruments as part of a 
measurement-based care approach to service delivery and policy planning.  
5.2.2 Service provision 
Like policy and system planning, incorporating evidence-based care into service delivery is just 
as important for improving mental health treatment outcomes for EA. This dissertation presents 
some considerations for treatment of EA broadly, as well as practices specific to anxiety, 
particularly the importance of assessing symptoms in addition to diagnosis. By reviewing the 
clinical characteristics associated with younger EA in each care setting, service providers can 
make use of this information to anticipate the types of care needs they are more likely to 
encounter and prepare accordingly. For instance, cannabis use, risk of self-harm, 
neurodevelopmental disorders, eating disorders, and personality disorders were all more 
prevalent among EA aged 18-25, signifying that more resources specific to these conditions are 
needed in settings that treat a high proportion of young EA. While clinical characteristics are the 
focus of psychological treatment, it is also necessary for service providers to account for 
sociodemographic factors that are more distinctive to young EA, such as enrolment in post-
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secondary education, unemployment, marital status, and living alone. Since sociodemographic 
characteristics can influence mental health outcomes through the availability of financial and 
social resources (Lindell & Campione-Barr, 2016; Newcomb-Anjo et al., 2017; O’Connor et al., 
2011; Power et al., 2015), it is valuable to incorporate these variables along with clinical 
characteristics when developing mental health care plans for EA. 
While understanding broad trends in clinical and sociodemographic characteristics 
among EA is useful for informing service planning, this dissertation illustrates that deeper 
examination into care outcomes and treatment patterns is needed to pinpoint where gaps are 
occurring. After developing an anxiety scale, this dissertation revealed that service providers 
working in psychiatric hospitals and units may under-detect symptoms of anxiety when treating 
EA. Since most anxiety disorders have an average age-of-onset in young- and mid-adulthood (de 
Lijster et al., 2017; Kessler et al., 2007), but are often untreated in the absence of comorbid 
depressive symptoms (Bandelow & Michaelis, 2015; Essau, 2005; Mackenzie et al., 2012; 
Preisig et al., 2001), it is likely that many individuals presenting with anxiety symptoms in 
psychiatric hospitals - especially EA - do not yet have a diagnosis. Further, individuals can 
experience symptoms of anxiety for years before they receive an anxiety disorder diagnosis 
(Bandelow & Michaelis, 2015). By increasing recognition of anxious symptoms, it may be 
possible to improve treatment outcomes for individuals who are undiagnosed, as having an 
anxiety disorder diagnosis conferred some advantages for both resource allocation in hospital 
and informal social support resources. Given that these benefits were also observed for non-
primary anxiety disorders and held constant when accounting for the severity of anxious 
symptoms, these results suggest that the act of identifying anxiety is important. Since the anxiety 
scale was predictive of anxiety disorders occurring within the same episode of care, it may also 
 
 288 
help care providers by serving as an indicator for potential new diagnoses, much like the 
interRAI DRS and depressive disorders in complex continuing care settings (Martin et al., 2008). 
Taken together, symptoms of anxiety must be routinely assessed and provided as a summary 
scale to clinical staff, enhancing the ability to detect anxiety and monitor treatment progress over 
time. This process can be facilitated using the interRAI assessment instruments, now that an 
initial anxiety scale has been developed, benefiting staff further by reducing the need to use 
external anxiety screening tools. In summary, it is recommended that service providers 
incorporate regional clinical assessment data into their care planning practices, with an emphasis 
on responding to developmental variations in care needs and detection of anxious symptoms 
among EA.  
5.3 Implications and recommendations for research 
5.3.1 Age ranges for defining EA  
Since EA is a cultural concept rather than a discrete developmental period defined by consistent 
changes in biology (Arnett, 2000; Arnett, 2007; Arnett et al., 2014), it is unclear what age range 
should be used in research, with the results from this dissertation indicating that it depends on 
study context. Few studies have explicitly investigated how different age ranges affect mental 
health research findings, and among those that have, there have been mixed findings. For 
example, while one study found that EA aged 18-25 had more substance use disorder diagnoses 
than adults aged 26-34 (Adams et al., 2014) – consistent with research reported in the DSM 5 
(APA, 2013) – another study reported no differences between the age groups of 15-22 and 23-29 
(Qadeer et al., 2019). Adding to the complexity of these results, this study found that in 
psychiatric service settings, substance use disorders were generally greater among individuals 
aged 26-35, though more EA between the ages of 18-25 had recently consumed cannabis. 
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Divergent patterns in substance use among EA was reflected in the substance use CAP, with 
more 18- to 25-year-olds triggering the ‘current substance use’ level, even though they had fewer 
substance use disorders than older age groups. A possible explanation for these findings is that 
substance use disorders are diagnosed differentially depending on the types of substances that are 
used. Since EA between the ages of 18-25 less recently consumed illicit substances such as 
cocaine and opiates, it is probable that they did not meet the same criteria for substance use 
disorder diagnoses as older adult age groups. Therefore, when investigating substance use trends 
among EA, it is necessary to stratify age groups appropriately so that important variat ions can be 
detected. The same consideration needs to be made for other clinical conditions that are more 
prevalent among EA aged 18-25, such as neurodevelopmental, personality, and eating disorders, 
as well as higher risk of self-harm. Further, sociodemographic characteristics also differed 
between the 18-25 and 26-30 age groups, which may be relevant factors that need to be 
accounted for in research. Altogether, depending on the context of the study and the research 
questions being investigated, it may be necessary to divide age groups within EA. Hence, it is 
recommended that researchers investigate potential influences of age ranges when investigating 
mental health trends and outcomes among EA. 
5.3.2 Anxiety scales and inclusion in interRAI assessments 
After identifying the urgent need to address anxiety among EA seeking mental health care in 
Canada, it was evident that the interRAI assessment instruments required a general anxiety 
symptoms scale that could aid in this effort, leading to the creation of an initial interRAI anxiety 
scale. Throughout the process of scale development, it was discovered that somatic health items 
did not contribute towards measuring anxiety, nor symptoms of compulsive behaviour, both of 
which have important implications for clinical anxiety research. Within the interRAI 
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organization, the introduction of an anxiety scale also poses some new considerations for 
research. Other than formally adopting the anxiety scale, interRAI should also consider the 
inclusion of new mood indicators that represent social anxiety disorder and GAD, as well 
incorporate the full set of anxiety items into the ESP.  
When deriving the interRAI anxiety scale, the HARS and BAI were used as guides for 
item selection and structural modeling because of the evidence supporting the reliability and 
validity of those scales. Although both the HARS and BAI contain a somatic health factor, a 
similar factor did not function well in the interRAI anxiety scale, indicating that somatic items 
may not be needed for measuring anxiety in clinical settings. One potential explanation for the 
poor performance of somatic indicators is that they are more strongly associated with certain 
types of anxiety disorders, such as panic disorder (De Ayala et al., 2005; Julian, 2011), and so 
they may be less useful for general anxiety measures. However, because the correlation matrix 
used in the factor analyses demonstrated weak relationships between somatic items and episodes 
of panic, it is unlikely that the presence of a somatic factor was obscured by broader anxiety 
symptoms. A more plausible reason is that somatic health items are not specific to anxiety 
(Julian, 2011), but pervasive physical health problems that are present across various subgroups 
of the psychiatric inpatient population, especially older adults with multiple comorbid medical 
conditions. Another benefit to excluding somatic items from the anxiety scale is that it reduces 
the total number of variables included and allows for a unidimensional scale, preserving the 
accuracy and appropriateness of the Cronbach’s alpha coefficient of reliability (Cortina, 1993; 
Henson, 2019). A possible disadvantage of excluding somatic health items is that it may reduce 
external validity in cultures where manifestations of anxiety are considered more physical than 
psychological (Reed et al., 2019). However, because the interRAI assessments contain somatic 
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health items, they are still evaluated as part of routine practice and can be incorporated into 
clinical judgement and research as needed. To summarize, the results of this dissertation suggest 
that somatic health items are not necessary for measuring clinical anxiety and so it is 
recommended that they are excluded from anxiety scales. 
 Another item excluded from the interRAI anxiety scale was compulsive behaviour, which 
was both rarely observed in the overall sample and was weakly discriminant of the latent anxiety 
construct. Compulsive behaviour is one of the primary symptoms involved in OCD, which was 
removed from the anxiety disorder category in both the DSM (APA, 2013) and ICD (Kogan et 
al., 2016) after several studies indicated that it is a biologically and functionally distinctive 
psychological disorder. However, the second symptom representing OCD – obsessive thoughts – 
was a relatively strong variable within the anxiety scale. Unlike compulsive behaviour, it is 
possible that the ‘obsessive thoughts’ variable captures some of the cognitive elements that are 
typically present in anxiety, such as excessive worrying and apprehension (APA, 2013; Porter et 
al., 2017; Spitzer et al., 2006). Given that unrealistic fears and phobias shared the strongest 
association with obsessive thoughts, it is reasonable to suspect that these thoughts occasionally 
functioned as the cognitive manifestation of an underlying fear. While further research is needed 
to confirm how obsessive thoughts are evaluated by clinical assessors, the present findings 
suggest that while compulsive behaviour is a distinctive symptom belonging to OCD and not 
anxiety, obsessive thoughts may be a shared feature between both disorders. As such, while there 
is tentative evidence supporting the inclusion of obsessive thoughts in the anxiety scale, general 
anxiety scales can reasonably exclude symptoms of compulsive behaviour.  
 Not only does the interRAI anxiety scale offer novel insight into measuring general 
anxiety for research with clinical populations, but also presents three research directions for the 
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interRAI mental health assessment instruments. Firstly, after establishing adequate construct and 
criterion validity of the anxiety scale, as well as its responsiveness to change over time, there is 
sufficient evidence supporting implementation of the anxiety scale as an official interRAI tool. 
Secondly, while the initial version of the interRAI anxiety scale has clinical and research utility 
as is, research is needed to determine whether adding new variables to the scale is helpful, such 
as symptoms related to social anxiety and GAD. Although adding new items into the assessment 
tools must be done with caution, as too many variables can create administrative burden for care 
staff (Aboraya et al., 2018), there may be sufficient justification for including these two 
symptoms of anxiety. For instance, social anxiety disorder is one of the most prevalent subtypes 
of anxiety in the general population of North America and is also prominent among adolescents 
and EA (APA, 2013; Kessler et al., 2009), making it a potentially useful item for screening 
anxiety in younger populations, as well as permitting research specific to this condition. 
Similarly, because GAD was the second most prevalent anxiety disorder subtype in the 
psychiatric population, including a relevant symptom would likely enhance the diagnostic 
predictive power of the anxiety scale. Further, incorporating a symptom measuring excessive 
worrying and apprehension could increase the utility of the anxiety scale by broadening its 
research applications, such as research on psychological well-being (Stones & Kozma, 1985). 
Lastly, given the prevalence of primary anxiety disorders observed in the ED among EA in both 
this dissertation as well as previous Canadian research (Brien et al., 2015; CIHI, 2019b; Gandhi 
et al., 2016), it is recommended that the full set of anxiety mood indicators be added to the ESP 
assessment. Taken together, the interRAI organization should formally adopt the anxiety scale to 
enable immediate use for research and clinical practice, as well as commit to ongoing research 
investigating the addition of new anxiety symptoms into the assessment instruments. 
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5.4 Overall strengths, limitations, and future research 
Given that the strengths and limitations for each chapter have already been described 
extensively, as well as opportunities for future research, only a brief overview of the major 
discussion points are summarized in this section. The chief methodological strength shared by 
each chapter of this dissertation was the extensiveness of the inpatient psychiatric sample. 
Following the provincial mandate to use the RAI-MH assessment instrument in all designated 
psychiatric hospitals and units across Ontario, fully representative data for all adults receiving 
care in these settings were available from 2005-2019. As a result, compared to previous studies 
described in the literature reviews, the psychiatric inpatient sample used throughout this 
dissertation was considerably larger and more comprehensive. Since the third and fourth chapters 
of this dissertation focused heavily on research involving primary anxiety disorder diagnoses, 
which are rarely observed in psychiatric hospital settings (Bandelow & Michaelis, 2015), it is 
essential that a large and representative sample was available for analysis. Another advantage of 
the provincial mandate is that it requires that the RAI-MH be administered at the time of 
discharge, meaning that this project was able to identify those individuals who received a 
diagnosis after the initial admission assessment. Further, change in anxious symptoms over the 
course of treatment was also able to be evaluated, without the limitation of sample attrition, 
strengthening the methodological rigour of this dissertation. 
Whereas the representativeness of the inpatient psychiatric sample is a notable strength of 
this dissertation, sampling restrictions inherent in the ED and community mental health datasets 
presented some limitations, as well as the inability to link these datasets together. In contrast to 
the RAI-MH, the CMH and ESP are used voluntarily by participating organizations. 
Consequently, the ED and community mental health samples were not fully representative of the 
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province, diminishing the generalizability of these datasets. Due to the diversity of community 
mental health agencies that provide services (CIHI, 2017), as well as the fragmented nature of 
this system, it is possible that sampling bias affected the results reported in the second chapter of 
this dissertation. Despite limitations in sampling of organizations, the sample sizes for the ED 
and community mental health datasets were large enough to permit investigation of clinical 
characteristics of EA receiving care in these settings, providing valuable information for system 
planning and service provision. Secondly, while this study was able to identify gaps in continuity 
of care among EA presenting to the ED with primary anxiety disorders, each care setting was 
analyzed as an independent, cross-sectional dataset. To properly examine cross-sectoral service 
use patterns among EA, future research is needed that links each of these datasets together, 
which was not a possibility at the time of this dissertation. 
Although this dissertation contained some limitations to addressing mental health care in 
community and ED settings, these issues can be addressed in future research studies. As more 
assessment data are added to the ESP and CMH datasets in the Chatham-Kent and Bluewater 
Health regions of Ontario, the next research direction is to link these datasets together - along 
with the RAI-MH - to examine longitudinal clinical and service use outcomes among EA. In 
particular, it would be valuable to determine the predictors of receiving follow-up care in 
community and psychiatric hospital settings following discharge from the ED, especially those 
with primary anxiety disorders. In addition to strengthening mental health research for EA in 
community and ED settings, there are also numerous research directions arising f rom the anxiety 
scale developed in this dissertation. Its use as a potential quality indicator for mental health 
settings has been described previously, as well as a screener to flag potential anxiety disorders. 
Other applications of the anxiety scale include the ability to track anxiety throughout the life 
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course as individuals access different points of the health care system, providing a longitudinal 
perspective on the chronicity and morbidity of this condition that is difficult to detect using 
cross-sectional data.  
Another avenue for research with the anxiety scale is to incorporate it into current and 
ongoing project initiatives within interRAI. For example, a previous study involving nursing 
home residents found that that while both self-reported and observer-rated scales of depression 
were reliable and valid, each captured different aspects of depression (Koehler et al., 2005). Due 
to the differences observed between clinician- and self-rated mood items, interRAI is considering 
the development of self-rated mental health indicators. An early version of an interRAI self-
reported mood scale has been proposed that contains three items with a three-day lookback 
period, one of which is ‘anxious, restless, or uneasy’ (Betini et al., 2021). Creating self -reported 
anxious items that are congruent with the clinician-rated anxiety scale would permit direct 
comparisons between these two types of raters, presenting a valuable research opportunity for the 
immediate future. At the time of literature review and data collection for this dissertation, the 
onset of the coronavirus disease 2019 (COVID-19) pandemic had not yet begun, and so its effect 
on anxious symptoms in health care settings could not be investigated. However, initial results 
from a web-based survey conducted with Canadian adults during the first wave of the COVID-19 
pandemic found that self-reported anxiety levels increased substantially following lockdown, 
especially among EA (Betini et al., 2021). As a result, it is possible that the prevalence of 
anxious symptoms in health care settings has also increased dramatically among EA since the 
end of the data collection period for this dissertation, warranting urgent investigation using both 
the anxiety scale and self-reported anxiety items. Further, it may be that certain types of anxious 
symptoms have increased more than others as a result of the pandemic, particularly social 
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anxiety and general worrying and apprehension, confirming the need to include these symptoms 
in the interRAI assessment instruments. Overall, expanding the findings of this dissertation by 
integrating the interRAI assessment datasets to examine mental health care trends among EA and 
confirming the items for the anxiety scale are promising avenues for future research.  
5.5 Conclusions 
Mental health systems that effectively meet the needs of EA require coordination of care 
between service providers, as well as research and data gathering strategies to inform evidence-
based evaluation and planning. Using measurement-based care and interRAI assessment 
instruments, this dissertation provides several recommendations for policy and research to 
improve the mental health care of EA. First, care pathways into psychiatric service settings must 
be restructured to promote ongoing care for EA with primary anxiety disorders, requiring 
integration between community mental health and EDs, as well as enhanced funding for 
community programs. Secondly, to support ongoing mental health research for EA, it is 
recommended that policymakers and service providers adopt a measurement-based care 
approach to system evaluation, which can be supported using the interRAI suite of mental health 
assessment instruments. Finally, for issues related to anxiety, the new interRAI anxiety scale can 
be used to evaluate service use patterns and treatment outcomes for EA, such as recognition of 
anxious symptoms and effects on social resources. The anxiety scale can also be used to inform 
broader research on anxiety, such as the exclusion of somatic health indicators and compulsive 
behaviours from measures of general anxiety. In conclusion, this dissertation demonstrates how 
policy makers, service providers, and researchers can use clinical assessment data to enhance 
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Appendix A: Description of interRAI scales and CAPS 
Scales 
Scales provide an overview of a person’s overall functioning within a specific domain, allowing 
clinicians to identify their strengths and needs more easily, and are calculated using items 
contained in the health assessment instruments. For all the scales used in this dissertation, this 
section describes what each of the scales represent, which variables go into their algorithm, and 
what the range of resulting scores are.  
Aggressive Behaviour Scale (ABS) 
The ABS is a clinical scale that is generated to determine an individual’s level of aggressive 
behaviour. The ABS is calculated based on the following items in the RAI-MH: verbal abuse, 
physical abuse, socially disruptive behaviour, and resistance of care. The scale ranges from 0-12, 
with higher scores signifying more frequent and more varied aggressive behaviour. 
Cognitive Performance Scale (CPS) 
The CPS is a clinical scale that is generated to determine an individual’s level of cognitive 
impairment. The CPS is calculated based on the following items in the RAI-MH: short term 
memory, cognitive skills for daily decision making, making self understood, and ADL self-
performance – eating. The scale ranges from 0-6, with higher scores signifying greater cognitive 
impairment.  
Depressive Severity Index (DSI) 
 
 326 
The DSI is a clinical scale that is generated to determine an individual’s level of depressive 
symptoms. The DSI is calculated based on the following items in the RAI-MH: sad/pained facial 
expression, negative statements, self-deprecation, guilt/shame, and hopelessness. The scale 
ranges from 0 to 15, with higher scores signifying more depressive symptoms. 
Positive Symptom Scale – Short version 
The PSS is a clinical scale that is generated to determine an individual’s level of positive 
psychotic symptoms. The PSS is calculated based on the following items in the RAI-MH: 
hallucinations, command hallucinations, delusions, and abnormal thought process. The scale 
ranges from 0-12, with higher scores signifying more positive symptoms.  
Social Withdrawal 
The social withdrawal scale is generated to determine an individual’s level of withdrawal from 
social activities. Social withdrawal is calculated based on the following items in the RAI-MH: 
anhedonia, withdrawal, lack of motivation, and reduced social interaction. The scale ranges from 
0-12, with higher scores signifying greater social withdrawal.   
Risk of Harm to Others (RHO) 
The RHO is a clinical algorithm that is designed to assess an individual’s risk for harming others. 
The RHO is calculated based on both individual items in the RAI-MH, as well as another scale. 
The following criteria for RHO are: delusions, insight into mental health, difficulty falling 
asleep, sleep problems due to hypomania, violence towards others, intimidation, violent ideation, 
extreme behaviour disturbance, police intervention for violent crime, and score on the ABS. The 
scale ranges from 0-6, with higher scores representing increased risk for harming someone else.  
Self-Care Index (SCI) 
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The SCI is a clinical algorithm based on psychiatric symptoms that is designed to assess an 
individual’s inability to care for self. The SCI is calculated based on the following items in the 
RAI-MH: daily decision making, insight into mental health, decreased energy, abnormal thought 
process, and making self understood. The scale ranges from 0-6, with higher scores representing 
decreased ability to care for self. 
Severity of Self-Harm (SoS) 
The SoS is a clinical algorithm that is designed to assess an individual’s risk for harming 
themselves. The SoS is calculated based on both individual items in the RAI-MH, as well as 
three other scales (one of which is based on the Emergency Screener for Psychiatry [ESP]). The 
following criteria for SoS are: most recent self-injurious attempt, intent of any self-injurious 
attempt was to kill themselves, family/others concerned about person’s risk for self -injury, 
suicide plan, score on the DSI, score on the CPS, and score on the ESP version of the PSS - 
short. The scale ranges from 0-6, with higher scores representing increased risk for harming 
oneself. 
Clinical Assessment Protocols 
CAPs were developed to support clinicians in using evidence-based information to evaluate 
patient care needs and service planning, including areas like exercise and interpersonal conflict. 
To do this, CAPs use variables contained in the RAI-MH to create predictive algorithms that 
distinguish between different “trigger levels.” Trigger levels denote either varying levels of risk 
(e.g. moderate versus high), or different contexts that are relevant to the risk in question (e.g. 
with or without accompanying cognitive deficits). Trigger levels help clinician’s identify 
patient’s strengths and needs and provide them with prevalence estimates and potential treatment 
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strategies. For all the CAPs used in this dissertation, this section describes what each CAP 
represents, what the trigger levels are, and what variables go into determining trigger levels. 
Criminal Activity 
The criminal activity CAP describes a person’s history of criminal behaviour. This CAP has one 
trigger for reducing risk of violent or nonviolent criminal behaviour. The following items are 
used to determine the trigger level: experienced police intervention for any history of violent 
crime or non-violent crime within the past year OR were admitted from a correctional facility or 
have been identified as a forensic admission. 
Interpersonal Conflict 
The interpersonal conflict CAP describes an individual’s dysfunctional interpersonal 
relationships and behaviours. This CAP includes triggers for 1) reducing widespread conflict, 
and 2) reducing conflict within specific relationships. The following items are used to determine 
trigger levels: anger, conflict with staff/others, conflict with family/friends, staff reports 
frustration in dealing with person. 
Sleep Disturbance 
The sleep disturbance CAP describes dysfunctions in an individual’s sleeping patterns. This CAP 
includes triggers for 1) current sleep disturbance and no worse than moderate cognitive 
impairment, and 2) current sleep disturbance and severe cognitive impairment. The following 





The social relationships CAP describes an individual’s experiences of social isolation. This CAP 
includes triggers for 1) reducing social isolation, and 2) family dysfunction and improving close 
friendships and family functioning. The following items from the RAI-MH are used to determine 
trigger levels: withdrawal, reduced social interactions, social activities, visit with family 
member, other interaction with family member, family overwhelmed by person’s illness, 
dysfunctional family relationship, presence of confidant, and conflict-laden relationship. 
Social Supports for Discharge (SSDIS) 
The SSDIS CAP describes post-discharge difficulties that an individual may experience due to 
lack of supportive resources. This CAP includes one trigger for possible difficulties. The 
following items are used to determine the trigger level: reason for assessment, residence admitted 
from, support person positive about discharge, help with childcare available, supervision for 
personal safety available, crisis support available, ADL/IADL support available, living status 
after discharge. 
Substance Use 
The substance use CAP describes an individual’s past and current history of substance abuse. 
This CAP includes triggers for 1) current problematic substance abuse, and 2) history of 
problematic substance abuse. The following items from the RAI-MH are used to determine 
trigger levels: intentional misuse of medications, number of alcoholic drinks in last 14 days, 
inhalant use, hallucinogen use, cocaine use, stimulant use, opiate use, cannabis use, injection 
drug use, told to cut down use, bothered by criticism about alcohol/drug use, guilt  about 
drinking/drug use, starts morning with alcohol/drugs, and social environment encourages use. 
Traumatic Life Events 
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The trauma CAP describes an individual’s history and experience of traumatic life events. This 
CAP includes triggers for 1) immediate safety concerns, and 2) reducing the impact of prior 
traumatic life events. The following items from the RAI-MH are used to determine trigger levels: 
intense fear, serious accident, death of a family member, lived in war zone, witnessed severe 
accident, victim of crime, victim of sexual assault, victim of physical assault, victim of emotional 




Appendix B: Ethics Clearance
 332 
 
